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Forensic Scientists need to be able to detect, and confidently identify, any explosive substance 
encountered during forensic casework. This means flexible analytical methods that provide 
comprehensive detection of explosives, their precursors, transformation products and related 
compounds are required. Existing analytical methods typically only target the most commonly 
encountered explosive substances and often cover relatively small sets of structurally related 
compounds. Liquid chromatography coupled to high resolution mass spectrometry (LC-HRMS) is 
emerging as a viable technique in many fields for screening, identification and quantification of 
larger numbers of compounds. The aim of this thesis is to investigate the suitability of LC-HRMS 
for screening and identification of large numbers of known, unknown and suspect energetic 
materials.  
An LC-HRMS method was developed and the chromatographic separation and ionisation 
conditions were optimised for a set of eighteen initial target analytes including nitroaromatics, 
nitramines, nitrate esters and peroxides. The method performance was then assessed for a larger 
number of target analytes to investigate the potential for suspect screening and non-target 
analysis of additional energetic materials without further optimisation. The effect of different 
identification criteria, such as mass accuracy thresholds, number and type of ions and retention 
time windows, on selectivity and sensitivity was also examined, to support the selection of 
evidence-based identification requirements for LC-HRMS analysis of energetic materials. Finally, 
retention time prediction was investigated for the potential to aid preliminary identification of 
suspect or non-target energetic materials by prioritising acquisition of reference materials or 
excluding isomers.  
Overall, generalisability of a developed LC-HRMS method to a larger set of energetic materials, 
including MEKP, nitrated sugars and organic gunshot residues, was demonstrated for the first 
time. This supported the use of full-scan LC-HRMS, for suspect screening and non-target analysis 
of energetic materials. However, even with high resolution and mass accuracy it was not always 
possible to unequivocally identify energetic materials using LC-HRMS, due to the presence of 
hundreds or even thousands of isomers in some cases. In-source fragment ions and the use of 
ion ratios, increased selectivity but at a cost of sensitivity. The LC-HRMS method was successfully 
applied to the detection of explosives in contact traces and on passive vapour samplers. The 
7 
 
retention time prediction models and prediction intervals presented in this thesis showed promise 
for adding value to suspect or non-target screening of energetic materials. Following a critical 
evaluation of the use of LC-HRMS, alone and in combination with other techniques, good 
chromatographic separation and tandem mass spectrometry are recommended for confirmatory 
analysis, along with a consideration of the number of isomers for individual compounds. Due to 
compromises in selectivity or sensitivity, identification criteria will likely differ for screening versus 
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1.1 Energetic Materials  
Energetic materials contain a large amount of energy that can be released in powerful exothermic 
combustion reactions, where heated gaseous reaction products rapidly expand. This expansion 
of hot gases can be used to propel a projectile (e.g. ammunition), or to produce a destructive 
pressure wave (i.e. an explosion). Energetic materials can be classified as either high explosives 
which detonate, producing a pressure wave that travels faster than the speed of sound, or low 
explosives which deflagrate, producing a pressure wave that travels slower than the speed of 
sound (Figure 1.1). High explosives can be further classified as either primary or secondary 
explosives based on their sensitivity to detonation. As primary explosives are more sensitive to 
detonation, small amounts of primary explosive are used to detonate less sensitive secondary 
explosives which are used as the main charge for military and commercial purposes, due to the 
comparative ease of handling, storage and transportation. The very high sensitivity of triacetone 
triperoxide (TATP) and hexamethylene triperoxide diamine (HMTD) to impact, friction and heat 
means they are considered too high risk for military or commercial purposes, but this has not 
prevented their use as homemade explosives in improvised devices. Some authors further split 
high explosives into primary, secondary and tertiary explosives [1]. This reflects the use of three 
stages in an explosive train, with a detonator, followed by a booster and then the main charge, in 
some instances.  
 

























 Explosives legislation in the UK  
When the manufacture, possession or use of an explosive substance is alleged, forensic 
scientists are asked to provide evidence to identify the substances in question and, for offences 
relating to an explosion, provide evidence that an explosion has occurred [3]. Additionally, for 
offences regarding explosive precursors and/or the manufacture of explosives, forensic scientists 
may also be required to identify explosive precursors and intermediates. A summary of the main 
offences, and the relevant legislation, relating to explosives is provided in Table 1.1. There are 
several pieces of legislation regarding explosives including the: Offences Against the Person Act 
(OAPA) 1861 [4], Criminal Damage Act 1971 [5], Poisons Act 1972 [6,7], Explosives Act 1875 [8], 
Criminal Law Act 1977 [9], Explosives Substances Act (ESA) 1883 [10], Terrorism Act 2000 [11], 
Fireworks Regulations 2004 [12] and Explosives Regulations 2014 [13,14]. The definition of an 
explosive substance varies between the different pieces of legislation. According to the 
Explosives Regulations 2014 an ‘explosive substance’ is a non-gaseous substance or preparation 
which is:   
“(a) capable by chemical reaction in itself of producing gas at such a temperature and pressure 
and at such a speed as could cause damage to surroundings; or  
(b) designed to produce an effect by heat, light, sound, gas or smoke, or a combination of these 
as a result of a non-detonative, self-sustaining, exothermic chemical reaction;” [13]. 
 
The definition of an ‘explosive substance’ included in the Explosive Substances Act 1883 also 
includes “any materials for making any explosive substance” [10].  Therefore, forensic scientists 
need to be able to identify any substance that can either produce an explosion or be used to make 
another substance that can produce an explosion. Given that there are thousands of known 
explosive substances [15], this is a challenging task.  
 
Table 1.1 (Continued): Summary of main offences relating to explosives. Adapted from [3]. 
Offence Relevant legislation Maximum 
sentence 
Cause an explosion likely to endanger life or cause serious injury 
to property 
ESA 1883, Section 2 Life 
Do any act with intent to cause, or conspiring to cause, an 
explosion likely to endanger life or cause serious injury to 
property 
ESA 1883, Section 3(1) a Life 
Makes, possesses or controls an explosive substance with intent 
to endanger life or cause serious injury to property 
ESA 1883, Section 3(1) b Life 
Makes, knowingly has in control or possession an explosive in 
suspicious circumstances 
ESA 1883, Section 4(1) Life 
Bomb making documents and/or recipes for the production of 
explosives (including pyrotechnics- low explosives) 
Terrorism Act 2000, Section 57 and 58  15 years and/or 
a fine 
Cause grievous bodily harm by the unlawful and malicious 
explosion of gunpowder or other explosive substance 
OAPA 1861, Section 28 Life 
Table .1: Summary of ain offences relati g to explosives. Adapted from [3]. 
 
Table 1.1 (Continued): Summary of main offences relating to explosives. Adapted from [3]. 
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Table 1.1 (Continued): Summary of main offences relating to explosives. Adapted from [3]. 
Offence Relevant legislation Maximum 
sentence 
Cause gunpowder or some other explosive substance to explode 
with the intent to cause grievous bodily harm 
OAPA 1861, Section 29 Life 
Placing explosives near buildings or ships with intent to do bodily 
injury 
OAPA 1861, Section 30 14 years 
Make or have an explosive substance with intent to commit any 
felony against the Act 
OAPA 1861, Section 64 2 years 
Causing or intending to cause damage or destroying property Criminal Damage Act 1971, Section 1(1) 
and (2)    
Life 
Place or post any article with the intention of inducing someone 
to believe that it is likely to ignite or explode and cause injury or 
damage property 
Criminal Law Act 1977, Section 51(1) 7 years 
Possession, of listed explosives precursors without a licence - 
after 3 March 2016 
Poisons Act 1972, Section 3(1). 
Amended by Deregulation Act 2015, 
Schedule 21 
2 years. 
Selling of listed explosives precursors to a person who does not 
hold a licence 
Poisons Act 1972, Section 3A. Amended 
by Deregulation Act 2015, Schedule 22 
2 years. 
Failing to report a suspicious transaction, loss or theft of a 
regulated or reportable precursor 
Poisons Act 1972, Section 3C. Amended 
by Deregulation Act 2015, Schedule 23 
3 months 
and/or a fine 
Acquiring /keeping explosives without a valid certificate* Explosives Regulations 2014, Regulation 
5 (1) and (2). 
2 years and/or 
fine** 
Manufacturing more than 100g of explosives without a licence Explosives Regulations 2014, Regulation 
6 (1) and (2). 
2 years and/or 
fine** 
Possession of an F2, F3 or F4 firework by a person under 18 in 
a public place  
Fireworks Regulations, 2004 (SI 1836: 
2004), Regulation 4  
6 months 
and/or fine 
Any person to be in possession of category 4 fireworks Fireworks Regulations, 2004 (SI 1836: 
2004), Regulation 5 
6 months 
and/or fine 
Using a firework at night other than during a permitted fireworks 
night 
Fireworks Regulations, 2004 (SI 1836: 
2004), Regulation 7 
6 months 
and/or fine 
Throwing or discharging a firework in a public place The Explosives Act 1875, Section 80 Fine 
* The explosive solutions analysed as part of this PhD were exempt from the Explosives Regulations 2014 according 
to Schedule 2, Part 2, 8(a) on the grounds that they contain less than 5 g of desensitised explosives and were acquired 
for research and analysis at a University. 
** Information obtained from [16]. 
 
 The chemistry of explosives 
In addition to the classification scheme shown in Figure 1.1, energetic materials can also be 
divided into organic and inorganic compounds and classified based on the functional groups they 
contain. For combustion, a fuel and an oxidant are required in appropriate quantities and 
concentrations. In the case of organic explosives, the focus of this thesis, the fuel and oxidant are 
contained within the same molecule; although depending on the oxygen balance of the molecule, 
additional oxygen may also be required [17]. The hydrocarbon backbone of organic explosives 
provides the fuel and functional groups containing oxygen and nitrogen act as the oxidants. 
Examples of some of the main chemical classes of organic explosives, encountered in forensic 
investigations: nitramines (R-N-NO2), nitrate esters (R-O-NO2), nitroaromatics (Ar-NO2) and 




Table 1.2 (Continued): Examples of nitramine, nitrate ester, nitroaromatic and peroxide explosives. 
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Table 1.2 (Continued): Examples of nitramine, nitrate ester, nitroaromatic and peroxide explosives. 


















































































































































Diacetone diperoxide (DADP) OO
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Peroxide 




























1.1.2.1 Explosive precursors and intermediates 
In the case of homemade explosives (HME), the availability of precursors can influence the type 
of explosives synthesized. For example, erythritol tetranitrate (ETN) has seen an increased use 
following the wider availability of precursor erythritol, which is now commonly used as an artificial 
sweetener [18,19]. It is for this reason that eight explosive precursors (including nitric and sulfuric 
acid which are used for nitration reactions) are regulated in the UK and require an Explosives 
Precursors and Poisons (EPP) license to purchase or supply them above a threshold 
concentration (e.g. 3 % w/w for nitric acid and 15 % w/w for sulphuric acid) [6,7]. A further 10 
explosive precursors are listed as reportable substances. Failure to report a suspicious 
transaction, loss or theft of a reportable substance is also an offence [6,7]. The lists of explosive 
precursors included in the Poisons Act 1972 and the Poisons Act 1972 (Explosives Precursors) 
(Amendment) Regulations 2018 are by no means comprehensive lists of explosive precursors. 
Other precursors and intermediates are also of interest in forensic science, especially for 
providing evidence that explosives have been/could be synthesized at a scene. Some examples 
of organic precursors and intermediates of interest to forensic science are shown in Table 1.3. In 
some cases, such as with the DNT isomers, precursors and intermediates may also be energetic 
themselves. As well as a precursor to TNT, 4-NT is one of three compounds (along with ethylene 
glycol dinitrate (EGDN) and 2,3-dimethyl-2,3-dinitrobutane (DMNB)) that can be used as a 
detection agent. A detection agent must be added to all plastic explosives, according to The 
Explosives Regulations 2014 [13].  
 
Table 1.3 (Continued): Organic explosive precursors and intermediates 
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Table 1.3 (Continued): Organic explosive precursors and intermediates 










































Triacetone triperoxide (TATP) 























































Xylitol pentanitrate (XPN) 
a Reportable explosive precursor; b Also known as hexamine; c Regulated ≥ 30 % w/w  
 
1.1.2.2 Degradation/transformation products of explosives 
Some of the precursors/intermediates shown in Table 1.3 can also be formed via degradation 
and/or transformation of explosives. For example, the MNGs and DNGs can be formed by 
hydrolysis of nitroglycerin [20]. Nitrate esters are particularly susceptible to chemical aging and 
degradation due to the relatively weak O-NO2 bond [20]. Therefore, identification of degradation 
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products may be of interest and might help match explosives synthesised at the same time, 
although degradation would also be affected by storage conditions and environmental factors. 
Explosives have also been shown to undergo bacterial degradation/transformation in soil samples 
[21]. The main transformation products of TNT are 2-amino-4,6-dinitrotoluene (2-A-4,6-DNT), 4-
amino-2,6-dinitrotoluene (4-A-2,6-DNT), 2,4-diamino-6-nitrotoluene (2,4-DA-6-NT) and 2,6-
diamino-4-nitrotoluene (2,6-DA-4-NT) [21]. Generally, these transformation products are of more 
interest for environmental analysis due to their toxicity. However, degradation/transformation 
products may also be encountered by forensic scientists, especially when analysing post-blast 
soil samples [22].  
1.1.2.3 Stabilisers and plasticisers 
Often commercial and military explosives are combined with stabilisers and/or plasticisers. 
Stabilisers are added to slow decomposition and increase shelf-life, especially of nitrate ester 
based explosives which are inherently chemically instable [23]. Plasticisers are added to some 
explosives, along with polymers, to make them safer to handle, store and transport. Energetic 
plasticisers have increased in popularity due to improved performance [24]. Some examples of 
stabilisers and plasticisers are shown in Table 1.4. Identification of these components may be of 
value in forensic science, especially for matching explosives found at different crime scenes or 
attempting to identify the manufacturer.  
Table 1.4 (Continued): Examples of explosive stabilisers and plasticisers 
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Table 1.4 (Continued): Examples of explosive stabilisers and plasticisers 
















































*Also known as ethyl centralite, centralite or centralite I. 
**Also known as methyl centralite or centralite II, 
 
 Requirements for forensic analysis of explosives 
Since forensic scientists need to be able to identify any explosive substance, to support 
Explosives regulations, analytical methods are required to identify all known explosives, plus any 
new explosives synthesized. For forensic evidence to be used in court, the Technical/Scientific 
Working Group for Fire and Explosions Analysis (T/SWGFEX) recommends the “use of multiple 
techniques based on different principles and methodologies” for the analysis of post-blast and 
intact explosives [25,26]. T/SWGFEX also categorised analytical techniques, identified in a 1999 
TWGFEX survey and so somewhat out of date, based on the amount of information provided. 
Category 1 techniques which “provide significant structural and/or elemental information”, such 
as liquid chromatography-mass spectrometry (LC-MS), offer the greatest confidence of 
identification [25,26]. More recently, the European Network of Forensic Science Institutes 
(ENFSI), highlighted the importance of estimating uncertainty for the forensic recovery, 
identification and analysis of explosives traces, which in the case of qualitative methods means 
assessing selectivity [27]. ENFSI also noted the current lack of consensus regarding the 
expression of uncertainty when identifying a chemical compound, other than to make a distinction 
between screening (higher uncertainty) and confirmatory (lower uncertainty) methods [27]. While 
confirmatory methods have a “lower degree of uncertainty”, some uncertainty remains which it is 
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important to estimate through appropriate selectivity experiments. The task of identifying any 
explosive substance is made even more challenging by the fact that traces of explosives may be 
all that is found on a suspect and very little explosive residue (sub-microgram [27]) remains after 
an explosion. Therefore, analytical methods need to have good sensitivity, as well as good 
selectivity. Given the number of explosive substances that may need to be identified, it would not 
be feasible to sequentially screen for all explosive compounds using tailored analytical methods, 
due to time and cost restraints. Instead, it would be desirable to have a single comprehensive 
screening method that could be used to detect all organic, explosive substances and direct 
confirmatory analysis. Ideally, a comprehensive screening method would also be able to detect 
precursors, intermediates, degradation/transformation products, stabilizers and plasticizers which 
may also be of value to forensic scientists.      
    
35 
 
1.2 Screening and identification of explosives using high 
performance liquid chromatography coupled to mass 
spectrometry (HPLC-MS) 
A wide range of methods are used for explosives detection from canine olfaction to laboratory-
based analytical technology. Chromatography coupled to mass spectrometry is arguably the most 
powerful technique for confirmatory identification of explosives due to the combined power of 
chromatographic separation along with the structural information provided by mass spectrometry 
(MS). Chromatography has the potential to separate analytes, both from other compounds that 
are indistinguishable by the detector, such as ions with the same mass, and from matrix 
components which may interfere with detection, for example by ion suppression in mass 
spectrometry. The importance of chromatographic separation and/or high resolution mass 
spectrometry for confirmatory identification of explosives was highlighted by Sisco et al. who used 
direct analysis in real-time (DART) MS for rapid explosives screening [28]. Confirmatory 
identification of specific explosive compounds was not always possible due to similar 
fragmentation, isobaric ions with the same nominal mass but different exact mass and isomers 
with identical exact mass. In the case of isobaric ions, the use of high resolution mass 
spectrometry would allow isobaric ions to be distinguished and in all cases combining with a 
chromatographic separation could enable confirmation.    
Gas chromatography (GC) has been used successfully for explosives detection [29-31]. However, 
the thermal instability of compounds such as HMX and PETN limits analysis time and hence the 
potential to separate the large numbers of compounds required in screening methods. As a result 
of this, high-performance liquid chromatography-mass spectrometry (HPLC-MS) is favoured and 
will be the focus of this thesis.   
 High performance liquid chromatography 
High performance liquid chromatography (HPLC) separates compounds based on their relative 
affinity for a stationary phase within a column and a liquid mobile phase pumped through the 
column under high pressure. Compounds with a higher affinity for the stationary phase will be 
retained for longer, resulting in different retention times. After passing through the column, the 
mobile phase enters a detector. Detector response versus time is plotted to give a chromatogram, 
with peaks observed when analytes elute from the column.  Ideally these peaks will be completely 
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separated allowing unambiguous analyte identification and accurate quantification using peak 
area. Resolution (Rs) is used to measure the degree of separation, with Rs>1.5 indicating baseline 
resolution between two Gaussian peaks. The equation for resolution is given in Equation 1.1. 










Equation 1.3: van Deemter Equation 




Resolution can be improved by increasing the difference in retention time (tR) of two analytes, in 
other words the selectivity of the method, or by reducing peak width (W) through improving 
efficiency and reducing band broadening.  Efficiency (N) is dependent on plate height (H) and 
column length (L), as shown in Equation 1.2. Plate height is directly proportional to the size of the 
solute band as it travels through the column. Hence, a smaller plate height leads to narrower 
peaks and greater efficiency. The factors affecting plate height are described in the van Deemter 
Equation (Equation 1.3) and the van Deemter Plot (Figure 1.2). The effect of multiple paths, of 
different lengths, through the column is described by the constant A; longitudinal diffusion by the 
constant B divided by the linear velocity (𝑢𝑥) and finally mass transfer in and between the 
stationary and mobile phase is described by the constant C multiplied by the linear velocity. 
Therefore, low flow rates reduce efficiency due to increased longitudinal diffusion, but high flow 
rates also reduce efficiency due to the increased effect of mass transfer. 
 
Figure 1.2: van Deemter Plot showing the effect of the A, B and C terms of the van Deemter Equation on 




As shown in a 2007 review by Gaurav et al.[56], a large number of studies have used HPLC for 
explosives analysis. However, the number of analytes included in these methods was relatively 
small, especially in comparison to the number of known explosives. Additionally, baseline 
separation of forensically-relevant analytes is still lacking. LC methods used for studies analysing 
multiple organic explosives are described in Table 1.5. Many of these methods were developed 
for environmental analysis and so focussed on separation of the compounds listed in the United 
States Environmental Protection Agency (US EPA) Method 8330, since updated to methods 
8330A and B. Method 8330 and 8330A do not contain any nitrate esters [57,58]. Instead they also 
include TNT transformation products, 2-amino-4,6-dinitrotoluene (2-A-4,6-DNT), 4-amino-2,6-
dinitrotoluene (4-A-2,6-DNT), 1,3,5-trinitrobenzene and 1,3-dinitrobenzene.  While method 8330B 
does include two nitrate esters, many forensically relevant explosives, such as ETN and EGDN, 
are still missing [59].  
The most common stationary phase used for organic explosives analysis is reversed-phase 
octadecylsilica (C18). However, C8 [49], bridged ethyl hybrid C18 [39,43], porous graphitic carbon 
[36-38], amide [53], phenyl [45] and diphenyl [50] phases have also been used in attempts to 
improve selectivity. Marple and LaCourse combined two different C18 columns in series in order 
to achieve separation of dinitrotoluene isomers 2,4-and 2,6-DNT and 2-A-4,6-DNT, since different 
pairs co-eluted on each column [55]. The combined columns also result in an increased length of 
stationary phase and hence increased efficiency (Equation 2).  Columns with smaller particle 
sizes, such as 1.7 µm, have been used by both Thomas et al. and Oehrle [39,43] to improve 
efficiency by reducing the effect of multiple paths and mass transfer. These are classed as ultra-
high performance liquid chromatography (UHPLC) columns as their particles are smaller than 2 
µm and they require an HPLC system compatible with ultra-high pressure due to increased 
backpressure with decreased particle size. Paull et al. used monolithic columns, with lower 
backpressure than the more common particle packed columns, in order to use higher flow rates 
and achieved baseline separation of seven explosives with a total run time of 3 minutes [52]. 
Apart from one study using photo-assisted electrochemical detection (PAED) [55], the detectors 
used for the methods outlined in Table 1.5 were ultra-violet light (UV) and/or mass spectrometry 
(MS). The most common wavelengths used for UV detection were 254 and 210 nm. As nitrate 
esters do not absorb at higher wavelengths they are only detected at 210 nm, but since this 
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LOD* (ng) Detector Comments 
DeTata 2013 
[32] 
24 nitroaromatics,  
9 nitrate esters,  
4 nitramines, 
4 peroxides,   
20 others 
Multistep gradient -
CH3OH:H2O, 10 mM 
NH4CHO2  
 
Phenomenex Kinetex C18 
(4.6 x 150 mm, 2.6 μm) 
40 1 13  10 0.1-1000 HRMS Separation of the 17 USEPA Method 8330B 
analytes in less than 6 min 
Baseline separation only attempted for 
isomers  
Xu 2014 [33] 15 nitroaromatics,  
4 nitrate esters,  
3 nitramines 
isocratic - 45:55 H2O: 
CH3OH, washed with 
100% CH3OH 
LichroSpher 100, RP18 (2 
x 250 mm, 5 μm) and 
Phenomenex 
Securityguard C18 (2 x 4 
mm) 
35 0.2 35  10 0.011- 2.6 UV and 
HRMS 
2,4/2,6-DNT not baseline resolved  
EGDN/DEGDN, TNT/3,4-DNT and tetryl/Cl-
20/1,2DNB/1,4DNB do not appear fully 
resolved, but unclear from stacked EICs.  
 
Separate method for peroxides TATP and HMTD Multistep gradient -
CH3OH:H2O, 2.5 mM 
NH4OAc  
GraceSmart RP18 (2.1 x 
150 mm, 3 μm) and guard 
column  






9 nitrate esters Isocratic- 70:30 
CH3OH:H2O 
Restek Allure C18 (2.1 x 
100  mm, 5 μm) 
n.s. 0.15 7  10 0.05 - 100 MS Nitrate esters only  
Isocratic- 70:30 
CH3OH:H2O 
Restek Allure C18 (3.2 x 
150 mm) 
n.s. 0.4 7  10 0.1 - 25 
Mathis 2005 
[35] 
1 nitroaromatics,  




Agilent Hypersil C18 (2.1 x 
100 mm) 
n.s. 0.15 10  10 n.s. 
< 1-600 
MS NG and TNT not separated 
Poor retention of EGDN (k=0.5)  
Tachon 2007 
[36] 
12 nitroaromatics,  
2 nitrate esters,  
2 nitramines 
Multistep gradient – 
1 mM NH4CHO2, 
H2O: CH3CN: IPA 
PGC Hypercarb (2.1 x 
100 mm, 5 μm) 
70 0.2 60 10 0.4-10.6  MS RDX/NG and 2,6/2,4 DNT not baseline 
resolved.   
Tachon 2008 
[37] 
6 nitroaromatics,  





C18 Allure (4.6 x 250 mm, 
5 μm) 




Separation of 2,4- and 2,6-DNT due to 
column retentivity rather than selectivity.  
Baseline separation achieved with high 
carbon load (27%) C18 allure  
Multistep gradient – 
1 mM NH4CHO2, 
H2O:CH3CN:IPA 
PGC Hypercarb (2.1 x 
100 mm, 5 μm) 
60 0.2 60  10 n.s. 
< 10 
UV and MS 
n.s. not specified, n.d. not detected 
*For comparison purposes, where limits of detection were not specified LOQs are given or they are estimated to be less than the amount detected in the lowest standard. 
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LOD* (ng) Detector Comments 
Holmgren 
2005 [38] 
7 nitroaromatics,  
1 nitrate ester,  
13 others 
Multistep gradient – 
H2O:CH3OH: 
CH3CN: CH2Cl2:toluene. 
Hypercarb PGC (4.6 x 




50 n.s. 0.5- 41.2  MS Report complete separation, but no 
chromatogram showing baseline resolution 
for all. With faster separation (17min), 3,4-
DNT, 2,3-DNT, 1,3-DNB and 1,4 DNB were 
not resolved but distinguished by MS.  
Thonas 2013 
[39] 
7 nitroaromatics,  
1 nitrate ester,  
13 others 
Multistep gradient – 
H2O: CH3CN:CH3OH, 2 
mM NH4OAc + 0.2 mM 
NH4Cl 
bridged ethyl hybrid (BEH) 
C18 (2.1 x 100 mm, 1.7 
µm). Plus BEH C8 guard 
column 
40 0.5 n.s. (>8) 20 0.4-64 MS/MS 3,4-DNT, 2,3-DNT, and 2-NT co-eluted as 
one peak  
NG and 4-NT not resolved. 
  
Xu 2004 [40] 14 nitroaromatics,  
4 nitrate esters,  
3 nitramines 
Isocratic - 50:50 
CH3OH:H2O, 
with/without 2.5 mM 
NH4OAc or 1 mM glycine 
Waters Nova-Pack C18 (3.9 
× 150 mm, 4 µm) 
n.s. 0.4 24  10 0.012-16 MS Identification by MS not LC separation. 2,4-
DNT/2,6-DNT unresolved.  
Song 2009 
[41] 
8 nitroaromatics,  
2 nitramines 
Isocratic - 50:50 
CH3OH:H2O, with 1 % 
CH2Cl2 for nitramines 






HRMS Nitroaromatics and nitramines analysed 
using different methods 
Baseline separation of isomers but tetryl/1,3-




14 nitroaromatics Isocratic - 43:57 
CH3OH:H2O with  
5 mM NH4OAc 
Acclaim Explosives E1 
(4.6 × 250 mm 5 μm) 
25 1 70 1 0.003  
-0.058  
MS/MS Explosives E1 column designed for 
separation USEPA Method 8330 analytes 




12 nitroaromatics,   
2 nitrate esters,  
3 nitramines  
1 peroxide 
Isocratic - 28:72 
CH3OH:H2O with 
NH4OAc  
Acquity UPLC BEH C18 
(2.1 x 100 mm, 1.7 µm) 
55 n.s. 10.5 n.s. low pg  UV and MS Baseline separation (excluding nitrate 
esters) with UV, not MS 
Gradient used with nitrate esters, NG and 
tetryl not baseline resolved.  
Perret 2008 
[44] 
TNT, RDX, PETN, 
NG, DPA and EC 
Isocratic - 70:30 
CH3CN:H2O with         1 
mM NH4OAc 
X Terra C18 (2.1 x 150 mm, 
3.5 µm) 
n.s. 0.2  12 5 µL 
loop 
0.005-4  MS/MS Very limited separation, identification based 
on MS/MS  
n.s. not specified, n.d. not detected 
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LOD* (ng) Detector Comments 
Ochsenbein 
2008 [45] 
5 nitroaromatics,  
2 nitrate esters,  
2 nitramines 
Multistep gradient – 
H2O:CH3OH 2.5 mM 
NH4OAc 
Xbridge phenyl (2.1 x 
150 mm, 3.5 μm) 
40 0.2 23 100 n.s. 
LOQs 
 3-100 
MS No chromatogram shown but resolution 
factors of 1.1 for the DA-NTs and 0.9 for A-
DNTs. 




15 nitroaromatics,  
1 nitrate esters,  
2 nitramines,  
1 other 
Isocratic - 57:43 
CH3OH:H2O 
Spherisorb C18 (2.4 X 250 
mm, 5 µm) 
n.s. 0.4 40  30 0.8-4.6  UV (λ=210 
or 254 nm) 
PA/Hexyl, 2-A-6-NT/1,3,5-TNB and 2,4,6-
TNT/4-A-2,6-DNT not baseline separated. 
DeTata 2013 
[47] 
13 nitroaromatics,  
2 nitrate esters,  
2 nitramines 
isocratic - 43:57 
CH3OH:H2O 
Acclaim E1 column (4.6 x 
250 mm, 5 µm) 
32 1 n.s. n.s. n.s. UV (λ=210 
and 254 
nm) 
Co-elution of NG and tetryl.  
Liu 2007 [48] 12 nitroaromatics,  
2 nitramines, 
Isocratic - 43:57 
CH3OH:H2O 
Acclaim Explosives E1 
(4.6 × 250 mm, 5 μm) 
30 1 40 5 0.2-4.6 UV (λ=254 
nm) 
Baseline separation of the 14 anayltes in 
method 8330 Dasing an isocratic method.  
13 nitroaromatics,  
2 nitrate esters,  
2 nitramines,  
1 other 
isocratic - 48:52 
CH3OH:H2O 
Acclaim Explosives E2 
column 
(4.6 × 250 mm5 μm) 
30 1 50 5 0.8-4.1 UV (λ=210 
nm) 
Resolution > 1.8 for all 
Borch 2004 
[49] 
16 nitroaromatics,  
2 nitramines,  
5 others 
Multistep gradient – 
H2O:CH3OH, 
0.025 M sodium 
phosphate 
Supelcosil octyl C-8 (4.6 x 
150 mm, 5 μm) Supelcosil 
LC-8 (4.6 x 20 mm, 5 μm) 




Baseline separation of EPA method 8330 
compounds  
When TNT metabolites were added, 




6 nitroaromatics Isocratic – 62:38 
CH3OH:H2O 
Symmetry Shield RP18 (3 
x 250 mm, 5 μm) 
n.s. 0.4 10 10 LOQ 200–
550 
UV  (λ=228, 
237 and 
247 nm) 
Resolution of 2,4- and 2,6-DNT was 1.25 on 
SymmetryShield RP18 column, 1.18 on the 
JSphere C18 column, and 1.64 on the 
diphenyl column.  
Isocratic – 62:38 
CH3OH:H2O 
JSphere H80 (3 x 150, 4 
μm) 
n.s. 0.4 15 10 LOQ 160–
420 ng/µL 
Multistep gradient – 
H2O:CH3CN  
diphenyl XRS (3 x 100 mm, 
5 μm) 
n.s. 0.4 25  10 LOQ 360–
1000 
n.s. not specified, n.d. not detected 
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LOD* (ng) Detector Comments 
Tyrrell 2011 
[51] 
12 nitroaromatics,     
2 nitrate esters,  
2 nitramines 
isocratic – 48:52 
CH3OH:H2O 
Acclaim Explosives E2 (3 x 
150 mm, 3 µm) 
30 0.42 30 5 µL 
loop 
0.6-6.9 UV (λ=210 
nm) 
TNT/tetryl, 4-A-2,6-DNT/2-A-4,6-DNT and 4-
NT/3-NT not baseline  
Minimum resolution was 0.92 for the 3-NT 
and 4-NT peak pair 
4 nitroaromatics,  
3 nitrate esters, 
2 nitramines 
Multistep gradient – 
CH3OH:H2O  
Acclaim Explosives E2 (3 x 
150 mm, 3 µm) 
32 0.7 23  5 µL 
loop 
1.55-7.7 UV (λ=210 
nm) 
Minimum resolution was 1.16 for tetryl/NG, 
and NG/TNT also only 1.23.  
2,4- and 2,6-DNT co-eluted  
Paull 2004 
[52] 
9 nitroaromatics,   
1 nitrate esters,  
2 nitramines 
Linear gradient - 
CH3OH:H2O 
Chromolith SpeedROD C18 
(4.6 x 50 mm) 
room 
temp. 
3 n.s.  
(> 6) 
10 0.21-0.94 UV (λ=210 
and 254 
nm) 
2,3- 2,4- and 2,6-DNT coelute.  
Linear gradient - 
CH3OH:H2O 
Chromolith SpeedROD C18 
(4.6 x 50 mm) Chromolith 
Performance C18 (4.6 x 100 
mm) 
60 3 n.s.  
(> 14) 
25 0.25-1.04 UV (λ=210 
and 254 
nm) 
Baseline separation without 2,4-DNT  
Linear gradient - 
CH3OH:H2O 
Chromolith SpeedROD C18 
(4.6 x 50 mm) 
60 8 3 n.s. n.s UV (λ=210 
and 254 
nm) 
Baseline separation of HMX, RDX, TNT, 2,4-
DNT, 2-NT, 3-NT and PETN  
Peak widths only 7-10 s  
Gaurav 2009 
[53] 
11 nitroaromatics isocratic - 43:57 
CH3OH:H2O  
Supelco Ascentis RP 
amide column (4.6 x 
150 mm, 5 μm) 




Baseline resolution but broad peaks 
Reifenrath 
2002 [54] 
9 nitroaromatics,   
2 nitramines  
1 other 
Isocratic – 50:50 
CH3OH:H2O 
Supelcosil LC-18-S (4.6 x 
250 mm, 5 µm), 
Supelguard LC-18-S (20 
mm) 





Large retention time bracket for dinitroaniline 
(10-12 min) over laps with TNT (12.00 min) 
and tetryl (10.09 min).  
4-A-2,6-DNT, 2-A-4,6-DNT, 2,6-DNT and 
2,4-DNT have close retention times (12.55, 
13.14, 13.31 and 13.47 min) but no peak 
widths or chromatograms. 
           
n.s. not specified, n.d. not detected 
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LOD* (ng) Detector Comments 
Marple 2005 
[55] 
13 nitroaromatics,   
3 nitrate esters,  
2 nitramines,  
1 other 
Isocratic – 50:50 
CH3OH:H2O with  
20 mM NH4OAc  
Denali (4.6 × 250 mm, 5 
μm) and SelectaPore (4.6 
× 250 mm, 5 μm) 









2,6-DNT/2-A-4,6-DNT coelute on one 
column, 2-A-4,6-DNT/2,4DNT on the other 
Coupling 2 columns improved separation, 
not quite baseline for 4-A-2,6-DNT/2,6-
DNT/2-A-4,6-DNT/2,4DNT (nitro esters and 
PA not included)  
On single column NQ unretained, and 
EGDN/RDX and 2,6-DNT/2-A-4,6-DNT not 
fully resolved.  
n.s. not specified, n.d. not detected 






components. Tachon et al. made use of the reduced selectivity at 210 nm in order to evaluate the 
effectiveness of their solid phase extraction (SPE) procedure for the removal of interfering 
compounds from a motor oil matrix that coelute with explosive compounds and may affect 
detection [37]. 
Since MS can distinguish between ions with different m/z, many LC-MS methods only attempt 
separation of isomers which cannot be distinguished by MS. However, for forensic purposes the 
extra confidence of identification achieved from both chromatographic separation and mass 
spectra is desirable, particularly when several explosives form common ions.  
 Mass spectrometry 
Mass spectrometers separate and detect ions based on their mass to charge ratio (m/z). There 
are three main components of a mass spectrometer, the ionisation source where gas-phase ions 
are produced, the mass analyser where these ions are separated based on their m/z and the 
detector. Ideally all ions would be transferred from the ion source to the mass analyser, but in 
reality, a large percentage may be lost along the way. Various ion guides, lenses and funnels 
have been designed to minimise these losses and hence improve sensitivity.  
1.2.2.1 Ionisation  
While mass spectrometry is often considered a universal detector, only charged molecules can 
be detected. Effective ionisation is crucial for an analyte to be detected. Atmospheric pressure 
ionisation sources are often used when coupled to HPLC, as can be seen in Table 1.6. While 
Song and Bartmess used atmospheric pressure photoionization (APPI), with UV radiation 
promoting ionization [41]; electrospray ionisation (ESI) and atmospheric pressure chemical 
ionisation (APCI) are the most common ionisation sources used for the detection of explosives.  
A schematic of ESI is shown in Figure 1.3. In ESI, the first stage in formation of gas phase ions 
is the production of charged droplets at the tip of the electrospray needle [60]. A solution is passed 
through a spray needle into an electric field which leads to partial separation between positive 
and negative ions in the solution. In negative ionisation mode, a high negative potential is applied 
to the tip of the needle and an electrochemical reduction reaction creates negative ions or 
removes positive ions at the needle tip. Repulsion of the negative ions at the tip of the spray 
needle and attraction towards the counter electrode results in formation of a Taylor cone causing 




Table 1.6 (Continued): Detection details for LC-MS analysis of multiple explosives 
Reference Analytes* LOD (ng on column) Ionisation Mass 
analyser 
Additives (pre/post column) Main 
positive 
ions 




DeTata 2013 [32] 24 nitro-aromatics,  
9 nitrate esters,  
4 nitramines,  
4 peroxides,   
20 others 
0.1-1000 APCI 
(+ and –) 










Xu 2014 [33] 15 nitro-aromatics,  
4 nitrate esters,  
3 nitramines 
0.011-2.6 APCI (-) LTQ-
Orbitrap 
4% v/v chloroform in methanol (post) n/a [M+Cl]-, [M-H]-, [M]- yes High 
(> 60,000 
resolving 
power) 2 peroxides 0.049-0.13 APCI (+) LTQ-
Orbitrap 
2.5 mM ammonium acetate (pre) [M+H]+, 
[M+NH4]+ 
n/a 





ESI (-) LCQDUO 
ion trap 
0.05 mM ammonium nitrate, 0.1 mM 
sodium nitrite, 0.2 mM propionic acid or 
0.1 mM ammonium chloride (post) 




0.1 - 25 APCI (-) LCQDUO 
ion trap 
0.2 % (v/v) dichloromethane, 
0.1 % (v/v) chloroform, 0.05 % (v/v) 
carbon tetrachloride or 0.3 mM  
ammonium chloride (post) 
n/a [M+Cl]- 
Mathis 2005 [35] 1 nitro-aromatics,  
3 nitrate esters,  
2 nitramines 
 






0.05 mM ammonium nitrate and 0.1 mM 
ammonium chloride (post). 
OR 0.05 mM  nitrate, 0.1 mM 
ammonium chloride, 0.1 mM ammonium 
formate and 0.1 mM ammonium acetate 
(pre) 




Tachon 2008 [37] 6 nitro-aromatics,  
3 nitrate esters,  
2 nitramines 
n.d. 1 ng/µL 
standard used 
APCI (-) Ion trap 
LCQ Ad-
vantage 
1 mM ammonium formate (pre) n/a [M+CHO2]-, [M]- no Low 
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Table 1.6 (Continued): Detection details for LC-MS analysis of multiple explosives 
Reference Analytes* LOD (ng on column) Ionisation Mass 
analyser 
Additives (pre/post column) Main 
positive 
ions 




Holgren 2005 [38] 7 nitro-aromatics,  
1 nitrate ester,  
13 others 
0.5 - 41.2 APCI 





1 % (v/v) dichloromethane (pre) [M]+ [M+Cl]-, [M]- yes Low 
Tachon 2007 [36] 12 nitro-aromatics,  













Thomas 2013 [39] 7 nitro-aromatics,  
1 nitrate ester,  
13 others 







0.2 mM ammonium chloride and 2 mM 
ammonium acetate (pre) 
[M+H]+ [M+Cl]-, [M-H]- yes Low 
Xu 2004 [40] 14 nitro-aromatics,  
4 nitrate esters,  
3 nitramines 
0.012-n.d. (APCI-) 
0.06-n.d.  (ESI-) 3.1-
16 (ESI+ with 
glycine, NTs only) 







2.5 mM ammonium acetate 











APPI (-) QSTAR 
XL triple 
QTOF 
toluene  (post) n/a [M+Cl]-, [M-H]-, [M]- no high 
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Reference Analytes* LOD (ng on column) Ionisation Mass 
analyser 
Additives (pre/post column) Main 
positive 
ions 






14 nitro-aromatics SIM  
0.002.9-0.050  MRM 
 0.004-0.058  
ESI (-) Agilent 
6410, 
QqQ 




[M+H]+ [M-H]- yes Low 
Oehrle 2008 [43] 12 nitro-aromatics,   
2 nitrate esters,  
3 nitramines  
1 peroxide 




SQ ammonium acetate (pre) [M+H]+ [M+OAc]-, [M-H]- no Low 
Perret 2008 [44] TNT, RDX, PETN, NG, DPA 
and EC 
0.001-0.8 IonSpray 




1 mM ammonium acetate (pre) [M+H]+ [M+OAc]-, [M-H]- yes Low 
Ochsenbein 2008 
[45] 
5 nitro-aromatics,  
2 nitrate esters,  
2 nitramines 
not determined, 
LOQ using SPE 
0.03-1 ng/ul in water 
ESI 
(+ and -) 
API 5000 
QqQ 
2.5 mM ammonium acetate (pre) [M+H]+ [M+OAc]-, [M-H]- yes Low 
*While Tetryl could be classed as a nitroaromatic and a nitramine, it has only been counted as a nitroaromatic to avoid double counting; QTof – quadrupole time of flight; QqQ – triple quadrupole 




Figure 1.3: Schematic of negative electrospray ionisation, adapted from [62], [60] and [61]. 
 
is reached (Coulombic  repulsion of  the  surface  charge  equals  surface tension) due to solvent 
evaporation, resulting in Coulombic fission. These droplets reduce in size until individual gas 
phase ions are formed which enter the mass spectrometer. Two mechanisms have been 
proposed for this process, the charge residue model (CRM) and the ion evaporation method 
(IEM). In both CRM and IEM, droplets initially decrease in size by solvent evaporation until 
Coulombic repulsion overcomes surface tension, leading to expulsion of smaller charged 
droplets. The CRM model proposes that solvent evaporation and Coulomb fission continues until 
no further evaporation is possible and dry charged residues, including single ions, remain. The 
IEM model proposes that once the charged droplets reach a certain size, direct emission of ions 
into the gas phase occurs because a lower charge is required on the droplet for ion emission than 
for Coulomb fission. IEM is considered the more likely mechanism for the formation of small ions 
[60]. CRM is more likely with large ions [61]. In both models, ESI is dependent on the presence 
of electrolyte ions in solution. If the electrolyte ions in solution are due to the analyte, then gas-
phase analyte ions will be produced. However, at high electrolyte concentrations the conversion 
to gas-phase ions is less efficient and the presence of buffers or other mobile phase additives in 
solution will compete with the analyte [60]. For the same reason ESI is susceptible to ion 
suppression due to matrix [61]. 
In APCI (Figure 1.4), the solution passes through a needle/capillary similar to that used in ESI, 
but with APCI the capillary is not charged. Instead, the first stage of APCI is vaporisation in a 
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heated chamber. Gas-phase molecules then pass a high voltage corona discharge needle which 
promotes ionisation of solvent molecules. The primary (solvent) ions then cause secondary 
ionisation of the analyte, as shown in the box in Figure 1.4: Schematic of positive atmospheric 
pressure chemical ionisation. Equations outlining the ionisation mechanism are from Awad et al. 
with S referring to the vaporised solvent and M referring to the analyte [61].Figure 1.4. In positive 
ion mode APCI, mechanisms for ionisation of the analyte include: charge exchange or electron 
transfer from a neutral analyte molecule (M) to a solvent ion (S+·); proton transfer from the solvent 
(S) to the analyte and adduct formation. In negative mode, mechanisms include: proton 
abstraction from the analyte by the solvent; associative electron capture, when the analyte gains 
an electron; dissociative electron capture, when the analyte gains an electron and fragments, and 
adduct formation [63].  
  
Figure 1.4: Schematic of positive atmospheric pressure chemical ionisation. Equations outlining the 
ionisation mechanism are from Awad et al. with S referring to the vaporised solvent and M referring to the 
analyte [61]. 
 
A significant difference between ESI and APCI is that in ESI the analyte is ionised in the liquid 
phase before being released into the gas phase, whereas in APCI the analyte is vaporised before 
being ionised. As a result of this, ESI ion formation tends to be more susceptible to non-volatile 
matrix components that can lead to ion suppression due to changes in droplet properties or 
competition for charge or space on the droplet surface [61]. The effect of this can be minimised 
by chromatographic separation from major matrix components. Additionally, the requirement for 
high vaporisation temperatures with APCI may be problematic for thermally unstable compounds.  
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ionisation of polar analytes, whereas APCI tends to be better for low-to-medium polarity analytes 
[61].  
Two of the main types of ion formed in both ESI and APCI are the protonated and deprotonated 
molecules, [M+H]+ and [M-H]-. Analytes containing amine groups, such as the explosive 
hexamethylene triperoxide diamine (HMTD) and stabilisers like diphenylamine (DPA), are basic 
and so readily form [M+H]+ ions in positive mode [33,39]. In contrast, most explosives containing 
nitro groups ionise more readily in negative mode. Nitrate esters (e.g. NG) and nitramines (e.g. 
RDX) have weak deprotonation due to low gas phase acidities. For these analytes the formation 
of adducts such as [M+OAc]-, [M+Cl]- or [M+NO3]- is often promoted by buffers or additives, such 
as ammonium acetate, chloride or nitrate, to improve ionisation and hence limits of detection 
[34,35]. However, nitrotoluenes (e.g. TNT) generally form [M-H]- (and/or [M]- in APCI) and ionise 
most efficiently with unbuffered mobile phases as the presence of buffers or additives leads to ion 
suppression [40]. Mono-nitrotoluenes (NTs) are particularly challenging to ionise and as such are 
missing from many of the MS methods shown in Table 1.6. Xu et al. found the formation of a 
glycine adduct in positive mode, [M+glycine]+, improved limits of detection and proposed 
confirmation by this method where an NT peak was detected by UV, which still had superior 
sensitivity to MS for these analytes [64]. Adducts are also used in positive mode for the detection 
of peroxides such as TATP and MEKP which are often detected as the ammonium adduct, 
[M+NH4]+ [32,33]. 
Since different classes of organic explosive ionise best under different conditions, several 
methods change ionisation parameters throughout the run by switching between positive and 
negative mode [32,38] or even switching between APCI and ESI [39,43]. However, switching 
polarity or between APCI/ESI takes additional time and so results in a slower total scan time and 
fewer data points per chromatographic peak. This may be problematic, particularly when coupled 
to UHPLC which has narrower peaks than conventional HPLC. Changing ionisation mode may 
also affect quantification by leading to variability in peak area, as found by Thomas et al. who 
reported 43 % relative standard deviation (RSD) for NG [39]. Other studies used multiple methods 
[33,40], allowing ionisation to be optimised for specific groups of analytes but resulting in more 
time-consuming analysis. Xu et al. decided against the use of dynamic polarity switching for their 
recent screening method as it decreased the mass accuracy of the Orbitrap Fourier transform 
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(FT) MS detection and instead used separate positive and negative methods which also allowed 
the use of different ionisation temperatures [33]. 
1.2.2.2 Mass analysers 
Mass analysers separate ions in space or time based on their mass to charge ratio through the 
use of electric or magnetic fields. A range of different mass analysers have been used for the 
detection of explosives including time of flight (TOF), quadrupole (Q), ion trap and Orbitrap mass 
analysers (Table 1.6). Time of flight analysers separate ions based on the time taken for ions to 
reach a detector, due to the slower velocity of ions with larger m/z. Quadrupole mass analysers 
separate ions based on their oscillation between four parallel rods to which a constant voltage 
and radio frequency oscillating voltage are applied. In the case of transmission quadrupoles, a 
two-dimensional electric field is set up that pushes or pulls ions of a particular m/z towards the 
detector with ions of other m/z neutralised through collision with one of the rods. In the case of a 
quadrupole ion trap, a three-dimensional electric field is set up resulting in all m/z ions being 
trapped in the quadrupole. Ions can be separated as they leave the trap based on their m/z, with 
the lowest m/z ions leaving first.  
Orbitrap mass analysers (Figure 1.5) trap ions between one inner and two outer electrodes using 
static electrostatic fields. Short packets of ions are injected into the Orbitrap with a velocity 
perpendicular to the z-axis. A radial electric field traps the ions radially and they orbit around the 
inner electrode, giving the Orbitrap its name. The ion injection point is offset from z=0 and an axial 
electric field causes ions to also oscillate along the z axis in a harmonic motion. The frequency of 
 
Figure 1.5: Cutaway view of an orbitrap mass analyser. Ions are injected perpendicular to the z-axis, 
displaced from z=0. This gives the ions potential energy in the z-direction causing them to oscillate along 







oscillations along the z-axis is dependent on m/z, and independent of energy and the spatial 
spread of ions. This allows ions with differing m/z to be distinguished with high mass accuracy 
and resolution [65].The two outer electrodes are used as receiver plates for broadband image 
current detection of the ions and their axial oscillations. The recorded time‐domain signal is then 
Fourier transformed into the frequency-domain and converted into a mass spectrum [66].   
The International Union of Pure and Applied Chemistry (IUPAC) defined mass resolution (m/Δm) 
as the mass of the ion of interest (m) divided by the difference in mass (Δm) that can be separated 
[67]. The difference in mass (Δm) can either be determined by the difference in mass between 
two adjacent peaks of equal height or based on the peak width of a single peak. When two 
adjacent peaks are used, the two peaks must have a valley of <10 % peak height between them 
[68]. For the peak width definition, Δm commonly refers to the full peak width at half maximum 
peak height (FWHM) [68]. It is the FWHM mass resolution definition that will be used in this thesis. 
Since resolution varies based on the m/z being measured (m), with fixed resolution, smaller 
differences in mass (Δm) can be separated for smaller ions.  Quadrupoles are low resolution 
mass analysers and commonly said to have unit mass resolution which actually refers to the Δm 
that can be separated, rather than m/Δm.  This means the [M-H]- ion for NG (C3H5N3O9, 
MW=227.00258) and TNT (C7H5N3O6, MW=227.01784) would appear at m/z 226 for both and be 
indistinguishable using a quadrupole mass analyser. However, they could be distinguished using 
a high-resolution mass analyser such as TOF or Orbitrap.  
Providing that the mass analyser also has high mass accuracy, high resolution mass spectrometry 
(HRMS) can distinguish between compounds with the same nominal mass and provides higher 
confidence of ion identification. Good mass resolution means that two ions with a small mass 
difference can be separated. However, good mass accuracy is also required to determine which 
ion is present, if only one peak is detected. When run in full scan mode, HRMS has the potential 
for suspect screening and non-target detection where post-acquisition data mining can be used 
for the detection of new target analytes as the need arises. Orbitraps are able to achieve even 
higher resolution than TOF mass analysers, with Orbitraps offering a resolving power of up to 
140,000 at full width half maximum (FWHM) [69] compared to 40,000 for TOF mass analysers 
[70]. Providing mass accuracy is also high, increased resolving power reduces the number of 
compounds with the same mass, increasing confidence in ion identification. However, it also 
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comes at the cost of longer scan speeds which may limit the compatibility of Orbitrap mass 
analysers with UHPLC, due to narrow peak widths.  
Tandem mass spectrometry (MS/MS), where precursor ions are fragmented into product ions, 
has also been used to increase confidence in identification of specific explosives by providing 
additional structural information [32,39,42,44,45]. The sensitivity of MS/MS techniques measuring 
specific precursor-product transitions is generally very good due to low background noise, as 
demonstrated by Bečanová et al. who reported limits of detection (LODs) of 2.9-50 pg µL-1 [42]. 
However, the usefulness of tandem MS in broad screening methods targeting a large number of 
analytes is limited by the acquisition time of each transition. Additionally, only analytes with the 
precursor-product transitions being monitored will be detected so it is unsuitable for non-targeted 
analysis. This issue might be resolved through the use of all ion fragmentation (AIF) where, 
instead of measuring specific transitions, full scan data is taken before and after fragmentation 
and product ions may be associated with precursor ions based on retention time. Alternatively, 
MS/MS could be used for confirmation following a positive result from a screening method.  
 Liquid chromatography - high resolution mass spectrometry (LC-HRMS) 
Recently, LC-HRMS has been used for the targeted analysis of multiple classes of explosive, with 
24 compounds detected by Xu et al. [33] and 62 detected by DeTata et al. [32]. Although, a slightly 
lower mass resolution (~20,000 FWHM) was used by DeTata et al., than by Xu et al. who used a 
mass resolution of 60,000-100,000 FHWM. Compared to low resolution MS, high mass resolution 
offers increased confidence of identification due to the ability to separate isobaric ions and 
improved selectivity from matrix for extracted ion chromatograms, even with full scan analysis. 
Full-scan HRMS analysis also offers the potential for suspect or non-target screening, which is 
yet to be explored for explosives analysis and will be discussed further in Section 1.3. The 
separation power of HPLC has also not yet been fully utilised with Xu et al. only attempting 
baseline separation for isomers and a number of structurally similar pairs including 2,4-DNT/2,6-
DNT, EGDN/DEGDN, TNT/3,4-DNT and 1,2-DNB/1,4-DNB not resolved to baseline by DeTata 
et al. Ionisation also remains a challenge with nitrobenzene (NB) not detected by DeTata et al. 
and outside the mass range of the method validated by Xu et al.    
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1.3 Suspect and non-target screening 
With full-scan HRMS, the analyst does not need to know in advance what they are looking for, 
since data for all ions (within a specified range) are collected. Krauss et al. took advantage of this 
and proposed three different workflows for environmental analysis of polar micropollutants such 
as pesticides, pharmaceuticals, and industrial chemicals [71]. The three workflows were for 
targeted analysis, suspects screening and non-target analysis and are summarised in Figure 1.6. 
With targeted analysis, reference standards were analysed at the same time as samples. This 
enabled matching of measured retention times and HRMS data for identification purposes and, if 
required, quantification using calibration standards. With suspect and non-target screening, 
reference materials were not analysed in the first instances and so HRMS data and predicted 
retention times were used to generate a list of likely suspect or non-target compounds present. 
Ibáñez et al.  made a further distinction  between  biased and unbiased non-target screening for  
 
Figure 1.6: Workflows for three approached to using LC-HRMS: targeted analysis, suspect screening and 
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new psychoactive substances [72]. In unbiased non-target screening, in theory the aim is to detect 
all components detected within a sample. In contrast, for biased non-target screening it is only 
structurally related unknowns that are of interest [72]. It is biased non-target screening that is of 
more interest for the analysis of unknown energetic materials as it is only the structurally related, 
energetic components of a sample that are of interest. 
Development of an LC-HRMS method that could be used both for targeted analysis of commonly 
encountered energetic materials, suspect-screening of less commonly encountered compounds 
and biased non-target analysis of new compounds could be of value in forensic science. While 
reference materials would ultimately be required to confirm identification, especially for forensic 
purposes; initial screening without reference materials could enable a greater number of 
compounds to be detected in one method, than would be feasible if reference materials were 
required for all compounds. Additionally, in some cases reference materials may not be readily 
available. Suitable retention time prediction models may also be required for energetic materials, 
to reduce the number of potential positives identified by HRMS data alone.      
 Retention time prediction using quantitative structure – retention relationships 
Quantitative structure – retention relationship (QSRR) prediction models use the relationship 
between numerical molecular descriptors and retention time to predict the retention time of either 
new compounds using the same chromatographic conditions or the same compounds using 
different chromatographic conditions [73]. The molecular descriptors may be theoretical 
descriptors (calculated or predicted from the chemical structure) or experimental descriptors 
(physical properties measured experimentally). For the prediction of new compounds, QSRR 
models based on theoretical descriptors are preferable as experimental descriptors may not be 
available and if experimental determination is required then the time and cost savings of using a 
QSRR model are lost and retention time may as well be obtained experimentally. The use of 
QSRRs for retention time prediction has been extensively reviewed by Put & Vander Heyden [73], 
Héberger [74], Kaliszan [75] and more recently Amos et al. [76]. Some key themes arising from 
these reviews are the importance of selecting appropriate descriptors, validating prediction 
models and determining an applicability domain, outlining descriptor values for which the model 
can be used without extrapolation. 
Linear models have been developed for predicting reversed-phase LC retention [77-81]. 
Multilinear regression (MLR) models are one of the simplest ways of predicting retention time and 
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are easy to interpret, since the sign and size of coefficients indicates whether the descriptors 
increase or decrease retention time and the importance of each descriptor within the model. 
However, MLR models are not always able to fully describe retention and both Aalizadeh et al. 
and Goodarzi et al. found performance of a non-linear model to be superior [80,81]. A number of 
non-linear models, including artificial neural networks (ANNs) [82-84] and support vector 
machines (SVMs) [80,81] have also been used for revered-phase LC retention time prediction. 
1.3.1.1 Artificial neural networks 
Artificial neural networks (ANNs) are analogous to biological neural networks in a brain. Like 
biological neurons, artificial neurons are connected within a network and each neuron receives 
input signals (either from the original data or the output of other neurons) that affect whether or 
not an output signal is sent [85]. Input signals have a strength (or weight) applied to them, which 
is optimized during training to minimise the prediction error for the training set. A neuron will only 
send an output signal if the input signals exceed a threshold level, which is also optimised during 
training [86]. An example of a feedforward neural network is shown in Figure 1.7, where signals 
are transmitted from the inputs (in this case molecular descriptors) forwards through any hidden 
units to the output (in this case predicted retention time). Figure 1.7 is also an example of a 3-
layer multilayer perceptron (MLP). In MLPs, each neuron in a particular layer is connected to each 
neuron in the next layer [41]. 3-layer MLPs consist of an input layer containing the independent 
variables, in this case molecular descriptors; one hidden layer and an output layer containing the 
dependent variable, in this case retention time.  
 
Figure 1.7: Schematic of a feed-forward ANN with an input layer, one hidden layer and an output layer 
containing four, three and one neurons respectively. Adapted from [73] and [87].  



























ANNs are one of the most well-known non-linear regression methods [87] and more flexible than 
multiple linear regression (MLR) since both linear and non-linear functions can be used, which 
may lead to improved prediction through description of more complex relationships [73]. However, 
the increased complexity means that ANN models are also more difficult to interpret than MLR 
models [73] and optimisation of network error may get stuck in local minima, rather than reaching 
the global minima during training [86]. To avoid problems with local minima, networks should be 
trained multiple times. The increased complexity of ANN models also means that they are 
susceptible to over-fitting and over-training. Neural networks are trained to minimize prediction 
error for a training set, but it is prediction of new compounds that is of more interest. Over-training 
or over-fitting results in an over complicated underlying function, that reduces the error for the 
training set but leads to poor generalizability for new compounds. The problem of over training 
can be reduced by early stopping [85], and the use of a selection set, distinct from the training 
set, to assess generalizability [86]. While training minimizes the true error function, the error for 
the select set will decrease along with the error for the training set. Over-training is indicated by 
an increase in the selection set error when the training set error is still decreasing and so can be 
avoided by selecting networks with balanced errors across the training and selection sets. As the 
selection set plays a key role in selecting the best network, it is not truly independent from the 
training process and so an additional independent test set is required [86]. 
ANNs have shown promise for predicting LC retention times to aid identification of new 
compounds detected by suspect or non-target screening. Over the past decade, QSRR ANNs 
have been developed for a number of applications, including: toxicology [88,89], anti-doping [82], 
wastewater analysis [83,90] and proteomics [91]. As shown in Table 1.7, a range of different 
methods have been used for descriptor selection including genetic algorithm feature selection, 
‘user curation’ where descriptors are selected by the authors and the use of previously published 
descriptors. The suitability of previously published descriptor sets, has not yet been investigated 
for energetic materials. Different measurements of accuracy, including root mean square error 
(RMSE), mean absolute error (MAE) and maximum error (Max E), have been reported, making it 
difficult to compare accuracy across papers. Additionally, these measures of accuracy give little 
indication of the confidence associated with a predicted retention time for a new compound. It is 
also worth noting that all the ANNs described in Table 1.7 were developed on C18 stationary 




Table 1.7: Prediction of LC retention time for new compounds using ANNs. 











Toxicology 52 3‐layer 
network 
C18 15 Genetic 
algorithm  
RMSE = 0.55 
Miller, 2013 
[82] 
Anti-doping 86 4-layer 
MLP 
C18 18 User 
curated 





166 GRNN C18 17 User 
curated 
MAE (± SD) = 0.99 







C18 16 Miller et al. RMSE=1.03 min 
Žuvela, 2016 
[91] 
Proteomics 280 MLP C18 10 Genetic 
Algorithm 
RMSEP = 9 % of tR 
Mollerup, 
2018 [89] 
Toxicology 869 4-layer 
MLP 
C18 16 Barron & 
McEneff 
MAE = 0.97 min, 
95th percentile = 
2.4 min 
   
 Evaluating the significance of a match 
For forensic analysis, it is essential to evaluate the significance of a match, with or without 
reference materials, and the probability of misidentification. In 2017 Rochat proposed the use of 
a confidence scale and identification score for known-unknown compounds in metabolomics 
using LC-HRMS [92]. The proposed scale included: a general identification category of 1-4, with 
1 indicating confirmed and 4 indicating unknown; a chromatography class of A-D, with a matching 
reference standard required for A, a predicted retention time <10 % for B and <25 % for C and, 
finally, an identification point level. According to Rochat’s scale, ‘very strong’ identification 
confidence could be achieved without a reference standard, but for confirmation a reference 
standard analysed by at least two orthogonal MS analysis, or confirmation by NMR, was required. 
The scale proposed by Rochat built upon the identification points system set out in the 2002 
European Commission Decision [93]. Xu et al. used the same identification points system for their 
LC-HRMS explosives screening method, with the slight modification of awarding an additional 
identification point to HRMS ions with a resolution of 60,000-100,000 rather than ~20,000 FWHM 
[33]. However, Lehotay et al. argued that the identification points system was arbitrary and 
fundamentally unscientific [94]. Therefore, further evidence is required to support the selection of 
identification requirements for LC-HRMS analysis. While reference materials will inevitably be 
required for confirmatory analysis, predicted retention times may be beneficial for excluding false 
positives with the same elemental composition and prioritising the compounds for which reference 
materials should be acquired or synthesised.  
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1.4 Aims and Objectives of the PhD thesis 
The overarching aim of this thesis is to investigate the suitability of liquid chromatography coupled 
to high resolution mass spectrometry for screening and identification of large numbers of known, 
unknown and suspect energetic materials in forensic casework. As such, the objectives of this 
thesis are:  
A. Develop a liquid chromatography – high resolution mass spectrometry (LC-HRMS) 
method for broad scope, flexible screening of multiple classes of explosives. 
B. Assess qualitative method performance for target compounds, focussing on the 
requirements for forensic identification of explosives. 
C. Assess the ability for the LC-HRMS method to detect new compounds. 
D. Use MLR and machine learning techniques for prediction of retention times, to support 
preliminary identification of new compounds.  
1.5 Outline 
The main advantages, challenges and proposed solutions to the use of LC-HRMS for screening 
and identification of energetic materials are summarised in Figure 1.8. LC-HRMS offers the 
potential to include more explosives in one method, but to do this chromatographic separation 
and simultaneous ionisation of more explosives with diverse functionalities would be required. 
Therefore, Chapter 2 will focus on LC-HRMS method development and optimisation for target 
compounds. HRMS offers greater confidence of identification due to the ability to separate 
isobaric ions which are indistinguishable by low-resolution MS. However, there is currently a lack 
of consensus regarding identification criteria for LC-HRMS and limited scientific evidence to 
demonstrate how low the uncertainty of identification is, in the case of energetic materials. 
Furthermore, it is important to understand any uncertainties associated with an identification in 
order to avoid a miscarriage of justice. Therefore, in Chapter 3, the effect of different LC-HRMS 
identification criteria on selectivity and sensitivity will be investigated and the number of isomers 
and theoretical elemental compositions indistinguishable by HRMS, from target explosives, will 
be determined. The third main advantage of LC-HRMS is the ability to perform suspect and biased 
non-target screening to detect explosives not included in targeted analysis. This presents the 
challenge of how to optimise and performance test the method for unknown compounds. To 
address this challenge, the LC-HRMS method was first optimised for a representative set of target 
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compounds (including nitroaromatics, nitrate esters, nitramines and peroxides), as described in 
Chapter 2. Method performance was then assessed, as described in Chapter 3, for a larger set 
of compounds, including compounds for which no optimisation was performed, as would be the 
case for unknowns. For suspect and non-target compounds there is also the challenge of 
identification, initially without reference standards. To address this, retention time prediction was 
investigated in Chapter 4 for the potential to prioritise the purchase/synthesis of reference 
materials and/or exclude non-explosive compounds. To the authors knowledge, this is the first 
time the use of LC-HRMS for suspect screening and non-target analysis, in addition to targeted 
analysis, has been investigated for energetic materials.                
Advantages
Optimise LC-HRMS method for 
representative target compounds 
(Chapter 2)
Test method performance for larger set 
of suspect compounds (Chapter 3)
Investigate effect of different 
identification criteria on selectivity and 
sensitivity (Chapter 3) 
Assess selectivity between explosives 
and from matrix  (Chapter 3)
Determine theoretical number of 
elemental compositions and number of 
known isomers (Chapter 3)
Challenges Proposed solutions
Retention time prediction (Chapter 4)
Optimise chromatography for target 
compounds (Chapter 2)

























Figure 1.8: Outline of the main advantages, challenges and proposed solutions for the use of LC-HRMS for 










Chapter 2: Multi-residue LC-HRMS 




High performance liquid chromatography (HPLC) and liquid chromatography coupled to mass 
spectrometry (LC-MS) has been widely used for screening and confirmatory identification of 
organic explosives both for environmental monitoring and forensic purposes as reported in 
Chapter 1 (Table 1.5 and Table 1.6). Compounds of interest vary depending on the application. 
For example, environmental monitoring focusses on toxic compounds and environmental 
transformation products, whereas forensic screens are more interested in pre- and post-blast 
compounds. Many methods have only focused on small numbers of explosives, or even individual 
explosives [95,96]. This has meant that multiple methods are required to provide comprehensive 
detection. Methods detecting multiple explosives have often focused on either one class of 
explosive e.g. nitrate esters [34] or nitroaromatics [42,50,53], or on more environmentally relevant 
analytes such as the 17 compounds included in the United States Environmental Protection 
Agency (EPA) methods 8330, 8330 A and 8330 B [57-59,97]. 
Recently liquid chromatography coupled to high resolution mass spectrometry (LC-HRMS) has 
also been used for forensic screening/identification of explosives [32,33]. The use of LC-HRMS 
offered the potential to simultaneously screen for a large number of explosives and related 
compounds that could be confidently identified based on their LC retention time in combination 
with high resolution, high accuracy m/z ratios. With tandem mass spectrometry, the number of 
explosive transitions that could be measured in the same method without sacrificing the number 
of data points per chromatographic peak was limited. This was not the case for full-scan high 
resolution mass spectrometry, as data for all ions is collected in each scan. This means more 
explosives could be included in one HRMS method. With full-scan HRMS, since data is collected 
for all ions, suspect or non-target compounds could also be detected through suspect or biased 
non-target screening of new analytes as and when the need arose. This presents the challenge 
of how to optimise a method for the detection of non-target analytes that are not selected in 
advance. To maximise the potential for suspect screening, it is important to optimize a method for 
target analytes with a range of functionalities to improve the chances of detecting non-target 
compounds. In Figure 2.1, eighteen initial target analytes of forensic interest are identified 
including eight nitroaromatics, four nitrate esters, two nitramines, one nitrosamine, two peroxides 
and tetryl which is both a nitroaromatic and a nitramine. The two main challenges when including 
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Figure 2.1: Eighteen organic explosives, including sixteen nitro-explosives, grouped based on their chemical 
structure and identified as initial target compounds for a forensic screen. Note: Tetryl has both nitroaromatic 
and nitramine functionality 
 








































































































































































































































































more explosive compounds, with a range of functionalities, in one method are achieving 
chromatographic separation and sufficient ionization of all compounds. 
In order for compounds to be detected by mass spectrometry, first they must be ionised. The two 
main ionisation sources used for the detection of explosives by LC-MS are electrospray ionisation 
(ESI) and atmospheric pressure chemical ionisation (APCI), but the ionisation conditions chosen 
have varied depending upon the explosive analytes included in the method. Since nitrate esters, 
nitramines and TATP do not readily form molecular ions or (de)protonated molecules, a range of 
mobile phase additives/buffers have been used to aid adduct formation including ammonium 
acetate [33,35,39,40,42-45], ammonium chloride [34,35,39], ammonium formate [32,36,37], 
ammonium nitrate [35] and dichloromethane [38]. Detection of adducts rather than molecular ions 
can make interpretation more complicated, especially for the identification of non-target 
compounds where identification of the elemental composition becomes more challenging. 
Ionisation, and particularly simultaneous ionisation of multiple types of explosives, remains a 
challenge since different explosives ionise most efficiently under different conditions.  
As shown in a 2007 review by Gaurav et al. [56], HPLC has been widely used for explosives. 
However, baseline separation of the initial target analytes identified in Figure 2.1 is still lacking. 
Since mass spectrometry can distinguish between ions with different m/z, many LC-MS methods 
have only attempted separation of isomers, which cannot be distinguished by m/z. However, for 
forensic purposes the extra confidence of identification achieved from both chromatographic 
separation and mass spectra is desirable, particularly when several explosives form common 
ions. For example, DeTata et al. reported detection of a nitrate ion (m/z = 61.9885) for eight 
different explosive compounds [32]. 
The main aim of this chapter is to show the development and optimisation of an LC-HRMS method 
for the screening and identification of multiple classes of organic explosives including the 18 initial 
target analytes shown in Figure 2.1. Here, a comprehensive chromatographic separation was 
more thoroughly pursued, in comparison to literature-reported methods through column/stationary 
phase comparison, gradient and temperature optimisation. A thorough assessment of ionisation 
parameters, including voltages, temperatures, mobile phase additives and a comparison of ESI 
and APCI was also completed to optimize ionization for broad screening of organic explosives. 
Finally, the optimized LC-HRMS method was used for the detection of explosives in latent 




2.2 Experimental  
2.2.1 Materials and reagents 
Unless otherwise stated, all reagents were of analytical or reagent grade and used without further 
purification. Standard solutions of the 18 initial target explosives: 2,4-dinitrotoluene (2,4-DNT, > 
99.9 % purity in methanol), 2,6-dinitrotoluene (2,6-DNT, > 99.9 % purity in methanol), 2-
nitrotoluene (2-NT, 99.0 % purity in 50:50 acetonitrile:methanol), 3,4-dinitrotoluene (3,4-DNT, 100 
% purity in methanol), 3-nitrotoluene (3-NT, 98.7 % purity in 50:50 acetonitrile:methanol), 4-
nitrotoluene (4-NT, 99.2 % purity in 50:50 acetonitrile:methanol), ethylene glycol dinitrate (EGDN, 
96.2 % purity in acetonitrile), erythritol tetranitrate (ETN, 99.9 % purity in acetonitrile), hexahydro-
1,3,5-trinitro-1,3,5-triazine (RDX, 98.6 % purity in 50:50 acetonitrile:methanol), hexahydro-1,3,5-
trinitroso-1,3,5-triazine (R-Salt, 99.8 % purity in acetonitrile), hexamethylene triperoxide diamine 
(HMTD, 98.4 %  purity in acetonitrile), nitrobenzene (NB, 99.8 % purity in methanol), nitroglycerin 
(NG, 99.4 % purity in purity in 97:3 ethanol:methanol), N-methyl-N,2,4,6-tetranitroaniline (Tetryl, 
98.6 % purity in 50:50 acetonitrile:methanol), octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazine (HMX, 
98.0 % purity in 50:50 acetonitrile:methanol), pentaerythritol tetranitrate (PETN, 99.3 % purity in 
methanol), triacetone triperoxide (TATP, 99.9 % in acetonitrile) and trinitrotoluene (TNT, >99.9 % 
purity in 50:50 acetonitrile:methanol) were purchased from Kinesis Ltd. (St Neots, UK) in either 
0.1 or 1 mg mL-1 solutions. Also purchased from Kinesis Ltd.  were individual standard solutions 
of diethylene glycol dinitrate (DEGDN, 99.9 % purity in 50:50 acetonitrile:methanol), nitromethane 
(NM, 100% purity in methanol), trinitrobenzene (TNB, 97.5 % purity in 50:50 
acetonitrile:methanol) and picric acid (PA, 99.1% purity in 50:50 acetonitrile:methanol). Solid 
dimethyl-2,3-dinitrobutane (DMNB, 98 % purity) and 2,3-dinitrotoluene (2,3-DNT, 99.9 % purity) 
were purchased from Sigma-Aldrich (Gillingham, UK). Individual standard solutions were stored 
at room temperature, 0-5 °C or -20 °C according to manufacturer’s recommendations. Dilutions 
and mixed standards were prepared using positive displacement pipettes in HPLC grade 
methanol (Fisher Scientific UK, Loughborough, UK). HPLC grade methanol was also used for 
mobile phases along with ultrapure water (18.2 MΩ.cm) delivered from a Millipore Milli-Q water 
ultra-purification system (Millipore, Bedford, MA, USA) and ammonium acetate or ammonium 
chloride which were purchased from Sigma-Aldrich (Poole, UK). All mobile phases were sonicated 




2.2.2 Optimisation of chromatographic separation conditions 
An Agilent HP 1100 series chromatograph (Agilent Technologies, Berkshire, UK) with a diode-
array detector was initially used for optimisation of chromatographic separation for the 16 nitro-
explosives identified as initial target analytes. Column selection experiments were run at 25 °C 
under isocratic conditions, with an 8 mM ammonium acetate, 60 % methanol, 40 % water mobile 
phase, at a flow rate of 0.15 mL min-1, unless otherwise stated. Seven columns were investigated: 
Cogent bidentate C18, Cogent diamond hydride, ACE Excel C18 HL, ACE Excel CN-ES, ACE Excel 
C18 Ar, YMC Triart C18 and YMC Triart PFP. All columns were obtained from HiChrom ltd. 
(Berkshire, UK) and further details, including dimensions, are given in Table 2.1.     











Cogent bidentate C18 150 2.1 4 16 Two points of attachment to silica 
Cogent diamond hydride 150 2.1 4 <2 
Silicon hydride surface with very small amount of 
carbon on surface 
ACE Excel C18 HL 150 2.1 3 15.5 HL stands for high carbon load  
ACE Excel CN-ES 150 2.1 3 12.6 
Terminal CN group and ‘C18-like’ extended 
spacer (ES) 
ACE Excel C18 Ar 150 2.1 3 15.5 C18 chain with integral phenyl functionality 
YMC Triart C18 150 2 3 20 Highest carbon load 
YMC Triart PFP 150 2 3 15 Pentafluorophenyl (PFP) 
 
Gradient separations were later developed on two columns, the YMC Triart PFP and the ACE C18 
Ar using 10 % CH3OH, 8 mM ammonium acetate for mobile phase A and 90 % CH3OH, 8 mM 
ammonium acetate for mobile phase B. The optimised separation on the YMC Triart PFP column 
involved a linear gradient of 40-55 % B over 0-50 min and a temperature program starting at 5 
°C, increasing to 45 °C at 10 min before decreasing back to 5 °C from 25 min. Whilst the optimised 
separation on the ACE C18 Ar column involved a 40-100 % B linear gradient over 0-30 min at 
20 °C. 
2.2.3 Optimisation of high resolution mass spectrometry conditions 
An ExactiveTM mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA), with an Ion 
Max API Source, an Accela UHPLC pump and HTC Pal autosampler (also from Thermo), was 
used for HRMS analysis. The Ion Max API Source could be used with either an atmospheric 
pressure chemical ionisation (APCI) or a heated electrospray ionization (HESI-II) probe fitted. A 
combination of direct infusion, flow injection analysis and LC-MS were used for optimisation of 




APCI coroner discharge, APCI vaporiser temperature, capillary temperature and the use of mobile 
phase additives. For experiments using +/- ESI, the optimised conditions were as follows: HESI 
heater temperature of 300 °C, capillary temperature of 250 °C, sheath gas flow rate of 40, auxiliary 
gas flow rate of 10, spray voltage of 3 kV, capillary voltage of -25 or +47.5 V, tube lens voltage of 
-65 or +50 V and a skimmer voltage of -18 or +16 V.  For experiments using APCI, the optimised 
conditions were: vaporizer temperature of 300 °C, capillary temperature of 250 °C, sheath gas 
flow rate of 50, auxiliary gas flow rate of 5, capillary voltage of -25 or +25 V, tube lens voltage of 
-55 or +50 V, skimmer voltage of -18 or +18 V and discharge current of 20 or 10 µA. A comparison 
of APCI and ESI method performance was also performed at 25, 2.5, 0.5 and 0.05 ng on column 
for the 18 target compounds.  
2.2.4 Optimised LC-HRMS conditions 
For the optimized method, the APCI conditions listed in Section 2.2.3 were used for ionisation. 
For chromatographic separation, the ACE C18 Ar column (150 × 2.1 mm, 3 μm) with a 1 cm guard 
column was used. The injection volume was set at 5 µL as an increased injection volume had a 
detrimental effect on separation. Gradient separation was performed at 0.3 mL min-1, using 10:90 
(v/v) methanol:water (A) and 90:10 (v/v) methanol:water (B) with 0.2 mM ammonium chloride in 
both phases. The optimized gradient was 40-95 % B over 0-15 min, 95-100% B 15-15.5 min, 
followed by 5 min at 100 % B and a 17.5 min re-equilibration time (half the time required for UV 
baseline to return to normal at 0.15 mL min-1). The column temperature was maintained at 20 °C 
using a model 7955 column oven from Jones Chromatography (Hengoed, UK).  
Data was acquired using XCalibur software Version 2.2 (Thermo Fisher Scientific), in full scan 
mode over a mass range of 59.9-625 m/z. High resolution (50,000 FWHM) and a mass tolerance 
of 5 ppm were used in line with previous work. Prior to analysis, the ExactiveTM was evaluated 
and/or calibrated for low mass analysis. For positive mode two additional analytes, N-butylamine 
(m/z=74.09643) and triethylamine (m/z=102.12773), were added to the standard positive ion 
calibration solution which contained caffeine, MRFA (met-arg-phe-ala) and Ultramark 1621 (a 
mixture of fluorinated phosphazines). A custom calibration solution containing sodium taurocholic 
acid (m/z=514.28441), sodium dodecyl sulphate (m/z=265.14791), phthalic acid 
(m/z=165.01933), benzoic acid (m/z=121.02950), glycolic acid (m/z=75.00877) and acetic acid 




2.2.5 Fingermark deposition and extraction procedures  
As recommended by Sears et al. [98], natural fingermarks, collected from donors during their 
normal daily routine, were used for all fingermark experiments. In order to produce natural 
fingermarks, for at least 30 minutes prior to sample collection, hands were not washed, not wiped 
deliberately across the face nor used to apply cosmetics. Fingermarks were collected and 
extracted based on a method used by Menzies for LC-MS analysis of drugs in fingermarks 
(unpublished work). Natural fingermarks were deposited onto 15 mm diameter glass coverslips 
(VWR International, Lutterworth, UK) after rubbing fingertips together to evenly distribute any 
residues. For recovery experiments, 6 donors (3 male, 3 female) were used and 0.5 µg of each 
analyte (100 µL of a 5 µg mL-1 mixed standard solution) was added to each fingermark and 
allowed to dry for 10 min before extraction. Fingermarks were then extracted in 15 mL scintillation 
vials with 0.5 mL of a 50:50 methanol:water solution using a KS 260 basic shaker (Staufen, 
Germany) at 300 rpm for 10 min.  
C4, a commercial explosive containing RDX, was acquired, stored and handled by licenced 
technicians from Precision Energetics (Somerset, UK) and EPC UK Ltd. (Essex, UK) in 
compliance with the Explosives Act 1875 [8] and the Explosives Regulations 2014 [14]. As with 
blank and spiked fingermarks, hands were not washed, wiped deliberately across the face or used 
to apply cosmetics for 30 minutes prior to sample collection. After handling, a fingermark depletion 
series (n=60) was produced by a single donor and a subset of marks were extracted and analysed 
as above. 
Ethical approval for the chemical analysis of energetic materials in fingermarks was granted by 
the King’s College London Biomedical Sciences, Medicine, Dentistry and Natural & Mathematical 
Sciences Research Ethics Sub-Committee (BDM RESC, Study reference: HR-15/16-1962). 
2.2.6 Data analysis 
HPLC-UV data were acquired using Agilent ChemStation B.02.01 software. ChemStation was 
also used to determine retention times (tR), peak width at half height (W0.5) and peak symmetry 
(As), which was defined as simply peak area before apex, divided by peak area after apex, unless 
inflection points were found [99]. Retention factor (k), selectivity factor (α) and resolution (Rs) were 
then calculated using Equation 2.1, Equation 2.2 and Equation 2.3. Chromatograms were plotted 





















LC-HRMS data were acquired using Thermo Xcalibur version 2.2. Xcalibur Qual Browser, with a 
5 ppm mass accuracy threshold from the exact m/z, was used to produce extracted ion 
chromatograms (EICs). Seven-point gaussian smoothing was used prior to integration for 
determination of peak height and/or area. The raw data for the EICs were normalized in excel to 
the largest and smallest intensity across the full mass chromatogram. Excel was used to plot all 
graphs. However, Minitab 18 was used to determine the line of best fit for the scatter plot in Figure 




2.3 Results and discussion  
2.3.1 Optimisation of chromatography conditions 
Initial chromatographic optimisation was performed using HPLC-UV rather than HPLC-HRMS. In 
addition to cost savings, using a UV detector allowed optimisation of chromatography without 
having to account for ionization challenges. The intensity of detector response for different 
compounds was also more similar (for the nitro-explosives that could be detected by UV) than 
when an HRMS detector was used. This allowed the resolution between two similar sized peaks 
to be calculated more easily. That said, since the peroxides (e.g. TATP and HMTD) do not contain 
a chromophore, they do not absorb UV light and so could not be detected by HPLC-UV. This 
meant that initial chromatographic optimization was only performed for the 16 nitro-explosives 
identified as initial target compounds and separation of the two peroxides was only assessed after 
optimisation of HRMS conditions.  
2.3.1.1 Separation on YMC Triart PFP column 
Initial work focussed on improving an existing chromatographic separation developed by L. Salvia 
using a pentafluorophenyl (PFP) column during previous work [100]. When comparing seven 
columns (six with a C18 stationary phase and one with a PFP phase), as part of an MSc research 
project, Salvia found the YMC Triart PFP column to give the best combined selectivity and 
efficiency for organic explosives and a gradient separation of 45-55 % B over 50 min, at 20 °C, 
was developed on this column. However, the desired baseline resolution was not achieved for all 
compounds and three pairs, HMX/R-Salt, NG/NB and 2,6-/2,4-DNT were unresolved. As baseline 
resolution was desirable for identification, here attempts were made to improve separation on the 
YMC Triart PFP column through the use of alternative gradients and temperature. 
2.3.1.1.1 Gradient separation 
A selection of the gradients investigated are shown in Figure 2.2, along with the gradient 
previously developed (45-55 % B over 0-50 min). Separation was improved by using a 40-55 % 






Figure 2.2: Gradient separations of 16 target analytes on a YMC Triart PFP column using: 50-55% B over 
0-50 min; 45-55% B over 0-50 min; 40-55% B over 0-50 min and 40-55% B over 0-60 min. All were at 20 
°C. 
 
2.3.1.1.2 Effect of temperature on gradient separation 
As shown by the van’t Hoff equation (Equation 2.4), which is defined under isocratic conditions, 
retention factor (k) is temperature dependent. 
Equation 2.4: Van’t Hoff equation 







To investigate the effect of temperature on this gradient separation, the optimised mobile phase 
gradient (40-55% B over 0-50 min) was run over a range of temperatures from 5 – 45 °C (Figure 
2.3). Separation of the first two peaks, R-Salt and HMX, was best at 5 °C. However, at 5 °C the 
efficiency and separation of the later eluting analytes, which was best at 20 °C, was lost. In 
contrast, separation of the isomers 2,4- and 2,6-DNT was best at 45 °C and the group of 4 
analytes in the middle of the run (NB, NG, TNT and Tetryl) were separated best at either 5 or 35 
°C. So in conclusion, different temperatures resulted in the optimum separation for different 
regions of the chromatogram and no one temperature achieved separation of all 16 initial target 




Figure 2.3: The effect of temperature on separation of 16 target analytes using the YMC Triart PFP column 
and a gradient of 42-54 % CH3OH over 0-50 min. Dashed boxes indicate areas of best separation. 
 
2.3.1.1.3 Optimised gradient with temperature program 
A thermal program, starting at 5 °C before increasing to 45 °C from 10 min and then decreasing 
back to 5 °C from 25 min, gave the best separation.  As shown by the dashed line in Figure 2.4, 




of PA, 2,3-DNT and all initial target analytes except for the isomers 2,4- and 2,6-DNT, was 
achieved (Figure 2.4). In order to further evaluate the separation, retention times and their relative 
standard deviation (RSD) were measured over 10 repeat injections. These are given in Table 2.2, 
along with calculated retention factors (k), peak symmetry (As), selectivity factor (α) and resolution 
(Rs). Unlike retention time (tR), the retention factor takes into consideration the void time (t0) and 
so allows comparison across columns with different dimensions. Peak symmetry refers to the 
peak shape and for an ideal Gaussian peak As = 1; values of As < 1 indicate peak tailing and As 
> 1 indicate peak fronting. Selectivity factor refers to the difference in retention factor of two 
adjacent peaks, with values of 1.00 indicating identical retention factors. Resolution is perhaps 
the best measure of separation as it takes into account peak width, or in this case peak width at 
half height (W0.5), as well as the two retention times (t1 and t2) and for Gaussian peaks Rs > 1.5 
indicates baseline resolution. In addition to 2,4- and 2,6-DNT, R-Salt/HMX, NG/NB, 4-NT/3,4-
DNT, 3,4-DNT/3-NT and ETN/PETN were also not fully baseline resolved with a resolution (Rs) 
less than 1.5 as shown in Table 2.2. As a result of this, alternative columns were investigated. 
 
Figure 2.4: Optimised separation including two additional target analytes using the YMC Triart PFP column, 
a gradient of 42-54 % CH3OH over 0-50 min and a temperature program of 5-45 °C mid-run. The measured 



















NM 3.80 0.04 0.82 0.81 1.82 5.54 
Sys peak† 4.83 0.04 1.32 0.50 1.27 2.14 
R-Salt* 7.94 0.13 2.81 0.79 1.64 5.70 
HMX* 8.49 0.16 3.08 0.77 1.07 1.07 
PA 8.94 0.18 3.30 0.70 1.05 0.82 
EGDN* 10.53 0.09 4.06 0.74 1.18 3.10 
RDX* 13.42 0.16 5.45 0.76 1.28 5.55 
DEGDN 14.20 0.10 5.82 0.82 1.06 1.44 
NG* 19.85 0.09 8.54 0.95 1.40 10.40 
NB* 20.47 0.13 8.84 0.85 1.03 1.13 
TNT* 21.41 0.09 9.29 0.82 1.05 1.63 
Tetryl* 23.82 0.12 10.44 0.85 1.11 4.09 
2,4 DNT* 27.45 0.01 12.19 0.82 1.15 6.00 
2,6 DNT* 27.47 0.19 12.20 0.81 1.00 0.03 
2-NT* 29.07 0.13 12.97 0.80 1.06 2.55 
4-NT* 30.26 0.12 13.54 0.82 1.04 1.79 
3,4-DNT* 31.23 0.12 14.00 0.82 1.03 1.41 
3-NT* 31.86 0.11 14.31 0.85 1.02 0.88 
2,3-DNT 32.97 0.11 14.84 0.83 1.04 1.50 
ETN* 34.51 0.06 15.58 0.75 1.05 2.12 
PETN* 35.50 0.06 16.05 0.79 1.03 1.30 
*Initial target analytes 
†Unidentified system peak present in all injections at 210 nm. 
 
2.3.1.2 Column Selection 
Key details of the six columns investigated alongside the YMC Triart PFP column, in order to 
compare efficiency and selectivity, are given in Table 2.1. A range of different phases were 
investigated including C18, bidentate C18, a cyano phase with a C18-like extended spacer (CN-
ES), a C18 phase with phenyl functionality (C18 Ar) and a diamond hydride phase. Column 
dimensions and particle sizes were selected that were as similar as possible to the PFP column, 
to aid comparison of the different phases. However, whilst all columns were available with 150 
mm length, for some the closest internal diameter (ID) was 2.1 mm (rather than 2 mm) and the 
smallest particle size available for the two cogent columns was 4 µm (rather than 3 µm). Using a 
larger particle size results in more band broadening and a less efficient separation. This is due to 
larger multiple path (A) and mass transfer (C) terms resulting in a larger plate height (H) as 
described by the van Deemter equation (Equation 1.3), where 𝑢𝑥 is the linear velocity and B the 
longitudinal diffusion constant. Using a smaller particle size leads to increased backpressure and 




a chromatographic peak.   
2.3.1.2.1 Efficiency/van Deemter plots 
As efficiency affects peak width and hence separation, the efficiency of the columns was 
compared by constructing van Deemter plots with RDX as a probe (Figure 2.5). The most efficient 
columns have the smallest plate heights and so are at the bottom of the plot. Perhaps 
unsurprisingly, the two least efficient columns were the two with the largest particle sizes, the 
cogent diamond hydride and bidentate C18 columns. The diamond hydride column had particularly 
poor efficiency which may be due to the mobile phase system used for comparison purposes, as 
this column has a very different phase to the other columns tested. Alternatively, this phase may 
just be better suited to separation of more polar analytes. At the other end of the spectrum, the 
CN-ES column was the most efficient followed by the PFP and then the C18 Ar. The CN-ES column 
also had a very flat C term. With good efficiency maintained at higher flow rates, faster analysis 
may be possible.  
  
Figure 2.5: Overlaid van Deemter plots, with RDX as a probe, for the comparison of column efficiencies. 









































2.3.1.2.2 Separation potential  
Along with good efficiency it is important to have good selectivity in order to achieve separation. 
The separation potential of the columns was investigated through comparison of an isocratic 
separation with 60 % methanol and 8 mM ammonium acetate (Figure 2.6). At this stage, the 
separation potential (i.e. how many distinct peaks could be detected for the mix of 16 target 
explosives) was of more interest than the retention order. Very poor retention was seen on the 
diamond hydride column, again this may be because the column is unsuitable for the separation 
of nitro-explosives or that an alternative mobile phase system would be required.  
The increased retention of RDX on the CN-ES column may explain why this column had the best 
efficiency according to the van Deemter plot in Figure 2.5, since efficiency (N) is directly 
proportional to retention time, as well as inversely proportional to peak width. The best selectivity 
was seen with the ACE C18 Ar column which also had good efficiency and so was chosen to take 
forward for development of a separation. 
2.3.1.3 Separation on ACE C18 Ar column 
2.3.1.3.1 Isocratic separation and the effect of temperature  
To investigate the effect of temperature on the ACE C18 Ar column, the isocratic separation was 
run over a range of temperatures from 5 – 45 °C and a van’t Hoff plot showing the relationship 
between 1/T and lnk was produced (Figure 2.7). Using the van’t Hoff equation (Equation 2.4), the 
enthalpy change, ΔH, was then calculated from the slope of the van’t Hoff plot which is -ΔH/R, 
where R is the gas constant. For all analytes, ΔH values were negative, indicating exothermic 
interactions with the stationary phase. Similar ΔH values, as seen for NG and NB, indicated similar 
temperature selectivity. This was not the case for all explosives, with the largest difference in ΔH 
values, and hence temperature selectivity, seen for EGDN (ΔH = -7.62 kJ mol-1) and Tetryl (ΔH 
= -16.1 kJ mol-1). 
Retention times for all the initial target analytes decreased with increased temperature. The last 
peak (PETN) reduced from 28.2 min at 5 °C to 15.3 min at 45 °C, as expected for exothermic 
interactions. Efficiency (N) also decreased with increased temperature (for PETN N =16200 at 5 
°C and N =11500 at 45 °C), which is perhaps less expected as increased temperature typically 
reduces the effect of mass transfer and hence band broadening. Selectivity changes were 





Figure 2.6: Isocratic separations of 16 target analytes at 210 nm. The position of RDX in each chromatogram 





elution order as temperature is altered due to differences in ΔH values. The best separation was 
achieved at 20 °C with all analytes baseline resolved apart from RDX and EGDN which coeluted 
and R-Salt which was not base-line resolved from the unidentified system peak present in all 
chromatograms at 210 nm.  
 
Figure 2.7: Van't Hoff plot for 16 initial target analytes on a C18Ar column over a temperature range of 5-45 
°C. Areas of selectivity change are highlighted in grey, the best separation is indicated by a dashed red 
rectangle and R2 values, slope (m) and ΔH values are shown on the right to 3 significant figures. 
 
2.3.1.3.2 Gradient optimisation 
Gradient elution was investigated in order to improve separation (Figure 2.8). Of the 20 min 
gradients ending with 70 % B (Figure 2.8 A), starting at 40 % B gave the best separation in the 
first half of the chromatogram (between R-Salt and the system peak and EGDN/RDX). However, 
separation of the second half of the chromatogram was best when starting at 60 % B. Therefore, 
both steeper gradients and multi-step gradients were attempted (Figure 2.8 B & C). The baseline 
for 210 nm was adversely affected by the use of a multi-step gradient, so single-step gradients 




0.996 1480 -12.3 
0.999 1620 -13.5 
0.999 1940 -16.1 
0.996 1380 -11.5 
0.999 1560 -13.0 
0.999 1610 -13.4 
0.999 1390 -11.6 
0.999 1380 -11.5 
0.999 1370 -11.4 
0.999 1540 -12.8 
0.997 1170 -9.71 
0.999 1170 -9.71 
0.998 1330 -11.1 
0.996 917 -7.62 
0.999 1280 -10.6 










Figure 2.8: Gradient method development on ACE C18 Ar column (λ = 210 nm). (i) Shows the effect of 
different starting mobile phase composition. (ii) Shows multi and singe step gradients starting with 40 % B. 
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40-50% B 0-10 min,
50-60% B 10-15 min,
60-70% B 15-35 min
40-90% B 0-30 min





2.3.1.3.3 Optimised gradient 
The optimised separation of the 16 initial target analytes, along with NM, DEGDN, PA and DMNB 
is shown in Figure 2.9 at both 210 and 254 nm. As in section 2.3.1.1.3, average retention time, 
relative standard deviation (RSD), retention factor (k), peak symmetry (As), selectivity factor (α) 
and resolution (Rs) were also determined for the optimised separation on the ACE C18 Ar column 
(Table 2.3).  All analytes were separated, although 2,4- and 2,6-DNT were still not baseline 
resolved.  
 
Figure 2.9: Optimised separation including some additional target analytes on the ACE C18 Ar column using 
a linear gradient, 40-100 % B over 0-30 min, at 20 °C. 
 
Table 2.3 (Continued): Retention, symmetry, selectivity and resolution of optimised separation on the ACE 













NM 3.41 0.11 0.31 0.76 1.06 0.98 
sys peak† 4.93 0.15 0.89 0.43 1.45 2.19 
R-Salt* 6.57 0.20 1.51 0.90 1.33 2.18 
HMX* 8.96 0.42 2.40 0.87 1.36 6.86 
EGDN* 10.69 0.19 3.09 0.98 1.20 5.27 
RDX* 11.71 0.28 3.46 0.91 1.09 3.06 
DEGDN 13.57 0.24 4.18 0.97 1.16 6.06 



















































































Table 2.3 (Continued): Retention, symmetry, selectivity and resolution of optimised separation on the ACE 













DMNB 14.80 0.25 4.65 0.94 1.06 2.91 
NB* 16.00 0.21 5.12 0.86 1.08 4.01 
NG* 18.02 0.25 5.88 0.98 1.13 6.91 
3,4-DNT* 20.24 0.25 6.73 0.92 1.12 8.26 
2-NT* 20.53 0.21 6.85 0.96 1.02 1.12 
4-NT* 20.88 0.21 6.98 0.90 1.02 1.20 
3-NT* 21.63 0.21 7.27 1.01 1.04 2.38 
2,6-DNT* 22.01 0.19 7.41 1.01 1.02 1.18 
2,4-DNT* 22.26 0.21 7.51 0.95 1.01 0.87 
ETN* 23.17 0.24 7.85 1.13 1.04 3.17 
Tetryl* 23.56 0.22 8.00 0.88 1.02 1.37 
TNT* 24.43 0.20 8.34 1.13 1.04 2.97 
PETN* 24.80 0.23 8.48 1.06 1.01 1.24 
*Initial target analytes 
†Unidentified system peak present in all injections at 210 nm. 
 
 
2.3.1.4 Comparison of two optimised LC methods 
The main advantage to the optimised separation on the ACE C18 Ar column over the YMC Triart 
PFP column was separation of the 2,4- and 2,6-DNT isomers as the resolution achieved using 
the ACE C18 Ar column (Rs = 0.87, Table 2.3) was much improved compared to the YMC Triart 
PFP separation (Rs = 0.03, Table 2.2). Resolution between R-Salt and HMX was also improved 
(Rs = 6.86 with C18 Ar compared to Rs =1.07 with PFP), as was resolution between 3,4-DNT and 
the adjacent NT peak (Rs = 1.12 between 3,4-DNT and 2-NT with C18 Ar compared to Rs = 0.88 
between 3,4-DNT and 3-NT with PFP. One pair of peaks where resolution was slightly better with 
the PFP method was 2- and 4-NT (Rs = 1.20 with C18 Ar compared to Rs =1.79 with PFP). Another 
advantage of the ACE C18 Ar separation was that it was simpler, as unlike with the PFP separation 
thermal programming was not required.  
Several HPLC methods for the identification of explosives use multiple columns with orthogonal 
selectivity in order to achieve confirmation [58,59]. Given that there was a change in retention 
order between the two optimised methods, their orthogonality was investigated by plotting the 
retention factor on the PFP column (kPFP) against the retention factor on the C18 Ar column (kC18Ar), 
Figure 2.10. Positive correlation was seen, which was unsurprising given that both phases had 
aromatic functionality. However, clearly the data did not fit to the line of y=x, indicating that the 




the PFP method. This may have been due to the more polar mobile phase (lower percentage of 
methanol) used in the PFP method which would result in increased retention of less-polar 
compounds. Interestingly, the three analytes that were relatively more retained on the C18 Ar 
column: PA (2,4,6-trinitrophenol), TNT (2,4,6-trinitrotoluene) and Tetryl (N-methyl-N,2,4,6-
trinitroaniline), all contain a 2,4,6-trinitro substituted benzene ring. This may be explained by the 
three electron-withdrawing nitro groups of the 2,4,6-trinitro substituted benzene ring resulting in 
the formation of stronger intermolecular π-π interactions with phenyl groups than 
pentafluorophenyl (PFP) groups which have five electronegative fluorine substituents, which are 
also electron-withdrawing leading to increased repulsion when π-π stacking two electron deficient 
rings. 
  
Figure 2.10: Scatter plot showing positive correlation between retention factor on the PFP column (kPFP) and 
retention factor on the C18Ar column (kC18AR) for target analytes, with the orthogonal regression line and 






























2.3.1.5 Increasing flow rate for LC-HRMS 
Including a wash step and re-equilibration, the total runtime for the separation at 0.15 mL min-1 
was 75 min. While relatively low throughput analysis means runtime is less important than 
confidence of identification for the forensic detection of explosives, a faster runtime would still be 
desirable. In order to shorten the total runtime, the effect of increased flow rate was investigated 
(Figure 2.11). This had the advantage of also shortening the wash and re-equilibration steps, 
doubling the flow rate to 0.3 mL min-1 also halved the total runtime to 37.5 min. However, due to 
an increased back pressure of 450 bar, it was only possible to use higher flow rates with the ultra-
high performance liquid chromatograph (UHPLC) attached to the HRMS and not for the HPLC-
UV system used. Therefore, using the instruments available, the effect of increased flow rate on 
separation could only be assessed for those analytes which were detected by HRMS. Baseline 
resolution between TNT and PETN was lost when the method was transferred from the HPLC-
UV system to the LC-HRMS system and a guard column was added. For all detected analytes 
except TNT and PETN, separation was maintained with increased flow rate. The considerably 
faster analysis time justified the slight loss in separation at 0.3 mL min-1, especially whilst 
optimising HRMS conditions.  
Even with HRMS, some of the overlaid extracted ion chromatograms (EICs) used in Figure 2.11 
had multiple peaks of different intensities, indicating common ions. For example, nitrate esters 
NG, ETN and PETN all produced peaks for the nitrate ion extracted mass (61.98837 ± 5 ppm), 
with the largest being due to PETN. Perhaps more surprisingly, the largest peak seen for the DNT 
[M-H]- ion extracted mass (181.02548 ± 5 ppm) was actually due to a fragment of Tetryl rather 
than any of the DNT isomers, demonstrating the importance of LC separation in the detection of 
organic explosives. 
2.3.2 Optimisation of high resolution mass spectrometry 
Both electrospray ionisation (ESI) and atmospheric pressure chemical ionisation (APCI) 
conditions were optimised before the performance of the two ionisation techniques were 






Figure 2.11: Overlaid LC-(ESI)-HRMS extracted ion chromatograms for target analytes at 0.15, 0.2, 0.25 




2.3.2.1 Optimisation of electrospray ionisation – high resolution mass spectrometry 
conditions 
2.3.2.1.1 Optimisation of ESI-HRMS parameters using ammonium acetate mobile phase 
Heated electrospray ionisation mass spectrometry (HESI-MS) parameters were initially optimised 
with the 8 mM ammonium acetate, methanol:water mobile phase used for optimisation of 
chromatography in Section 2.3.1 and in existing LC-MS/MS methods at the Forensic Explosives 
Laboratory (unpublished work) where the ammonium acetate was used to form acetate adducts 
of NG, RDX, HMX and PETN and ammonium adducts of TATP.  As ammonium acetate was also 
used for other research projects regularly using the same LC-HRMS instrument for the detection 
of pharmaceuticals [83], another reason for starting with this mobile phase additive was that it 
minimised the time required to equilibrate the system between users.  
Ion optic parameters were optimised for each of the nitro-explosives detected via direct infusion 
by auto-tuning for the [M-H]- or [M+OAc]- ions. Very little improvement was found for the other 
analytes when the RDX tune file was used as a starting point and so the same tune file was used 
across the run. As a result of this, there were no gaps in the run where non-target analytes could 
be missed due to changing acquisition files. A different tune file was required for the two peroxides 
which, unlike the nitro-explosives, were detected using positive ionisation, as [M+H]+ or [M+NH4]+ 
ions. Spray voltage, capillary temperature and HESI heater temperature were optimised by LC-
HRMS analysis and the effect of each of these parameters on LC peak areas for the nitro-
explosives are shown in Figure 2.12. Changing the spray voltage from -2.5 to -4.0 kV had very 
little effect on peak area, but temperature had a greater effect. The most temperature dependant 
analytes were the dinitrotoluenes (DNTs) which increased in intensity with temperature and RDX 
which decreased in intensity with increased temperature. Compromise temperatures of 300 °C 
for capillary temperature and 240 °C for heater temperature were selected. 
Only twelve of the eighteen initial target analytes were detected using ESI and the ammonium 
acetate mobile phase, with ions for NB, the NT’s and EGDN not detected. Detection of the other 
nitroesters was also problematic. Whilst the acetate adduct of NG, [NG+OAc]-, has been detected 
in previous studies using an ESI source [44], here NG was only detected as a nitrate ion no matter 
what ionisation and ion optic parameters were used. This may be due to differences in the 





ion was also detected for ETN and PETN this was not deemed sufficient for identification and the 
tentative identification of NG was based on retention time rather than the detection of a unique 
ion. For forensic casework, further confirmation would be required. ETN was detected as the 
nitrate adduct, [M+NO3]-, but with low intensity and was not detected below 1.25 ng on column.  
2.3.2.1.2 Effect of mobile phase additives on LC-(ESI)-HRMS 
Due to the poor detection of the nitrate esters, nitrobenzene and nitrotoluenes with ammonium 
acetate in the mobile phase, alternative mobile phase additives were investigated. Previously 
Zhao et al. and Thomas et al. found, ammonium chloride aided detection of nitroesters [34,39]  
whilst Xu et al. found the use of no additives in the mobile phase best for nitroaromatics [40]. 
Therefore, the use of ammonium chloride and no mobile phase additives were both compared to 
the  ammonium  acetate  mobile  phase  and  a  summary  of  the  results  is  given  in  Table 2.4.  
Figure 2.12: Optimisation of ESI-HRMS parameters for the nitro-explosives: a) spray voltage, b) HESI heater 
temperature and c) capillary temperature. Error bars represent standard deviation of n=3 repeats. Note. 2-




Table 2.4: LC-(ESI)-HRMS sensitivity and linear range for target nitro-explosives detected in negative mode using ammonium chloride, ammonium acetate or no mobile phase additive. 
Analyte 

















R-Salt [M+CHO2]- 50 - - [M+CHO2]- 5 5 - 5000 0.992 [M+CHO2]- 5 5 - 5000 0.992 
[M+Cl]- 5 5 - 2500 0.993 [M+OAc]- 5 5 - 5000 0.994     
HMX [M+CHO2]- 500 - - [M+CHO2]- 5 5 - 5000 0.992 [M+CHO2]- 5 5 - 5000 0.992 
[M+Cl]- 5 5 - 1000 0.992 [M+OAc]- 5 5 - 5000 0.994     
RDX [M+CHO2]- 250 - - [M+CHO2]- 5 5 - 5000 0.993 [M+CHO2]- 5 50 - 5000 0.997 
[M+Cl]- 5 5 - 2500 0.994 [M+OAc]- 5 5 - 5000 0.994     
EGDN [M+Cl]- 5000 - - n.d. - - - n.d. - - - 
PA [M-H]- 5 5 - 5000 0.993 [M-H]- 5 - - [M-H]- 5 5 - 5000 0.994 
NG [NO3]- 25 25 - 5000 0.997 [NO3]- 25 25 - 5000 0.997 [NO3]- 25 25 - 5000 0.996 
[M+NO3]- 500 - - [M+NO3]- n.d. - - [M+NO3]- 25 25 - 5000 0.997 
[M+Cl]- 10 10 - 5000 0.992 [M+OAc]- n.d. - -     
3,4-DNT [M-H]- 100 100-5000 0.994 [M-H]- 2500 - - [M-H]- 250 - - 
2,4/2,6-DNT* [M-H]- 25 25 - 5000 0.990 [M-H]- 100 100 - 5000 0.999 [M-H]- 50 50 - 5000 0.997 
ETN [NO3]- 25 25 - 2500 0.997 [NO3]- 25 25 - 5000 0.995 [NO3]- 50 - - 
[M+NO3]- 100 500 - 5000 0.991 [M+NO3]- 250 - - [M+NO3]- 10 50 - 5000 0.991 
[M+Cl]- 10 10 - 5000 0.998 [M+OAc]- n.d. - -     
Tetryl [M+CH3O]- 50 100 - 1000 0.993 [M+CH3O]- 5 5 - 5000 0.992 [M+CH3O]- 5 50 - 2500 0.993 
[M-NO]- 500 - - [M-NO]- 5 5 - 5000 0.991 [M-NO]- 5 - -  
[M+Cl]- 5 5 - 2500 0.995 [M+OAc]- n.d.       
TNT [M-H]- 5 5 - 5000 0.997 [M-H]- 5 5 - 5000 0.996 [M-H]- 5 5 - 2500 0.991 
PETN [NO3]- 5 5 - 5000 0.996 [NO3]- 5 5 - 5000 0.997 [NO3]- 10 50 - 5000 0.992 
[M+NO3]- 10 10 - 2500 0.993 [M+NO3]- 10 25 - 1000 0.997 [M+NO3]- 10 10 - 5000 0.997 
[M+Cl]- 5 5 - 5000 0.994 [M+OAc]- 250 - -     
* Only one peak was detected in mixture for 2,4/2,6-DNT peak height was used for this peak, as it was not fully resolved from a peak of same accurate mass attributed to tetryl. 
Cal 1- lowest concentration of standards run (5, 10, 25, 50, 75, 100, 250, 500, 750, 1000, 2500 and 5000 pg µL-1) in which analyte was detected, n.d. - not detected in 5000 pg µL-1  
Linear range - concentration range over which R2 > 0.99 for bi-logarithmic linear trendline 
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Calibration curves were run with 8 mM ammonium acetate, 0.2 mM ammonium chloride or no 
additive in the mobile phase using a mixed standard at a range of concentrations from 5 – 5000 
pg µL-1. As the concentration used (5, 10, 25, 50, 75, 100, 250, 500, 750, 1000, 2500 and 5000 
pg µL-1) covered multiple orders of magnitude, bi-logarithmic calibration lines were used to ensure 
a more even spread and therefore weighting of the data points.  Sensitivity was compared based 
on the concentration of the lowest standard run in which the ion was detected, Calibrant 1 (Cal 
1), since limits of detection were not explicitly determined yet. In many cases, where an ion was 
detected but no linear range is given, the bi-logarithmic calibration line fit well (R2 > 0.99) to a 
quadratic equation instead.  
As found previously [40], ionization of the nitroaromatics was most efficient with no mobile phase 
additives present. The ammonium chloride resulted in less ion suppression than the ammonium 
acetate, perhaps due to the lower concentration required (0.2 mM ammonium chloride compared 
to 8 mM ammonium acetate).  Un-buffered mobile phase is generally not recommended because 
it led to less repeatable retention times, as shown by the size of error bars in Figure 2.13. The 
retention time of picric acid (PA) was affected the most by changing the mobile phase and the
 
Figure 2.13: Average retention times for LC-(ESI)-HRMS with NH4OAc, NH4Cl or no additive. Error bars 




peak shape was poor without any buffer. Picric acid was ionised with all mobile phases used (pH 
6.4-7.8), due to the very acidic hydroxyl group attached to the benzene ring with three electron-
withdrawing nitro groups (Figure 2.14).  
 
Figure 2.14: Chemical structure and acid dissociation constant (predicted using Percepta PhysChem 
Profiler) of picric acid, which was predominantly charged at the pH of all mobile phase. 
 
In addition to sensitivity and linear range, it is also important to consider the type of ions detected 
when comparing mobile phases. Ions formed by deprotonation of the molecular ion or due to the 
addition of an adduct to the molecular ion were considered preferable and of greater forensic 
values than fragments such as nitrate which may be shared by multiple analytes. Chloride adducts 
were detected for all four nitrate esters with good sensitivity (except for EGDN) when ammonium 
chloride was present in the mobile phase. Therefore, despite the nitrate ion being detected with 
good sensitivity using all mobile phases, using ammonium chloride improved detection of the 
nitrate esters.  
Overall, ammonium chloride was found to be the best mobile phase additive for this purpose and, 
since retention times varied somewhat, it was necessary to alter the gradient slightly in order to 
achieve good separation. The optimised separation with 0.2 mM ammonium chloride used a 
gradient of 40-90 % B over 15 min, followed by a wash step at 100% B for 5 minutes which was 
added after peaks were noticed in blanks peaks after prolonged use.    
2.3.2.2 Optimisation of atmospheric pressure chemical ionisation – high resolution mass 
spectrometry parameters 
Atmospheric pressure chemical ionisation mass spectrometry (APCI-MS) parameters were 
investigated and optimised for the initial 18 target analytes (Figure 2.15), using LC-MS with a 0.3 
mL min-1 flow rate and 0.2 mM ammonium chloride in the mobile phases. All 18 target analytes 
were detected. Here, chromatographic peak height was used rather than peak area as two peaks 
were detected for 2,4- and 2,6-DNT but they were not quite resolved to baseline, preventing the 




































Figure 2.15: Optimisation of APCI parameters: a) corona discharge current, b) vaporiser temperature and c) 
capillary temperature. Dashed red boxes indicate the setting used for other optimisation experiments. 
  
ionisation was used for the peroxides, TATP and HMTD. The dashed red boxes in Figure 2.15 
indicate the settings used for the other two optimisation experiments. Therefore, in theory the 
three boxes should line up. Clearly this is not the case with chromatographic peak heights for the 
Capillary Temperature experiments appearing lower than for the other two experiments. This can 
be explained by the fact the Capillary Temperature experiments were run on a different date to 
the corona discharge current and vaporiser temperature when the overall sensitivity of the 
instrument was poorer, but the instrument still passed calibration. 
Increasing corona discharge current led to an increase in chromatographic peak height until the 
effect levelled off after 10 kV which was selected as the corona discharge current (Figure 2.15 
A). As was seen for ESI (Figure 2.12), the effect of APCI temperatures was compound dependent 
(Figure 2.15 B and C). With APCI, TNT and the dinitrotoluene isomers produced the strongest 
signal and were less effected by temperature than with ESI. However, two nitroaromatics (2-NT 
and 4-NT) still saw a marked increase in peak height with increased APCI vaporiser temperature. 
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As with ESI, increased temperatures had a detrimental effect on the peak height of the nitrate 
esters and to a lesser extent the nitramines.  Therefore, a compromise was required when 
selecting vaporiser temperature and capillary temperature for a multi-analyte method. In this 
instance, a 300 °C vaporiser temperature and a 250 °C capillary temperature were selected for 
the optimised method. While these temperatures are lower than the typical 350 to 450 °C 
vaporiser temperature and 350 to 380 °C capillary temperature suggested by the manufacturer 
for this flow rate [101,102], they are not as low as the temperatures used in some methods for 
explosive analysis. For example, Xu et al. used a heated capillary temperature of 125 °C and 
vaporiser temperature of 160 °C [33]. In this study, one of the considerations when selecting the 
250 °C capillary temperature was that lower capillary temperatures (200 °C and 225 °C) led to 
warnings about the vacuum and for the same reason temperatures below 200 °C were not 
investigated. In future work, it might be possible to overcome this challenge with a higher sheath 
gas setting than the 50 out of a maximum of 80 used here or a lower LC flow rate which would 
have resulted in a longer runtime. Xu et al. used a flow rate of 0.2 mL min-1 [33], which may explain 
the use of lower temperatures. DeTata et al. on the other hand used a slightly higher vaporiser 
temperature (325 °C) and a much higher flow rate (1 mL min-1) [32].     
2.3.2.3 Comparison of ESI and APCI for broad screening of organic explosives 
Following optimization of ionization parameters for both electrospray ionization (ESI) (Figure 2.12) 
and atmospheric pressure chemical ionization (APCI) (Figure 2.15), a comparison of the two 
ionization techniques was performed for the initial target analytes (Figure 2.16). Both negative 
and positive ionization modes were required for detection of the 18 target compounds as the 
peroxides could only be detected in positive mode while the nitro-compounds were detected in 
negative mode. Molecular ions, (de)protonated molecules and chloride or ammonium adducts 
were used for all, except for EGDN where only an [NO3]- fragment ion was detected.  
Even at 25 ng on column, the three nitrotoluenes (2-NT, 3-NT and 4-NT), nitrobenzene (NB) and 
ethylene glycol dinitrate (EGDN) were not detected using ESI. Apart from EGDN, the nitrate esters 
formed chloride adducts and were detected with greater sensitivity by ESI than APCI. The 
nitramines (RDX and HMX) and nitrosamine (R-Salt) were also detected as chloride adducts but 
were detected with good sensitivity by both ionisation methods.  The nitroaromatics on the other 




Figure 2.16: Number of initial target analytes detected by: A) APCI and B) ESI at 25, 2.5, 0.5 and 0.05 ng 
on column. N.b. for the purpose of this figure Tetryl is classed as a nitroaromatic not a nitramine. 
 
as a nitramine and was the only nitroaromatic detected as a chloride adduct. All other 
nitroaromatics were detected as the molecular ion, M-·, and/or deprotonated molecule, [M-H]-. 
The peroxides were also detected with greater sensitivity by APCI than ESI. Due to detection of 
all the target analytes, the APCI method was selected to test against a larger set of compounds 
for generalizability in Chapter 3.   
2.3.3 Instrumental method performance of optimised multi-residue LC-APCI-HRMS 
method  
A brief assessment of the optimized LC-APCI-HRMS method performance for the initial 18 target 
analytes is shown in Table 2.5. Method performance will be assessed in more detail and for a 
larger number of analytes in Chapter 3. Here, retention time ± standard deviation (SD), average 
m/z and mass accuracy are given for the molecular ion, (de)protonated molecule or adduct ion 
although these are not always the most intense ion. The only exception to this is EGDN where 




















































screening and identification. In order to provide an indication of method sensitivity a calibration 
line was run and the lowest concentration in which the specified ion was detected (Cal 1) is given 
in Table 2.5. Determination of limits of detection for LC-HRMS methods is somewhat complicated 
by the lack of noise in many extract ion chromatograms (EICs). The method performance varied 
widely between analytes with TNT, 2,4-DNT, 2,6-DNT and 3,4-DNT molecular ions or 
deprotonated molecules detected in the lowest concentration standard analysed (1 pg µL-1) but 
the ETN chloride adduct only detected in the highest concentration standard (10 ng µL-1).    
Table 2.5 (Continued): APCI method performance for eighteen initial target analytes. 









Cal 1 c 
(pg µL-1) 
Linear range 
d (pg)  
Linearity 
(R2) 
HMTD 2.85 0.05 [M+H]+ 209.0763 -2.59 100 75-10000 e 0.998 
R-Salt 3.6 0.03 [M+Cl]- 209.0194 -3.44 2.5 2.5-1000 0.995 
HMX 4.7 0.07 [M+Cl]- 331.0157 -2.31 2.5 2.5-1000 0.997 
EGDN 5.5 0.04 [NO3]- 61.9884 1.14 250 750-10000 0.995 
RDX 6.1 0.07 [M+Cl]- 257.0041 -2.82 2.5 2.5-1000 0.997 
NB 7.8 0.08 [M]-. 123.0326 -0.06 1000 2500-10000 0.97 
NG 9.2 0.08 [M+Cl]- 261.9719 -2.39 250 250-10000 e 0.983 
3,4-DNT 10.4 0.1 [M]-. 182.0332 -0.67 1 1-1000 0.993 
2-NT 10.7 0.1 [M-H]- 136.0403 -0.58 250 250-1000 0.984 
4-NT 11 0.13 [M-H]- 136.0403 -0.52 500 500-1000 0.999 
3-NT 11.1 0.01 [M]-. 137.0482 -0.49 7500 - - 
2,6-DNT 11.3 0.11 [M]-. 182.0331 -0.87 1 1-1000 0.993 
2,4-DNT 11.4 0.1 [M-H]- 181.0253 -0.87 1 1-1000 0.998 
ETN 12 0.09 [M+Cl]- 336.9681 1.35 10000 - - 
Tetryl 12.1 0.12 [M+Cl]- 321.9831 -2.07 100 100-10000 e 0.996 
TATP 12.22 0.08 [M+NH4]+ 240.1441 -0.46 250 250-10000 0.998 
TNT 12.5 0.11 [M]-. 227.0182 -0.81 1 1-1000 0.993 
PETN 12.7 0.09 [M+Cl]- 350.9832 -1.83 75 75-10000 e 0.994 
a Average of n=18 
b Average of n=6 
c Lowest concentration of standards run (1, 2.5, 5, 10, 7.5, 25, 50, 75, 100, 250, 500, 750, 1000, 2500, 5000, 7500 and 
10000 pg µL-1) in which analyte was detected 
d Linear range for bi-logarithmic calibration line 
e Fitted to a non-linear trendline.  
 
2.3.4 Application of LC-HRMS method to the detection of explosives in contact traces 
2.3.4.1 Recovery of organic explosives from latent fingermarks 
Recovery of organic explosives from latent fingermaks was determined by spiking six fingermarks 
with a mixed standard containing the initial 16 nitro-explosives plus nitromethane (NM), picric acid 
(PA), diethylene glycol dinitrate (DEGDN) and trinitrobenzene (TNB). The results of this 
experiment are shown in Figure 2.17. Due to the variability of fingermarks even from the same 
donor, it was not possible to produce a matrix matched standard and so the recoveries given are 




Figure 2.17: Example of spiked fingermark with average recoveries given in brackets ± standard deviation 
(n=6). LC-(APCI)_HRMS extracted ion chromatograms with a 5 ppm mass accuracy for A: m/z 60.00910, B: 
m/z 209.01955, C: m/z 331.01593, D: m/z 61.98837, E: m/z 257.00430, F: m/z 227.98983, G: m/z 
123.03258, H: m/z 213.00274, I: m/z 182.03331, J: m/z 136.04040, K: m/z 181.02548, L: m/z 241.02146 
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relative to a standard in methanol. As a result of this, stated recoveries, which were all > 70 %, 
may have included enhancement or suppression due to the matrix as well as the percentage 
recovery of the extraction method.   
Of the 20 explosives analyzed, 19 were detected with recoveries greater than 70 %. 3-NT was 
not detected at all which was not surprising given that even 100 % recovery would have resulted 
in a concentration (1 ng µL-1) lower than the instrumental LOD for 3-NT. Instrumental sensitivity 
was also a challenge for NB which was detected close to LOD, with large background noise 
relative to signal obtained. The nitrate esters were only detected as nitrate ions but with good 
calculated recoveries (88-106 %). Based on the assessment of instrumental method performance 
shown in Table 2.5, the chloride adducts for EGDN and ETN were expected to be below the LOD.    
The overlaid extracted ion chromatograms (EICs) shown in Figure 2.17 also demonstrate the 
chromatographic separation achieved by the optimised LC-HRMS method. Each EIC was 
normalized to 100 % but the target analyte was not always the only peak present. As expected 
the nitrate ion was not very selective with peaks present for each of the nitrate esters included in 
the mix. All three dinitrotoluenes produce both the [M]- and [M-H]- ions and while 2,4-DNT and 
2,6-DNT were not fully baseline resolved some separation was achieved and they could also be 
distinguished based on the fact 2,4-DNT forms more of the deprotonated molecule while 2,6-DNT 
forms more of the molecular ion. In the case of NB, the target analyte was not responsible for 
base peak as there was a larger peak corresponding to the retention time of 2,4-DNT in the EIC 
for m/z 123.03258 ± 5 ppm. Additionally, there was a second peak in the RDX chloride adduct 
EIC (m/z 257.00430 ± 5 ppm) corresponding to HMX retention time. The effect of common ions 
on selectivity will be considered in more detail in Chapter 3.  
2.3.4.2 Detection of trace explosives in latent human fingermarks after handling 
commercial explosives 
In order to test the method under more realistic conditions, a fingermark depletion series was 
carried out after the donor had handled a bulk explosive. The results for the 1st, 11th, 21st, 31st, 
41st, 51st and 61st marks are shown in Figure 2.18, along with a blank fingermark (from a donor 
who had not been in contact with explosives) and 0.01 ng µL-1 standards for comparison. A peak 
for the RDX chloride adduct was visible in all seven depletion series samples. A change in signal 
was also observed for the HMX chloride adduct, in all but the 51st fingermark sample, but at a 




Figure 2.18: Fingermark depletion series following contact with a commercial explosive. Part A shows 
overlaid LC-(APCI)-HRMS extracted ion chromatograms for [RDX+Cl]-, m/z 257.00430 ± 5 ppm and part B 
shows overlaid extracted ion chromatogram for [HMX+Cl]-, m/z 331.01593 ± 5 ppm. Data points represent 
unsmoothed data and lines are plotted with 7 point gaussian smoothing. NL = normalised intensity 









































tR = 6.51 min
51st fingermark 
NL: 7.11E+02 
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tR = 5.10 min 
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NL: 1.56E+02 
tR = 5.11 min 
11th fingermark
NL: 4.02E+02




limit of detection it was difficult to assess the significance of this change in signal and whether or 
not it can actually be considered a peak. Table 2.6 shows which samples contained a peak 
detected by Xcalibur Qual Browser software using the default peak detection settings, with and 
without 7-point gaussian smoothing. Whether or not smoothing was used affected the results with 
peaks detected for RDX in all the smoothed depletion series samples but not in the 41st and 61st 
samples without smoothing. For HMX peaks were only detected in the 1st and 11th fingermarks 
with smoothing and, more surprisingly, the 61st fingermark without smoothing. Additional detection 
criteria, such as a peak height threshold, would change the results again, with no RDX peak 
detected in the 51st fingermark and no HMX peaks detected in any of the depletion series samples 
above 1000 counts.   
Table 2.6: Compounds detected by LC-(APCI)-HRMS in fingermark depletion series using default peak 
detection settings with and without smoothing. 
 RDX (m/z 257.00430 ± 5 ppm) HMX (m/z 331.01593 ± 5 ppm) 
Sample Smoothed*  Unsmoothed Smoothed*  Unsmoothed 
0.1 ng µL-1 PEAK PEAK PEAK PEAK 
0.01 ng µL-1 PEAK PEAK PEAK PEAK 
1st Fingermark PEAK PEAK PEAK NO PEAK 
11th Fingermark PEAK PEAK PEAK NO PEAK 
21st Fingermark PEAK PEAK NO PEAK NO PEAK 
31st Fingermark PEAK PEAK NO PEAK NO PEAK 
41st Fingermark PEAK NO PEAK NO PEAK NO PEAK 
51st Fingermark PEAK PEAK NO PEAK NO PEAK 
61st Fingermark PEAK NO PEAK NO PEAK PEAK 
Blank Fingermark NO PEAK NO PEAK NO PEAK NO PEAK 
*7-point gaussian smoothing performed in Xcalibur Qual browser 
 
 
The ambiguity regarding LC-HRMS peak detection when approaching the detection limits of the 
instrument is problematic, particularly for the use of LC-HRMS in forensic science where results 
need to stand up in a court of law. For confident detection and identification of explosives the 
sensitivity and selectivity of the method requires further investigation and will be revisited in 





An LC-HRMS method was developed for 18 initial target analytes, including 9 nitroaromatics, 4 
nitrate esters, 3 nitramines, 1 nitrosamine and 2 peroxides.  Separation of 20 forensically relevant 
explosives, including 16 of the initial target analytes was achieved by HPLC-UV using an ACE 
C18 Ar column. All analytes were well separated and had good resolution, except for isomers 2,4- 
and 2,6-DNT which only had a resolution of 0.87.   Ionisation of the 18 initial target analytes was 
achieved using APCI, in negative mode for the nitro explosives and positive mode for the 
peroxides. Ammonium chloride was used in the mobile phase to facilitate formation of chloride 
adducts in negative mode and ammonium adducts in positive mode. Compromise conditions were 
required to allow detection of all target analytes and, by using these conditions, the main cost was 
in the sensitivity of the nitrate ester detection. Using ESI and lower ionisation temperatures would 
be preferable if a targeted method just for nitrate esters was required.  
In optimisation experiments, the optimised conditions will inevitably be influenced by the starting 
conditions. Here, the majority of the chromatographic optimization was performed using LC-UV 
not LC-HRMS and with ammonium acetate in the mobile phase, not ammonium chloride. 
Changing to ammonium chloride had some effect on the separation and so the results of the 
column selection and gradient optimisation experiments may have differed if performed using an 
ammonium chloride mobile phase. In hindsight, it may have been better if ionisation conditions 
and in particular the use of mobile phase additives was optimised first. However, at the beginning 
of this project it was assumed that ammonium acetate would be a suitable mobile phase additive, 
since it had been used to aid ionisation in previous methods. Changing from UV to HRMS 
detection also affected the chromatographic separation as there was a bigger difference in 
instrumental response between analytes when using LC-HRMS.  This meant that while two peaks 
with a similar height by UV may be resolved, if one was much larger than the other by HRMS it 
could become a shoulder and not fully resolved. This could be an argument against the use of 
HPLC-UV for the optimisation of HPLC-HRMS methods. However, the cost of instrument hire 
meant it was not feasible to perform all optimisation experiments by LC-HRMS for this project.  
Similarly, the comparison of mobile phase additives was performed using ESI rather than APCI 
which might perform differently with different mobile phases.   
The presented optimized method may not be the optimum method for explosives detection, but it 
was an improvement upon the existing method that was used as a starting point. Further 
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improvements may be seen if optimization experiments were repeated using the optimized 
conditions as a starting point. However, provided a method is fit for purpose there is little value in 
continuing optimization indefinitely.  Additionally, optimum conditions are likely to vary between 
instruments with differences in the architecture of the ion source and subsequent ion transfer, as 
was seen in this study by the lack of detection of the nitroglycerin acetate adduct using the 
ExactiveTM mass spectrometer.  
The method was applied to the detection of explosives in contact traces, with 19 nitro explosives 
detected in spiked fingermarks. RDX and HMX chloride adduct, extracted ion chromatograms for 
a fingermark depletion series were also presented. While RDX was clearly detected following 
handling of a commercial explosive, these results raised questions regarding detection criteria 
when using LC-HRMS. For example, without any background noise, what change in signal is 
required for a peak to be detected, how many consecutive scans does this signal change need 
to be detected in and is smoothing beneficial or misleading? 
In this chapter, full-scan HRMS has not yet been used to its full potential and the method 
performance of only one ion (typically the molecular ion, (de)protonated molecule or adduct ion) 
has been considered for each analyte. In the next chapter, the method performance including 
both selectivity and sensitivity will be considered in greater detail along with effect of using multiple 
ions, fragments and isotope ratios for detection and identification. Additionally, the method 
performance of compounds not considered during the optimization phase will also be investigated 










Chapter 3: Performance of LC-HRMS 
method against an expanded set of 




High resolution mass spectrometry coupled to liquid chromatography (LC-HRMS) has become a 
popular choice for screening and confirmation of explosives due to the ability to detect numerous 
compounds with high mass resolution and high mass accuracy in a single method [32,33]. As 
discussed in Chapter 2, the use of full-scan HRMS allows more explosives to be included in a 
method, without sacrificing the number of data points per chromatographic peak, since data for 
all ions is collected in each scan. Another advantage with full-scan HRMS is that since data is 
collected for all ions, new compounds may also be detected through suspect screening, providing 
they are sufficiently ionised. Post-acquisition data mining has already been used in this way for a 
range of applications including: drugs and pharmaceuticals in the environment [103], 
contaminants and additives in food [104,105] and new psychoactive substances [106] by LC-
HRMS. Non-target analysis can be particularly challenging for explosive compounds, which unlike 
most drugs, tend not to be very acidic or basic and are therefore difficult to ionise. Additionally, it 
is not possible to optimise and performance test a method for individual non-target compounds if 
it is not known in advance that they will be of interest. Therefore, in Chapter 2 an LC-HRMS 
method was optimised for 18 representative explosives with a range of functional groups to 
maximise applicability to new compounds. The first aim of this chapter is to assess the LC-HRMS 
method performance for 62 compounds, including an additional 44 compounds for which the 
method has not been optimised, to mimic the situation with suspect and biased non-target 
screening. Qualitative method performance was assessed only, since selectivity (both between 
explosives and from matrix) and limits of detection and/or identification are most important for 
screening and identification purposes. 
Greater confidence of identification is possible using HRMS as it can separate isobaric ions with 
the same nominal mass but different exact masses.  However, questions remain regarding how 
much greater this confidence is, how it can be measured and what this means for identification 
criteria for explosives using HRMS methods. Xu et al. adapted the identification point system 
initially defined in the European Commission decision (2002/657/EC) to allocate additional points 
to orbitrap MS ions [33,93]. According to the original identification points system, two identification 
points (IPs) could be earned per HRMS ion. Therefore, at least 2 ions were required to achieve 
the 4 IPs needed for confirmation of ‘substances having anabolic effect and unauthorized 
substances’ or the 3 IPs needed for confirmation of veterinary drugs and contaminants. A 
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minimum of at least one ion ratio within the permitted tolerance (20-50 % depending on the 
relative intensity) was also required in both cases [93]. Xu et al. argued that the greater mass 
resolution achieved by orbitrap MS (≥ 60,000 FWHM) compared to the definition of HRMS used 
in the European Commission decision (~20,000 FWHM) warranted 3 IPs per orbitrap HRMS ion, 
with an additional IP available when the isotopic pattern and isobaric profile fit to the theoretical 
one [33]. Based on these assignments the required 3 or 4 IPs could be reached with a single 
orbitrap HRMS ion.  Xu et al. also interpreted the ion ratio requirement as only necessary if 
calculating the sum of IPs for different ions, rather than essential for confirmation. Allowing a 
single HRMS ion to provide enough IPs for identification, ignores potential problems with common 
ions and isomers with the same elemental composition. Also, increased resolution may not 
automatically result in increased confidence, especially if the mass accuracy remains the same. 
Increased resolution may physically separate an analyte from more interferences but without 
increased mass accuracy it would still be unclear whether a peak was due to the analyte or 
interferences. The main increase in confidence provided by higher mass resolution, when 
combined with improved mass accuracy, is fewer possible elemental compositions. If the 
achievable mass accuracy remains unchanged then, even with increased resolution, there would 
be no change in the number of possible elemental compositions. Additionally, there will be a limit 
to the additional value and confidence gained by increased resolution and accuracy, as once the 
elemental composition of an ion has been unequivocally identified, no additional information can 
be gained by either increased resolution or through matching isotopic patterns.   
Lehotay et al. argued that “the identification-point system is not scientific” with the number of IPs 
required for identification arbitrary, rather than based on a rigorous assessment of the number of 
false positives and negatives [94], and the same could be said for increasing the number of IPs 
awarded to an HRMS ion to 3. Lehotay et al. also pointed out that HRMS does not always provide 
a unique elemental composition, especially without any elements with large mass defects, and 
HRMS cannot distinguish between isomers with the same elemental composition [94]. Therefore, 
there is a limit to how much additional selectivity can be provided by increased mass resolution, 
mass accuracy and isotopic patterns. These factors can only confirm the elemental composition 
of the ion, which is not the same as the identity of the compound. 
Mol et al. found relying on the exact mass and retention time of a single diagnostic ion for 
qualitative screening of pesticides resulted in too many false positives and recommended the use 
102 
 
of isotopes or fragments as secondary diagnostic ions [104]. When using less common isotopes 
as a second diagnostic ion, Mol et al. reduced the number of false positives from 600 to 36 [104]. 
Whilst consideration of isotopes is clearly of benefit, 36 false positives are still too many for 
confirmatory identification, especially for forensic purposes where they could contribute towards 
a miscarriage of justice. Also, isotopes will only ever be able to confirm the elemental composition 
and, unlike fragment ions, do not provide any additional structural information. A more recent 
guidance document, on analytical quality control and method validation procedures for pesticide 
residues and analysis in food and feed, by the European Commission recommends the use of at 
least 2 ions with a mass accuracy of ≤ 5 ppm (< 1 mDa for m/z < 200), preferably including the 
molecular ion, (de)protonated molecule or adduct ion and including at least one fragment ion 
[107]. Again, evidence to support the use of these identification requirements for the forensic 
identification of explosives is currently lacking. Use of stricter identification requirements may lead 
to more false negatives and for screening methods, minimising false negatives is of greater 
importance than minimising false positives [93].  
Therefore, the second aim of this chapter was to investigate the effect of different identification 
criteria on selectivity and limits of detection to further understand identification requirements for 
explosive compounds by LC-HRMS. Theoretical experiments were performed to determine the 
number of elemental compositions within 5 ppm of the exact mass and the number of isomers 
with the same elemental composition. The effect of mass accuracy, number and type of ions and 
retention time windows on selectivity and detection limits was then investigated. This will provide 






Reference materials for 62 explosives, precursors or transformation products were either 
purchased from Kinesis Ltd. (St Neots, UK) or Sigma-Aldrich (Gillingham, UK), or donated by the 
Forensic Explosives Laboratory (FEL). Details of the compounds used can be found in Table 3.1. 
For most compounds (n=53), purity was greater than 98 %. No purity information was available 
for diacetone diperoxide (DADP), mannitol hexanitrate (MHN), methyl ethyl ketone peroxide 
(MEKP) or sorbitol hexanitrate (SHN) which were donated by FEL. Therefore, stated 
concentrations for these compounds were over estimations based on 100 % purity.  HPLC grade 
methanol (Fisher Scientific UK, Loughborough, UK) and ultrapure water (18.2 MΩ.cm) delivered 
from a Millipore Milli-Q water ultra-purification system (Millipore, Bedford, MA, USA) were used 
for mobile phases along with ammonium chloride which was purchased from Sigma-Aldrich. All 
mobile phases were sonicated for 15 min and filtered before use. 
 Liquid chromatography-high resolution mass spectrometry conditions 
The LC-HRMS method optimised during Chapter 2, with an ACE C18 Ar column and atmospheric 
pressure chemical ionisation (APCI) in either positive or negative mode, was used for all analysis. 
For experiments investigating the use of higher-energy C-trap dissociation (HCD), a method 
alternating between HCD with a collision energy of 20 and full-scan MS was compared to the full-
scan MS method developed during Chapter 2.   
 Assessing instrumental method performance 
Calibration lines were run for 49 compounds in a mixed standard. Unretained compounds (e.g. 
aspirin, erythritol, mannitol, salicylic acid, sorbitol, urea and xylitol), compounds where purity was 
unknown (e.g. MHN, SHN, DADP and MEKP) and compounds that could not be distinguished 
from other compounds in the mixed standard (e.g. 1-MNG and ammonium picrate) were not 
included. All other compounds with a signal/noise ≥ 5 x 105 at 10 ng µL-1 were included at 1, 2.5, 
5, 7.5, 10, 25, 50, 75, 100, 250, 500, 750 and 1000 pg µL-1. Compounds with a signal/noise ≤ 5 x 
105 at 10 ng µL-1 were included at 10 times these concentrations. This was due to significant 
differences in response between compounds, with the most sensitive compounds plateauing at 
the higher concentrations, but the least sensitive compounds detected at insufficient 
concentrations to plot a calibration line. Six replicate injections were also analysed at three 




Table 3.1 (Continued): Purity, concentration and source of reference materials. 
Analyte Abbreviation IUPAC name Purity 
(%) 
Solvent Concentration (µg 
mL-1) 
Source 
1,2-Diaminopropane 1,2-DAP propane-1,2-diamine 99.8 CH3OH 100 Kinesis ltd. 
1,2-Dinitrobenzene 1,2-DNB 1,2-Dinitrobenzene ≥ 99 CH3OH 1000 Kinesis ltd. 
1,2-Dinitroglycerin 1,2-DNG 3-Hydroxy-1,2-propanediyl dinitrate 98.6 CH3CN:CH3OH 100 Kinesis ltd. 
1,3-Dinitrobenzene 1,3-DNB 1,3-Dinitrobenzene 97 CH3CN:CH3OH 1000 Kinesis ltd. 
1,3-Dinitroglycerin 1,3-DNG 2-Hydroxy-1,3-propanediyl dinitrate 99.3 CH3CN:CH3OH 100 Kinesis ltd. 
1-Nitroglycerin 1-MNG 2,3-Dihydroxypropyl nitrate  99.8 CH3CN:CH3OH 100 Kinesis ltd. 
2,4-Diamino-6-nitrotoluene 2,4-DA-6-NT 4-Methyl-5-nitro-1,3-benzenediamine 99 CH3CN 100 Kinesis ltd. 
2,4-Dinitrotoluenea 2,4-DNT 1-Methyl-2,4-dinitrobenzene ≥ 99.9 CH3OH 1000 Kinesis ltd. 
2,6-Bis(Picrylamino)-3,5-dinitropyridine PYX 3,5-Dinitro-N,N'-bis(2,4,6-trinitrophenyl)-2,6-
pyridinediamine 
98.3 CH3CN 100 Kinesis ltd. 
2,6-Diamino-4-nitrotoluene 2,6-DA-4-NT 2-Methyl-5-nitro-1,3-benzenediamine 99.7 CH3CN 100 Kinesis ltd. 
2,6-Dinitrotoluenea 2,6-DNT 2-methyl-1,3-dinitrobenzene ≥ 99.9 CH3OH 1000 Kinesis ltd. 
2-Amino-4,6-dinitrotoluene 2-A-4,6-DNT 2-Methyl-3,5-dinitroaniline 100 CH3CN:CH3OH 1000 Kinesis ltd. 
2-Nitroglycerin 2-MNG 1,3-Dihydroxy-2-propanyl nitrate 99 CH3CN:CH3OH 100 Kinesis ltd. 
2-Nitrotoluenea 2-NT 1-Methyl-2-nitrobenzene 99.0 CH3CN:CH3OH 1000 Kinesis ltd. 
3,4-Dinitrotoluenea 3,4-DNT 4-methyl-1,2-dinitrobenzene 100.0 CH3OH 1000 Kinesis ltd. 
3,5-Dinitroaniline 3,5-DNA 3,5-Dinitroaniline 100 CH3CN:CH3OH 100 Kinesis ltd. 
3-Nitrotoluenea 3-NT 1-Methyl-3-nitrobenzene 98.7 CH3CN:CH3OH 1000 Kinesis ltd. 
4-Amino-2,6-dinitrotoluene 4-A-2,6-DNT 4-Methyl-3,5-dinitroaniline 100 CH3CN:CH3OH 1000 Kinesis ltd. 
4-Nitrotoluenea 4-NT 1-Methyl-4-nitrobenzene 99.2 CH3CN:CH3OH 1000 Kinesis ltd. 
Acetyl salicylic acid Aspirin 2-Acetoxybenzoic acid ≥ 99 Solid - Sigma-Aldrich 
Ammonium picrate  Ammonium 2,4,6-trinitrophenolate  99.8 CH3CN 100 Kinesis ltd. 
Diacetone diperoxide DADP 3,3,6,6-Tetramethyl-1,2,4,5-tetroxane N/A CH3CN ~1000 FEL 
Diazodinitrophenol DDNP 6-Diazonio-2,4-dinitro-2,4-cyclohexadien-1-olate 99.5 CH3CN 1000 Kinesis ltd. 
Table 3.1: Purity, concentration and source of reference aterials. 
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Table 3.1 (Continued): Purity, concentration and source of reference materials. 
Analyte Abbreviation IUPAC name Purity 
(%) 
Solvent Concentration (µg 
mL-1) 
Source 
Diethyl diphenylurea DEDPU 1,3-Diethyl-1,3-diphenylurea  99 Solid - Sigma-Aldrich 
Diethylene glycol dinitrate  DEGDN Oxydi-2,1-ethanediyl dinitrate 99.9 CH3CN:CH3OH 100 Kinesis ltd. 
Dimethyl diphenylurea DMDPU 1,3-Dimethyl-1,3-diphenylurea 99 Solid - Sigma-Aldrich 
Dimethyldinitrobutane  DMNB 2,3-Dimethyl-2,3-dinitrobutane  98 Solid - Sigma-Aldrich 
Dinitrosalicylic acid DNSA 2-Hydroxy-3,5-dinitrobenzoic acid  98 Solid - Sigma-Aldrich 
Diphenylamine DPA N-Phenylaniline ≥ 99 CH3CH2OH 1000 Kinesis ltd. 
Erythritol 
 
(2R,3S)-1,2,3,4-Butanetetrol  ≥ 99 Solid - Sigma-Aldrich 
Erythritol tetranitratea ETN (2S,3R)-3,4-Bis(nitrooxy)-1,2-butanediyl dinitrate 99.9 CH3CN 1000 Kinesis ltd. 
Ethylene glycol dinitratea EGDN 1,2-Ethanediyl dinitrate 96.2 CH3CN 100 Kinesis ltd. 
Hexahydro-1,3,5-trinitro-1,3,5-triazinea RDX 1,3,5-Trinitro-1,3,5-triazinane 98.6 CH3CN:CH3OH 1000 Kinesis ltd. 
Hexahydro-1,3,5-trinitroso-1,3,5-triazinea R-Salt 1,3,5-Trinitroso-1,3,5-triazinane 99.8 CH3CN 100 Kinesis ltd. 
Hexamethylene diperoxide diaminea HMDD 3,4,8,9-Tetraoxa-1,6-diazabicyclo[4.4.2]dodecane ≥ 99 CH3CN 100 Kinesis ltd. 
Hexamethylene triperoxide diamineb HMTD 3,4,8,9,12,13-Hexaoxa-1,6-diazabicyclo[4.4.4]tetradecane  98.4 CH3CN 100 Kinesis ltd. 
Hexamethylenetetramine HMTA  1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane ≥ 99 Solid - Sigma-Aldrich 
Hexanitrodiphenylamine HNDPA 2,4,6-Trinitro-N-(2,4,6-trinitrophenyl)aniline 97.9 CH3CN:CH3OH 100 Kinesis ltd. 
Mannitol 
 
D-Mannitol ≥ 98 Solid - Sigma-Aldrich 
Mannitol hexanitrate  MHN 1,2,3,4,5,6-Hexa-O-nitro-D-mannitol N/A CH3CN ~1000 FEL 
Methyl ethyl ketone peroxidec  MEKP Depends on oligomer N/A CH3OH ~100 FEL 
Nitrobenzenea NB Nitrobenzene 99.8 CH3OH 1000 Kinesis ltd. 
Nitroglycerina NG 1,2,3-Propanetriyl trinitrate 99.4 97CH3CH2OH:3CH3OH 1000 Kinesis ltd. 
Nitroguanidine NQ 1-Nitroguanidine ≥ 99 CH3OH 100 Kinesis ltd. 
Nitromethane  NM Nitromethane ≥ 99 CH3OH 100 Kinesis ltd. 
N-methyl-N,2,4,6-tetranitroanilinea Tetryl N-Methyl-N,2,4,6-tetranitroaniline 98.6 CH3CN:CH3OH 1000 Kinesis ltd. 
Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazinea HMX 1,3,5,7-Tetranitro-1,3,5,7-tetrazocane 98.0 CH3CN:CH3OH 1000 Kinesis ltd. 
Pentaerythritol tetranitratea PETN 3-(Nitrooxy)-2,2-bis[(nitrooxy)methyl]propyl nitrate 99.3 CH3OH 1000 Kinesis ltd. 
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Table 3.1 (Continued): Purity, concentration and source of reference materials. 
Analyte Abbreviation IUPAC name Purity 
(%) 





2-Amino-4,6-dinitrophenol ≥ 99 CH3CN:CH3OH 100 Kinesis ltd. 
Picric acid  PA 2,4,6-Trinitrophenol 99.1 CH3CN:CH3OH 100 Kinesis ltd. 
Propylene glycol dinitrate PGDN 1,2-Propanediyl dinitrate 99.4 CH3OH 100 Kinesis ltd. 
Salicylic acid 
 
Salicylic acid ≥ 99 Solid - Sigma-Aldrich 
Sorbitol 
 
D-Glucitol ≥ 98 Solid - Sigma-Aldrich 
Sorbitol hexanitrate SHN 1,2,3,4,5,6-Hexa-O-nitro-D-glucitol N/A CH3CN ~1500 FEL 
Triacetone triperoxidea TATP 3,3,6,6,9,9-Hexamethyl-1,2,4,5,7,8-hexoxonane 99.9 CH3CN 100 Kinesis ltd. 
Triaminotrinitrobenzene TATB 2,4,6-Trinitro-1,3,5-benzenetriamine  99.6 (CH3)2NCH 40 Kinesis ltd. 
Triethylene glycol dinitrate TEGDN 1,2-Ethanediylbis(oxy-2,1-ethanediyl) dinitrate 97.4 CH3CN:CH3OH 100 Kinesis ltd. 
Trimethylolethane trinitrate TMETN 2-Methyl-3-(nitrooxy)-2-[(nitrooxy)methyl]propyl nitrate 98.5 CH3CN:CH3OH 100 Kinesis ltd. 
Trinitrobenzene TNB 1,3,5-Trinitrobenzene 97.5 CH3CN:CH3OH 1000 Kinesis ltd. 
Trinitrotoluenea TNT  2-Methyl-1,3,5-trinitrobenzene  ≥ 99.9 CH3CN:CH3OH 1000 Kinesis ltd. 
Urea   Urea  ≥ 99 Solid - Sigma-Aldrich 
Xylitol   D-Xylitol ≥ 99 Solid - Sigma-Aldrich 
aInitial 18 target analytes used for method optimisation in Chapter 2  
bHMDD standard was discontinued due to stability issues and so not included in all experiments. 
cMEKP is a polymer with multiple oligomers rather than a single compound 
N/A = Information not available 
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day and at 500 pg µL-1 or 5000 pg µL-1 across three consecutive days.  
Limits of detection (LOD) were estimated for each ion based on the standard deviation of the 
response (σ) and the slope (S), as described by the International Conference on Harmonisation 
of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines 
for the validation of analytical procedures (Error! Reference source not found.) [108]. The 
standard deviation of the response in the lowest concentration detected in six replicate injections 
was used and slope was calculated from a plot of peak height versus concentration.  





In addition to estimating LODs, detection probability was measured for the ion with greatest 
signal-to-noise at 1 ng on column by analysing 30 injections. Peaks were detected using Xcalibur 
ICIS peak detection (with a default minimum peak width of 3 scans) and INCOS noise (a single 
pass algorithm used by the software to determine the noise level). This value is used by the ICIS 
peak detection algorithm. As some noise was also integrated, EICs were also visually examined 
to ensure peaks had a signal-to-noise ratio of more than 3:1 and were not just electronic spikes.   
3.2.3.1 Investigating the number of isomers and theoretical elemental compositions  
A molecular formula search of Chemspider (Royal Society of Chemistry, UK) database was 
performed on the 14/06/17 for 60 compounds to determine the number of isomers with the same 
molecular formula. Results were limited to single component structures only and isotopically 
labelled structures were disregarded. Since ammonium picrate contains two components 
(ammonium ion and picrate ion) it was excluded from this experiment. MEKP was also excluded 
due to the presence of multiple oligomers.  The number of elemental compositions within 5 parts 
per million (ppm) of the exact mass of each of the 60 compounds was also determined using 
Thermo Xcalibur Qual browser software. The potential elemental compositions were restricted to 
the five elements included in the ions detected in Chapter 2, carbon, hydrogen, nitrogen, oxygen 
and chlorine, but the amount of each element was only restricted by the upper end of the mass 
range. This lead to consideration of the following elemental compositions: C(0-52)H(0-620)N(0-44)O(0-
39)Cl(0-17).   
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3.2.3.2 Assessing selectivity 
Selectivity between explosive compounds (n=60) was assessed by analysing extracted ion 
chromatograms for the exact mass (± 5 ppm) of the ions identified in Table 3.2 for all other target 
compounds in individual 10 ng µL-1 standards. False positives were only recorded if EIC peaks 
overlaid with the chromatographic peak of the most abundant ion of the explosive standard being 
analysed. This was to ensure common ions were produced by the main component of the 
standard and not due to the presence of closely related explosive compounds present as 
impurities. Again, MEKP was not included in the experiment due to the multiple oligomers. HMDD 
was also not included because the reference standard was discontinued before a 10 ng µL-1 
standard was analysed.  
A selection of matrices relevant for forensic investigations were chosen to give an initial indication 
of selectivity issues in matrix. The chosen matrices were natural fingermarks, indoor dirt and 
outdoor dirt, n=6 for each matrix. Natural fingermarks from six donors were collected on glass 
coverslips, extracted in 50:50 methanol:water and injected without any further sample 
preparation, as described in Chapter 2, Section 2.2.5.  The six indoor dirt samples were collected 
from six different surfaces including: a laboratory floor, a window sill, a carpeted floor, an office 
shelf, a kitchen counter and a kitchen hob. Similarly, the six outdoor dirt samples were collected 
in central London from a range of surfaces including: a Perspex sign, a poster, a window sill, a 
metal gate, a paving slab and a wooden door. All dirt samples were collected using moistened 
cotton wool swabs, following an existing protocol for sample collection and extraction 
(unpublished work). Before sample collection, cotton swabs were placed in a 15 mL glass vial 
with 5 mL of 50:50 ethanol:water. Excess solvent was left in the vial and the moistened swab was 
used to systematically wipe the required area before being returned to the vial. The swabs were 
agitated within the solvent for 2 minutes before the resulting solution was drawn up through the 
cotton swab using a glass Pasteur pipette and placed into a new vial. The extraction process was 
then repeated with a second 5 mL of 50:50 ethanol:water and the two extracts were combined in 
the same vial. The swab extracts were then concentrated using solid phase extraction (SPE). 
ISOLUTE ENV + 100 mg/6 mL SPE cartridges (Biotage, Uppsala, Sweden) were initially 
conditioned with 1 mL of 50:50 ethanol:water. Swab extracts were then loaded onto the cartridges 
under gravity before elution in 1 mL of acetonitrile and analysis by LC-HRMS.   
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 Passive vapour sampling of an explosives magazine  
As part of a project developing “Novel passive samplers for semi-targeted explosive vapour 
screening” at KCL, funded by the Cross-Government Innovative Research Call in Explosives and 
Weapons Detection 2013 initiative; passive samplers were prepared by coating Nomex swabs 
(DSA Detection, MA, USA) with a 40 mg mL-1 solution of Tenax TA (60-80 mesh, Sigma-Aldrich) 
in dichloromethane (Sigma-Aldrich) and allowed to air dry as reported by McEneff et al. [109]. 
Passive samplers were then hung from the roof of a licenced explosive magazine and exposed 
for 24 hours. The contents of the explosives magazine were unknown to prevent biasing the 
experiment and to emulate a true screening case. Following exposure, samplers were extracted 
in 0.5 mL methanol and stored at -20 °C in crimp-capped LC vials until analysis, again as reported 
by McEneff et al. [109].  
 Data analysis 
The majority of graphs were plotted in Excel. For normalised extracted ion chromatograms (EICs), 
the EICs were extracted in Xcalibur Qual Browser with 5 ppm mass accuracy from the exact m/z 
of the ion and no smoothing was applied. They were then normalised in Excel to the largest and 
smallest intensity across the full mass chromatogram. For the HCD comparison experiment, two 
EICs were extracted, one for each of the two MS scan types, and both were normalised to the 
largest intensity in either scan type, to facilitate comparison between the two scan types. SPSS 
was used for the elemental compositions boxplot (Figure 3.12), the one-way multivariate analysis 
of variance (MANOVA) and Tukey’s post-hoc test. Ion ratios were calculated in excel, using EIC 




3.3 Results and discussion 
 HRMS method development 
It was not possible to optimise a method for non-target compounds. Instead an LC-HRMS method 
was optimised for 18 representative compounds in Chapter 2 before, the generalisable method 
performance of a wider set of compounds was assessed here. Achieving simultaneous ionization 
of a wide range of compounds is key for the development of a universal screening method, but a 
significant challenge for explosives analysis. Even being able to simultaneously ionize the 18 
initial target compounds was a significant challenge addressed in Chapter 2. Here, the ability to 
ionise and detect additional explosive compounds was also considered and assessed. 
Additionally, fragmentation which was not addressed in Chapter 2 was considered. 
When mass spectrometry is used as a confirmatory identification technique, typically a 
combination of fragments and molecular ions are used, either through full-scan electron impact 
experiments where fragments are produced during the ionisation process or tandem MS 
experiments looking at multiple transitions. In the case of the Exactive, the HRMS instrument 
used for this study, it was not possible to perform tandem mass spectrometry experiments such 
as product ion scanning where the first mass analyser selects a precursor ion which is then 
fragmented before the second mass analyser determines the m/z of the product ions. There are 
other HRMS instruments available (e.g. QExactive and QTOF) which can perform tandem MS 
experiments. However, in selecting precursor ions for fragmentation, detection becomes limited 
to a predetermined set of target compound and the potential for suspect and non-target screening 
is lost. Additionally, the quadrupole mass analyser used to select precursor ions is a low-
resolution mass analyser and so only the fragment ions are separated with high resolution. A 
separate MS scan, with no fragmentation, would be required to determine the accurate mass of 
the selected precursor ions.  
Orbitrap HRMS instruments, such as the Exactive used in this study, can perform all ion 
fragmentation (AIF) MS experiments, either by in-source collision induced dissociation (CID) or 
by using higher-energy C-trap dissociation (HCD). Alternating between full-scan and AIF MS 
experiments throughout an LC-MS run allows precursor and product ions that elute at the same 
retention time to be linked. However, this is not the same as product ion scans in tandem mass 
spectrometry (where specific precursor ions are selected by m/z for fragmentation [67]) and 
coeluting compounds could also be responsible for fragment ions produced by AIF.  
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Use of HCD fragmentation was considered in this study. Figure 3.1 shows the mass spectra 
recorded with and without HCD fragmentation for three explosives: a nitramine (RDX), a nitrate 
ester (PETN) and a nitroaromatic (TNT). Even in the full-scan mass spectra (Figure 3.1 (i)) 
fragment ions were detected for all three explosives. Extracted ion chromatograms are also 
shown for these three explosives in Figure 3.2, confirming that the ions detected in the mass 
spectra are associated with the chromatographic peak and not just background ions present in 
the mobile phase. Figure 3.2 also shows that for all the fragment ions detected for RDX and 
PETN, peak intensity was at least four times greater in the full-scan spectra (solid line) than when 
the HCD cell was used for fragmentation (dashed line). For TNT, an increase in intensity was 
seen for the smaller fragments when the HCD cell was used. However, all TNT fragments were 
also detected in the full-scan spectra and the two largest fragments (m/z 210.0153 and 197.0201 
due to [M-OH]- and [M-NO]-) were still more abundant in the full-scan spectra. Therefore, it was 
not necessary to use the HCD cell to induce fragmentation and instead of switching between full-
scan and all ion fragmentation, which reduced the number of data point per chromatographic 
peak, for this study all analysis was performed in full-scan mode.   
The presence of fragment ions in the full-scan spectra indicated that in-source fragmentation was 
occurring without introducing any additional energy. Despite both being considered soft ionisation 
techniques, in-source fragmentation is more common with APCI than ESI. This is because ions 
are more likely to have excess energy in APCI, which can lead to fragmentation, than in ESI 
where ions are formed in solution and so collisional cooling occurs before they reach the gas 
phase [110]. Unintended in-source fragmentation reduces the abundance of molecular ions, 
(de)protonated molecules and adduct ions. This was particularly true for nitrate esters such as 
PETN where the nitrate ion (m/z 61.9884) dominated the mass spectrum (Figure 3.1 B(i)). As 
discussed in Chapter 2, Section 2.3.2.1.1, autotune was used to optimise the ion optics for this 
study. Further optimisation of lens voltages might reduce (or increase) the amount of 
fragmentation and could be explored in future work, especially for targeted methods. However, 
the in-source fragmentation also provided additional structural information which could aid 
identification and no further optimisation of lens voltages was performed.    
The presence of two chromatographic peaks in Figure 3.2 A and B highlighted the problem of 
common ions with explosives. For example, HMX produced a peak in the EICs of all the RDX 
ions (Figure 3.2 A) and ETN shared fragment ions with PETN (Figure 3.2 B). This demonstrated  
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Figure 3.1: LC-HRMS mass spectra for RDX (A), PETN (B) and TNT (C), with full-scan MS spectra shown in (i) and all ion fragmentation with HCD 
collision energy of 20 shown in (ii). 
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Figure 3.2: Effect of all ion fragmentation (AIF) on extracted ion chromatograms for RDX (A), PETN (B) and 
TNT (C) in a 10 ng µL-1 mixed standard solution. Solid lines represent full-scan MS and dashed lines indicate 

































































































































the importance of developing a good chromatographic separation in Chapter 2 and the need to 
assess selectivity between explosive compounds here. Equally, for suspect screening 
applications, chromatographic selectivity is very important to help identify new compounds 
through retention time prediction.   
 Ions detected by LC-(APCI)-HRMS  
A range of different types of ions were detected by LC-(APCI)-HRMS, as shown in Table 3.2. For 
example, TNT formed the molecular ion, 2,4-DNT the deprotonated molecule, HMTD the 
protonated molecule, RDX the chloride adduct and TATP the ammonium adduct. Various 
fragment ions were also produced by in-source fragmentation. For the purpose of this thesis, “Ion 
1” and “Ion 2” refer to the ions with the largest and second largest signal/noise in a 10 ng µL-1 
standard. “Ion 3” was then selected to ensure inclusion of both a fragment ion and a molecular 
ion/(de)protonated molecule/adduct ion which contained the intact molecule. Therefore, in the 
case of TNT where Ions 1 and 2 were the molecular ion and deprotonated molecule, ion 3 was 
selected as the most abundant fragment ion. Conversely, for nitroglycerin (NG) the chlorine 
adduct was selected as Ion 3 since the two most abundant ions were both fragment ions. For 
RDX, the two most abundant ions included both the chloride adduct and a fragment ion and so 
Ion 3 was simply the third most abundant ion. Signal-to-noise ratio of the chromatographic peak 
from the EIC was used to select Ions 1 and 2, rather than absolute intensity in the mass spectrum, 
to take account of background intensities which ranged from essentially no noise to in the order 
of 106 for the nitrate ion, making absolute intensities misleading.  
Figure 3.3 shows the signal-to-noise ratio in a 10 ng µL-1 standard for the ions identified as ‘Ion 
1’, ‘Ion 2’and ‘Ion 3’ for 60 compounds. HMDD was discontinued for sale before it could be 
analysed at 10 ng µL-1 and MEKP, discussed in more detail in Section 3.3.2.4, was excluded from 
the majority of experiments due to the presence of multiple oligomers. The instrumental method 
sensitivity varied widely between compounds and often there was a large difference in the 
sensitivity between ‘Ion 1’ and ‘Ion 3’. In fact, it was not always possible to find three ions including 
both a fragment ion and a molecular ion/(de)protonated molecule/adduct ion. In the case of 
diphenylamine (DPA) and dinitroaniline (3,5-DNA), use of the HCD cell might have helped 
produce fragment ions; but the HCD cell could not help with urea or nitromethane which have 
molecular weights of approximately 60 and 61 Da, meaning that any fragments produced would 




Table 3.2 (Continued): Ions detected by LC-(APCI)-HRMS method including proposed identity and mass accuracy (n=61 compounds, MEKP oligomers not included). 























1,2-DAP 75.09156 C3H11N2+ [M+H]+ -1.52 n.d. - - - n.d. - - - 
1,2-DNB 168.01796 C6H4O4N2- [M]- 1.81 138.01993 C6H4O3N- [M-NO]- 1.90 154.01488 C6H4O4N- [M-N]- 1.93 
1,2-DNG 216.98737 C3H6O7N2Cl- [M+Cl]- 2.08 61.98839 NO3- [NO3]- 0.36 172.00218 C3H7O5NCl- [M-NO2+HCl]- 2.00 
1,3-DNB 168.01727 C6H4O4N2- [M]- -2.30 138.01938 C6H4O3N- [M-NO]- -2.08 167.00951 C6H3O4N2- [M-H]- -1.93 
1,3-DNG 61.98836 NO3- [NO3]- -0.12 216.98721 C3H6O7N2Cl- [M+Cl]- 1.34 172.00212 C3H7O5NCl- [M-NO2+HCl]- 1.66 
1-MNG 91.04012 C3H7O3- [M-NO2]- 0.56 172.00201 C3H7O5NCl- [M+Cl]- 1.02 61.98831 NO3- [NO3]- -0.93 
2,4-DA-6-NT 168.07683 C7H10O2N3+ [M+H]+ 0.46 166.06082 C7H8O2N3+ [M-H2]+ -1.71 121.0762 C6H8O2N3+ [M-HNO2]+ 1.20 
2,4-DNT 181.02571 C7H5O4N2- [M-H]- 1.26 182.03329 C7H6O4N2- [M]- -0.09 165.03072 C7H5O3N2- [M-OH]- 0.93 
2,6-DA-4-NT 168.07684 C7H10O2N3+ [M+H]+ 0.52 180.07698 C8H10O2N3+ [M+CH]+ 1.26 122.08385 C6H9O2N3+ [M-NO2]+ 0.00 
2,6-DNT 182.03363 C7H6O4N2- [M]- 1.78 152.03558 C7H6O3N- [M-NO]- 1.73 181.02589 C7H5O4N2- [M-H]- 2.26 
2-A-4,6-DNT 196.03633 C7H6O4N3- [M-H]- -0.26 232.01302 C7H7O4N3- [M+Cl]- -0.20 180.04146 C7H6O3N3- [M-OH]- -0.03 
2-MNG 172.00166 C3H7O5NCl- [M+Cl]- -1.02 91.04008 C3H7O3- [M-NO2]- 0.13 61.98844 NO3- [NO3]- 1.17 
2-NT 136.04053 C7H6O2N- [M-H]- 0.94 121.05344 C7H7ON- [M-O]- 1.05 120.0456 C7H5ON- [M-OH]- 0.94 
3,4-DNT 182.03334 C7H6O4N2- [M]- 0.18 152.0354 C7H6O3N- [M-NO]- 0.54 181.02563 C7H5O4N2- [M-H]- 0.82 
3,5-DNA 183.02884 C6H5O4N3- [M]- 1.55 182.02107 C6H4O4N3- [M-H]- 1.86 n.d. - - - 
3-NT 121.05334 C7H7ON- [M-O]- 0.23 137.04819 C7H7O2N- [M]- -0.27 138.05602 C7H8O2N- [M+H]- -0.24 
4-A-2,6-DNT 196.03621 C7H6O4N3- [M-H]- -0.87 232.01344 C7H7O4N3- [M+Cl]- 1.61 167.04602 C7H7O3N2- [M-NO]- -1.18 
4-NT 136.0405 C7H6O2N- [M-H]- 0.72 120.04552 C7H5ON- [M-OH]- 0.27 121.05342 C7H7ON- [M-O]- 0.89 
Aspirin 198.07619 C9H12O4N+ [M+NH4]+ 0.53 n.d. - - - n.d. - - - 
DADP 89.05962 C4H9O2+ [M-C2H3O2]+ -0.97 91.03892 C3H7O3+ [M-C3H5O]+ -0.56 n.d. - - - 
DDNP 183.00497 C6H3O5N2- [M+H-N2]- 1.17 213.0154 C7H5O6N2- [M+OCH3-N2]- 0.36 244.97188 C6H2O5N4Cl- [M+Cl]- -0.21 
DNSA 226.99460 C7H3O7N2- [M-H]- 0.04 210.99968 C7H3O6N2- [M-OH]- 0.03 228.00224 C7H4O7N2- [M]- -0.77 
Table 3.2: Ions detected by LC-(APCI)-HRMS method including proposed identity and mass accuracy (n=61 compounds, MEKP oligomers not included). 
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Table 3.2 (Continued): Ions detected by LC-(APCI)-HRMS method including proposed identity and mass accuracy (n=61 compounds, MEKP oligomers not included). 























DEDPU 269.1651 C17H21ON2+ [M+H]+ 0.97 120.04443 C7H6ON+ [M-C10H14N]+ 0.33 148.07552 C9H10ON+ [M-C8H10N]+ -1.15 
DEGDN 61.98846 NO3- [NO3]- 1.49 103.04008 C4H7O3- [M-HO4N2]- 0.11 231.00261 C4H8O7N2Cl- [M+Cl]- 0.18 
DMDPU 241.13382 C15H17ON2+ [M+H]+ 1.16 134.06027 C8H8ON+ [M-C7H8N]+ 1.71 106.06505 C7H8N+ [M-C8H8NO]+ -0.71 
DMNB 194.11378 C6H16O4N3+ [M+NH4]+ 1.27 74.05998 C3H8ON+ [M-C3H4O3N]+ -0.82 99.08051 C6H11O+ [M-HO3N2]+ 0.69 
DPA 170.0965 C12H12N+ [M+H]+ 0.41 n.d. - - - n.d. - - - 
EGDN 61.98828 NO3- [NO3]- -1.41 n.d. - - - n.d. - - - 
Erythritol 157.02744 C4H10O4Cl- [M+Cl]- 0.77 121.05072 C4H9O4- [M-H]- 0.71 102.03231 C4H6O3- [M-H4O]- 0.65 
ETN 115.00348 C4H3O4- [M-H3N4O8]- -1.77 86.00088 C3H2O3- [M-CH4O9N4]- -0.74 336.96756 C4H6O12N4Cl- [M+Cl]- -0.27 
HMDD 177.08704 C6H13O4N2+ [M+H]+ 0.31 129.0659 C5H9O2N2+ [M-CH3O2]+ 0.35 113.07096 C5H9ON2+ [M-CH3O3]+ 0.18 
HMTA 141.1136 C6H13N4+ [M+H]+ 0.90 106.08631 C4H12O2N+ [M-C2N2+O2]+ 0.51 150.11264 C6H16O3N+ [M-N3+H4O3]+ 1.13 
HMTD 145.06075 C5H9O3N2+ [M-CH3O3]+ -0.13 179.06628 C5H11O5N2+ [M-CHO]+ 0.17 209.07692 C6H13O6N2+ [M+H]+ 0.51 
HMX 331.01703 C4H8O8N8Cl- [M+Cl]- 3.33 102.03102 C2H4O2N3- [M-C2H4N5O6]- 1.17 284.01559 C4H7O6N7Cl- [M-HNO2+Cl]- 1.39 
HNDPA 438.99979 C12H5O12N7- [M]- -0.87 437.99216 C12H4O12N7- [M-H]- -0.43 376.00452 C12H4O9N6- [M-HNO3]- -0.02 
Mannitol 217.04832 C6H14O6Cl- [M+Cl]- -0.61 181.07172 C6H13O6- [M-H]- -0.24 163.0611 C6H11O5- [M-H3O]- -0.60 
MHN 251.0153 C6H7O9N2- [M-HN4O9]- -1.62 314.01089 C6H8O12N3- [M-N3O6]- -1.47 513.97681 C6H8O21N7- [M+NO3]- -2.08 
NB 107.03773 C6H5ON- [M-O]- 0.63 123.03263 C6H5O2N- [M]- 0.43 138.01968 C6H4O3N- [M-H+O]- 0.09 
NG 86.00093 C3H2O3- [M-H3N3O6]- -0.16 61.98841 NO3- [NO3]- 0.68 261.97183 C3H5O9N3Cl- [M+Cl]- -0.65 
NM 60.0092 CH2O2N- [M-H]- 1.62 n.d. - - - n.d. - - - 
NQ 105.04071 CH5O2N4+ [M+H]+ 0.07 122.06736 CH8O2N5+ [M+NH4]+ 0.89 75.04263 CH5ON3+ [M-NO+H]+ -1.11 
PA 227.98943 C6H2O7N3- [M-H]- -1.74 211.99448 C6H2O6N3- [M-OH]- -2.03 228.9979 C6H3O7N3- [M]- 1.09 
PETN 61.98839 NO3- [NO3]- 0.36 350.98288 C5H8O12N4Cl- [M+Cl]- -1.20 101.02435 C4H5O3- [M-CH3O9N4]- -0.68 
PGDN 61.98839 NO3- [NO3]- 0.36 118.01488 C3H4O4N- [M-H2NO2]- 2.52 200.99277 C3H6O6N2Cl- [M+Cl]- 3.82 
Picramic acid 198.01532 C6H4O5N3- [M-H]- -1.64 182.02109 C6H4O4N3- [M-OH]- 1.93 199.02298 C6H5O5N3- [M]- -2.47 
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Table 3.2 (Continued): Ions detected by LC-(APCI)-HRMS method including proposed identity and mass accuracy (n=61 compounds, MEKP oligomers not included). 























Picrate  227.98967 C6H2O7N3- [M]- -0.68 211.99474 C6H2O6N3- [M-O]- -0.80 228.99736 C6H3O7N3- [M+H]- -1.27 
PYX 621.00659 C17H7O16N11- [M]- -1.91 619.99921 C17H6O16N11- [M-H]- -1.20 210.0027 C6H2O5N4- [M-C11H5O11N7]- -1.76 
RDX 257.00494 C3H6O6N6Cl- [M+Cl]- 2.50 102.0311 C2H4O2N3- [M-CH2N3O4]- 1.95 129.04213 C3H5O2N4- [M-HN2O4]- 2.56 
R-Salt 209.01941 C3H6O3N6Cl- [M+Cl]- -0.65 144.05257 C3H6O2N5- [M-NO]- -0.89 86.0359 C2H4ON3- [M-CH2O2N3]- -0.99 
Salicylic acid 137.02446 C7H5O3- [M-H]- 0.30 93.03456 C7H6O3Cl- [M+Cl]- -0.31 173.0011 C6H5O- [M-CHO2]- -0.01 
SHN 251.0154 C6H7O9N2- [M-HN4O9]- -1.22 314.01102 C6H8O12N3- [M-N3O6]- -1.05 513.97711 C6H8O21N7- [M+NO3]- -1.50 
Sorbitol 217.04837 C6H14O6Cl- [M+Cl]- -0.38 181.07176 C6H13O6- [M-H]- -0.02 163.0611 C6H11O5- [M-H3O]- -0.60 
TATB 257.02789 C6H5O6N6- [M-H]- 1.10 240.02499 C6H4O5N6- [M-H2O]- 0.51 241.03287 C6H5O5N6- [M-HO]- 0.74 
TATP 89.05963 C4H9O2+ [M-C5H9O4]+ -0.86 91.03892 C3H7O3+ [M-C6H11O3]+ -0.56 240.14447 C9H22O6N+ [M+NH4]+ 1.27 
TEGDN 258.09302 C6H16O8N3+ [M+NH4]+ -0.67 151.09634 C6H15O4+ [M-N2O4+H3]+ -0.97 196.08145 C6H14O6N+ [M-NO2+2H]+ -0.59 
Tetryl 241.0218 C7H5O6N4- [M-NO2]- 1.41 212.01907 C6H4O5N4- [M-CHNO3]- 1.65 321.98364 C7H5O8N5Cl- [M+Cl]- 1.27 
TMETN 85.0296 C4H5O2- [M-CH4O7N3]- 1.13 290.0033 C5H9O9N3Cl- [M+Cl]- 0.00 245.01801 C5H10O7N2Cl- [M-NO2+HCl]- -0.85 
TNB 213.00252 C6H3O6N3- [M]- -1.01 183.00456 C6H3O5N2- [M-NO]- -1.02 244.02081 C7H6O7N3- [M+CH3O]- -1.29 
TNT 227.01862 C7H5O6N3- [M]- 1.03 226.01089 C7H4O6N3- [M-H]- 1.46 197.02061 C7H5O5N2- [M-NO]- 1.08 
Urea 61.03968 CH5O2+ [M+H]+ 0.67 78.06612 CH8O2N+ [M+NH4]+ -0.88 n.d.    
Xylitol 187.03787 C5H12O5Cl- [M+Cl]- -0.09 151.06119 C5H11O5- [M-H]- -0.06 132.04276 C5H8O4- [M-H3O]- -0.37 
a.Ion giving EIC peak with largest S:N 
b.Ion giving EIC peak with second largest S:N 
cmolecular ion/(de)protonated molecule/adduct ion with largest S:N if 1 and 2 are both fragments, fragment ion with largest S:N if 1 and 2 are both molecular ion/(de)protonated molecule/adduct ions or ion with third largest 
S:N if ions 1 and 2 are a molecular ion/(de)protonated molecule/adduct and a fragment ion 
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(including the molecular ion/(de)protonated molecule/adduct ion and a fragment ion) could be 
detected at the highest concentration (10 ng µL-1) and at least one ion was detected for all 61 
compounds.  
In addition to the recorded accurate m/z, Table 3.2 includes the proposed ion, elemental 
composition and mass difference (Δ) in parts per million (ppm) between the measured accurate 
mass and calculated exact mass. Where fragmentation pathways have been previously studied 
and fragment ion structures have already been identified, fragment ions were easily identified. 
However, fragmentation pathways were not always available in the literature and in some 
instances multiple elemental compositions had an exact mass within 5 ppm. Further experiments, 
such as using isotopically labelled starting materials, would be required to identify fragment ions 
in those cases.  
In general, the nitro-explosives were detected in negative mode APCI while the peroxides and 
amines were detected in positive mode APCI. This meant that either separate injections for each 
ionization mode or polarity switching were required. While polarity switching is worth considering 
if speed of analysis is a priority, here separate injections were used for positive and negative 
analysis to maximize both the number of data points per chromatographic peak and instrumental 
method sensitivity which was adversely affected by polarity switching (data not shown).  
3.3.2.1 Nitramines 
The nitramines (RDX, HMX and Tetryl) were detected as chloride adducts rather than molecular 
ions or deprotonated molecules. RDX and HMX shared common fragment ions, as shown in 
Figure 3.2. For RDX, the fragment ions detected here with an accurate m/z of 102.0311 and 
129.04213 had a nominal mass consistent with fragments previously identified in the literature by 
gas chromatography coupled to mass spectrometry (GC/MS) using negative ion chemical 
ionisation (NICI) [111]. The measured accurate masses were also consistent (∆ = 1.95 and 2.56 
ppm, Table 3.2) with the elemental compositions of the fragment ion structures reported by Florián 
et al. [111]. Interestingly neither of these fragment ions were reported by Xu et al. [33] or DeTata 
et al. [32] when they used APCI, the same ionization source used here, in their HRMS screening 
methods. R-Salt, a nitrosamine sometimes referred to as trinitroso-RDX or TNX, also formed a 
chloride adduct, but in this case [M-NO]- was the major fragment. Again, the two R-Salt fragment 
ions detected here had accurate masses consistent with the nominal masses and fragmentation 
pathways reported by Florián et al. [111]. For Tetryl, which contains both nitramine and 
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nitroaromatic functionality, the [M-NO2]- ion was the most abundant ion as reported by Xu et al. 
[33] and DeTata et al. [32].  
3.3.2.2 Nitroaromatics 
The nitroaromatics are typically detected by negative mode ionization, forming both molecular 
ions and/or deprotonated molecules. The only exception to this were the diamino-nitrotoluenes 
(2,4-DA-6-NT and 2,6-DA-4-NT) which ionised in positive mode to form protonated molecules. 
Other than Tetryl, the only nitroaromatics detected as chloride adducts were the amino-
dinitrotoluenes (2-A-4,6-DNT and 4-A-2,6-DNT) and diazodinitrophenol (DDNP). The hydroxylate 
isoform, [M+H]-, and protonated molecule, [M+H]+, were also detected for DDNP as reported by 
Havliková et al. [112], but here they were detected with accurate masses of 211.0109 and 
211.0098 with the difference in the two masses (0.0011 Da) explained by the difference in 
electrons (± 0.00055 Da). The base peak for DDNP (m/z of 183.00479) also had the same 
nominal mass as the most abundant fragment ion (m/z 182.9, due to the loss of N2 from the 
hydroxylate isoform) reported by Havliková et al. [112]. The most challenging nitroaromatics to 
detect were the nitrotoluenes, particularly 3-NT, and nitrobenzene (NB). Interestingly for both 3-
NT and NB, an ion corresponding to the loss of oxygen, [M-O]-, had the largest signal to noise 
ratio.  
For the nitroaromatics detected in negative mode, the most common fragment ions were [M-NO]- 
and/or [M-OH]-. Fragmentation pathways for TNT to the [M-OH]- and [M-NO]- ions have been 
proposed elsewhere [113] and these fragments were also detected by DeTata et al. following 
precursor selection and fragmentation [32]. Density functional theory calculations by Nguyen Van 
et al. suggested that formation of an aci-isomer of TNT radical anion, where the ortho nitro-group 
gained a hydrogen from the methyl group, followed by loss of a hydroxyl radical was the favoured 




















































in formation of the [M-NO]- ion  [113]. This could also explain why Table 3.2 shows that formation 
of the [M-NO]- fragment was favoured over the [M-OH]- fragment for 3,4-DNT and the DNB 
isomers, since 3,4-DNT does not contain an ortho nitro-group and the DNB isomers do not contain 
a methyl group. Interestingly 2,4-DNT and 2-A-4,6-DNT, which contain both an ortho and a para 
nitro-group, favoured formation of the [M-OH]- fragment; whereas 2,6-DNT and 4-A-2,6-DNT, 
which contain two ortho nitro groups, favoured formation of the [M-NO]- fragment. This suggested 
that the presence of a para nitro group may also aid formation of the [M-OH]- fragment. 
Additionally, ion ratios may be useful for distinguishing between isomers which produced 
fragment ions with the same m/z and so should be investigated.   
3.3.2.3 Nitrate esters 
The majority of nitrate esters (10 out of 14) were detected as chloride adducts (Table 3.2), as 
reported elsewhere [33,34]. The only exceptions were EGDN which was only detected as a nitrate 
ion, mannitol and sorbitol hexanitrate (MHN and SHN) which formed a nitrate adduct in preference 
and TEGDN which was detected best in positive mode and formed an ammonium adduct. 
DEGDN was also detected in positive mode as an ammonium adduct (m/z=214.06731) and 
fragment ions (m/z=122.08140 and m/z=169.08217), but as overall signal-to-noise was better in 
negative mode, the negative mode ions were used here in preference. Fragment ions had the 
greatest signal-to-noise ratio for all nitrate esters, except for TEGDN and the DNG isomers, 
despite often having greater background noise than the adduct ions. The nitrate ion (NO3-) was 
detected for all 14 nitrate esters analyzed here and has previously been used by DeTata et al. for 
detection of 1- and 2-MNG, 1,2- and 1,3-DNG, EGDN, PGDN, DEGDN and TEGDN [32]. 
Screening for the nitrate ion may therefore be useful for biased non-target screening, when 
searching for unknown nitrate ester peaks of interest which may otherwise be difficult to find 
amongst all the full-scan data collected. 
The mannitol hexanitrate (MHN) sample was of unknown purity and multiple chromatographic 
peaks corresponding to the m/z for the chloride adducts and the loss of NO2 from mannitol 
pentanitrate (MPN) and tetranitrate (MTN) were also detected (Figure 3.5). The sample of sorbitol 
hexanitrate (SHN), a stereoisomer of MHN, was also of unknown purity and again, peaks 
corresponding to partially nitrated sugars, in this case sorbitol dinitrate (SDN) and trinitrate (STriN) 
as well as the tetranitrate (STN) and pentanitrate (SPN), were also detected (Figure 3.5). The 




Figure 3.5: Chromatographic separation of: a) mannitol hexanitrate and b) sorbitol hexanitrate from the less 
nitrated sugars, pentanitrate (MPH and SPN), tetranitrate (MTN and STN) trinitrate (MTriN ansSTriN) and 






























































































































sorbitol hexanitrate, or more degradation post synthesis, compared to the mannitol hexanitrate 
sample. However, as neither sample was analysed immediately after synthesis it was not possible 
to determine which was the main factor. Ostrinskaya et al. also reported detection of partially 
nitrated mannitol and sorbitol [114]. However, only one chromatographic peak was shown for 
MPN  and  SDN,  STriN,  STN  and  SPN  were  reported  as  coeluting  in  one  peak.  Furthermore, 
for the majority of experiments, Ostrinskaya et al. did not use any chromatography and so were 
unable to distinguish between in-source fragmentation of the hexanitrates and partially nitrated 
sugars.    
Here, three peaks were detected in the EICs for MPN which has three isomers due to different 
locations of the hydroxyl group (Figure 3.6). Three peaks were also seen for SPN, although as 
SHN does not have the rotational symmetry present in MHN, theoretically there are six isomers 
of SPN. However, given that a chiral stationary phase was not used, separation of pairs of 
sterioisomers was not expected. For the same reason, it was unsurprising that mannitol and 
sorbitol hexanitrate were not chromatographically separated, as they are also stereoisomers. 
Figure 3.5 does show chromatographic separation between structural isomers. However, as 
individual reference materials were unavailable it was not possible to determine which peak was 
due to which isomer.  
Figure 3.6: Chemical structures of A) mannitol hexanitrate, B) sorbitol hexanitrate and C) the three isomers 
of mannitol pentanitrate. 
 



























































































































































Chromatographic separation was also seen between MHN or SHN and most peaks 
corresponding to the exact m/z for, pentanitrate, tetranitrate, trinitrate and dinitrate ions, indicating 
that these were due to partially nitrated sugars rather than in-source fragmentation of MHN or 
SHN. However, it was not possible to conclusively identify peaks due to the partially nitrated 
sugars without reference standards. In some cases, peaks detected in the EICs, shown in Figure 
3.5, could be due to the loss of a nitro group, a deprotonated molecule of a less nitrated sugar, 
or the loss of multiple nitro groups from a more-nitrated sugar. For example, in addition to [SPN-
NO2]- ions, peaks in the EIC for m/z: 361.01211 ± 5 ppm could also be due to [STN-H]- or [SHN-
2NO2+H]- ions which would both also have an elemental composition of C6H9N4O14-. It was 
expected that the compounds with greater nitration were retained on the column for longer since 
each nitrate group (-ONO2) replaces a more hydrophilic hydroxyl group (-OH), which unlike the 
nitrate group can act as both a hydrogen donor and hydrogen acceptor for hydrogen bonding with 
the mobile phase. While the nitrogen atom in a nitrate group has a positive charge due to the 
formation of four bonds, this is balanced by the negative charge on one of the oxygen atoms 
which is only able to form one bond, resulting in a net neutral charge. Therefore, nitrate groups 
are only able to form permanent dipole interactions or act as a hydrogen acceptor in hydrogen 
bonding. As pure reference standards were not available for the nitrated sugars, it was not 
possible to confirm the theory that the more nitrated sugars would be retained longer. However, 
in Chapter 4, predicted retention times will be determined and identification of the partially nitrated 
sugars will be revisited.            
3.3.2.4 Peroxides 
Hexamethylene triperoxide diamine (HMTD) and hexamethylene diperoxide diamine (HMDD) 
were the only peroxides detected as the protonated molecule. The two ions with the greatest 
signal-to-noise ratio for HMTD were fragment ions with similar accurate masses (145.0606 vs 
145.06075 and 179.0660 vs 179.06628) to ions detected by Colizza et al. and tentatively identified 
[115]. Colizza et al. found that the protonated molecule of HMTD was the most abundant ion 
when they used an acetonitrile mobile phase but with a methanol mobile phase HMTD reacted in 
the gas phase to produce an ion with a m/z of 207.0979 ([HMTD + H+ + MeOH – H2O2]+) [115]; 
this ion was also detected in this study, although the fragment ions were more abundant. 
Triacetone triperoxide (TATP) and methyl ethyl ketone peroxide (MEKP) were detected as 
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ammonium adducts rather than protonated molecules and diacetone diperoxide (DADP) was only 
detected as fragment ions.  
The most abundant ion for both TATP and DADP was C4H9O2+, with an accurate mass of 89.0596. 
Widmer et al. reported an ion with m/z 89 as the base peak for TATP in their LC-MS method over 
15 years ago, but at that point the structure was unknown [96]. Recently, through LC-HRMS 
analysis of TATP and d18-TATP, Colizza et al. showed that the TATP ion with an exact m/z of 
89.0597 was a gas-phase reaction product of TATP with one or two methanol molecules [116].  
The reaction mechanism proposed by Colizza et al. is shown in Figure 3.7. Due to the similarity 
in structure between DADP and TATP, it is likely that formation of the m/z 89.0596 ion follows a 
similar mechanism for DADP with the incorporation of one (Figure 3.8) or two (Figure 3.7 B) 
methanol molecules. The second most abundant ion seen here for TATP and DADP was C3H7O3+ 
with an accurate mass of 91.0389. Colizza et al. reported two structures for this ion (exact m/z 
91.0390), one with and one without the incorporation of a methanol molecule [116]. Whilst Colizza 
et al. were also using HRMS, it is worth noting the greater mass accuracy detected here (absolute 
∆ < 1 ppm, for the m/z 89.0596 and m/z 91.0390 ions) compared to the mass accuracy reported 









































Figure 3.7: Mechanisms proposed by Colizza et al. for A) the addition of one molecule of methanol to TATP 























Figure 3.8: Proposed mechanism for the addition of one methanol molecule to DADP. 
 
Methyl ethyl ketone peroxide (MEKP) was not included in Table 3.2, or the method performance 
experiments because it is a polymer which can form cyclic or linear oligomers of various sizes 
(Figure 3.9). The MEKP sample analysed here contained multiple chromatographic peaks with 
ions corresponding to the ammonium adduct of various oligomers of MEKP (Figure 3.10). The
 
Figure 3.9: Chemical structures and monoisotopic masses for cyclic peroxide (CP) and dihydroperoxy 




































































































m/z = 194.13869  5 ppm
NL: 7.53E3
DHP Tetramer, [M+NH4]+
m/z = 404.24903  5 ppm
NL: 1.01E5
CP Tetramer, [M+NH4]+
m/z = 370.24355  5 ppm
NL: 5.75E3
DHP Trimer, [M+NH4]+
m/z = 316.19660  5 ppm
NL: 1.25E5
CP Trimer, [M+NH4]+
m/z = 282.19112  5 ppm
NL:1.37E5
DHP Dimer, [M+NH4]+
m/z = 228.14417  5 ppm
NL: 1.86E4
DHP Pentamer, [M+NH4]+
m/z = 492.30146  5 ppm
NL: 1.39E4
tR = 17.32 min
tR = 13.07 min
tR = 13.08 min
tR = 18.23 min
tR= 16.22 min
tR = 18.21 min
tR = 8.77 min
tR = 8.78 min
tR = 13.05 min
tR = 16.23 min
tR = 8.92 min
tR = 8.92 min
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first two peaks at 8.78 and 8.92 min were not fully resolved and both peaks had masses for the 
ammonium adducts of MEKP linear dihydroperoxy peroxide (DHP) and cyclic peroxide (CP) 
dimers, suggesting that they either interconverted at the ionisation source, or the DHP formed a 
[M-H2O2+NH4]+ fragment ion and the CP formed a [M+H2O2+NH4]+ adduct ion. The 
chromatographic peaks at 13.07 and 16.22 min were thought to be due to the DHP trimer and 
tetramer, respectively. Although ions with a m/z corresponding to the ammonium adducts of 
smaller cyclic peroxides were also detected at these retention times, it was thought that these 
were due to common fragment ions. The peak at 17.32 min was thought to be due to the MEKP 
CP trimer. The extracted ion chromatograms for the exact m/z ± 5 ppm of the ammonium adducts 
of both the MEKP DHP pentamer and the MEKP CP tetramer had a peak at 18.22 min which 
appeared to be split and so may have been due to two unresolved chromatographic peaks.  
As individual standards were not available it was not possible to confirm the elution order of the 
MEKP oligomers. However, based on polarity it is logical that larger oligomers would be retained 
longer as they have a larger hydrophobic section which is able to interact with the non-polar C18 
Ar stationary phase. It is also logical that DHPs would be less retained than CPs due to the polar 
hydroperoxy (-O-O-H) groups on the end of the DHPs which are able to hydrogen bond with the 
polar mobile phase. Retention time prediction, which will be discussed in the next chapter may 
help clarify the elution order. Collizza et al. also reported the detection of ammonium adducts of 
three MEKP CPs and four MEKP DHPs, when investigating acetonitrile ion suppression [115]. 
However, individual standards were not analysed and all analysis was performed by flow injection  
analysis, so no chromatographic separation was shown. DeTata et al. did also demonstrate 
chromatographic separation between the ammonium adducts for MEKP DHP trimer, tetramer, 
pentamer and hexamer [32], but detection of the MEKP CPs was not reported. It is unclear 
whether this was because their presence was not investigated or if different syntheses resulted 
in different mixtures of MEKP oligomers. 
3.3.2.5 Sugars 
Three ions were detected for the sugars (erythritol, mannitol, sorbitol and xylitol) in both positive 
and negative ionization mode. In positive ionization mode they were detected as the protonated 
molecule, ammonium adduct and a fragment ion (typically [M-OH]-) but the negative ions were 
used for this study due to larger signal-to-noise ratios, especially for ions 1 and 2. The sugars and 
urea were unretained on the LC column and nitroguanidine (NQ) was barely retained. This is 
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unsurprising given the highly polar nature of these five compounds and the use of a non-polar, 
C18 Ar, stationary phase. 
 Instrumental method performance 
For qualitative methods the most important performance criteria are selectivity and limit of 
detection. Selectivity will be discussed in greater detail in subsequent sections when considering 
the use of different identification criteria. Average retention time (tR), relative standard deviation 
(RSD) of tR and estimated limits of detection are shown in Table 3.3. for all three ions. When 
determining LODs it was necessary to first consider what constituted a peak. At higher 
concentrations, peak identification is relatively straight forward and unambiguous; but as the 
concentration is lowered a grey area is reached where different peak detection criteria lead to 
differing results. This was particularly the case here when using HRMS analysis, as background 
noise was not present in all extracted ion chromatograms and so it was not always possible to 
use a 3:1 signal-to-noise ratio to determine the limit of detection. However, use of standard 
deviation of response and slope to calculate LODs [108] provided an acceptable approximation. 
Since LODs were calculated from a slope, linear range and linearity (R2) are also given in Table 
3.3 and it was only possible to calculate LODs for ions detected in enough concentrations to plot 
a calibration line. This was not the case for any of the ions of 3-NT, NB or NM. Although the m/z 
range was set from 60.00-625.00 when the LOD experiment was performed, the lowest m/z 
actually detected was 60.0172, greater than the m/z of deprotonated NM (m/z 60.0091). For the 
detection probability experiment, and all future experiments, the m/z range was set from 59.90-
625.00 enabling detection of deprotonated NM. LODs were at the low pg level on column for 
many ions. Interestingly, the lowest LOD of the three ions did not always correspond to the ion 
with the greatest signal-to-noise in a 10 ng µL-1 standard, as some calibration curves levelled off 
before reaching 10 ng µL-1. Measured detection probability at a threshold level is arguably of more 
value than estimated limits of detection for forensic analysis. Here detection probability was 
calculated for ion 1 at 1 ng on column. Whether or not a compound was detected depended on 
the peak detection criteria used, including minimum peak width, the noise method and the amount 




Table 3.3 (Continued): LC-APCI-HRMS performance: estimated limits of detection (LOD), linearity, repeatability, reproducibility and detection probability (n= 61, MEKP oligomers not included) 
Analyte Av. tR (min)a RSD (%)a 
Estimated LOD 
Ion 1 (pg) 
Estimated 
LOD Ion 2 (pg) 
Estimated 
LOD Ion 3 
(pg) 






RSD (%)b, c  
Peak area 
reproducibility  
RSD (%)a, b  
Detection probability 
(%)b, d  
1,2-DAP 3.90 0.0 N.D N.A. N.A. N.D. N.D. N.D. N.D. 0 
1,2-DNB 8.12 1.1 19 13 95 1-1000 0.994 12 10 100 
1,2-DNG 4.47 0.9 56 583 985 10-1000 0.996 12 19 100 
1,3-DNB 9.18 1.0 18 84 194 1-1000 0.996 9 12 100 
1,3-DNG 4.04 0.8 169 120 829 250-1000 0.998 8 16 100 
2,4-DA-6-NT 3.59 1.6 5 155 1851 1-1000 0.997 11 8 100 
2,4-DNT 11.44 0.9 36 N.D. 142 1-1000 0.998 10 16 100 
2,6-DA-4-NT 3.15 1.4 5 150 1339 1-1000 0.996 10 8 100 
2,6-DNT 11.27 0.9 24 24 N.D. 1-1000 0.993 12 14 100 
2-A-4,6-DNT 10.88 1.0 20 12 527 1-1000 0.997 10 14 100 
2-MNG 1.73 0.5 19 1199 N.D. 5-1000 0.996 13 14 100 
2-NT 10.70 0.9 1977 N.D. N.D. 250-1000 0.984 31 40 100 
3,4-DNT 10.36 1.0 19 15 32 1-1000 0.993 11 12 100 
3,5-DNA 9.42 1.1 30 3 N.A. 5-1000 0.992 13 14 - 
3-NT 11.09 0.9 N.D N.D. N.D. N.D. N.D. N.D. N.D. 0 
4-A-2,6-DNT 10.54 1.1 9 10 24 2.5-1000 0.994 10 16 100 
4-NT 11.02 1.2 1033 N.D. N.D. 500-1000 0.999 29 33 100 
DDNP 4.14 1.2 605 690 N.D. 100-1000 0.843 18 23 100 
DEDPU 15.08 0.6 10 N.D. 535 1-1000 0.995 12 10 100 
DEGDN 6.85 0.9 8135 N.D. 2392 N.D. N.D. 14 11 100 
DMDPU 12.69 0.7 9 635 711 1-1000 0.991 13 10 100 
DMNB 7.46 1.2 91 N.D. 9948 25-10000 0.994 14 14 30 
DNSA 7.17 1.7 6 434 657 25-10000 0.981 19 17 100 
 
Table 3.3: LC-APCI-HRMS performance: estimated li its of detection (LOD), linearity, repeatability, reproducibility and detection probability (n= 61, MEKP oligomers not included) 
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Table 3.3 (Continued): LC-APCI-HRMS performance: estimated limits of detection (LOD), linearity, repeatability, reproducibility and detection probability (n= 61, MEKP oligomers not included) 
Analyte Av. tR (min)a RSD (%)a 
Estimated LOD 
Ion 1 (pg) 
Estimated 
LOD Ion 2 (pg) 
Estimated 
LOD Ion 3 
(pg) 






RSD (%)b, c  
Peak area 
reproducibility  
RSD (%)a, b  
Detection probability 
(%)b, d  
DPA 14.24 0.7 8 N.A. N.A. 1-1000 0.994 11 10 100 
EGDN 5.52 0.8 1206 N.A. N.A. 750-10000 0.995 22 21 100 
ETN 12.02 0.7 1294 5183 N.D. 500-10000 0.997 18 19 100 
HMDD 4.50 1.5 9 340 721 2.5-1000 0.997 9 13 - 
HMTA 1.39 1.6 11 N.D. 628 2.5-1000 0.993 9 9 100 
HMTD 2.84 19.9 101 49 474 25-10000 0.992 10 8 13 
HMX 4.72 1.5 9 73 115 2.5-1000 0.986 18 18 100 
HNDPA 17.57 0.7 21 17 25 1-1000 0.992 13 13 100 
NB 7.75 1.1 N.D. N.D. N.D. N.D. N.D. 10 64 53 
NG 9.16 0.8 697 612 1726 250-10000 0.996 19 18 93 
NM 1.80 1.1 N.D. N.D. N.D. N.D. N.D. N.D. N.D. 40 
NQ 1.52 1.4 6 2076 893 2.5-1000 0.995 6 8 100 
PA 7.34 1.4 17 32 34 1-1000 0.992 14 14 100 
PETN 12.67 0.7 659 361 1928 250-10000 0.998 6 12 100 
PGDN 7.64 7.5 1476 N.D. N.D. 100-10000 0.995 5 10 100 
Picramic acid 7.61 0.8 6 30 25 2.5-1000 0.993 15 29 - 
PYX 22.64 1.2 24 18 225 1-1000 0.988 7 23 100 
RDX 6.05 0.9 15 101 147 2.5-1000 0.996 17 17 100 
R-Salt 3.59 0.7 10 48 238 2.5-1000 0.992 14 16 100 
TATB 9.52 0.7 19 414 209 1-1000 0.996 16 18 100 
TATP 12.22 1.1 86 1048 655 25-10000 0.999 9 9 63 
TEGDN 7.79 1.0 70 726 316 5-1000 0.995 11 14 100 
Tetryl 12.07 0.7 26 36 1907 10-10000 0.993 12 11 100 
TMETN 12.03 1.0 220 235 1879 50-10000 0.996 6 11 100 
TNB 9.96 0.9 19 27 12 5-1000 0.995 11 11 100 
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Table 3.3 (Continued): LC-APCI-HRMS performance: estimated limits of detection (LOD), linearity, repeatability, reproducibility and detection probability (n= 61, MEKP oligomers not included) 
Analyte Av. tR (min)a RSD (%)a 
Estimated LOD 
Ion 1 (pg) 
Estimated 
LOD Ion 2 (pg) 
Estimated 
LOD Ion 3 
(pg) 






RSD (%)b, c  
Peak area 
reproducibility  
RSD (%)a, b  
Detection probability 
(%)b, d  
TNT 12.48 0.0 24 17 16 1-1000 0.993 12 11 100 
1-MNG 1.72e 0.6 - - - - - - - - 
Aspirin 1.45f 0.0 - - - - - - - - 
DADP 8.48g 1.0 - - - - - - - - 
Erythritol 1.46f 0.7 - - - - - - - - 
Mannitol 1.44f 0.7 - - - - - - - - 
MHN 14.51g 1.0 - - - - - - - - 
Picrate 7.61h 1.5 - - - - - - - - 
Salicylic acid 1.49f 1.0 - - - - - - - - 
SHN 14.50g 0.7 - - - - - - - - 
Sorbitol 1.44f 1.3 - - - - - - - - 
Urea 1.48f 0.7 - - - - - - - - 
Xylitol 1.44f 0.0 - - - - - - - - 
N.A. Not applicable as no Ion 2 and/or Ion 3 detected; N.D. Not determined as detected in insufficient concentrations/injections; “-“ Analyte not included due to a lack of pure standard at time of experiment.  
a Average, SD or RSD of n=18 injections over 3 days; b Calculated for Ion 1 only; cn=6 injections; dn=30 injections of 1 ng on column; e Not included in method performance mix as indistinguishable from 2-MNG;  





 Effect of using different identification criteria on selectivity 
3.3.4.1 Selectivity achieved by HRMS  
The accurate mass of an ion determined by HRMS can be used to determine the elemental 
composition. This is because, apart from carbon, elements do not have integer masses and 
therefore different elemental compositions result in different exact masses, even if they have the 
same nominal mass (i.e. isobars). However, the ability to separate isobars effectively and 
determine unique elemental compositions is dependent on high mass accuracy as well as high 
mass resolution. Here, the number of elemental compositions generated by instrument software 
was investigated with 5, 2 and 1 ppm mass accuracy thresholds.  
This was a theoretical experiment and some caveats are required before interpreting the results. 
Firstly, elemental compositions were generated based on the monoisotopic mass of the molecule 
rather than the mass of an ion for simplicity. Not all compounds will form the same ions and other 
compounds may form adduct or fragment ions with a similar mass. However, without mass 
spectra it was difficult to predict which ions would for and this would likely differ between different 
instruments and ionisation sources. Currently, open access mass spectral databases are still 
limited, especially in comparison to the 63 million compounds included in ChemSpider [117]. For 
example, when this study was performed, MassBank contained 41,092 mass spectra but only 
633 of those were acquired using LC-APCI-QTOF and none were acquired using an orbitrap 
mass analyser [118]. Additionally, elemental compositions were limited to the most abundant 
isotopes of the elements included in the ions detected in Table 3.2 (i.e. carbon, hydrogen, 
nitrogen, oxygen and chlorine) with the number of each element included limited only by the mass. 
Compounds containing other, less common, elements and/or isotopes may also have an 
elemental composition within the specified mass accuracy threshold. Conversely, compounds 
were not found (within the ChemSpider database at least) with all the theoretical elemental 
compositions generated. These restrictions were necessary to simplify the theoretical experiment 
and while the theoretical number of elemental compositions generated here will likely differ from 
the number of elemental compositions of known compounds or ions; since all compounds and 
mass accuracy thresholds were treated in the same manner the generated theoretical elemental 
compositions were still of value for assessing the effect of mass accuracy thresholds.    
Another important consideration when identifying a compound from an exact mass is the number 
of isomers with the same elemental composition. For each of the explosives-related compounds 
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considered here, the number of compounds listed in the ChemSpider database with the same 
elemental composition (isomers) are shown in Table 3.4 along with the number of theoretical 
elemental compositions within 5, 2 and 1 ppm of the monoisotopic mass as generated by Xcalibur 
Qual browser. Ammonium picrate was not included in these theoretical experiments as it is not a 
single component structure and so would be excluded from the Chemspider search. 
Table 3.4 (Continued): Isomers and elemental compositions within 5, 2 and 1 ppm of monoisotopic mass 










within 5 ppm 
Elemental 
compositions†  
within 2 ppm 
Elemental 
compositions†  
within 1 ppm 
1,2-DAP C3H10N2 74.084396 16 1 1 1 
1,2-DNB C6H4O4N2 168.017105 54 2 1 1 
1,2-DNG C3H6O7N2 182.017502 7 2 2 2 
1,3-DNB C6H4O4N2 168.017105 54 2 1 1 
1,3-DNG C3H6O7N2 182.017502 7 2 2 2 
1-MNG C3H7O5N 137.032425 9 2 2 2 
2,4-DA-6-NT C7H9O2N3 167.069473 1064 2 1 1 
2,4-DNT C7H6O4N2 182.032761 184 3 1 1 
2,6-DA-4-NT C7H9O2N3 167.069473 1064 2 1 1 
2,6-DNT C7H6O4N2 182.032761 184 3 1 1 
2-A-4,6-DNT C7H7O4N3 197.043655 184 3 1 1 
2-MNG C3H7O5N 137.032425 9 2 2 2 
2-NT C7H7O2N 137.047684 337 2 1 1 
3,4-DNT C7H6O4N2 182.032761 184 3 1 1 
3,5-DNA C6H5O4N3 183.028 72 3 1 1 
3-NT C7H7O2N 137.047684 337 2 1 1 
4-A-2,6-DNT C7H7O4N3 197.043655 184 3 1 1 
4-NT C7H7O2N 137.047684 337 2 1 1 
Aspirin C9H8O4 180.042252 304 3 1 1 
DADP C6H12O4 148.073563 396 1 1 1 
DDNP C6H2O5N4 210.002518 7 4 1 1 
DEDPU C17H20ON2 268.157562 10083 4 3 1 
DEGDN C4H8O7N2 196.033157 5 3 2 2 
DMDPU C15H16ON2 240.126266 4777 3 1 1 
DMNB C6H12O4N2 176.079712 265 1 1 1 
DNSA C7H4O7N2 228.001846 14 5 1 1 
DPA C12H11N 169.089142 164 1 1 1 
EGDN C2H4O6N2 152.006943 2 1 1 1 
Erythritol C4H10O4 122.057907 14 1 1 1 
ETN C4H6O12N4 301.99823 3 19 9 5 
HMDD C6H12O4N2 176.079712 265 1 1 1 
HMTA C6H12N4 140.106201 349 1 1 1 
able 3.4: Isomers and elemental compositions within 5, 2 and 1 ppm of monoisotopic mass (n=60 
compounds, MEKP oligomers and ammoniu  picrate not included) 
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Table 3.4 (Continued): Isomers and elemental compositions within 5, 2 and 1 ppm of monoisotopic mass 










within 5 ppm 
Elemental 
compositions†  
within 2 ppm 
Elemental 
compositions†  
within 1 ppm 
HMTD C6H12O6N2 208.069534 21 3 2 2 
HMX C4H8O8N8 296.046509 3 19 9 4 
HNDPA C12H5O12N7 438.999634 4 56 24 13 
Mannitol C6H14O6 182.079041 38 3 2 2 
MHN C6H8O18N6 451.989502 4 69 30 12 
NB C6H5O2N 123.032028 100 2 1 1 
NG C3H5O9N3 227.002579 2 4 1 1 
NM CH3O2N 61.016376 9 1 1 1 
NQ CH4O2N4 104.033424 4 1 1 1 
PA C6H3O7N3 228.997101 7 4 1 1 
PETN C5H8O12N4 316.013885 1 22 10 5 
PGDN C3H6O6N2 166.022583 6 2 2 2 
Picramic acid C6H5O5N3 199.022919 39 3 1 1 
PYX C17H7O16N11 621.007202 3 223 91 46 
RDX C3H6O6N6 222.034882 6 4 2 2 
R-Salt C3H6O3N6 174.05014 6 2 1 1 
Salicylic acid C7H6O3 138.031693 95 2 1 1 
SHN C6H8O18N6 451.989502 4 69 30 12 
Sorbitol C6H14O6 182.079041 38 3 2 2 
TATB C6H6O6N6 258.034882 10 7 6 2 
TATP C9H18O6 222.110336 112 3 2 2 
TEGDN C6H12O8N2 240.059372 1 4 3 2 
Tetryl C7H5O8N5 287.013824 4 15 6 2 
TMETN C5H9O9N3 255.033875 2 7 4 2 
TNB C6H3O6N3 213.002182 9 4 1 1 
TNT C7H5O6N3 227.017838 26 4 1 1 
Urea CH4N2O 60.032364 11 1 1 1 
Xylitol C5H12O5 152.068466 16 2 2 2 
* Single-Component structures in Chemspider database matching the molecular formula (Accurate as of 14/06/17) 
† Theoretical elemental compositions generated by Xcalibur (C(0-52)H(0-620)N(0-44)O(0-39)Cl(0-17)) 
 
3.3.4.1.1 Effect of mass accuracy on number of possible elemental compositions  
For the majority of compounds (n=49) more than one theoretical elemental composition fell within 
5 ppm of the monoisotopic mass, as shown in Table 3.4, Figure 3.11 and Figure 3.12. This 
number was reduced when a stricter mass accuracy threshold was used and the median number 
of elemental compositions with a mass accuracy threshold of either 1 or 2 ppm was 1 (Figure 
3.12). However, the absolute number of theoretical elemental compositions for each compound 





Figure 3.12: Boxplot showing the effect of mass accuracy thresholds and including/excluding chlorine on the 
number of elemental compositions (n=60, MEKP oligomers and ammonium picrate not included). Boxes 
indicate interquartile range, whiskers are 1.5 times the height of the box, circles show outliers with values 
1.5-3 times height of box and stars show extreme outliers with values >3 times the height of the box.   
 
threshold, 23 compounds had more than one theoretical elemental composition (Figure 3.11). As 
shown in the boxplot (Figure 3.12) the number of possible elemental compositions was much 
higher for outliers with a maximum of 223 possible elemental compositions within 5 ppm, 91 within 
2 ppm and 46 within 1 ppm for PYX. This was reduced to 34 within 5 ppm, 13 within 2 ppm and 
7 within 1 ppm when chlorine was excluded from possible elemental compositions. For this 
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Figure 3.11: Pie charts summarising the number of elemental compositions (EC) within 5, 2 or 1 ppm of the 






within each mass accuracy threshold. However, the relatively large mass defect of chlorine 
(-0.03115 Da) has previously been reported to increase HRMS selectivity when considering 
compounds in a National Institute of Standards and Technology (NIST) library [94]. Therefore, 
further work is required to more thoroughly investigate the effect of detecting chloride adducts on 
HRMS selectivity.  
Unsurprisingly, positive correlation was seen between monoisotopic mass and the number of 
theoretical elemental compositions that fell within 1, 2 or 5 ppm of the exact mass of each 
compound (Figure 3.13). The data fit well to a cubic equation (R2 > 0.99 for 2 and 5 ppm), although 
more compounds with a monoisotopic mass of > 350 Da would be required to fully characterize 
the relationship between mass and the number of theoretical elemental compositions. Figure 3.13 
also showed that reducing the mass accuracy window from 5 to 2 or even 1 ppm had a greater 
effect on the number of elemental compositions for larger compounds (especially those with 
monoisotopic mass >400 Da) than smaller compounds. However, while theoretically the number 
of possible elemental compositions increases continuously with mass, this is not reflected by 
known compounds as demonstrated by Little et al. who showed that the number of compounds 
in the ChemSpider database peaked in the mass range of 300-400 Da and dramatically 
decreased after 600 Da [119].    
 
Figure 3.13: Correlation between monoisotopic mass and number of molecular formulae within 1, 2 and 
5 ppm (n=60, MEKP oligomers and ammonium picrate not included) 
y = 2E-06x 3 - 0.0005x2 + 0.0673x - 1.825
R² = 0.9969
y = 6E-07x3 - 0.0001x 2 + 0.0034x + 1.3128
R² = 0.9945
































When selecting a mass accuracy threshold, it was also important to consider the mass accuracy 
of the analytical method. The mass accuracy of ions detected for the compounds used in this 
study are shown in Figure 3.14. While over 90 % of ions had a mass accuracy within 2 ppm of 
the exact mass, the measured mass accuracy of this LC-HRMS method ranged from -2.5 to 3.8 
ppm in standard solutions (Figure 3.14). Therefore, a mass accuracy window of 5 ppm was 
selected to reduce the risk of false negative results. While ultimately false positives are more 
problematic in Forensic Science, as they may lead to miscarriages of justice or reduced 
confidence in results; for a screening method, minimising false negatives is more important than 
minimising false positives. This is because false positives should be identified by subsequent 
confirmatory analysis but normally no further analysis would be performed following a negative 
result from a screen.   
 
Figure 3.14: Mass accuracy of the three ions detected for each compound in a 10 ng µL-1 standard (n=61, 
MEKP oligomers not included). 
 
With newer and improved instrumentation, it may be possible to apply stricter mass accuracy 
criteria. This could be worth considering in the future, especially for larger compounds where 
mass accuracy had a greater effect on the number of possible elemental compositions. However, 



































elemental compositions since here it was not always possible to unequivocally determine the 
elemental composition even with a mass accuracy of 1 ppm.   
3.3.4.1.2 Isotope patterns 
Where there were multiple possible elemental compositions within the required mass accuracy 
threshold, isotope patterns could have been used to reduce the number of possible compositions. 
For example, if there was a chlorine included in the molecule or ion then the isotope pattern 
should include two peaks approximately two mass units apart with the first peak, due to the 
chlorine-35 isotope, approximately three times the intensity of the second peak, due to the 
chlorine-37 isotope, based on the natural abundancies. While chorine isotopes were relatively 
easy to identify visually for the chloride adducts, software is available that considers more 
complicated isotope patterns. One such software, TraceFinder 3.1 (Thermo Scientific) was briefly 
investigated. However, as TraceFinder 3.1 was unable to detect all compounds detected by 
Xcalibur in a reference standard, it was not pursued further. Negative mode molecular ions, [M]-, 
were particularly problematic for TraceFinder 3.1 which automatically switched to the 
deprotonated molecular ion, [M-H]-, when calculating theoretical isotope patterns for these ions. 
More recent versions of TraceFinder or alternative software may perform better and could be 
worth investigating in future studies to streamline data analysis. Regardless, it is also worth 
bearing in mind that rarer isotopes are unlikely to be detected close to the limit of detection for 
the most abundant isotope. Additionally, isotope patterns cannot distinguish between isomers 
since they have the same elemental composition. 
3.3.4.1.3 Number of isomers with the same molecular formula 
Figure 3.15 and Table 3.4 show the number of matches to a molecular formula search of the 
ChemSpider database. In almost all cases, there were multiple isomers with the same molecular 
formula. Pentaerythritol tetranitrate (PETN) and triethylene glycol dinitrate (TEGDN) were the only 
exceptions, This meant that even when the molecular formula could be confirmed by HRMS, it 
was not always possible to confirm the compound identity. In the most extreme case, 
diethyldiphenylurea (DEDPU), also known as ethyl centralite, there were 10,083 compounds 
listed with the same molecular formula. This was even after filtering for single component 
compounds only and disregarding isotopically labelled structures. Most compounds fell 
somewhere in between these two extremes.  
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It is worth considering the number of isomers when setting identification criteria. Often it is 
possible to separate pairs of isomers based on their chromatographic retention time, and/or 
fragment ions but the chance of other isomers having the same retention time and/or fragment 
ions will increase with the number of isomers.  However, it would be extremely time consuming 
and costly to determine experimentally whether all 10,084 isomers of DEDPU could be 
distinguished based on their ions and/or retention times. This study has instead focussed on the 
more feasible aim of assessing selectivity both between 60 explosives-related compounds and 
from relevant matrix samples.  
3.3.4.1.4 Selectivity between explosive compounds using HRMS data only 
Due to structural similarities, many of the explosives-related compounds analysed here produced 
common ions. Therefore, it was important to investigate the ability to distinguish between target 
analytes (n=60) when assessing the selectivity of the method and setting identification 
requirements. Initially, when investigating which factors had the greatest influence on selectivity, 
the accurate masses detected were considered in isolation. Figure 3.16 shows the number of 
other target compounds (out of a maximum of 59) that also produced ions within 5 ppm of the 
exact mass of the ions identified in Table 3.2. In some cases, there were up to 15 other 
compounds that produced the same ion and could lead to a false positive if the ion with the 
greatest signal-to-noise (Ion 1) was the only identification criteria used. Adding the ion with the 
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Figure 3.15: Pie chart summarising the number of matches from a molecular formula search of the 





Figure 3.16: Selectivity achieved between explosive compounds when HRMS ions were used for identification without retention time windows (n=60, MEKP oligomers and HMDD not 




























































































































































































































































































Ion 1 Ion 1 + Ion 2 M type + Fragment Ion 1 + Ion 2 + Ion 3
†
† = Ion 1 only




positives, but as not all compounds produced two ions it also led to false negatives in the case of 
acetyl salicylic acid (Aspirin), diphenylamine (DPA), ethylene glycol dinitrate (EGDN) and 
nitromethane (NM). In most cases, when the two ions had to be a molecular ion/(de)protonated 
molecule/adduct ion and a fragment ion (M type + Fragment) the number of false positives was 
reduced further. However, it is worth noting that this was not always the case and for 4-A-2,6-
DNT, mannitol and sorbitol the two ions with the greatest signal-to-noise (Ion 1 and Ion 2) were 
more selective. Finally, in some cases (e.g. for DEGDN) a further reduction in false positives was 
achieved when all three ions were used. However, for 1,2-DNG, 3-NT, MHN, NB, RDX and SHN 
the number of ions used for identification had no effect on the number of false positives. 
Additionally, no false positives were seen for DEDPU, DMDPU, DMNB, DPA, HMTD, HMX, 
HNDPA, NM, NQ, PYX, R-Salt, TATB, TEGDN or TNT even when only Ion 1, the most abundant 
ion, was used as the identification criteria. 
3.3.4.2 Selectivity achieved with a retention time window 
The effect of including chromatographic retention time windows of average measured tR ± 2.5 % 
in the identification criteria was examined for all compounds with a retention factor (k) greater 
than 1, in line with the chromatographic separation performance criteria outlined by the European 
Commission, 2002/657/EC [107]. As shown in Figure 3.17, including a retention time window in 
the identification criteria led to a greater reduction in the total number of false positives than the 
inclusion of additional ions. When using the ion with the greatest signal-to-noise ratio (Ion 1) and 
 
Figure 3.17: A comparison of the number of explosive related compounds resulting in false positives (within 
5 ppm) with and without the use of retention time windows for identification of compounds with a retention 






























a retention time window of ± 2.5 %, only 14 false positives were detected, compared to 197 
without any retention time windows. Erythritol tetranitrate (ETN) had a common fragment ion with 
trimethylolethane trinitrate (TMETN) and their retention times were within 2.5 %, but outside the 
0.1 min tolerance recommended by SANTE/11813/2017 [107]. Picric acid and picrate from 
ammonium picrate appeared identical to this LC-HRMS method and both also shared three ions 
with dinitrosalicylic acid (DNSA) which also fell within the 2.5 % retention window. The remaining 
selectivity issues were due to pairs of isomers: 2- and 4- nitrotoluene (NT), mannitol and sorbitol 
hexanitrate, 2-amino and 4-amino-dinitrotoluene (A-DNT) and 2,4- and 2,6-dinitrotoluene (DNT). 
Stricter retention windows could separate some of these pairs, but also led to more false 
negatives. When using a retention window of ± 2.5 %, in most cases additional ions had no effect 
on the number of false positives. The only exceptions were for TMETN, where inclusion of any 
second ion provided sufficient selectivity from ETN and 2-A-4,6-DNT where inclusion of a 
fragment ion provided sufficient selectivity from 4-A-2,6-DNT.     
3.3.4.3 Ion ratios for discriminating between isomers 
Ion ratios were investigated to aid discrimination between isomers such as the dinitrotoluene 
(DNT) isomers (Figure 3.18). 2,4-DNT was the only isomer which favoured formation of the 
deprotonated molecule rather than the molecular ion (Figure 3.18). A one-way multivariate 
analysis of variance (MANOVA) revealed that there was a statistically significant difference 
(p<0.0005) in all three ion ratios obtained based on the different DNT isomers. Tukey’s post-hoc 
test revealed a significant difference between 2,4-DNT and the other two isomers for all three ion 
ratios (p<0.0005). No significant difference was found between 2,6- and 3,4-DNT for the [M-H]-
/[M]- and [M-NO]-/[M]- ion ratios (p=0.146 and 0.032 respectively) but a significant difference was 
seen between these isomers for the [M-OH]-/[M-H]- ion ratio (p<0.0005). It is worth noting that [M-
OH]- was not one of the three most abundant ions for either 2,6- or 3,4-DNT and so using this ion 
as a detection criterion would adversely affect sensitivity. Given that these two isomers were 
easily separated by chromatography, the cost in sensitivity was not outweighed by an 
improvement in selectivity. For 2,4- and 2,6-DNT, on the other hand, ion ratios were of greater 
value as these isomers were not fully resolved chromatographically but could be distinguished 
based on the ion ratio of the two most abundant ions ([M-H]-/[M]-). All ion ratios shown in Figure 
3.18 were determined using EIC peak height in standards and so further work may be required 




Figure 3.18: Ion ratios for 2,4-, 2,6- and 3,4-dinitrotoluene isomers. Error bars represent 95 % confidence 
intervals, n=6. 
 
 Selectivity in a selection of matrices 
Selectivity from matrix components was also investigated using 18 samples of blank matrix, 6 
natural fingermarks from different donors, 6 indoor dirt swabs and 6 outdoor dirt swabs. Figure 
3.19 shows how many of the 18 matrix samples were positive for each compound when different 
HRMS ions were required for identification without any retention time restrictions. Figure 3.20 
shows that the number of false positives reduced when chromatographic retention time was also 
included in the identification criteria. Fewer compounds were included in Figure 3.20 than Figure 
3.19 because while it was possible to compare the ions detected for unretained compounds (e.g. 
the sugars), the lack of chromatographic retention prevented the use of retention time as an 
identification requirement. For the majority of retained compounds, no false positives were 
detected when a retention time window of ± 2.5 % was used. The only exceptions were 1,3-DNB, 
2,4-DNT, 2,6-DNT and TNT, with 2,4-DNT the only compound for which multiple ions were 
detected. Examination of the negative controls used for these experiments showed no ions in the 
solvent blanks but the 2,4-DNT ions were also present in SPE extracts of blank cotton swabs, 
indicating that either the cotton swabs or the SPE cartridges were the source of these ions rather 




























Figure 3.19: Selectivity issues in 18 matrices when relying on HRMS ions (m/z ± 5 ppm) only for identification of target compounds (n=61, MEKP oligomers not included). 
 










































































































































































































































































































































































































































































































































Figure 3.21: Fingermark depletion series EICs for RDX ion 1 (257.0043 ± 5 ppm, dark blue), RDX ion 2 (102.0309 ± 5 ppm, mid blue) and RDX ion 3 (129.0418 ± 5 ppm, light blue). A 
0.01 ng µL-1 RDX standard is shown in A; the 1st, 11th, 21st, 31st, 41st, 51st, and 61st fingermark of the depletion series are shown in B-H and I shows a blank fingermark. Lines show 7-































































































































































































































































 Detection of fragment ions in fingermark depletion series 
Having identified the presence of multiple ions for RDX and HMX it was decided to revisit the 
fingermark depletion series analysed in Chapter 2. The extracted ion chromatograms for RDX 
ions 1, 2 and 3 are shown in Figure 3.21. Using the Xcalibur Qual Browser default peak detection 
settings, without smoothing, the two fragment ions were only detected in the first fingermark, 
although changes in intensity were also seen in later fingermarks. Even the 0.01 ng uL-1 standard 
did not meet the default peak detection requirements. This highlights the compromise in sensitivity 
when multiple ions are included in the detection requirements.  
  
Figure 3.22: Ion ratios for RDX fragments versus chloride adduct ions in fingermark depletion series. Lines 
show average ion ratio in a 1 ng µL-1 RDX standard (n=6) and ± 30 %, the permitted tolerance for ions with 
relative intensity of 10-20 % according to 2002/657/EC [93].  
 
Ion ratios were also calculated, based on the peak height of the smoothed EIC of the fragment 
ions relative to the chloride adduct (Figure 3.22). For six of the seven fingermarks analysed from 
the depletion series, the 102.0309/257.0043 ion ratio fell within ± 30 % of the average ion ratio in 
a 1 ng µL-1 RDX standard, the permitted tolerance according to 2002/657/EC [93]. In the case of 
the 129.0418/257.0043 ion ratio, four of the seven fingermarks fell within ± 30 % of the RDX 




































‘peaks’ had to be manually integrated as even with smoothing they were not detected by the 
software. Therefore, these results support the use of ion ratios for in-source fragment ions, with 
the proviso that more concentrated samples are required to detect less abundant ions.      
 Method application to passive vapour sampling of explosives  
Passive vapour samplers were screened for explosives following exposure to an explosives 
magazine for 24 hours. Extracted ion chromatograms for the ions detected are shown in Figure 
3.23. While the explosive magazine was known to contain explosives, no information was 
provided regarding the type of explosives currently or previously stored in the magazine. 
Environmental conditions and dimensions of the building were also not known. It is acknowledged 
that this information would be necessary for replication of the experiment and should be recorded 
where possible. However, in this instance, even if the total volume of the magazine was known 
this would not correspond to the volume of air, since the magazine was not empty. Additionally, 
it was not a closed environment throughout the experiment as Explosive Technicians working on 
the site needed access to the magazine. Despite these limitations, 12 compounds were detected, 
demonstrating the potential of this screening method.  
All three ions included in Table 3.2 were detected for 1,2-DNB, 1,3-DNB, 2,4-DNT, 3,4-DNT and 
TNT (Figure 3.23 A-C) within 2.5 % of the retention time of a standard; although the [M-H]- peak 
for 3,4-DNT had an intensity of <1 % of the 2,4-DNT peak for that ion. Two ions were also detected 
for 2,6-DNT but Ion 3, the [M-H]- ion, was missing in this case. This may have been due to the 
greater intensity of the 2,4-DNT peak, which was not fully resolved from 2,6-DNT, masking this 
peak. The dinitrobenzene (DNB) and dinitrotoluene (DNT) isomers are likely to have originated 
from TNT based explosives since 1,3-DNB, 2,4-DNT, 2,6-DNT and 3,4-DNT have all been 
detected as impurities in TNT previously [120]. TNT is often used in military explosives and comes 
in a range of forms including flake which can be melted and cast into specific shapes (e.g. to fill 
shells). The greater intensity of the 2,4-DNT peaks detected compared to TNT may be explained 
by the greater vapour pressure of 2,4-DNT (4.1 x 10-7 atm at 25 °C, compared to 9.2 x 10-9 atm 
for TNT [121]). Alternatively, smokeless powders containing 2,4-DNT may also have been present 
in the magazine.    
Two ions were also detected for the nitrotoluene isomers, 2-NT and 4-NT, within 2.5 % of the 
retention time of a standard (Figure 3.23 D), although in both cases the second ion was close to 
the limit of detection. Therefore, the lack of a third ion may be due to this ion being below the limit  
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Figure 3.23: Passive vapour sampling of an explosives magazine with overlaid extracted ion chromatograms 
showing Ions 1-3 for: A) 1,2- and 1,3-DNB; B) 2,4-, 2,6- and 3,4-DNT; C) TNT; D) 2- and 4-NT; E) RDX; F) 




























































































































































































































































































of detection but, depending on the identification requirements used, 2- and 4-NT may be reported 
as not detected. The presence 2- and 4-NT vapours in the explosive magazine could have been 
due to these compounds being impurities in TNT explosives since they are intermediates in the 
synthesis of TNT, like the DNT isomers. Alternatively, they may have been used as detection 
agents to facilitate detection of plastic explosives via the vapour phase [122]; due to their high 
vapour pressure in comparison to PETN, RDX and HMX (~6.5 x 10-5 atm at 25 °C, compared to 
1.1 x 10-11,  4.9 x 10-12 and 2.4 x 10-17 atm for PETN, RDX and HMX, respectively [121]). 
Changes in intensity were also seen in the extracted ion chromatograms for all three ions of RDX 
(Figure 3.23 E), within 2.5 % of the retention time of a standard, but intensities were very low and 
only two of the three ions were detected as peaks by the instrumental software without any 
smoothing. The presence of RDX in the magazine was unsurprising given that RDX is used in 
plastic explosives such as C4 and SEMTEX. However, given the low vapour pressure of RDX 
(2.4 x 10-17 atm at 25 °C [121]), detection of RDX on the passive vapour sampler was perhaps 
more surprising. However, Nacson and Grigoriev demonstrated that dust aided the detection of 
RDX in air [123]. Therefore, airborne particles containing RDX may have been detected here, 
rather than RDX vapours.    
One ion was also detected for 2,3-dimethyl-2,3-dinitrobutane (DMNB), diphenylamine (DPA) and 
EGDN (Figure 3.23 F-H). In the case of DPA and EGDN only 1 ion was detected even in the 
highest concentration of standard and limits of detection were poor for the other two ions of DMNB 
which may explain the presence of only one ion. However, in all cases use of an alternative 
method would be recommended if confirmatory identification was required. DMNB and EGDN 
may also have been used as a detection agent to facilitate detection of plastic explosives via the 
vapour phase [122]. EGDN is also used in commercial blasting explosives which may explain why 
EGDN had the largest intensity of all the peaks detected. DPA is used as a stabiliser for 
nitrocellulose explosives and propellants [124], which could explain the presence of DPA in the 
magazine.    
Ion ratios were calculated using EIC peak heights, for compounds where multiple ions were 
detected, to provided added confidence of correct identification. Figure 3.24 shows the calculated 




ion ratio of a standard in solution. The upper and lower threshold used, shown as green lines in 
Figure 3.24, was dependent on the relative abundance of the least abundant ion, with a threshold 
of ± 20, 25, 30 or 50 % used for relative abundancies > 50 %, 20-50 %, 10-20 % or < 10 % 
respectively [93]. As shown in Figure 3.24 A-C, for all three exposed passive samplers, all ion 
ratios calculated for ions assigned to 1,2-DNB (square marker, solid line) and 1,3-DNB (round 
marker, dotted line), based on retention time, fell within the relevant ion ratio thresholds. 
Additionally, there was no overlap between any of the ion ratio thresholds for 1,2- and 1,3-DNB, 
demonstrating the value of ion ratios for discriminating between isomers. 
Results for the dinitrotoluenes (Figure 3.24 D-F): 3,4-DNT (square marker, solid line), 2,6-DNT 
(round marker, dotted line) and 2,4-DNT (diamond marker, dashed line) were more mixed. For all 
three passive samplers, the [M-H]-/[M]- ion ratios for 2,4-DNT fell within the appropriate threshold, 
but the 3,4-DNT ion ratios fell below the lower threshold for 3,4-DNT but within the overlapping 
thresholds for 2,6-DNT (Figure 3.24 D). The [M-NO]-/[M]- ion ratios (Figure 3.24 E) for all three 
DNTs fell within their respective thresholds and while the thresholds for 3,4-DNT and 2,6-DNT 
overlapped, neither overlapped with the thresholds for 2,4-DNT. The [M-OH]-/[M]- ion ratios 
(Figure 3.24 F) for 2,4-DNT, also fell within the ion ratio thresholds for 2,4-DNT and outside the 
thresholds for 2,6- and 3,4-DNT. All calculated TNT ion ratios fell within the threshold levels 
(Figure 3.24 G and H). For RDX (Figure 3.24 I and J), the only calculated ion ratio that fell outside 
the ± 30 % threshold was for the third passive sampler where the intensity of RDX ions detected 
was lower than for the other two passive samplers. Overall, the use of ion ratios for the in-source 
fragment ions detected here showed promise, especially for the discrimination of isomers. 
Additionally, in most cases, the use of reference ion ratios determined in solution rather than 
matrix was not problematic. However, unlike the use of chromatographic retention time, using ion 
ratios for greater selectivity comes at a cost of poorer sensitivity as it is reliant on detection of a 





Figure 3.24: Ion ratios for ions detected on passive samplers. Blue lines show average ion ratio in standard 





























































































































 Alignment with method validation guidelines 
In this chapter, the aim was to assess performance and understand the capability of this LC-
HRMS method, without having a set of recognised criteria that the method must meet for forensic 
application. The International Organization for Standardization (ISO) and the International 
Electrotechnical Commission (IEC) defined validation as the “provision of objective evidence that 
a given item fulfils specified requirements, where the specified requirements are adequate for an 
intended use” in the  ISO/IEC 17025:2017 General requirements for the competence of testing 
and calibration laboratories [125]. Method validation, against a set of specified requirements or 
performance criteria, should be performed before implementation in a forensic laboratory, and the 
analysis of casework samples, to demonstrate fitness for purpose. No specific validation 
guidelines were found for the field of forensic explosives analysis. However, the European 
Network of Forensic Science Institutes (ENFSI) recommended following the International Union 
of Pure and Applied Chemistry (IUPAC) and Eurachem validation guidelines [126-128].  
For qualitative method validation, ENFSI highlighted the following performance parameters: 
precision; trueness or bias, in terms of the false positive and negative rates; measurement range, 
specifically a LOD or threshold and ruggedness, the effect of variation in individual test 
parameters on the outcome of the test [126]. The rate of false positives is also a measure of the 
selectivity of a method which was considered in Sections 3.3.4 and 3.3.5. Limits of detection were 
also estimated (Table 3.3). Robustness is another term for ruggedness and both refer to how 
reproducible results are with small changes [129]. Reproducibility of retention times and peak 
areas over three different days was investigated in this study (Table 3.3). Other variables that 
might affect ruggedness, such as different analysts, different lots of reagents and different 
environmental temperatures may also need to be assessed in the future However, as the ENFSI 
guidelines were very general, specific performance criteria and experimental design requirements 
for validation of LC-HRMS methods were not provided.  
Both the Eurachem and the ICH validation guidelines stated that selectivity/specificity were the 
only performance criteria requiring validation for identification (qualitative) methods [108,128]. 
Presumably, this refers to identification of the main component of a sample which might be 
expected to be far above the LOD. For trace detection of explosives, LOD would also be important 




present at all. The Eurachem and ICH guidelines both recognised the importance of LOD as well 
as selectivity/specificity for limit testing of impurities methods [108,128], which would be more 
similar to trace detection of explosives. The IUPAC guidelines did not specify which performance 
characteristics are relevant to qualitative methods [127].   
Whilst method validation against a set of specified requirements has not been carried out here, 
both LOD and selectivity have been evaluated approximately. Here an instrumental LOD was 
estimated based on 3.3 times the standard deviation of the response of 6 replicates divided by 
the slope of a calibration line (Error! Reference source not found.), one of the methods outlined 
for calculating LOD in the ICH guidelines [108]. The IUPAC guidelines highlight some of the 
challenges with establishing an accurate detection limit and the value of using a simple definition 
to provide a rough estimation of LOD whilst also recognising that instrumental LODs are often too 
low and inappropriate for method validation [127]. Therefore, the IUPAC guidelines recommend 
estimating precision based on the standard deviation (S0) in 6 or more matrix blanks or low-level 
materials and using 3S0 to calculate an estimated LOD [127].  The Eurachem guidelines also 
recommend the use of three times standard deviation to estimate LOD; but using S’0 which factors 
in the number of replicates used to estimate standard deviation [128]. While 10 replicates are 
recommended in the Eurachem quick reference on LODs, the guidelines also stated that the 
number of replicates should be “sufficient to obtain an adequate estimate of the standard 
deviation”, which they say typically requires between 6 and 15 replicates [128]. The Eurachem 
guidelines do also recognise that not all laboratories have the time and resources to carry out all 
the validation experiments described and using fewer replicates will still yield useful information 
[128]. For forensic analysis it is important that any uncertainties relating to the methods used are 
well understood to avoid miscarriages of justice.   
For suspect or non-target screening it is hard to see how methods could be validated in advance, 
without reference materials. Following a positive result, confirmation would likely be required 
using a validated method for results to stand up in court. However, when using a screening 
method, knowledge of the rate of false negatives is important for making decisions since a 
negative result from a screen will often result in no further analysis. According to the European 
Commission Decision 2002/657/EC, only methods with false compliant (false negative) rates of 




products [93]. If this requirement was also applied to screening of energetic materials, then 
appropriate reference materials would be needed to demonstrate this which is not possible for 
non-target compounds. For suspect and non-target screening methods, perhaps all that can be 
validated is the ability for the method to detect target or suspect compounds not included in 
method performance and/or optimisation experiments. That was the approach taken here when 
assessing method performance and at least 1 ion was detected at 10 ng µL-1 for all of the 44 






Overall, the LC-HRMS method performed well and generalised to a much larger set of target 
compounds. At least one ion was detected for all 62 compounds studied here. Additionally, 
multiple oligomers of MEKP were detected, as were mannitol and sorbitol penta- and tetra- 
nitrates and sorbitol tri- and di- nitrates. For 54 compounds, at least three ions (including the 
molecular ion/(de)protonated molecule/adduct ion and a fragment ion) could be detected at the 
highest concentration (10 ng µL-1), even without the use of HCD fragmentation. Although, signal 
to noise ratios and LODs varied greatly for different compounds and for different ions of the same 
compound.  HRMS analysis was not always able to provide a unique elemental composition, even 
with a mass accuracy threshold of 1 ppm. Changing the mass accuracy threshold had little effect 
on the number of elemental compositions for smaller molecules so a mass accuracy threshold of 
5 ppm was used here to minimise false negatives. Even if a unique elemental composition could 
be determined, for all bar two compounds, there were multiple isomers with the same elemental 
composition. This is a common challenge and it stressed particularly the need for selective 
separation of isomers with chromatography, or otherwise, to achieve the greatest confidence in 
identification. In some cases, using multiple ions led to improved selectivity between different 
explosive compounds and from matrix. However, the greatest improvement in selectivity was 
seen through the use of a retention time window, highlighting the value of developing a good 
chromatographic separation. Unlike, the use of multiple ions, utilising the chromatographic 
separation did not result in poorer LODs. Even with retention time windows there were a few 
cases of selectivity issues between pairs of isomers on this C18 Ar phase, but in the case of 2,4- 
and 2,6-DNT the use of ion ratios provided sufficient discrimination. The method was also 
successfully used to screen for explosives, with RDX detected in fingermarks and 12 explosives 
detected on passive vapour samplers exposed to an explosive magazine. For use as a screening 
method, the selectivity issues encountered here were not too problematic. However, confirmation 
by an additional technique or further investigation of potential selectivity issues would be 
recommended for confirmatory identification. Additionally, full method validation would be 
required though guidelines are not available yet for suspect and non-target screening LC-HRMS 
methods.     










Chapter 4: Retention time prediction 
using multiple linear regression and 






Chapter 3 highlighted the importance of chromatographic retention time for the identification of 
explosives by LC-HRMS. This presents a challenge for the identification of new compounds when 
reference materials may not be immediately available and in some cases hundreds, or even 
thousands, of compounds share the same elemental composition. Prediction of retention times 
using quantitative structure-retention relationships (QSRRs), based on a set of molecular 
descriptors, may allow for a reduction in the number of compounds for which measured retention 
times need to be obtained. QSRR models, using different sets of descriptors, have already been 
used to predict the retention times of small compounds for anti-doping [77,82] and environmental 
monitoring [80,83,84,90]. One limitation with existing QSRR models is that they are often only 
applicable to the specific LC conditions used to generate the method. Barron and McEneff 
demonstrated the generalisability of their artificial neural network (ANN) QSRR model across 10 
different instrumental methods and matrices [84]. However, limited diversity in stationary phase 
was demonstrated, with a C18 column used for 9 of the 10 methods and a C8 column used for the 
remaining method. Both of these stationary phases can only form Van der Waals forces and so 
generalisability across reversed phase HPLC columns that can also form π-π or permanent dipole 
interactions has not yet been shown. Additionally, QSRR models have not yet been used to 
predict retention times for energetic materials. Therefore, the first aim of this chapter was to 
investigate the suitability of ANN models using previously selected descriptors for the prediction 
of explosive retention times for the C18 Ar, gradient LC method discussed in Chapter 2. Molecular 
descriptors were then selected specifically for this LC method and set of analytes and prediction 
performance was compared. The second aim of this chapter was to use the best prediction 
models to predict retention times for explosives not included during the training and selection of 
prediction models. Prediction intervals were calculated to provide a measure of confidence in the 
predictions and the best two models were used to predict retention times for methyl ethyl ketone 
peroxide (MEKP) oligomers and mannitol and sorbitol nitrates. Finally, to investigate the potential 
for the models to reduce the number of compounds for which measured retention times must be 
acquired, retention times were also predicted for structural isomers with the same elemental 




4.2 Experimental  
4.2.1.1 Acquisition of HPLC retention times 
The LC-APCI-HRMS method optimised in Chapter 2 and performance tested in Chapter 3 was 
used to generate measured retention times for 47 explosives-related compounds. To expand the 
data set, chromatographic retention times were also obtained for 102 pharmaceuticals using the 
same column and gradient conditions. A list of the compounds used can be found in the Appendix. 
For the pharmaceuticals; heated electrospray ionisation, with conditions optimised for 
pharmaceuticals by Munro et al. [83], was used.  A mixed standard, containing all 149 
compounds, was analysed (n=6 injections) in both negative and positive mode, with both APCI 
and ESI to determine average measured retention times which were used to develop a retention 
time prediction model. Standard deviation was also calculated.  
Measured retention times were determined in a fingermark matrix by extracting fingermarks (n=6, 
3 male and 3 female donors) in 500 µL of the mixed standard. For measured retention time in 
pond water, grab samples were used. Following storage at -20 °C in Nalgene bottles, pond water 
samples were defrosted and acidified with 37% (w/v) hydrochloric acid solution to pH 2. Pond 
water samples were then filtered under vacuum using Whatman GF/F 0.7 μm glass microfibre 
filters and the solid phase extraction (SPE) method optimised by Rapp-Wright et al. was used 
[130]. This involved Oasis HLB (6 mL × 200 mg) cartridges (Waters Corp., Hertfordshire, UK) 
which were conditioned with 5 mL methanol and washed with 10 mL ultrapure water before 100 
mL of the acidified water samples (n=3) were loaded onto the SPE cartridges at 5-10 mL min-1. 
Cartridges were then washed with 5 mL ultrapure water and dried under vacuum for 10 min before 
elution with 2.5 mL of mixed standard in acetonitrile. This solution was then injected onto the LC-
HRMS. 
4.2.1.2 Generation of molecular descriptors 
Simplified Molecular Input Line Entry Specification (SMILES) strings were extracted from 
PubChem [131] and ChemSpider [117], or generated from a molecular structure drawn in 
ACD/ChemSketch (freeware) [132] if not found in either database. A list of these SMILES strings 
can be found in the Appendix, Table A. 1. The SMILES were then input into Parameter Client, an 
open access applet from the Virtual Computational Chemistry Laboratory (VCCLAB) [133] which 




an E-state indices calculation module; two fragment-based indices calculation programs (cfrag 
and cfrag-I) and ALOGPS which calculated LogP (lipophilicity) and LogS (aqueous solubility).  
Further information about the number and types of descriptors generated using Parameter Client 
is summarised in Table 4.1. Percepta PhysChem Profiler (ACD Laboratories, ON, Canada) was 
used to generate ACD/pKa(acid), ACD/pKa(base), ACD/LogP and ACD/LogD at pH 7 from the 
SMILES, since pKa and LogD could not be calculated using Parameter Client. 
4.2.1.3 Selection of molecular descriptors 
Initially whole sets of descriptors with missing values or zero variance for the explosives subset 
were removed. Where two descriptors had a linear correlation of R2 ≥ 0.98, the descriptor least 
correlated with measured retention time was also removed. Two methods of descriptor selection 
were used to down select from the remaining 1096 descriptors. The first method involved using 
the forward selection algorithm in Trajan 6.0 neural network simulator (Trajan Software Ltd., 
Lincolnshire, UK). This was performed (n=6) for each group of descriptors outlined in Table 4.1. 
The descriptors from each group, maximum of 10, which gave the smallest network error were 
then selected and combined with ACD/LogP and ACD/LogD to give 187 descriptors. The second 
method of selection involved running the genetic algorithm in Trajan 6.0 on all 1096 descriptors 
(n=10) with a unit penalty of 0.1.        
4.2.1.4 ANN modelling 
Trajan 6.0 neural network simulator was used for all ANN modelling. The three-step optimisation 
process outlined by Barron and McEneff [84], was followed for ANN optimisation using descriptors 
previously selected by Barron & McEneff [84], Goryński et al. [77] and Aalizadeh et al. [80]. As 
recommended by Barron and McEneff, a 70:15:15 ratio was used to split the dataset into training 
(n=105), selection (n=22) and test (n=22) sets. During the first phase of optimisation, the datasets 
were randomly reassigned within these numbers for each network to be tested. The intelligent 
problem solver tool was run for 15 mins and set to balance network error (based on the selection 
set) with diversity. At this stage, probabilistic neural networks (PNNs), generalised regression 
neural networks (GRNNs), radial basis functions (RBFs) and three and four-layer multilayer 
perceptrons (MLPs) were all evaluated. The best network type was selected from a shortlist of 50 
retained networks, based on the lowest consistent prediction errors across the training, selection 




Table 4.1: Groups of molecular descriptors generated using Parameter Client [133]. 
Group of descriptors Total Further details 
2D autocorrelations 96 Calculated from molecular graph by summing the products of atom weights of the terminal atoms of all the paths of the considered path length (the lag).  
3D-MoRSE descriptors 160 Molecular descriptors calculated by summing atom weights viewed by a different angular scattering function. 
Atom-centred fragments 120 Molecular descriptors based on the counting of 120 atom-cantered fragments, as defined by Ghose-Crippen. Some fragments are undefined by the authors. 
BCUT descriptors 64 Molecular descriptors obtained from the positive and negative eigenvalues of the adjacency matrix, weighting the diagonal elements with atom weights. 
Charge descriptors 14 Fourteen charge descriptors, which are reliable only when charges are estimated by quantum molecular method. 
Connectivity indices 33 Topological molecular descriptors calculated from the vertex degree of the atoms in the H-depleted molecular graph. 
Constitutional descriptors 48 OD-descriptors, independent from molecular connectivity and conformations. Atom and bond counts, molecular weight sum of atomic properties, etc. 
Edge adjacency indices 107 Topological molecular descriptors derived from the edge adjacency matrix, which encodes the connectivity between graph edges.  
Eigenvalue-based indices 44 Topological descriptors calculated by the eigenvalues of a square (usually symmetric) matrix representing a molecular graph. 
E-state Indices 382 Atom-type and bond-type electrotopological state (E-State) indices.  
ET-state Properties 3 By-product of the calculation of ET-state Indices. These can be used to check if the molecules were processed correctly by the program.  
Functional group counts 121 Molecular descriptors based on the counting of chemical functional groups. 
Geometrical descriptors 74 Conformationally dependent descriptors based on the molecular geometry. Reliable values are obtained if reliable conformations were previously calculated.  
GETAWAY descriptors 197 Descriptors calculated from the leverage matrix obtained by the centred atomic coordinates (molecular influence matrix, MIM).  
GSFRAG  307 Occurrence numbers of special molecular fragments on k=2,...,10 vertices in a molecular graph G  
GSFRAG-L  886 Occurrence numbers of special molecular fragments on k=2,...,7 vertices containing one labelled vertex.  
Information indices 47 Molecular descriptors calculated as information content of molecules, based on the calculation of equivalence classes from the molecular graph.  
Molecular properties 28 Molecular properties calculated from models together with some empirical descriptors.  
Randic molecular profiles 41 Derived from the distance distribution moments of the geometry matrix, average row sum of its entries raised at the kth power, normalized by the factor k! 
RDF descriptors 150 Molecular descriptors obtained by radial basis functions cantered on different interatomic distances (from 0.5A to 15.5A). 
Topological charge indices 21 First 10 eigenvalues (absolute values) obtained from a corrected adjacency matrix. 
Topological descriptors 119 Molecular descriptors obtained from molecular graph (usually H-depleted), i.e. 2D-descriptors conformationally independent. 
Walk and path counts 47 Molecular descriptors obtained from the molecular graph, counting paths, walks and self-returning walks of different lengths. 




the best network type was further evaluated, and the test set fixed according to the best network 
from the previous stage (but the training and selection sets were randomly resampled). This time 
the best network architecture was selected from a shortlist of 50 retained networks, again based 
on the balance of prediction errors across the training, selection and test sets. Finally, the best 
network type and architecture was replicated (n=6) with the training, selection and test sets fixed.       
Optimisation of ANN models using descriptors selected by forward selection or genetic algorithm 
followed the same general process as above. However, the option for the intelligent problem 
solver to select a subset of descriptors was used up until the final stage where the best network 
was replicated. Due to the relatively large number of descriptors at the start of the process, an 
additional 15 min optimisation stage was used at the beginning and only the descriptors used in 
the best network (based on the balance of prediction errors across the training, selection and test 
sets) were taken forward to the next stages of optimisation.    
4.2.1.5 Multiple linear regression modelling 
Multiple linear regression (MLR) models published by Goryński et al. [77] and Aalizadeh et al. [80] 
were tested on this dataset by calculating the predicted retention time in Excel using the published 
equations. Scatter plots for predicted versus measured retention times and prediction error versus 
retention time were also plotted in Excel. IBM SPSS statistics 24 was used to optimise the MLR 
models for this LC method based on the training set (n=105 compounds) used for the best ANN 
model with the same descriptors. Performance of the optimised MLR model on a test set (n=44 
compounds) was then tested in Excel as described above.   
4.2.1.6 Statistical analysis 
Excel was used to calculate R2 between descriptors, plot all scatter plots and calculate R2, slope 
and gradient for measured versus predicted retention times. Mean absolute error (MAE) and root 
mean squared error (RMSE) were also calculated in Excel, along with percentiles, interquartile 
range and total range for prediction errors. SPSS was used to assess the statistical significance 
of Pearson’s correlation and Spearman’s rank order correlation. SPSS was also used for a paired 
T-test, between the residual errors of the best models, the Shapiro-Wilk test for normality and 
generation of normal Q-Q plots. Stacked histograms for the training, selection and test errors 
were plotted using Excel. Performance intervals were also calculated in Excel, the details of which 




4.3 Results and discussion 
4.3.1 Building a dataset of measured retention times 
Average measured retention times (n=6) were initially generated for 47 compounds relevant to 
the forensic analysis of explosives using the LC-APCI-HRMS method developed in Chapter 2 and 
performance tested in Chapter 3. In addition to predicting the retention times of explosives, the 
ability to predict the retention times of non-explosives with the same elemental composition was 
desirable for exclusion purposes and to expand the chemical diversity of the model. Therefore, 
retention times were also obtained for 102 drugs and pharmaceuticals using the same LC method 
but with ESI conditions optimised for drugs by Munro, during a previous study [83]. This gave a 
combined dataset of 149 compounds which was still a relatively small dataset in comparison to 
the 550 compounds used by Bade et al. [90]. Barron & McEneff investigated the minimum number 
of cases required for ANN learning and found that, whilst prediction accuracy improved when 
larger datasets were used for training, a network trained using 36 compounds was still able to 
provide good prediction accuracy (average absolute error in retention time, ΔtR = 1.15 ± 1.05) for 
the blind test set [84].  
4.3.2 Developing prediction models with molecular descriptors from previous studies 
Three sets of molecular descriptors from published QSRR studies (Table 4.2), were investigated 
here for prediction of retention times for the gradient LC separation developed using a C18 Ar 
column in Chapter 2. These included the descriptors used by: Goryński et al. for separation of 
illicit drugs, metabolites and other anti-doping compounds on a PFP column [77]; Barron & 
McEneff for separation of pharmaceuticals, drugs of abuse, biocides and industrial chemicals, 
using C18 and C8 columns [84] and Aalizadeh et al. for separation of pesticides and other emerging 
contaminants detected in negative ionisation mode on a C18 column [80]. The only descriptor used 
in all three models was the Ghose–Crippen logarithmic octanol–water partition coefficient 
(ALOGP). Although, the logarithmic octanol water distribution coefficient (LOGD) was also used 
by both Barron & McEneff and Aalizadeh et al. Due to the pH dependant nature of LogD, here it 
was calculated at pH 7 to reflect the mobile phase used for this LC-HRMS method, despite Barron 












et al. 2016 
ALOGP Ghose–Crippen octanol–water partition coefficient X X X 
MLOGP Moriguchi octanol–water partition coefficient - X - 
LOGD Log of the octanol water distribution coefficient - X X 
BLTA96 Verhaar baseline toxicities for Algae (mmol L−1) - - X 
Ui Unsaturation index - X - 
Hy Hydrophilic factor - X - 
R2p R autocorrelation of lag 2, weighted by atomic polarizabilities, X - - 
HATS6m Leverage-weighted autocorrelation of lag 6/weighted by mass - - X 
BELe6 
Lowest Burden eigenvalue 6, weighted by atomic Sanderson 
electronegativities 
X - - 
BEHm4 Highest Burden eigenvalue 4, weighted by atomic masses - - X 
EEig14r 
Eigenvalue 14 from edge adj. matrix weighted by resonance 
integrals 
- - X 
CIC1 
Complementary Information Content index (neighbourhood 
symmetry 1-order) 
- - X 
nDB Number of double bonds - X - 
nTB Number of triple bonds - X - 
nC Number of carbons - X - 
nO Number of oxygens - X - 
nR04 Number of 4 membered rings - X - 
nR05 Number of 5 membered rings - X - 
nR06 Number of 6 membered rings - X - 
nR07 Number of 7 membered rings - X - 
nR08 Number of 8 membered rings - X - 
nR09 Number of 9 membered rings - X - 
nBnz Number of benzene-like rings - X - 
X = Descriptor included in model 
 
4.3.2.1 Artificial neural networks with molecular descriptors from previous studies 
In order to evaluate the suitability of the three sets of molecular descriptors for predicting the 
gradient retention time of explosives on a C18 Ar stationary phase, neural networks were optimised 
for each set of descriptors using Trajan 6.0 and the three-step optimisation process outlined by 
Barron & McEneff [84]. The correlation between predicted and measured retention times for the 
best neural networks using each set of descriptors are shown in Figure 4.1 A, with the prediction 
error plotted against retention time in Figure 4.1 B. Three-layer multilayer perceptrons (MLPs) 
provided the best neural network models for the 16 descriptors used by Barron & McEneff and 
the 7 descriptors used by Aalizadeh, whereas a radial based function (RBF) provided the best 
model for the 3 descriptors used by Goryński et al. Statistically significant negative correlation 
(p<0.001) was seen between retention time and prediction error for all three models, with over 




    
Figure 4.1: Correlation between measured and predicted retention times (A) and prediction error (B) for the 
best models using three different sets of molecular descriptors. Grey lines indicate perfect prediction and 
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indicating that the models were not fully explaining the retention mechanism. This trend was 
strongest for the model using the Goryński et al. descriptors with a Pearson correlation coefficient 
(R) of -0.559, compared to -0.437 and -0.399 for the models using Barron & McEneff and 
Aalizadeh descriptors respectively.  
When optimising each neural network, the data was randomly divided into three data sets: training 
set (n=105) which as the name suggests was used to train the model based on the known 
retention times; selection set (n=22) which was used during the optimisation process to control 
for over fitting and the test set (n=22) which was not involved in network optimisation but was also 
considered when selecting the best network. Due to the random assignment of compounds into 
training, selection and test sets during the first stage of ANN optimisation, the test set was not 
consistent for the models using different molecular descriptors. Additionally, that test set did not 
always have the largest errors. This was perhaps unsurprising given that this was an internal test 
set and consistency in errors across training, selection and test sets was a network selection 
criterion. Therefore, it was important to consider the errors across all datasets and not just the 
test set error when evaluating performance of the models. For all models the training, selection 
and test sets each contained a mixture of explosives and drugs. To ensure that the models were 
performing well for both explosive and non-explosive compounds the results were also analysed 
for explosive and drug subsets individually as well as for the combined dataset.  
Performance statistics, including: R2, slope and intercept of lines of best fit are shown in Table 
4.3. Across all subsets the model using the descriptors from Goryński et al. showed the poorest 
correlation between measured and predicted retention times with the lowest R2 values and the 
slopes and intercepts furthest from 1 and 0, which would be the case if x=y and the predicted 
retention time was equal to the measured retention time. The model using the descriptors from 
Barron & McEneff had the highest R2 values for all subsets apart from the explosives in the test 
set. Whereas the model using the descriptors from Aalizadeh et al. had the slope and intercept 
closest to 1 and 0 for the test sets, but the slope and intercept furthest from 1 and 0 for the 
explosives in the selection set.  
Table 4.3 also shows the root mean square error (RMSE) and mean absolute error (MAE) for the 
models using each set of descriptors. The RMSE for the combined test set was very similar for 





Table 4.3: Performance of the best ANN for each set of descriptors 
 Goryński et al. (RBF:3-9-1) Baron & McEneff (MLP:16-14-1) Aalizadeh et al. (MLP:7-7-1) 


















Training - Explosives 0.67 0.55 3.57 2.53 2.00 0.91 0.91 0.54 1.28 1.05 0.90 0.82 1.24 1.48 1.12 
Training - Drugs 0.75 0.79 2.05 2.21 1.86 0.83 0.83 1.53 1.63 1.27 0.81 0.84 1.33 1.74 1.38 
Training - Combined 0.71 0.71 2.53 2.32 1.91 0.86 0.86 1.17 1.52 1.20 0.84 0.83 1.32 1.66 1.29 
                
Selection - Explosives 0.39 0.44 4.39 1.51 1.32 0.94 0.91 -0.23 1.38 1.23 0.71 0.36 5.67 1.49 1.16 
Selection - Drugs 0.61 0.68 2.66 1.86 1.39 0.89 0.83 1.22 1.16 1.00 0.88 0.88 1.32 1.28 0.95 
Selection - Combined 0.59 0.64 2.89 1.77 1.37 0.90 0.81 1.18 1.23 1.07 0.84 0.81 1.83 1.35 1.01 
                
Test - Explosives  0.65 0.46 4.46 3.08 2.57 0.76 0.73 2.86 1.78 1.69 0.96 1.00 -1.16 1.46 1.20 
Test - Drugs 0.65 0.68 2.37 1.58 1.30 0.93 0.73 2.46 1.40 1.26 0.84 0.91 0.59 1.53 1.13 
Test - Combined  0.62 0.56 3.40 2.10 1.65 0.89 0.74 2.50 1.52 1.38 0.87 0.94 0.02 1.51 1.15 
                
All 0.69 0.69 2.62 2.22 1.79 0.86 0.84 1.35 1.48 1.21 0.84 0.84 1.26 1.59 1.23 






1.51 min, respectively), whereas the model using the descriptors selected by Goryński et al. had 
a RMSE of 2.10 min. Interestingly this was still lower than the RMSE of 3.45 min reported by 
Goryński et al. for predicting the retention times on a PFP column using their multiple linear 
regression model [77]. In contrast, Aalizadeh et al. reported a much lower RMSE of 0.40 min for 
their best nonlinear model for predicting retention times on a C18 column [80]. The MAE of the 
combined test set, which is less affected by outliers than the RMSE, was also largest for the 
model using the descriptors from Goryński et al. (MAE = 1.65 min), followed by the model using 
the descriptors from Barron & McEneff with MAE of 1.38 min. This was greater than the best 
performing model reported by Barron & McEneff for prediction of retention times on a C18 column, 
which had an MAE of 0.37 min, but lower than the poorest performing model which had an MAE 
of 1.82 min [84]. The fact that the model using only three descriptors, selected by Goryński et al., 
had the largest prediction errors suggested that those three descriptors led to an over simplified 
prediction model. Similarly, the larger ANN prediction errors, using descriptors selected by Barron 
& McEneff, for the C18Ar column used here than for the C18 and C8 columns used in the original 
paper, suggested that the descriptors may not fully describe retention on a C18 Ar column. In 
addition to the van Der Waals forces formed on a C18 or C8 column, π-π interactions are also 
possible on a C18 Ar column. 
4.3.2.2 Linear prediction models with molecular descriptors from previous studies 
While Barron & McEneff used non-linear artificial neural networks (ANN) [84], Aalizadeh et al. 
used both linear (multiple linear regression, MLR) and non-linear (ANN and support vector 
machines, SVM) models [80] and Goryński et al. used a linear MLR model [77]. Therefore, linear 
MLR models were also investigated for the prediction of gradient retention times on a C18 Ar 
column. Initially the MLR models developed by Goryński et al. (tR = 9.67R2p + 3.67BELe6 + 
1.70ALogP) [77] and Aalizadeh et al. (tR = - 0.4297+ 0.6242logD + 0.4649AlogP - 0.08647BLTA96 
- 0.6998EEig14r + 0.7589CIC1 + 1.551BEHm4 + 0.7907HATS6m) [80] for their respective LC 
methods were tested on this dataset using the C18 Ar column to check for generalizability.  
The scatter plots for predicted versus measured retention times (Figure 4.2A(i)) and prediction 
error over time (Figure 4.2B(i)) showed some separation between drugs and explosives for the 
Goryński et al. MLR model, with over prediction of all drug retention times but under prediction of 




negative correlation (R2 = 0.81) between the prediction error and retention time for both the drugs 
and explosives subsets (Figure 4.2B(ii)). For both MLR models the RMSE and MAE (Table 4.4) 
were greater than for the best ANN models using the same molecular descriptors (Table 4.3). 
Additionally, the RMSE were greater for this dataset than for the test sets presented in the original 
publications, with a combined RMSE of 5.32 min, compared to 3.45 min [77], for the Goryński et 
al. model and a combined RMSE of 2.75 min, compared to 1.22 min [80], for the Aalizadeh et al. 
MLR model.  
    
Figure 4.2: Performance of previous MLR models on this dataset with A) showing the correlation between 
predicted and measured retention times and B) showing the prediction error across the run. Grey lines 
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Table 4.4: Performance of published MLR models on this dataset. 
 Goryński et al. Aalizadeh et al. 
 MLR: tR = 9.67R2p + 3.67BELe6 + 1.70ALOGP MLR: tR = - 0.4297+ 0.6242LOGD + 0.4649ALOGP - 
0.08647BLTA96 - 0.6998EEig14r + 0.7589CIC1 + 
1.551BEHm4 + 0.7907HATS6m 












Explosives 0.32 0.53 3.50 3.78 2.99 0.71 0.49 3.41 2.63 2.28 
Drugs 0.60 0.74 8.71 5.22 6.52 0.62 0.34 5.17 2.80 2.33 
Combined 0.27 0.63 7.37 5.32 5.40 0.63 0.39 4.62 2.75 2.32 
  
The two previous MLR models did not generalise well to this LC method. However, given that 
retention times, and therefore the coefficients included in an MLR model, are affected by the LC 
conditions used (e.g. flow rate, mobile phase composition, stationary phase, particle size, column 
length and diameter); it was unsurprising that the MLR models performed worse when tested with 
a dataset using a different LC method and stationary phase. Neither was it surprising that MLR 
models trained using retention times from a different LC-method performed worse than the neural 
networks which were trained using measured retention times for this LC method. For a fairer 
comparison, multiple regression analysis was performed in SPSS, for both the Goryński et al. and 
Aalizadeh et al. descriptors. MLR models were trained using the same training sets (n=105) as 
the respective ANN model, before the remaining compounds (n=44) from the select and test sets 
were used to assess prediction. Performance of the optimised MLR models are shown in Figure 
4.3 and Table 4.5. 
The MLR model trained using the Goryński et al. descriptors had the following equation:  
tR = 9.334(±1.020) -11.546(±2.047)R2p + 5.683(±0.203)BELe6 + 1.954(±0.203)ALOGP.  
Multiple regression analysis showed that the three variables (R2p, BELe6 and ALOGP) predicted 
the retention time with statistical significance (p < 0.0005, R2 = 0.615) and each of the three 
variables added significantly to the prediction (p < 0.0005). Figure 4.3 shows that including a 
mixture of explosives and drugs in the training set removed the separation between the two 
subsets witnessed in Figure 4.2.  Optimisation of the coefficients for this dataset improved 
predictive accuracy, with the median error (50th percentile) reduced to -0.11 min in Figure 4.3 B(i), 
compared to 5.07 min in Figure 4.2 B(i) and the mean bias error (MBE) reduced from 4.30 to 0.27 
min. The maximum and average errors were also reduced, indicating improved precision, with 




Table 4.5: Performance of MLR models optimised for this dataset. 
 Goryński et al. Aalizadeh et al. 
 MLR: tR = 9.334 -11.546R2p + 5.683BELe6 + 
1.954ALOGP 
MLR: tR = -1.933 + 0.131LOGD - 0.747ALOGP – 
1.560 BLTA96 +0.507EEig14r +0.822CIC1 
+1.464BEHm4 +2.422HATS6m 












Training - Explosives 0.68 0.54 3.30 2.61 2.24 0.60 0.54 3.58 2.76 2.38 
Training - Drugs 0.63 0.66 3.43 2.63 2.21 0.09 0.11 7.36 3.86 3.02 
Training - Combined 0.62 0.62 3.40 2.62 2.22 0.27 0.27 6.06 3.54 2.81 
Test - Explosives 0.33 0.36 4.90 2.99 2.46 0.32 0.45 3.95 3.19 2.36 
Test - Drugs 0.24 0.43 5.29 2.94 2.46 0.26 0.22 7.10 3.22 2.57 
Test - Combined 0.25 0.40 5.28 2.95 2.46 0.23 0.27 6.36 3.17 2.46 
All 0.54 0.57 3.86 2.72 2.29 0.26 0.27 6.13 3.44 2.71 
 
          
Figure 4.3: Performance of MLR models developed for this dataset with A) showing correlation between 
predicted and measured retention times and B) showing the prediction error over time. Grey lines indicate 































Training - Explosives Test - Explosives
Training - Drugs Test - Drugs
Gorynski et al.
























Total range = 12.64 min

































Measured retention time (min)
Aalizadeh et al.
MLR: tR = -1.933 + 0.131LOGD - 0.747ALOGP 



























Measured retention time (min)
B(ii)
Total range = 17.44 min









in the original paper, but not as low as the combined test set RMSE of 2.10 min for the ANN model 
using these descriptors (Table 4.3).  
The MLR model trained using the Aalizadeh et al. descriptors had the following equation:  
tR = -1.933(±2.812) + 0.131(±0.305)LOGD - 0.747(±0.535)ALOGP – 1.560(±0.644)BLTA96 
+0.507(±0.714)EEig14r +0.822(±0.762)CIC1 +1.464(±0.895)BEHm4 +2.422(±1.375)HATS6m.  
Multiple regression analysis showed that these seven variables (LOGD, ALOGP, BLTA96, 
EEig14r, CIC1, BEHm4 and HATS6m) predicted the retention time with statistical significance 
(p < 0.0005). However, BLTA96 was the only descriptor which had a significant contribution to 
the model (p<0.05). As shown in Figure 4.3A(ii), correlation between predicted and measured 
retention times was also low. The coefficient of determination (R2) was 0.23 for combined test set, 
indicating that only 23% of the variance in retention time was explained by this model. Optimising 
the coefficients did reduce prediction bias with the median errors reduced from -0.62 to -0.25 min 
and the MBE reduced from -0.49 to 0.002 min. However, in this case the absolute prediction 
errors for the combined test set were even larger than for the MLR model optimised for Aalizadeh 
et al.’s LC method (RMSE = 3.17 min versus RMSE = 2.75 min, MAE = 2.46 min versus 
MAE = 2.32 min). In both cases, the best ANN model had lower errors (RMSE = 1.51 min, 
MAE = 1.15 min).       
Overall, non-linear, ANN models performed better than linear MLR models for the descriptors 
investigated here. ANN models using the descriptors selected by Barron & McEneff and Aalizadeh 
et al. performed better than the ANN model using descriptors selected by Goryński et al. However, 
in both cases performance was not as good as the best model presented in the original papers. 
This may be due to differences between the C18 Ar stationary phase used here and the C18 or C8 
phases used in the previous studies. Descriptors selected to predict retention on a C18 or C8 
column, where Van der Waals forces are the only interactions, may not fully describe retention 
on a C18 Ar column where there is the potential for additional interactions (e.g. π-π interactions) 
with the stationary phase.  
4.3.3 Selecting molecular descriptors for retention time prediction on a C18 Ar column 
Using a free online software (VCCLAB, Parameter Client [133]), 3224 molecular descriptors were 
easily generated using simplified molecular input line entry systems (SMILES) to describe 




generated using ADC Labs PhysChem profiler to give a total of 3227 descriptors. Too many 
independent variables, in this case molecular descriptors, can cause problems for prediction 
models. For example, if there are enough molecular descriptors to describe each molecule in the 
training set uniquely then the model will suffer from overtraining and poor generalisability, since 
the model would no longer be working from trends. Larger numbers of descriptors also require 
increased computational time due to increased complexity [134]. Therefore, a selection process 
was required to reduce the number of molecular descriptors.   
4.3.3.1 Reducing the number of descriptors 
Initially, descriptors containing very little or no information were removed. Removal of descriptors 
with missing values reduced the number of descriptors from 3224 to 2788. Then descriptors with 
zero variance across the data set were removed, reducing the number of descriptors to 1900; 
followed by all descriptors with zero variance for the explosives subset which further reduced the 
number of molecular descriptors to 1515. Four of the descriptors used by Barron & McEneff (nTB, 
nR04, nR05 and nR07) were eliminated at this stage due to having zero variance for the 
explosives subset.  
Highly correlated descriptors encode the same underlying information [134] resulting in limited 
value from including multiple highly correlated descriptors in a model. While some neural networks 
can ignore useless or redundant variables (e.g. multilayer peceptrons), others (e.g. radial based 
functions) cannot and are adversely affected [86]. Therefore, where two descriptors were highly 
linearly correlated (defined here as R2>0.98), the descriptor least correlated with retention time 
was removed. This reduced the number of molecular descriptors to 1096. Two more of the 
descriptors used in previous methods, MLOGP and BLTA96 were removed at this stage due to 
high linear correlation (R2> 0.9999) with the Verhaar model of Daphnia base-line toxicity from 
MLOGP (BLTD48), as shown in Figure 4.4. A third descriptor based on the Verhaar model of 
base-line toxicity from MLOGP, but this time in Fish (BLTF96), was also highly correlated with 
BLTD48 (again, R2> 0.9999) and so also removed. 
4.3.3.2 Linearity between descriptors and measured retention time 
Before developing a neural network, linearity between the measured retention times and each 
molecular descriptor was examined. Initially this was performed by calculating R2 values for the 




   
Figure 4.4: Collinearity between A) BLTD48 and BLTA96 and B) BLTD48 and MLOGP. Lines of best fit are 
shown in dark blue for explosives, light blue for drugs and black for the combined dataset. 
 
correlation had been removed. Scatter plots were then examined for the descriptors with the 
greatest R2 values (Figure 4.5). The three descriptors showing greatest linearity with measured 
retention time for the explosives subset were ACD/LogD at pH 7, ACD/LogP and BLTD48 (Figure 
4.5 A-C). ACD/LogD at pH 7 and ACD/LogP, two descriptors calculated by ACD Labs Percepta 
software, were also within the top five descriptors for the drugs subset. ACD/LogD and ACD/LogP 
showed positive correlation with retention time, as expected for reversed-phase chromatography 
where more hydrophobic compounds are retained longer on the non-polar stationary phase. 
BLTD48 showed negative correlation with retention time. This is because toxicity is related to 
lipophilicity, due to bioavailability, with low values of BLTD48 indicating high toxicity and therefore 
high lipophilicity which results in longer retention times by reverse-phase chromatography. 
ACD/LogP is a fragment-based approach for predicting the partition coefficient (LogP) from a 
compounds chemical structure [135]. LogP describes the partition of the unionised form of a 
compound between octanol and water at equilibrium. Two other methods for predicting LogP were 
also used to generate the initial set of molecular descriptors: Ghose–Crippen LogP (ALOGP) 
which is an atom based approach [136] and Moriguchi LogP (MLOGP) which is based on 
topological descriptors [137]. In most cases the three different prediction methods resulted in 
different LogP values which leaves the question of which was the most accurate LogP prediction? 
Manhold et al. found performance of ACD/LogP > ALOGP > MLOGP for predicting Log P using 
a public dataset but ACD/LogP did not perform as well as ALOGP or MLOGP for their in-house 
datasets [138].  For this study,  accuracy of  LogP  prediction  was  less  of a   priority,  but  it  was  
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Figure 4.5: Linear correlation between measured retention time and A) ACD/LogD at pH 7, B) ACD/LogP C) 
BLTD48 and D) number of carbon atoms (nC). Lines of best fit are shown in dark blue for explosives, light 
blue for drugs and black for the combined dataset. 
 
important to remember that these were only predicted LogP values when interpreting the 
correlation with retention time. LogP also only considers unionised compounds, so for ionised 
compounds the pH dependent distribution coefficient (LogD), which describes the distribution of 
ionised and unionised compounds between octanol and water, may be more appropriate.  
The majority of explosives were neither acidic nor basic and so ACD/LogD was equal to 
ACD/LogP as shown in Figure 4.6 A. The two main exceptions to this were picric acid (PA), with 
a pKa (acid) of 0.62 (LogD (pH=7) = LogP - 3.15), and nitroguanidine (NQ), with a pKa (acid) of 
5.23 (LogD (pH=7) = LogP - 1.58). HMTD, with pKa (base) of 5.28, also had a slight difference 
between ACD/LogD and ACD/LogP (–0.01) but very little would have been ionised at the relevant 
pH for this LC method. For the drugs subset (Figure 4.6 B), 72 out of 104 compounds had a LogD 
<LogP at pH 7, indicating ionisation. This was perhaps unsurprising given that drugs often contain 
acidic and/or basic groups. What was perhaps more surprising was that ACD/LogP had a slightly  
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Figure 4.6: Correlation between LogP and LogD at pH 7 for A) explosives and B) drugs with the dashed line 
showing x=y. 
 
greater correlation with retention than ACD/LogD for the drugs subset and the combined dataset, 
but ACD/LogD had greater correlation with retention time for explosives (Figure 4.5). Use of LogD 
might be more appropriate than LogP, provided accurate pH and pKa values are known, due to 
the consideration of ionisation which will affect retention. For the majority of explosives 
consideration of ionised compounds was not important and so LogP might be a suitable 
alternative if only interested in the prediction of retention times for organic, high-order explosives. 
However, consideration of ionised compounds will likely be important for exclusion purposes 
when generalisability to non-explosive compounds is required.  
The descriptor with the greatest linear correlation with retention time for the drugs subset was the 
number of carbon atoms (nC), shown in Figure 4.5 D. The number of carbons showed poor 
linearity (R2 = 0.2511) for the combined data set due to some separation between the explosives 
and drugs subsets. While the majority of drugs had more than 10 carbon atoms, the majority of 
explosives contained less than 10 carbon atoms, with 15 explosives containing 6 carbon atoms 
and 12 explosives with 7 carbon atoms. The explosives subset also showed greater 
chromatographic retention of compounds with fewer carbon atoms. This was likely due to a 
combination of the drugs dataset containing more acidic/basic groups which would favour 
interactions with the polar mobile phase and the explosives dataset containing lots of aromatic 































between the two subsets highlights the importance of including explosives in the training set when 
developing a model for the prediction of explosive retention times, rather than simply using a 
model developed for drugs. 
Of course, linear correlation is not the only form of correlation and it is possible that other 
descriptors would fit better to polynomial or logarithmic equations. Additionally, with a non-linear 
prediction model, descriptors may be transformed and/or combined when incorporated into the 
model. This could lead to interdependencies, where variables may be of limited use individually 
but valuable in combination with another variable. Therefore, poor linear correlation with retention 
time does not inherently mean a descriptor would not be of value for modelling retention times 
and so descriptors were not eliminated due to poor linearity.   
4.3.3.3 Selection of independent variables 
Once descriptors with missing values, zero variance and high collinearity (R2 > 0.98) were 
removed, 1096 descriptors remained; too many for use in a prediction model and so further 
selection was required. In their review paper, Yousefinejad and Hemmateenejad highlighted the 
importance of variable selection and discussed a number of classical and artificial intelligence 
methods for selection [87]. The neural network software used here, Trajan 6.0, provided the option 
of three different variable selection algorithms: forward selection, backward selection and genetic 
algorithm [86]. With forward selection, independent variables are introduced one at a time, starting 
with the variable that gives the best prediction on its own, followed by the variable that most 
improves the prediction, until the stopping criteria is reached [87]. Starting with the variables that 
provide the best prediction is an efficient method for selecting from a large number of variables, 
as is the case here. However, once a variable enters the model, it cannot be removed. This means 
combinations without previously selected descriptors are not tested, which is one of the main 
disadvantages of using forward selection [87]. With backward selection, initially all independent 
variables are included in the model and they are removed one by one according to selection 
criteria until either all remaining variables are significant, or only one variable remains. Backwards 
selection suffers from a similar disadvantage to forward selection in that not all combinations are 
tested [87]. However, backwards selection does keep important interdependent variables, that 
will not be included by forward selection unless they also improve the model individually. The 




numbers of variables as is the case here, since all variables are included in the initial evaluations 
for backwards selection [86]. Large numbers of variables also make it difficult for the backwards 
selection algorithm to work well, especially if there are only a few weakly predictive variables in 
the set [86]. Additionally, backwards selection tends to select a higher number of variables than 
required which can lead to over-fitted models [87].    
The genetic algorithm is an artificial intelligence method of variable selection based on natural 
selection in biological evolution [87]. Independent variables are represented as binary strings with 
a 0 indicating that a variable should not be used and a 1 indicating that it should be used [86]. 
The genetic algorithm randomly generates an initial population of strings and a portion of this 
population is selected, using a fitness function, for transfer to each successive generation, 
resulting in improved strings. Cross-overs (where two strings swap ends) and mutations (where 
some variables are randomly flipped from 0 to 1 or vice versa) vary the combination of variables 
future generations inherit from their parents. The algorithm terminates once the maximum number 
of generations, time or a plateau in the fitness function is reached [87]. The main advantage of 
using genetic algorithms for feature selection is their ability to recognise interdependent variables, 
especially when located close to each other on the string [86]. Genetic algorithms are relatively 
time consuming but essentially unaffected by the number of variables [86], making them a good 
option for selecting from the large number of molecular descriptors available here.   
Due to the large number of independent variables (1096 molecular descriptors) from which to 
select, and the disadvantages of using backwards selection for large numbers of molecular 
descriptors only forwards selection and genetic algorithm feature selection methods were used 
here. After the use of feature selection methods, the number of descriptors was reduced even 
further by allowing a subset of variables to be selected during the first stage of neural network 
training and optimisation. This meant that the final selection of descriptors was performed using 
the type of neural network used for the actual prediction model, rather than the generalised 
regression neural network (GRNN) used by the feature selection algorithms due to the speed of 
training [86].   
4.3.3.3.1 Forwards feature selection for ANN retention time prediction 
Attempts to run the forward selection algorithm on all 1096 descriptors at the same time 




Therefore, the forward selection algorithm was run on each group of descriptors individually and 
the 10 best descriptors from each group (based on smallest network error) were selected. Each 
time the forward selection algorithm was run (n=6 for each group of descriptors), differences were 
seen in the descriptors selected. Given that in theory when using the forward selection algorithm 
descriptors should be added to the model in order of the impact they have on prediction, this was 
perhaps surprising and may indicate the presence of interrelated descriptors. It also highlights the 
randomness of the feature selection process. Where more than 10 descriptors were selected for 
each group, only the 10 descriptors leading to the lowest network error were taken onto the next 
stage to keep the number of descriptors low. Even so, 187 descriptors were taken through to the 
next stage, use of the Intelligent Problem Solver function to select subsets of these descriptors 
for optimisation of neural networks. A subset of 32 descriptors (Table 4.6) gave the best prediction 
model, a 3-layer multilayer perceptron (MLP:32-2-1). Sensitivity analysis was performed to test 
how well the model performed without each descriptor in turn and the ratio of network errors 
without/with the descriptor was calculated and used to order the descriptors shown in Table 4.6. 
Removal of LogD had the biggest effect, increasing the network error by 1.312 times. At the other 
end of the table, p1p1p2-6N had an error ratio of <1 indicating that the network error was reduced 
by its removal. However, attempts to retrain a model without this descriptor did not result in 
improved performance. Sensitivity analysis only evaluates the importance of each descriptor 
within the context of a particular network and it is not possible to fully link sensitivity analysis with 
the importance of each descriptor for predicting retention time more generally [86]. Here, an 
average of 6 networks with fixed datasets and the same architecture, but different optimised 
weightings associated with each, was used to account for some of the variability in sensitivity 
analysis between networks. However, interdependent and correlated descriptors would still affect 
the results of sensitivity analysis. 
 
Table 4.6 (Continued): Subset of 32 forward selected descriptors and sensitivity of MLP:32-2-1 to these descriptors 
Descriptor Definition Group Sensitivity* SD** 
LogD (pH = 7) Log of the octanol water distribution coefficient at pH 7 
predicted by ACD Labs. 
Molecular properties 1.312 0.135 
GATS1m Geary autocorrelation - lag 1 / weighted by atomic 
masses 
2D autocorrelations 1.149 0.070 
BLTD48 Verhaar model of Daphnia base-line toxicity from 
MLOGP (mmol/l) 
Molecular properties 1.144 0.138 




Table 4.6 (Continued): Subset of 32 forward selected descriptors and sensitivity of MLP:32-2-1 to these descriptors 
Descriptor Definition Group Sensitivity* SD** 
Hypertens-80 Ghose-Viswanadhan-Wendoloski antihypertensive at 
80% (drug-like index) 
Molecular properties 1.129 0.071 
BIC1 Bond information content (neighbourhood symmetry of 1-
order) 
Information indices 1.120 0.055 
RDF055e Radial Distribution Function - 5.5 / weighted by atomic 
Sanderson electronegativities 
RDF descriptors 1.120 0.086 
ATS6p Broto-Moreau autocorrelation of a topological structure - 
lag 6 / weighted by atomic polarizabilities 
2D autocorrelations 1.104 0.094 
MPC02 Molecular path count of order 02 (Gordon-Scantlebury 
index) 
Walk and path 
counts 
1.099 0.104 
ACD/LogP Log of octanol-water partition coefficient predicted by 
ACD Labs 
Molecular properties 1.074 0.071 
DP15 Molecular profile no. 15 Randic molecular 
profiles 
1.063 0.096 
p2Bp2B Fragment containing two paths of length 2 with attached 
chains at position B 
GSFRAG 1.050 0.098 










GGI7 Topological charge index of order 7 Topological charge 
indices 
1.040 0.058 
D/D Distance/detour index Topological 
descriptors 
1.040 0.042 
N-068 Three aliphatic groups attached to a nitrogen atom Atom-centred 
fragments 
1.040 0.055 
p4p4 Fragment containing two paths of length 4  GSFRAG 1.038 0.039 
H7u H autocorrelation of lag 7 / unweighted GETAWAY 
descriptors 
1.028 0.025 
IDE Mean information content on the distance equality Information indices 1.025 0.025 
RDF050e Radial Distribution Function - 5.0 / weighted by atomic 
Sanderson electronegativities 
RDF descriptors 1.024 0.039 
H-048 H attached to C2(sp3) / C1(sp2) / C0(sp) Atom-centred 
fragments 
1.020 0.029 
TIE E-state topological parameter Topological 
descriptors 
1.019 0.022 





p1p4-4N Fragment containing two paths of length 1 and 4, with a 















Table 4.6 (Continued): Subset of 32 forward selected descriptors and sensitivity of MLP:32-2-1 to these descriptors 
Descriptor Definition Group Sensitivity* SD** 
Neoplastic-50 Ghose-Viswanadhan-Wendoloski antineoplastic at 50% 
(drug-like index) 
Molecular properties 1.014 0.015 





R3v+ R maximal autocorrelation of lag 3 / weighted by atomic 









p4-3N Fragment containing a path of length 4, with a nitrogen 




p1p1p2-6N Fragment containing two paths of length 1 and one path 




* Average ratio of network error without descriptor/with descriptor for n=6 networks, ** n=6.  
 
 
4.3.3.3.2 Genetic feature selection for ANN retention time prediction 
The genetic algorithm feature selection was run 10 times on the full 1096 descriptors and resulted 
in a different selection of descriptors each time, due to different randomly assigned initial 
populations. The only descriptors selected each time were ACD/LogP, ACD/LogD(pH=7), 
BLTD48, MLOGP2, ALOGP and the mean electrotopological state (Ms).   The electrotopological 
state (E-state) of each skeletal atom in a molecule combines both the electronic character and 
the topological environment of the atom [139]. A unit penalty was used, which was multiplied by 
the number of variables in a network and added to the network selection error, to penalise 
networks containing large numbers of descriptors. Even when this unit penalty was set to 0.1 
(compared to a default of 0.0001) the smallest number of descriptors selected was 181, still more 
than the number of compounds available to train the model. Therefore, further selection was 
required. Instead of running the genetic algorithm for further generations, the ‘select a subset of 
variables’ feature in the intelligent problem solver was used to develop a neural network using 
fewer molecular descriptors. The best model, MLP:11-3-1, used the eleven descriptors shown in 
Table 4.7. LogD was the only descriptor included in both the subset of forward selected and the 
subset of genetic algorithm selected descriptors. In both cases, the models were most sensitive 
to the removal of LogD and the network error was 1.552 times greater without LogD for the model 







Table 4.7: Subset of 11 genetic algorithm descriptors and sensitivity of MLP:11-3-1 to these descriptors 
Descriptor Definition Group Sensitivity* SD**  
LogD (pH = 7) Log of the octanol water distribution coefficient at pH 7, 




MLOGP2 Squared Moriguchi octanol-water partition coefficient  Molecular 
properties 
1.282 0.140 
RDF090E Radial Distribution Function - 9.0 / weighted by atomic 
Sanderson electronegativities 
RDF descriptors 1.155 0.114 





ATS8P Broto-Moreau autocorrelation of a topological structure - 




P3P5 Fragment containing one path of length 3 and one path of 
length 5  
GSFRAG 1.057 0.066 
BELE8 Lowest eigenvalue n. 8 of Burden matrix / weighted by 




H-050 H attached to heteroatom atom-centred 
fragments 
1.051 0.021 
JGI10 Mean topological charge index of order 10 Topological 
charge indices 
1.043 0.058 
P1P4B Fragment containing one path of length 1 and one path of 
length 4 with attached chain at position B 
GSFRAG 1.037 0.048 
GATS6M Geary autocorrelation - lag 6 / weighted by atomic masses 2D 
autocorrelations 
1.008 0.013 
* Average of n=6 networks, ** n=6 
 
 
4.3.4 Performance of neural networks using selected descriptors  
Correlation between measured and predicted retention times and prediction errors for the best 
neural networks using a subset of the descriptors selected by forward selection and genetic 
algorithms are shown in Figure 4.7. In both cases 3-layer multilayer perceptrons (MLPs) gave the 
best prediction models. The total range of prediction errors was larger (7.54 min compared to 
6.59 min)  for  the model using 32 of the  descriptors selected by forward selection  (MLP:32-2-1) 
compared to the model using 11 of the descriptors selected by genetic algorithm (MLP:11-3-1), 
Figure 4.7 B, but this was still an improvement upon the smallest error range (8.45 min) seen for 
a model using molecular descriptors from a previous study (Figure 4.1 B(ii)). Further performance 
criteria are shown in Table 4.8 for MLP:32-2-1 and Table 4.9 for MLP:11-3-1. Overall, MLP:32-
2-1 had a lower RMSE and MAE for the combined test set. However, the RMSE and MAE of the 
explosives test set were greater than the drugs test set for MLP:32-2-1 but lower than the than 
the drugs test set for MLP:11-3-1. Conversely, the RMSE and MAE were lower for the explosives 
training set than the drugs training set for MLP:32-2-1, but greater for MLP:11-3-1. As discussed 




Table 4.8: Performance of the best model and an ensemble of 6 models using a subset of 32 of the molecular 
descriptors selected by forward selection 
 Best model: MLP:32-2-1 Ensemble: 6xMLP:32-2-1 














Training - Explosives 0.92 0.97 0.13 1.12 0.95 0.92 0.92 0.51 1.16 0.99 
Training - Drugs 0.83 0.81 1.49 1.59 1.31 0.84 0.78 1.85 1.60 1.29 
Training - Combined 0.86 0.86 1.04 1.45 1.18 0.86 0.82 1.42 1.47 1.19 
           
Select - Explosives 0.90 0.86 1.14 1.54 1.39 0.90 0.87 0.75 1.61 1.49 
Select - Drugs 0.96 0.89 1.36 1.05 0.91 0.97 0.84 1.82 1.05 0.88 
Select - Combined 0.94 0.87 1.36 1.20 1.04 0.94 0.84 1.60 1.23 1.05 
           
Test - Explosives 0.87 0.99 -0.52 1.64 1.40 0.86 1.06 -1.04 1.74 1.60 
Test - Drugs 0.94 0.94 0.43 0.92 0.70 0.93 0.85 1.24 1.03 0.84 
Test - Combined 0.91 0.95 0.17 1.20 0.92 0.89 0.92 0.53 1.30 1.08 
           
All 0.88 0.88 1.00 1.38 1.12 0.88 0.84 1.34 1.41 1.15 
 
 
     
Figure 4.7: Correlation between measured and predicted retention times (A) and prediction error (B) for the 
best models using a subset of descriptors selected by (i) forward selection and (ii) genetic algorithm. Grey 





























Interquartile range = 1.83 min
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Interquartile range = 1.98 min





Table 4.9: Performance of best model and an ensemble of six models using a subset of the descriptors 
selected by genetic selection. 
 Best model: MLP:11-3-1 Ensemble: 6xMLP:11-3-1 














Training - Explosives 0.89 0.96 -0.08 1.44 1.14 0.89 0.82 1.21 1.44 1.15 
Training - Drugs 0.87 0.88 1.15 1.41 1.14 0.83 0.80 1.79 1.62 1.34 
Training - Combined 0.87 0.91 0.72 1.42 1.13 0.85 0.80 1.59 1.56 1.27 
           
Select - Explosives 0.94 0.70 2.65 1.38 1.16 0.91 0.61 3.42 1.73 1.42 
Select - Drugs 0.91 0.93 0.90 1.08 0.86 0.86 0.82 1.85 1.35 1.06 
Select - Combined 0.91 0.86 1.48 1.17 0.94 0.86 0.75 2.36 1.46 1.16 
           
Test - Explosives 0.91 0.96 0.11 1.29 0.96 0.83 0.90 0.53 1.77 1.60 
Test - Drugs 0.90 0.84 1.88 1.50 1.14 0.87 0.78 2.19 1.63 1.27 
Test - Combined 0.90 0.85 1.70 1.46 1.10 0.87 0.80 2.01 1.67 1.34 
           
All 0.88 0.89 0.99 1.39 1.10 0.85 0.80 1.77 1.56 1.27 
 
subsets during the first stage of network optimisation. Therefore, the 22 compounds included in 
the blind test set were not the same for both models; with 7 explosives in the test set for 
MLP:32-2-1 but only 5 explosives in the test set for MLP:11-3-1, and so the two subsets were not 
directly comparable. Performance of the two models for all subsets (training, selection and test) 
combined was very similar, with R2=0.88, a slope of 0.88 or 0.89, an intercept of 1.00 or 0.99 min, 
a RMSE of 1.38 or 1.39 min and a MAE of 1.12 or 1.10 min. A paired T-test showed no significant 
difference (p=0.783) between the absolute errors of the two models.  
4.3.4.1 Performance of ensembles 
Ensembles of six repeated networks were also created, since the ultimate aim of developing a 
prediction model was to be able to generalise the model for the prediction of unknowns. Forming 
an ensemble of neural networks has been shown to improve generalisability [140]. Hansen and 
Salamon argued that forming an ensemble reduced generalisation errors which differ between 
individual networks, due to multiple local minima.  Here, each of the six networks were given equal 
weightings and the retention time prediction from each model was averaged and the results are 
shown in Figure 4.8. For MLP:32-2-1, an ensemble of 6 networks with the same architecture 
reduced the total range of errors from 7.54 min (-3.79 to 3.75 min) to 6.90 min (-3.60 to 3.30 min). 
However, for MLP:11-3-1, the total error range of the ensemble (7.52 min) was larger than for the 
best individual network (6.59 min). The test sets should provide the best indication of 





    
Figure 4.8: Correlation between measured and predicted retention times (A) and prediction error (B) for the 
ensembles (n=6) using a subset of descriptors selected by (i) forward selection and (ii) genetic algorithm. 
Grey lines indicate perfect prediction and dashed green lines show percentiles. 
 
optimisation of the networks. However, as shown in Table 4.8 and Table 4.9, the RMSE and MAE 
for the explosives, drugs and combined test sets were larger for the ensemble than the best 
network for both MLP:32-2-1 and MLP:11-3-1. A paired T-test showed no significant difference 
between the absolute errors from the best model and ensemble of 6 models for MLP:32-2-1 
(p=0.388), but a significant difference was seen for MLP:11-3-1 (p=0.005), with a larger MAE for 
the ensemble. As a result of this, and due to the narrower total error ranges, the best ensemble 
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4.3.4.2 Prediction order and rank correlation 
In some instances, such as for the prediction of mannitol pentanitrate isomer elution order after 
three peaks have been detected, the ability to predict retention order may be just as valuable as 
predictive accuracy. Especially given the relatively large prediction errors in comparison to the 
differences in isomer retention times. Therefore, rank order correlation was also assessed. As 
shown in Table 4.10, Spearman’s rank order correlation coefficient, rs, was found to be statistically 
significant (p<0.001) for all models, suggesting that they were able to predict the general retention 
order. However, as shown in Figure 4.9 A, there was some scatter, especially in the middle of the 
run and in many of the 149 cases the retention order was incorrectly predicted. To investigate 
whether the retention order of a smaller number of more closely related compounds could be 
more accurately predicted, the retention order of the 12 nitrate esters included in the training, 
selection or test sets was also investigated. For both models, Spearman’s correlation coefficient 
was greater for the nitrate esters alone (rs 0.96 and 0.98) than for all compounds (rs 0.92 and 
0.93). As shown in Figure 4.9 B(i), the ensemble of 6xMLP:32-2-1 also correctly predicted the 
retention order of all the nitrate esters included in the training set; however, the retention orders 
of those included in the selection set (ETN and PETN) and test set (1,3-DNG) were incorrectly 
predicted. MLP:11-3-1 did correctly predict the retention order of ETN, which was again in the 
selection set (Figure 4.9 B(ii)); however, using this model the retention orders of two of the 
compounds in the training set (TEGDN and NG) were incorrectly predicted. Therefore, whilst there 
was strong correlation between the measured and predicted retention order, further work would 
be required (including the assessment of a greater number of related blind test compounds) 
before either model could be used to confidently predict retention order for new/unknown 
compounds.      
Table 4.10: Spearman's rank order correlation between predicted and measured retention times  
 All compounds (n=149) Nitrate esters only (n=12) 
Neural network Spearman’s coefficient (rs) Significance (p) Spearman’s coefficient (rs) Significance (p) 
6xMLP:32-2-1 0.926 <0.001 0.963 <0.001 






Figure 4.9: Rank order correlation for A) all 149 compounds and B) nitrate esters using I) the ensemble of 6 
MLP:32-2-1 and ii) the best MLP:11-3-1. 
 
4.3.4.3 Setting a retention range for prediction of new compounds 
When predicting the retention time of new/unknown compounds it is the individual prediction error 
rather than the mean prediction error that is of interest. The prediction interval (PI) is the range 
likely to include the response of a single new observation and so this was calculated instead of 
the confidence interval (CI) of prediction, the range likely to contain the mean response. Due to 
the increased uncertainty of predicting a single response rather than the mean response, the PI 
is normally wider than the CI. The prediction interval was given by the new predicted value (ŷℎ) 
plus or minus the appropriate t-value (t) multiplied by the standard error of prediction (𝑠𝑝𝑟𝑒𝑑) [141],  
as shown in Equation 4.1. As the standard error of prediction for the entire population was not 
known, an estimate of the standard error of prediction (𝑠𝑒𝑠𝑡), was calculated based on the standard 
error of the sample of 149 compounds used for training and testing the networks using Equation 
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the number of compounds in the sample. For the sample size used here (149 compounds), the t-
value (to 3 significant figures) was 1.98 for a 95% PI, close to the t-value for infinity degrees of 
freedom (1.96) [143,144]. The calculated prediction intervals are shown in Table 4.11. As 
expected, the size of the prediction intervals increased as the confidence level increased. For a 
99 % probability that the true retention time would fall within the prediction interval, a 7.4 min (± 
3.7 min) PI was required. Whereas, if only a 75 % probability that the true retention time would 
fall within the PI was required, a 3.2 min (± 1.6 min) PI could be used. In order to use the prediction 
model for exclusion purposes, the highest possible probability that the true value would fall within 
the PI should be used to limit false negatives. However, when prioritising compounds to obtain 
reference materials for confirmation of unknowns a more relaxed PI might be more appropriate, 
at least in the first instance, to limit the number of compounds for which reference materials need 
to be purchased and/or synthesised.      
Equation 4.1: Prediction interval 
𝑃𝐼 =  ŷℎ ± 𝑡(𝛼 2,𝑛−2)⁄ × 𝑠𝑝𝑟𝑒𝑑 





Table 4.11: Prediction intervals  
Model 
Prediction interval (min) 
50 %  75 %  80 % 90 % 95 % 99 %  
MLP:11-3-1 ± 0.95 ± 1.62 ± 1.81 ± 2.32 ± 2.77 ± 3.67 
6xMLP:11-3-1 ± 1.06 ± 1.82 ± 2.03 ± 2.61 ± 3.11 ± 4.11 
MLP:32-2-1 ± 0.94 ± 1.61 ± 1.79 ± 2.31 ± 2.75 ± 3.64 
6xMLP:32-2-1 ± 0.96 ± 1.64 ± 1.83 ± 2.36 ± 2.81 ± 3.72 
 
Calculation of the PI was based on the assumption that the residual errors were normally 
distributed; since for a normal distribution, 95 % of responses fall within 2 standard deviations of 
the population mean. Although, as neither the population mean, nor the population standard 
deviation were known in this case, they were estimated based on the sample and the errors 
associated with using such an estimate. As shown by the roughly bell-shaped histograms (Figure 
4.10 A) and the minimal deviation from the line in the normal Q-Q plots (Figure 4.10 B), the 
residual errors were approximately normally distributed, with the mean error close to zero, for 





Figure 4.10: Assessment of normal distribution of prediction errors using A) histograms and B) normal Q-Q 
plots for i) 6xMLP:33-2-1 and ii) MLP:11-3-1. 
 
normality showed no significant deviation from normality for either the ensemble of 6 MLP:32-2-
1 (p=0.869, 0.684 and 0.530 for training, select and test sets respectively) or MLP:11-3-1 
(p=0.692, 0.976 and 0.359 for training, select and test sets respectively).    
4.3.4.4 Summary of performance assessment 
Based on the assessment of performance presented in this section, it was not possible to 
conclusively determine the best model for predicting the retention times of new compounds. The 
99 % prediction intervals for MLP:11-3-1, MLP:32-2-1 and the ensemble 6xMLP:32-2-1 were very 
similar (± 3.67, 3.64 and 3.72 min, respectively). As were the overall MAE (1.10, 1.12 and 1.15 
min, respectively) and the RMSE (1.39, 1.38 and 1.41 min respectively). Therefore, further 
assessment of method performance, preferably for new compounds not considered during 
training, optimisation or selection of the neural networks, was necessary before one model could 




4.3.5 Application of retention time prediction to new compounds 
4.3.5.1 Prediction of organic gunshot residue retention times  
Several of the energetic materials included in the explosives dataset may also be found in organic 
gunshot residue (OGSR). For example, DPA, DEDPU, DMDPU, NG and 2,4-DNT have all been 
detected in smokeless powders [39]. A gun surveillance standard including dimethyl phthalate 
(DMP), 2,4’-, 2,4-, 2,2’- and 4,4’-dinitrodiphenylamine (DNDPA), 2- and 4-nitrodiphenylamine 
(NDPA), N-Nitrosodiphenylamine (N-NDPA) and diphenylamine (DPA, also included in 
explosives dataset) was analysed on the same day as the mixture used to develop the ANNs. 
The extracted ion chromatograms are shown in Figure 4.11. Multiple peaks were detected in 
several of the EICs due to DNDPA and NDPA isomers and closely related compounds N-NDPA 
and DPA which produced common ions. In all cases there was baseline separation, highlighting 
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the value of optimising chromatography during Chapter 2.  At least three ions, including both a 
molecular ion or (de)protonated molecule and a fragment ion, were detected for all compounds 
apart from N-NDPA, reinforcing the generalisability of the developed LC-HRMS method. In the 
case of N-NDPA, two ions were still detected but in both cases the nitroso (-N=O) group was lost 
during in-source fragmentation. As seen for other nitroaromatics, the nitro- and dinitro-DPAs 
produced [M-OH]- fragment ions and ion ratios differed between isomers.  
Individual standards were also analysed for DMP, 2,4- and 4,4’-DNDPA, 2- and 4- NDPA and N-
NDPA to confirm retention times and order (labelled in Figure 4.11). These six compounds were 
then used as an external test set to further assess performance of the prediction models and their 
chemical structures are shown in Figure 4.12. Without reference standards it was not possible to 
identify which of the middle two DNDPA peaks were due to 2,2’- or 2,4’-DNDPA and so these 











































2,4-DNDPA 4,4’-DNDPA DMP  
Figure 4.12: Chemical structures of new OGSR compounds used as an external test set for validation of 
prediction models. 
 
The predicted retention times and prediction errors for the six new, to the prediction model at 
least, energetic materials, using MLP:11-3-1, MLP:32-2-1 and 6xMLP:32-2-1, are shown in 
Table 4.12. This small external test set indicated that MLP:32-2-1 and 6XMLP:32-2-1 were more 
generalisable and accurate than MLP:11-3-1. All predicted retention times using MLP:32-2-1 and 
6xMLP:32-2-1 fell within the 95 % PIs (± 2.75 and 2.81 min, respectively) and 4 out of 6 fell within 
the 50 % PI (± 0.94 and 0.96 min, respectively). In contrast, 3 out of 6 predicted retention times 





Table 4.12: Measured and predicted retention times for OGSR components. 
          MLP:11-3-1 MLP:32-2-1 6xMLP:32-2-1 

















DMP [M+H]+ 195.0652 7.38 0.02 9.29 1.91 7.91 0.53 7.50 0.12 
N-NDPA [M-NO]- 168.0819 13.45 0.02 12.31 -1.14 14.27 0.82 14.04 0.59 
4-NDPA [M-H]- 213.0670 14.19 0.03 10.66 -3.53 14.53 0.34 14.22 0.03 
4,4'-DNDPA [M-H]- 258.0520 14.87 0.03 10.39 -4.48 14.05 -0.82 13.97 -0.90 
2-NDPA [M-H]- 213.0670 16.43 0.02 12.44 -3.99 14.76 -1.67 14.37 -2.06 
2,4-DNDPA [M-H]- 258.0520 16.58 0.03 11.72 -4.86 13.94 -2.64 13.87 -2.71 
   MAE (min) 3.32 1.14 1.07 
   RMSE (min) 3.58 1.38 1.46 
 
validating prediction models using an external test set with known retention times, before relying 
on a prediction model to make decisions. In terms of retention order, all three models correctly 
predicted that 4-NDPA would elute before 2-NDPA. MLP:11-3-1 also correctly predicted that 4,4’-
DNDPA would elute before 2,4-DNDPA, but MLP:32-2-1 and 6xMLP:32-2-1 did not. MLP:32-2-1 
and 6xMLP:32-2-1, also underestimated the separation achieved between the two pairs of closely 
related structural isomers. However, overall prediction accuracy was better for MLP:32-2-1 and 
6xMLP:32-2-1, with MAE and RMSE less than half those for MLP:11-3-1. Additionally, the MAE 
and RMSE using MLP:11-3-1 were 3.0 and 2.6 times greater, respectively, for the new 
compounds than for the combined training, selection and test sets used to develop and select the 
model. Whereas, using MLP:32-2-1 and 6xMLP:32-2-1 the MAE and RMSE for the new 
compounds were within 0.05 min of the MAE and RMSE for the original dataset. 
Even this relatively small validation set called into question the generalisability of the MLP:11-3-
1 model and the prediction intervals calculated in Section 4.3.4.3 for this network. However, the 
MLP:32-2-1 single network, 6XMLP:32-2-1 ensemble and their PIs performed better. Prediction 
errors for the MLP:32-2-1 single network and 6xMLP:32-2-1 ensemble were similar, with the MAE 
slightly lower for the ensemble and the RMSE slightly lower for the single network. Based on 
previous work suggesting that the formation of ensembles improves generalisability [140], 
6xMLP:32-2-1 was selected to use for retention time prediction of MEKP oligomers, sugar nitrates 
and structural isomers of RDX, TATB and PYX. Prediction of these compounds using MLP:11-




may also be required to investigate generalisability and applicability of the PIs to a wider variety 
of new compounds.      
4.3.5.2 Prediction of MEKP oligomer retention times 
As discussed in Chapter 3, Section 3.3.2.4, Methyl ethyl ketone peroxide (MEKP) includes cyclic 
peroxide (CP) and linear dihydroperoxy peroxide (DHP) oligomers of various sizes (Figure 3.9) 
and reference materials for individual oligomers were not available. A number of these oligomers 
were detected in a sample of MEKP analysed using this LC-HRMS method, but it was not always 
clear which chromatographic peak corresponded to which oligomer due to multiple peaks in some 
extracted ion chromatograms and peaks with the same retention time seen in multiple EICs 
(Figure 3.10). Here, MEKP was revisited again to see if the predictive model (6xMLP:32-2-1) 
could aid assignment of chromatographic peaks to specific MEKP oligomers. The MEKP sample 
was analysed again on the same day as the ANN training, selection and test compounds and the 
measured retention times (tRM) obtained for the EIC corresponding to the ammonium adduct of 
each oligomer are shown in Table 4.13. Fewer peaks were detected than the first time the MEKP 
sample was analysed and no peaks were detected in the EIC for the CP tetramer this time. This 
may have been due to sample degradation, since several months elapsed in between analysis.  
The predicted retention times (tRP) are also shown in Table 4.13, along with the prediction order 
and the difference in retention time from each of the chromatographic peaks detected. All 
retention times fell within the 99 % prediction interval, further supporting the generalisability of the 
ensemble, 6XMLP:32-2-1. As expected, the prediction model ordered the oligomers by size with 
Table 4.13: Predicted retention time and order for MEKP oligomers using 6xMLP:32-2-1. 
MEKP Oligomer Formula 
[M+NH4]+ 
Exact m/z 
tRM (min) tRP (min) tRP Order ΔtR (min) 










DHP trimer C12H26O8 316.1966 12.93 14.62 3 1.69 
CP trimer C12H24O6 282.1911 17.14 14.72 4 -2.42 
CP tetramer C16H32O8 370.2435 n.d.* 16.14 5 - 
DHP tetramer C16H34O10 404.2490 16.01 17.19 6 1.18 






M – measured retention time for peaks detected with m/z ± 5 ppm of [M+NH4]
+ ion; tRP – Predicted retention time; ΔtR – 
difference between prediction and measured retention time; n.d. not detected; *Previously detected with a retention time 





dimer < trimer < tetramer < pentamer. What was perhaps more surprising was that while the 
predicted order was DHP < CP for trimers, it was CP < DHP for the dimers and tetramers. Due to 
the polar dihydroperoxy (R-O-OH) groups at each end of the DHP oligomers, they might be 
expected to be more polar than the corresponding CP oligomer. This was reflected in the ALOGP 
and MLOGP predicted LogP values where DHP < CP for the dimer, trimer and tetramer (Table 
4.14). However, for ACD/LogP this trend was reversed with CP < DHP for all three oligomer pairs. 
While ACD/LogP was the only predicted LogP included in the 6xMLP:32-2-1 model; BLTD48 
another descriptor used by the model was highly correlated (R2> 0.9999) with MLOGP which, 
along with contributions from the other 30 descriptors, may explain the switch in prediction order 
for this model. Based on the prediction order of the model, the CP dimer would elute first (i.e. 
8.66 min) and the DHP dimer would elute second (i.e. 8.77 or 8.82 min). However, both peaks 
were closer to the predicted retention time of the CP dimer and there was significant overlap 
between the prediction intervals. Therefore, if only one peak was detected the model would not 
be able to accurately predict whether that peak was due to the CP or DHP dimer.          
Table 4.14: LogP values and order for MEKP oligomers 















3.19 2 2.297 1 1.438 1 
8.77 
DHP trimer 12.93 4.91 5 3.906 3 2.341 3 
CP trimer 17.14 3.44 3 4.826 4 2.645 4 
CP tetramer n.d.* 4.5 4 6.435 6 3.396 6 
DHP tetramer 16.01 6.65 6 5.514 5 3.131 5 
DHP pentamer 
18.14 
8.28 7 7.123 7 3.849 7 
18.29 
tR
M – Measured retention time for peaks detected with m/z ± 5 ppm of [M+NH4]
+ ion;  
n.d. not detected; *Previously detected with a retention time of 18.23 min. 
 
4.3.5.3 Prediction of nitrated sugar retention times  
Purity of the mannitol hexanitrate (MHN) and sorbitol hexanitrate (SHN) samples was unknown, 
as would be the case for real samples encountered during forensic casework. As shown in 
Chapter 3, both the MHN and SHN samples contained multiple chromatographic peaks (Figure 




sugars (i.e. penta-, tetra-, tri-, di- or mono-nitrates). Multiple ions were also detected at each 
retention time and in the case of the peak at 13.73 min in the MHN sample, five ions were detected 
including ions with 3, 4 and 5 nitrogen atoms. While it was thought likely that the general retention 
order was mononitrates < dinitrates < trinitrate < tetranitrates < pentanitrates < hexanitrates; due 
to similarities in structure, it was not always clear which nitrated sugar was the source of each 
ion. For example, the ion with an elemental composition of C6H9O14N4- could be due to either a 
tetranitrate [M-H]- ion, a pentanitrate [M-NO2]- ion or a hexanitrate [M-2NO2+H]- ion (Figure 4.13). 
The C6H9O14N4- ion could have the same structure, regardless of whether it was formed by APCI 
of MHN, an MPN isomer or an MTN isomer. Therefore, in this instance, tandem mass 
spectrometry would not help identify the source of the ion.     
 
Figure 4.13: Formation of a C6H9O14N4+ ion from mannitol hexanitrate (MHN), pentanitrate (MPN) and 
tetranitrate (MTN). 
 
Here retention times were predicted for various mannitol nitrates using the ensemble of 
6xMLP:32-2-1 (Table 4.15). The model did predict retention times for the hexanitrate (MHN) > the 
pentanitrates (MPNs) > the tetranitrates (MTN) > the trinitrates (MTriN), as expected due to the 
greater polarity and hydrogen bonding ability of hydroxyl (-OH) groups compared to nitrate 
(-ONO2) groups. The predicted retention time for MHN was closest to the peak detected at 
14.55 min (∆tR = 1.06 min), supporting assignment of this peak as MHN. Although, the MTriN 
isomers were the only compounds to fall outside the 99 % PI for this peak and so the only 
compounds that could be excluded using a 99 % PI. The MPNs had the closest predicted retention 
times to the peaks at 13.73 and 13.29 min (∆tR = 0.40-0.70 and 0.04-0.26 min, respectively). 
Again, the MTriN isomers fell outside the 99 % PI for these peaks, supporting the theory that the 

















Table 4.15: Predicted retention times for mannitol nitrates using ensemble of 6xMLP:32-2-1 
 































Compound tRP (min) ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR   
MHN 15.61 1.06 1.88 2.32 3.09 4.78 5.20 5.63 5.78 6.36  Key* 
M-1,2,3,5,6-PN 13.33 1.22 0.40 0.04 0.81 2.50 2.92 3.35 3.50 4.08  25 % PI 
M-1,2,3,4,5-PN 13.06 1.49 0.67 0.23 0.54 2.23 2.65 3.08 3.23 3.81  50 % PI 
M-1,2,3,4,6-PN 13.03 1.52 0.70 0.26 0.51 2.20 2.62 3.05 3.20 3.78  75 % PI 
M-1,2,4,5-TN 12.01 2.54 1.72 1.28 0.51 1.18 1.60 2.03 2.18 2.76  80 % PI 
M-1,3,4,6-TN 11.91 2.64 1.82 1.38 0.61 1.08 1.50 1.93 2.08 2.66  90 % PI 
M-2,3,4,5-TN 11.72 2.83 2.01 1.57 0.80 0.89 1.31 1.74 1.89 2.47  95 % PI 
M-1,2,4,6-TN  11.69 2.86 2.04 1.60 0.83 0.86 1.28 1.71 1.86 2.44  99 % PI 
M-1,3,4,5-TN 11.67 2.88 2.06 1.62 0.85 0.84 1.26 1.69 1.84 2.42   
M-1,2,3,6-TN 11.66 2.89 2.07 1.63 0.86 0.83 1.25 1.68 1.83 2.41   
M-1,2,5,6-TN 11.53 3.02 2.20 1.76 0.99 0.70 1.12 1.55 1.70 2.28   
M-1,2,3,4-TN 11.39 3.16 2.34 1.90 1.13 0.56 0.98 1.41 1.56 2.14   
M-1,2,3,5-TN 11.26 3.29 2.47 2.03 1.26 0.43 0.85 1.28 1.43 2.01   
M-1,3,6-TriN  7.96 6.59 5.77 5.33 4.56 2.87 2.45 2.02 1.87 1.29   
M-1,3,4-TriN 7.65 6.90 6.08 5.64 4.87 3.18 2.76 2.33 2.18 1.60   
M-1,2,6-TriN 7.63 6.92 6.10 5.66 4.89 3.20 2.78 2.35 2.20 1.62   
M-1,2,3-TriN 7.63 6.92 6.10 5.66 4.89 3.20 2.78 2.35 2.20 1.62   
M-2,3,4-TriN 7.53 7.02 6.20 5.76 4.99 3.30 2.88 2.45 2.30 1.72   
M-1,2,4-TriN 7.52 7.04 6.22 5.78 5.01 3.32 2.90 2.47 2.32 1.74   





Retention times were also predicted for sorbitol nitrates using the ensemble of 6xMLP:32-2-1 
(Table 4.16). As sorbitol has less symmetry than mannitol, there are more isomers for the sorbitol 
nitrates than the mannitol nitrates. Additionally, ions with a lower m/z and fewer nitrogen atoms 
were detected in the SHN sample, suggesting the presence of less-nitrated sugars, i.e. STriN and 
SDN as well as STN, SPN and SHN (Table 4.17). As with the mannitol nitrates, the predicted 
retention times followed the general trend of predicted retention times for sorbitol hexanitrate 
(SHN) > the pentanitrate (SPN) isomers > the tetranitrate (STN) isomers > the trinitrate (STriN) 
isomers > the dinitrate (SDN) isomers > the mononitrate (SMN) isomers. SHN, all SPN isomers 
and all STN isomers had predicted retention times outside of the 99 % PI for the peaks at 6.45, 
5.02, 4.88, 3.75 and 2.36 min, supporting the theory that the ions detected at these retention 
times (Table 4.17) were due to STriN or SDN isomers rather than fragment ions from the more-
nitrated sugars. For the peak at 2.36 min, the retention times predicted for the STriN isomers also 
fell outside the 99 % PI suggesting that the C6H11O10N2- ion detected at this retention time was 
due to a SDN [M-H]- rather than a STriN [M-NO2]-.   
It is worth pointing out that if the MLP:11-3-1 network had been selected to generate predicted 
retention times then the predicted retention times and conclusions made based on prediction 
intervals would have differed. For example, using MLP:11-3-1, predicted retention times for some 
STN isomers did fall within the 99% PI for the peaks at 6.45, 5.02 and 4.88 min and the predicted 
retention time for some STriN isomers fell within the 99 % PI for the peak at 2.36 min (Table A. 
5). This highlights the risk associated with relying upon predicted retention times for identification 
and the importance of selecting the best model for prediction, since different models will lead to 
different results. Ideally, predicted retention times should later be confirmed using reference 
standards, with predicted retention times used to prioritise the compounds for which reference 
materials are purchased or synthesised. However, here individual reference standards were not 





Table 4.16 (Continued): Predicted retention times for sorbitol nitrates using the ensemble of 6xMLP:32-2-1 
 tRM (min) 14.50 13.37 12.91 12.62 10.30 10.07 9.77 9.24 8.84 6.45 5.02 4.88 3.75 2.36   
Compound tRP (min) ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR   
SHN 15.84 1.34 2.47 2.93 3.22 5.54 5.77 6.07 6.60 7.00 9.39 10.82 10.96 12.09 13.48  Key* 
S-1,2,3,5,6-PN 13.42 1.08 0.05 0.51 0.80 3.12 3.35 3.65 4.18 4.58 6.97 8.40 8.54 9.67 11.06  25 % PI 
S-1,2,3,4,6-PN 13.40 1.10 0.03 0.49 0.78 3.10 3.33 3.63 4.16 4.56 6.95 8.38 8.52 9.65 11.04  50 % PI 
S-1,2,4,5,6-PN 13.36 1.14 0.01 0.45 0.74 3.06 3.29 3.59 4.12 4.52 6.91 8.34 8.48 9.61 11.00  75 % PI 
S-1,2,3,4,5-PN 13.21 1.29 0.16 0.30 0.59 2.91 3.14 3.44 3.97 4.37 6.76 8.19 8.33 9.46 10.85  80 % PI 
S-1,3,4,5,6-PN 13.00 1.50 0.37 0.09 0.38 2.70 2.93 3.23 3.76 4.16 6.55 7.98 8.12 9.25 10.64  90 % PI 
S-2,3,4,5,6-PN 12.90 1.60 0.47 0.01 0.28 2.60 2.83 3.13 3.66 4.06 6.45 7.88 8.02 9.15 10.54  95 % PI 
S-2,3,5,6-TN 12.23 2.27 1.14 0.68 0.39 1.93 2.16 2.46 2.99 3.39 5.78 7.21 7.35 8.48 9.87  99 % PI 
S-1,3,4,6-TN 11.98 2.52 1.39 0.93 0.64 1.68 1.91 2.21 2.74 3.14 5.53 6.96 7.10 8.23 9.62   
S-3,4,5,6-TN 11.89 2.61 1.48 1.02 0.73 1.59 1.82 2.12 2.65 3.05 5.44 6.87 7.01 8.14 9.53   
S-1,4,5,6-TN 11.84 2.66 1.53 1.07 0.78 1.54 1.77 2.07 2.60 3.00 5.39 6.82 6.96 8.09 9.48   
S-2,4,5,6-TN 11.77 2.73 1.60 1.14 0.85 1.47 1.70 2.00 2.53 2.93 5.32 6.75 6.89 8.02 9.41   
S-1,3,4,5-TN 11.76 2.74 1.61 1.15 0.86 1.46 1.69 1.99 2.52 2.92 5.31 6.74 6.88 8.01 9.40   
S-1,2,3,6-TN 11.75 2.75 1.62 1.16 0.87 1.45 1.68 1.98 2.51 2.91 5.30 6.73 6.87 8.00 9.39   
S-2,3,4,6-TN 11.61 2.89 1.76 1.30 1.01 1.31 1.54 1.84 2.37 2.77 5.16 6.59 6.73 7.86 9.25   
S-1,3,5,6-TN 11.59 2.91 1.78 1.32 1.03 1.29 1.52 1.82 2.35 2.75 5.14 6.57 6.71 7.84 9.23   
S-1,2,4,5-TN 11.50 3.00 1.87 1.41 1.12 1.20 1.43 1.73 2.26 2.66 5.05 6.48 6.62 7.75 9.14   
S-1,2,3,5-TN 11.45 3.05 1.92 1.46 1.17 1.15 1.38 1.68 2.21 2.61 5.00 6.43 6.57 7.70 9.09   
S-1,2,4,6-TN 11.42 3.08 1.95 1.49 1.20 1.12 1.35 1.65 2.18 2.58 4.97 6.40 6.54 7.67 9.06   
S-2,3,4,5-TN 11.40 3.10 1.97 1.51 1.22 1.10 1.33 1.63 2.16 2.56 4.95 6.38 6.52 7.65 9.04   
S-1,2,3,4-TN 11.36 3.14 2.01 1.55 1.26 1.06 1.29 1.59 2.12 2.52 4.91 6.34 6.48 7.61 9.00   




Table 4.16 (Continued): Predicted retention times for sorbitol nitrates using the ensemble of 6xMLP:32-2-1 
 tRM (min) 14.50 13.37 12.91 12.62 10.30 10.07 9.77 9.24 8.84 6.45 5.02 4.88 3.75 2.36   
Compound tRP (min) ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR   
S-1,2,5,6-TN 11.23 3.27 2.14 1.68 1.39 0.93 1.16 1.46 1.99 2.39 4.78 6.21 6.35 7.48 8.87  Key* 
S-2,3,6-TriN 7.93 6.57 5.44 4.98 4.69 2.37 2.14 1.84 1.31 0.91 1.48 2.91 3.05 4.18 5.57  25 % PI 
S-2,3,5-TriN 7.89 6.61 5.48 5.02 4.73 2.41 2.18 1.88 1.35 0.95 1.44 2.87 3.01 4.14 5.53  50 % PI 
S-4,5,6-TriN 7.84 6.66 5.53 5.07 4.78 2.46 2.23 1.93 1.40 1.00 1.39 2.82 2.96 4.09 5.48  75 % PI 
S-3,4,6-TriN 7.83 6.67 5.54 5.08 4.79 2.47 2.24 1.94 1.41 1.01 1.38 2.81 2.95 4.08 5.47  80 % PI 
S-1,3,4-TriN 7.77 6.73 5.60 5.14 4.85 2.53 2.30 2.00 1.47 1.07 1.32 2.75 2.89 4.02 5.41  90 % PI 
S-1,2,3-TriN 7.76 6.74 5.61 5.15 4.86 2.54 2.31 2.01 1.48 1.08 1.31 2.74 2.88 4.01 5.40  95 % PI 
S-3,4,5-TriN 7.74 6.76 5.63 5.17 4.88 2.56 2.33 2.03 1.50 1.10 1.29 2.72 2.86 3.99 5.38  99 % PI 
S-2,5,6-TriN 7.67 6.83 5.70 5.24 4.95 2.63 2.40 2.10 1.57 1.17 1.22 2.65 2.79 3.92 5.31   
S-1,2,5-TriN 7.52 6.98 5.85 5.39 5.10 2.78 2.55 2.25 1.72 1.32 1.07 2.50 2.64 3.77 5.16   
S-1,2,6-TriN 7.51 6.99 5.86 5.40 5.11 2.79 2.56 2.26 1.73 1.33 1.06 2.49 2.63 3.76 5.15   
S-1,3,6-TriN 7.48 7.02 5.89 5.43 5.14 2.82 2.59 2.29 1.76 1.36 1.03 2.46 2.60 3.73 5.12   
S-3,5,6-TriN 7.43 7.07 5.94 5.48 5.19 2.87 2.64 2.34 1.81 1.41 0.98 2.41 2.55 3.68 5.07   
S-1,2,4-TriN 7.42 7.08 5.95 5.49 5.20 2.88 2.65 2.35 1.82 1.42 0.97 2.40 2.54 3.67 5.06   
S-2,3,4-TriN 7.39 7.11 5.98 5.52 5.23 2.91 2.68 2.38 1.85 1.45 0.94 2.37 2.51 3.64 5.03   
S-2,4,5-TriN 7.36 7.14 6.01 5.55 5.26 2.94 2.71 2.41 1.88 1.48 0.91 2.34 2.48 3.61 5.00   
S-1,3,5-TriN 7.35 7.15 6.02 5.56 5.27 2.95 2.72 2.42 1.89 1.49 0.90 2.33 2.47 3.60 4.99   
S-2,4,6-TriN 7.21 7.29 6.16 5.70 5.41 3.09 2.86 2.56 2.03 1.63 0.76 2.19 2.33 3.46 4.85   
S-2,3-DN 4.69 9.81 8.68 8.22 7.93 5.61 5.38 5.08 4.55 4.15 1.76 0.33 0.19 0.94 2.33   
S-2,5-DN 4.65 9.85 8.72 8.26 7.97 5.65 5.42 5.12 4.59 4.19 1.80 0.37 0.23 0.90 2.29   
S-3,4-DN 4.61 9.89 8.76 8.30 8.01 5.69 5.46 5.16 4.63 4.23 1.84 0.41 0.27 0.86 2.25   




Table 4.16 (Continued): Predicted retention times for sorbitol nitrates using the ensemble of 6xMLP:32-2-1 
 tRM (min) 14.50 13.37 12.91 12.62 10.30 10.07 9.77 9.24 8.84 6.45 5.02 4.88 3.75 2.36   
Compound tRP (min) ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR ∆tR   
S-3,6-DN 4.53 9.97 8.84 8.38 8.09 5.77 5.54 5.24 4.71 4.31 1.92 0.49 0.35 0.78 2.17  Key* 
S-3,5-DN 4.52 9.99 8.86 8.40 8.11 5.79 5.56 5.26 4.73 4.33 1.94 0.51 0.37 0.77 2.16  25 % PI 
S-4,6-DN 4.45 10.05 8.92 8.46 8.17 5.85 5.62 5.32 4.79 4.39 2.00 0.57 0.43 0.70 2.09  50 % PI 
S-1,4-DN 4.44 10.07 8.94 8.48 8.19 5.87 5.64 5.34 4.81 4.41 2.02 0.59 0.45 0.69 2.08  75 % PI 
S-2,6-DN 4.41 10.09 8.96 8.50 8.21 5.89 5.66 5.36 4.83 4.43 2.04 0.61 0.47 0.66 2.05  80 % PI 
S-4,5-DN 4.41 10.09 8.96 8.50 8.21 5.89 5.66 5.36 4.83 4.43 2.04 0.61 0.47 0.66 2.05  90 % PI 
S-1,6-DN 4.39 10.11 8.98 8.52 8.23 5.91 5.68 5.38 4.85 4.45 2.06 0.63 0.49 0.64 2.03  95 % PI 
S-1,2-DN 4.37 10.13 9.00 8.54 8.25 5.93 5.70 5.40 4.87 4.47 2.08 0.65 0.51 0.62 2.01  99 % PI 
S-1,5-DN 4.34 10.16 9.03 8.57 8.28 5.96 5.73 5.43 4.90 4.50 2.11 0.68 0.54 0.59 1.98   
S-5,6-DN 4.32 10.18 9.05 8.59 8.30 5.98 5.75 5.45 4.92 4.52 2.13 0.70 0.56 0.57 1.96   
S-2,4-DN 4.27 10.24 9.11 8.65 8.36 6.04 5.81 5.51 4.98 4.58 2.19 0.76 0.62 0.52 1.91   
S-2-MN 2.08 12.43 11.30 10.84 10.55 8.23 8.00 7.70 7.17 6.77 4.38 2.95 2.81 1.68 0.29   
S-4-MN 2.04 12.46 11.33 10.87 10.58 8.26 8.03 7.73 7.20 6.80 4.41 2.98 2.84 1.71 0.32   
S-5-MN 2.02 12.48 11.35 10.89 10.60 8.28 8.05 7.75 7.22 6.82 4.43 3.00 2.86 1.73 0.34   
S-3-MN 2.01 12.49 11.36 10.90 10.61 8.29 8.06 7.76 7.23 6.83 4.44 3.01 2.87 1.74 0.35   
S-1-MN 1.91 12.59 11.46 11.00 10.71 8.39 8.16 7.86 7.33 6.93 4.54 3.11 2.97 1.84 0.45   
S-6-MN 1.88 12.62 11.49 11.03 10.74 8.42 8.19 7.89 7.36 6.96 4.57 3.14 3.00 1.87 0.48   





Table 4.17: Ions detected for each chromatographic peak in SHN sample 
tRM (min) Ion Exact m/z  tRM (min) Ion Exact m/z 
14.50 C6H8O21N7- 513.9779  9.24 C6H9O14N4- 361.0121 
 C6H8O16N5- 405.9972   C6H10O14N4Cl- 396.9888 
 C6H9O14N4- 361.0121   C6H10O12N3- 316.0270 
13.37 C6H9O16N5Cl- 441.9739  8.84 C6H10O14N4Cl- 396.9888 
 C6H9O14N4- 361.0121   C6H10O12N3- 316.0270 
12.91 C6H8O16N5- 405.9972  6.45 C6H10O12N3- 316.0270 
 C6H9O16N5Cl- 441.9739   C6H11O12N3Cl- 352.0037 
 C6H9O14N4- 361.0121   C6H11O10N2-  271.0419 
12.62 C6H9O16N5Cl- 441.9739   C6H12O10N2Cl-  307.0186 
 C6H9O14N4- 361.0121  5.02 C6H11O12N3Cl- 352.0037 
10.30 C6H10O14N4Cl- 396.9888   C6H11O10N2- 271.0419 
 C6H10O12N3- 316.0270  4.88 C6H10O12N3- 316.0270 
10.07 C6H9O14N4- 361.0121   C6H11O10N2- 271.0419 
 C6H10O14N4Cl- 396.9888  3.75 C6H10O12N3- 316.0270 
 C6H10O12N3- 316.0270   C6H11O12N3Cl- 352.0037 
 C6H11O12N3Cl-  352.0037   C6H11O10N2- 271.0419 
9.77 C6H9O14N4- 361.0121  2.36 C6H11O10N2-  271.0419 
 C6H10O14N4Cl- 396.9888    C6H12O10N2Cl-   307.0186 
 C6H10O12N3- 316.0270     
 
4.3.5.4 Excluding compounds with the same elemental composition 
In addition to predicting the retention times of explosives, retention time prediction could be of 
value for excluding other compounds that share the same elemental composition. To test this 
theory, the ensemble (6xMLP:32-2-1) was used to predict the retention times for all compounds 
found in Chemspider with the same elemental composition as three of the explosives, RDX, PYX 
and TATB, included in the test set for this model. There were six compounds (including RDX) with 
an elemental composition of C3H6O6N6, three compounds (including PYX) with an elemental 
composition of C17H7O16N11 and nine compounds (including TATB) with an elemental composition 









Table 4.18 (Continued): Predicted retention times for compounds with the same elemental composition 
as RDX (C3H6O6N6), PYX (C3H6O6N6) and TATB (C6H6O6N6). 
Elemental 
composition 
Chemical structure Systematic name 
6xMLP:32-2-1 


















































2,4,6-Trinitro-1,3,5-triazinane  4.15 -1.80 
aRDX; bPYX; cTATB 
 
Table 4.18: Predicted retention times for compounds with the same elemental composition as RDX 
























































































Table 4.18 (Continued): Predicted retention times for compounds with the same elemental composition 
as RDX (C3H6O6N6), PYX (C3H6O6N6) and TATB (C6H6O6N6). 
Elemental 
composition 
Chemical structure Systematic name 
6xMLP:32-2-1 























































































































































Table 4.18 (Continued): Predicted retention times for compounds with the same elemental composition 
as RDX (C3H6O6N6), PYX (C3H6O6N6) and TATB (C6H6O6N6). 
Elemental 
composition 
Chemical structure Systematic name 
6xMLP:32-2-1 






































































































































Table 4.18 (Continued): Predicted retention times for compounds with the same elemental composition 
as RDX (C3H6O6N6), PYX (C3H6O6N6) and TATB (C6H6O6N6). 
Elemental 
composition 
Chemical structure Systematic name 
6xMLP:32-2-1 
























































4,5,6-Trinitro-1,2,3-benzenetriamine 11.55 2.15 









































































Table 4.18 (Continued): Predicted retention times for compounds with the same elemental composition 
as RDX (C3H6O6N6), PYX (C3H6O6N6) and TATB (C6H6O6N6). 
Elemental 
composition 
Chemical structure Systematic name 
6xMLP:32-2-1 











2,4,6-Trinitro-1,3,5-benzenetriaminec 11.92c 2.52c 
aRDX; bPYX; cTATB 
 
As shown in Figure 4.14, using the ensemble of 6xMLP:32-2-1, all six compounds with an 
elemental composition of C3H6O6N6 had a predicted retention time within the 99 % PI of the 
measured retention time of RDX. Only one of the six compounds had a predicted retention time 
within the 75 % PI, but this was not RDX. Therefore, in this instance the model was not able to 
reduce the number of possible compounds. Similarly, this model was not able to distinguish 
between the three compounds with an elemental composition of C17H7O16N11 as all three 
compounds had a predicted retention time within the 75 % PI of the measured retention time for 
PYX. This was perhaps unsurprising given the structural similarity of these three compounds, 
which only differed in the location of the amine and nitro groups on the central pyridine ring (Table 
4.18). Five of the nine compounds with an elemental composition of C6H6O6N6 did have a 
  
Figure 4.14: Experimental and predicted retention times for RDX, TATB and PYX compared to predicted 
retention times of structural isomers using A) ensemble of 6xMLP:32-2-1 and B) MLP:11-3-1. Grey error 
bars show 99 % PI and black error bars show 75 % PI.  































predicted retention time outside of the 99 % PI from the measured retention time obtained for 
TATB and so could potentially be excluded. There remains approximately a 1 % probability that 
the retention model would lead to prediction errors outside of the 99 % PI. However, given that 
the predicted retention times for these five compounds were ≥ 2.5 min less than the 99 % PI, it 
was thought unlikely that any of these compounds would have the same retention time as TATB. 
Two compounds fell within the 75 % PI, but neither were TATB.  For confirmatory identification of 
TATB, the chromatographic retention time and/or MS/MS spectra need to differ from the other 8 
isomers. Therefore, it may be necessary to show that the other three compounds that fell within 
the 99 % PI, had different measured retention times and/or MS/MS spectra, regardless of whether 
or not they fell within the 75 % PI. 
 
4.3.6 Prediction of retention times in matrix 
For trace analysis of explosives, samples will likely be received in complex matrices. Munro et al. 
highlighted the importance of using matrix-matched standards for reliable ANN modelling of 
pharmaceutical retention times in wastewater [83]. Here the effect of two matrices, latent human 
fingermarks and pond water, on the measured retention times of 149 explosives and drugs was 
investigated. One explosive (HNDPA) and thirteen drugs were not detected in the spiked pond 
water sample and nine drugs were not detected in the spiked fingermark samples, presumably 
due to matrix suppression. In the fingermark samples, the average (n=6) retention times for 94 % 
of detected explosives (44 out of 47) and 98 % of detected drugs (91 out of 93) were within 2.5 
% of the average retention time in solvent. For the pond water samples, the average (n=3) 
retention times for 98 % of detected explosives (45 out of the 46) and 52 % of detected drugs (46 
out of 89) were within 2.5 % of the average retention time in solvent. The effect of the two matrices 
on retention time is shown in Figure 4.15, with x-error bars indicating standard deviation in solvent 
and y-error bars indicating standard deviation in matrix. In the majority of cases, the pond water 
matrix had a greater effect on retention time than the fingermark matrix. Notable exceptions to 
this were three explosives PA, PYX and HDNPA (not detected in pond water) which had the least 
reproducible retention times in solvent (standard deviation (SD) = 0.11, 0.22 and 0.13 min 
respectively). The biggest differences in retention time were seen for HMDD (∆tR = -1.07 min in 
spiked pond water, tR = 4.43 min in solvent), bumetanide (∆tR = +1.15 min in spiked pond water, 






Figure 4.15: Effect of pond water and fingermark matrices on retention times for drugs and explosives. 
Vertical error bars indicate standard deviation in matrix (n=3 for pond water, n=6 for fingermarks) and x-error 
bars indicate standard deviation in solvent (n=6). Dashed grey lines show ± 2.5 % retention time in solvent.  
 
solvent). Ideally matrix matched standards should be used to train the ANN model. Due to the 
vast range of matrices encountered during trace-explosive forensic casework, this may pose a 
challenge. Without matrix-matched standards, or suitable sample clean-up to remove matrix 
effects, larger prediction errors would be expected for some compounds due to the effect of matrix 
on measured retention time and larger prediction intervals would be required to account for 
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Average retention times of 149 compounds (47 explosives and 102 drugs) were obtained for a 
gradient LC separation on a C18 Ar column. ANN models were initially developed for this dataset 
using three sets of descriptors previously selected for QSRR models on C18 columns. Models 
using descriptors selected by Aalizadeh et al. and Barron & McEneff performed better than the 
best model using descriptors selected by Goryński et al. However, for both of these models, 
overall prediction errors were larger for this dataset, than for the best models presented in the 
original publications for the prediction of retention time on a C18 column, perhaps due to additional 
retention mechanisms on a C18 Ar column. MLR models were also investigated using the 
descriptors selected by Goryński et al. and Aalizadeh et al. but performance was poorer than for 
the ANN models developed using these same descriptors. Two sets of descriptors were selected 
specifically for this dataset and LC separation. The first contained 32 descriptors which were a 
subset from the descriptors selected by forward selection and the second contained 11 
descriptors which were a subset from the descriptors initially selected by genetic algorithm. In 
both cases, a 3-layer MLP was the best performing neural network. Prediction errors for the best 
models developed using these descriptors were lower than prediction errors for the models using 
previously selected descriptors. An ensemble of six repeated networks was formed using both 
sets of descriptors and no significant difference was found between the ensemble and best 
MLP:32-2-1 network, but prediction errors were significantly larger for the ensemble than best 
MLP:11-3-1 network. Predicted retention order was investigated for the 6xMLP:32-2-1 ensemble 
and individual MLP:11-3-1 network. Significant correlation between predicted retention order and 
measured retention order was found, but even when just looking at the nitrate esters, there were 
cases with both models where the predicted retention order was incorrect. While predicted 
retention times may provide an initial indication, it would be necessary to confirm predicted 
retention orders with reference standards. Prediction intervals (PI) were calculated to indicate 
confidence in predicted retention times and the 75 % and 99 % PI were approximately ± 1.6 min 
and ± 3.7 mins, respectively for both MLP:11-3-1 and 6xMLP:11-3-1. Based on the MAE, RMSE 
and PIs, determined for the original 149 compounds used for training, selection and testing; 
performance of the 6xMLP:32-2-1 ensemble and MLP:11-3-1 network was comparable, and it 
was not possible to choose one model over the other. However, when used to predict retention 
times for six new OGSR compounds, the 6xMLP:32-2-1 was clearly superior with the MAE and 
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RMSE for 6xMLP:32-2-1 less than half those for MLP:11-3-1. Additionally, half of the retention 
times predicted using MLP:11-3-1 fell outside of the corresponding 99 % PI; whereas, the 
predicted retention times for all six new compounds fell within the 95 % PI when 6xMLP:32-2-1 
was used. Therefore, 6xMLP:32-2-1 was selected for prediction of retention times for the 
remaining new compounds, due to better generalisability of the model and associated PIs. The 
predicted retention times for all MEKP oligomers also fell within the 99 % PIs. Retention time 
prediction for mannitol and sorbitol nitrates, and the use of 99 % PI for exclusion purposes, 
supported identification of sugar nitrates where the [M-H]- ion of a less-nitrated sugar and the 
[M-NO2]- ion of a more-nitrated sugar would have the same exact mass. Additionally, 99 % PI 
were used to exclude some TATB isomers. However, measured retention times would still be 
required to confirm identification and in the case of RDX and PYX, retention time prediction did 
not reduce the number of possible compounds with the same elemental composition as all 
predicted retention times fell within the 99 % PI. For more confident exclusion of non-explosives, 
further testing using a wider range of non-explosive compounds, than the drugs used here, and 
a larger number of blind test compounds may be required to further assess the generalisability of 
the PIs used here. The majority of explosives retention times were unaffected by either the 
fingermark or pond water matrices. However, the potential effect of matrix on the retention times 
for both explosive and non-explosive compounds should be considered if attempting to use a 
prediction model for exclusion purposes. Overall, the prediction models developed here may 
support the preliminary identification of suspect or unknown explosives detected by LC-HRMS 
and provide the potential to eliminate some compounds with the same elemental composition, 
reducing the time and cost implications of purchasing/synthesising and analysing reference 


















The aim of this thesis was to investigate the suitability of LC-HRMS for screening and identification 
of energetic materials. Chapter 1, examined the status quo of screening and identification of 
energetic materials, for which targeted LC-MS methods have often been used. The requirement 
for forensic scientists to be able to detect and identify any explosive substance was also 
discussed, along with the potential value of LC-HRMS for targeted analysis, suspect screening 
and non-target analysis to assist forensic scientists in meeting this requirement. Additional 
benefits, such as the potential to include more compounds in one method and achieve greater 
confidence of identification with LC-HRMS, were also discussed. Several challenges to utilising 
the potential of LC-HRMS were recognised. These included the challenges of: (a) achieving 
chromatographic separation and simultaneous ionisation, in order to include more compounds in 
one method; (b) setting evidence-based identification criteria and assessing the greater 
confidence of identification provided by LC-HRMS; (c) optimising and performance testing LC-
HRMS method for suspect and non-target explosive substances and (d) how suspect or non-
target explosive substances can be identified without reference materials, at least in the first 
instance. 
The first challenges, achieving chromatographic separation and simultaneous ionisation, were 
addressed in Chapter 2, where the objective was to develop a liquid chromatography – high 
resolution mass spectrometry (LC-HRMS) method for screening multiple classes of explosives. 
Sixteen nitro-explosives, including nitrate esters, nitroaromatics and nitramines, plus two 
peroxides, were selected for method development and optimisation. Chromatographic separation 
for the existing method, on a PFP column, was improved by using a temperature gradient, but the 
best separation was achieved through gradient elution on a C18Ar column, at a fixed temperature 
of 20 °C. With ESI and the ammonium acetate mobile phase additive, used for a previous LC-
MS/MS method, here no acetate adduct was detected for nitroglycerin, despite it being detected 
with the previous method. This demonstrated the need to optimise MS conditions for specific 
instruments, rather than simply transferring methods, especially when detecting adduct ions 
where stability may be affected by differences in instrumentation. Additionally, nitrobenzene and 
the nitrotoluenes were not detected at all with ESI. Ionisation of all 18 initial target analytes was 
achieved using ammonium chloride and APCI. Negative mode APCI was used for the nitro 
explosives and chloride adducts were detected for the nitramines and nitrate esters. The 
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peroxides were detected in positive mode APCI and ammonium adducts formed for TATP. 
However, compromise ionisation conditions, particularly in terms of capillary and vaporiser 
temperatures, were required to allow detection of all the target analytes. Greater sensitivity could 
be achieved using conditions optimised for individual classes of explosive. For example, the 
nitrate esters favoured lower temperatures than those selected here and were detected at lower 
concentrations using ESI (pg versus ng levels). 
The challenge of setting evidence-based identification criteria and assessing the greater 
confidence of identification provided by LC-HRMS was addressed in Chapter 3. While HRMS 
offers greater confidence of identification due to the ability to separate isobaric ions, which are 
indistinguishable by low-resolution MS, a lack of consensus and scientific evidence to support the 
selection of identification criteria for LC-HRMS analysis of energetic materials was identified. 
Theoretical experiments were performed to determine the number of theoretical elemental 
compositions within 1, 2 and 5 ppm of the monoisotopic mass of 60 explosive substances and 
the number of isomers with the same elemental composition. Mass accuracy had a greater effect 
on the number of theoretical elemental compositions of larger compounds with 223 theoretically 
possible elemental compositions within 5 ppm of PYX. Even with a mass accuracy threshold of 1 
ppm, 23 compounds had more than one theoretically possible elemental composition. While 
narrower mass accuracy thresholds and isotope profiles could reduce the number of possible 
elemental compositions, they could not provide any discrimination between isomers. The number 
of other isomers listed in the ChemSpider database ranged from none for PETN and TEGDN to 
10,083 for DEDPU. This illustrated the need to consider the compounds being identified when 
setting identification requirements, since confirming the presence of DEDPU rather than one of 
the other 10,083 isomers would be much more challenging than confirming the presence of PETN 
or TEGDN. Regardless, detection of a single HRMS ion is unlikely to be sufficient for identification. 
Using APCI, a range of different ions were detected, including in-source fragment ions and adduct 
ions, in addition to molecular ions and (de)protonated molecules. Therefore, the elemental 
composition of a detected ion could be due to a fragment of a larger molecule as well as isomers 
with the same elemental composition. The effect of identification requirements, such as the 
number and type of ions and retention time windows, on selectivity (both between explosives and 
from fingermark, indoor dirt and outdoor dirt matrices) and detection limits for explosives was also 
investigated. Several cases of different explosive compounds producing common ions were 
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identified, with 15 compounds producing a nitrate ion and HMX producing ions with the same m/z 
as all three RDX ions. In some cases, the use of multiple ions led to improved selectivity between 
different explosive compounds and from matrix. However, with vastly poorer detection limits for 
less abundant ions, in some cases, this came at the cost of reduced sensitivity. The greatest 
improvement in selectivity was seen when a retention time window was applied. Even with a 2.5 
% retention time window, there were a few cases of selectivity issues between pairs of isomers, 
but in the case of 2,4- and 2,6-DNT the use of ion ratios provided sufficient discrimination. Due to 
the compromise between selectivity and sensitivity, recommended identification requirements 
would vary depending on how LC-HRMS was used. For use as a screening method, where 
positive results would be confirmed using another method and minimising the number of false 
negatives was the priority, accurate mass of the most abundant ion and retention time may be 
sufficient. For confirmatory analysis, even with LC-HRMS, detection of precursor ion, multiple 
fragment ions and calculation of corresponding ion ratios may be required to provide sufficient 
discrimination between isomers and other compounds producing common ions.   
The challenge of optimising and performance testing an LC-HRMS method for suspect and non-
target explosive substances was addressed by optimising the method for a set of 18 initial target 
analytes in Chapter 2 and then assessing generalisability and performance for an additional 44 
compounds in Chapter 3, for which no method optimisation had been performed, to mimic suspect 
or non-target compounds. Overall, the LC-HRMS method generalised well to the larger set of 
target compounds, with at least one ion detected at 10 ng µL-1 in all cases. Additionally, for 54 
compounds, at least three ions (including the molecular ion/(de)protonated molecule/adduct ion 
and a fragment ion) were detected, even without the use of HCD fragmentation. However, signal 
to noise ratios and LODs varied greatly for different compounds (from low pg to ng levels) and for 
different ions of the same compound. Multiple oligomers of MEKP were also detected, as were 
mannitol and sorbitol penta- and tetra- nitrates and sorbitol tri- and di- nitrates. In Chapter 4, an 
additional eight organic gunshot residue compounds were also detected with baseline 
chromatographic separation between the two nitro- and four dinitro- diphenylamine isomers, 
without any further chromatographic optimisation required.   
The final challenge, preliminary identification of suspect or non-target explosive substances was 
addressed in Chapter 4, where prediction of chromatographic retention times was investigated 
for the LC method optimised in Chapter 2. This was because prediction of retention times for 
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isomers with the same elemental composition may enable prioritisation and/or reduction of the 
number of compounds for which reference materials need to be purchased and/or synthesised. 
Average measured retention times for 149 compounds (47 explosives and 102 drugs) were 
obtained for the gradient LC separation on the C18 Ar column and automatically split into training, 
selection and test sets when used to develop prediction models. Initially, the suitability of three 
previously selected descriptor sets (used by Goryński et al., Barron & McEneff and Aalizadeh et 
al.) was investigated using machine learning (specifically artificial neural networks, ANN) for the 
prediction of explosive retention times for this LC method. The models using descriptors selected 
by Aalizadeh et al. and Barron & McEneff performed better than the best model using descriptors 
selected by Goryński et al. However, prediction errors were still greater for this dataset, than those 
presented in the original publications. This suggested that descriptors selected for the prediction 
of retention times on a C18 column, may not fully describe retention mechanisms on a C18 Ar 
column. Multiple linear regression (MLR) models were also investigated, but performance was 
poorer than for the equivalent ANN model. Two sets of molecular descriptors were then selected 
specifically for this LC method and set of analytes. The first set of descriptors were selected by 
forward selection and a subset of 32 descriptors produced the best prediction model (MLP:32-2-
1) and ensemble (6xMLP:32-2-1). The second set of descriptors were selected by genetic 
algorithm and in this case a subset of 11 descriptors led to the best prediction model (MLP:11-3-
1). Prediction errors for the best models using both these sets of descriptors were lower than the 
prediction errors for models using previously published descriptors. This suggested that it was 
worth selecting descriptors specifically for the LC method used, rather than simply using 
previously published descriptor sets. Prediction intervals (PI) were calculated to indicate 
confidence in predicted retention times and the 75 and 99 % PI were approximately ± 1.6 and ± 
3.7 mins, respectively, for the best models. Based on the MAE, RMSE and PIs, determined for 
the original 149 compounds used for training, selection and testing, performance of the 
6xMLP:32-2-1 and MLP:11-3-1 models was comparable, and it was not possible to choose one 
over the other. However, when an external test set was used the 6xMLP:32-2-1 model was clearly 
superior, with the MAE and RMSE for 6xMLP:32-2-1 less than half those for MLP:11-3-1. This 
demonstrated the importance of testing prediction models using an external test set, rather than 
simply using the internal test set which, although not used for training, was still considered during 
model selection. The 6xMLP:32-2-1 model demonstrated good generalisability to the external test 
set, with all predicted retention times falling within the 95 % PI. Therefore, 6xMLP:32-2-1 was 
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selected for prediction of retention times for the remaining new compounds. The predicted 
retention times for all MEKP oligomers fell within the 99 % PIs. Retention time prediction for 
mannitol and sorbitol nitrates, and the use of 99 % PI for exclusion purposes, supported 
identification of sugar nitrates where the [M-H]- ion of a less-nitrated sugar and the [M-NO2]- ion 
of a more-nitrated sugar would have the same exact mass. Additionally, 99 % PI were used to 
exclude some TATB isomers, supporting the hypothesis that retention time prediction may enable 
prioritisation and/or reduction of the number of compounds for which reference materials need to 
be purchased and/or synthesised. However, in the case of RDX and PYX, retention time 
prediction did not reduce the number of possible compounds with the same elemental 
composition, as all predicted retention times fell within the 99 % PI. Therefore, retention time 
prediction may be of value in some, but not all, cases. For confirmatory identification, measured 
retention times and MS/MS would still be required, especially for forensic purposes.   
Application of the LC-HRMS method to the detection of explosives in a number of matrices was 
also demonstrated. The method was used to detect explosives in contact traces and 19 nitro-
explosives were detected in spiked fingermarks. RDX and HMX chloride adducts and RDX 
fragment ions were also detected in extracted ion chromatograms for a fingermark depletion 
series, following handling of a commercial explosive. The results from this depletion series also 
highlighted the subjectivity of low level peak detection in LC-HRMS, when there is often no 
background noise for determination of a signal-to-noise ratio. The method was also successfully 
used to screen for explosives on a passive vapour sampler, with 12 explosive compounds 
detected following a 24-hour exposure in an explosive magazine. For the DNBs, DNTs, RDX and 
TNT, multiple ions were detected and at least one ion ratio fell within the relevant tolerance from 
average ion ratios calculated in solution. Ion ratios could also be used to distinguish DNB and 
DNT isomers. Finally, retention times for the 47 explosives used to develop prediction models 
were also obtained in fingermark and pond water matrices. In the majority of cases retention times 
were not affected by matrix. The only exceptions were PA, HMDD, HNDPA and PYX for which 




5.2 Conclusions and recommendations 
1. LC-HRMS can be used to include more explosives in one method and here the ability to 
separate chromatographically and simultaneously ionize multiple classes of explosives has 
been demonstrated. However, due to different ionization conditions resulting in the greatest 
sensitivity for different classes of explosives, this came at a cost of reduced sensitivity for 
some compounds. 
2. Generalizability of an LC-HRMS method, developed and optimized for 18 target explosives, 
to a larger set of energetic materials has also been demonstrated for the first time. This 
supports the potential use of full-scan LC-HRMS, for suspect screening and non-target 
analysis of energetic materials.  
3. Good chromatographic separation and tandem mass spectrometry are recommended for 
confirmatory analysis, along with a consideration of the number of isomers for individual 
compounds. While in-source fragment ions and the use of ion ratios were used to increase 
selectivity; greater confidence of identification might be achieved through isolation of a 
precursor ion for fragmentation, rather than simply relying on chromatographic retention time 
to link precursor and fragment ions. Here, it was not always possible to unequivocally identify 
energetic materials using LC-HRMS, due to the presence of hundreds or even thousands of 
isomers in some cases. Even using LC-MS/HRMS it may not be possible to eliminate all 
10,083 other isomers and unequivocally identify DEDPU. Additionally, for some compounds, 
there were multiple possible elemental compositions within the achievable mass accuracy 
and resolution. This was further complicated by the fact that, with APCI, a measured accurate 
mass could have been due to a fragment and/or adduct ion, as well as a molecular ion and/or 
(de)protonated molecule.  
4. While reference materials would be required for confirmatory identification of explosive 
substances, the ANNs developed in this thesis may be of value for prioritizing the acquisition 
of reference materials following detection of suspect or non-target energetic materials. 
Additionally, the use of 99 % prediction intervals for ANNs demonstrated potential for the 
exclusion of compounds with the same elemental composition, but less than a 1 % chance of 
having the same retention time.    
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5.3 Recommendations for future work 
 Validation of LC-HRMS method and ANN prediction model 
While method performance has been assessed here, full method validation, to demonstrate that 
the method fulfils specified requirements and is adequate for its intended use,  would be required 
before the LC-HRMS method could be used for routine forensic analysis. As discussed in Chapter 
3, there are currently no agreed validation guidelines specifically for LC-HRMS analysis of 
energetic materials, and so before validation could be performed an agreement on the 
performance criteria that must be met would be needed. Validating LC-HRMS methods for 
suspect screening and non-targeted analysis presents further challenges as reference materials 
are not normally analysed in advance. One approach could be to obtain reference materials and 
validate the method for all suspect compounds. Whilst time consuming and costly, this would also 
present an opportunity to build a larger database of reference spectra and retention times 
obtained using the LC-HRMS method in question. The database could then be used to support 
the preliminary identification of suspect compounds, for which reference materials are not run 
during routine analysis. Of course, this would still not be possible for non-target compounds which 
are unknown to the analyst in advance.  
If the LC-HRMS method was validated for additional suspect energetic materials, this would 
provide a larger number of external blind test compounds with measured retention times that 
could be used to further assess accuracy of the retention time prediction model developed in 
Chapter 4 for new energetic materials. Further validation of the prediction model and prediction 
intervals would also be required for more confident exclusion of non-explosives. The number of 
compounds used for ANN modelling here was also relatively small, especially in comparison to 
the number of known compounds (>63 million compounds in the ChemSpider database). Further 
testing using a wider range of non-explosive compounds, than the drugs used here, would be 
required to further assess the generalisability of the prediction intervals used here. Determination 
of the applicability domain of the model may also increase confidence in predicted results, through 
identification of compounds which are outliers.  
 Non-target screening 
Here, the suitability of LC-HRMS has only been demonstrated for targeted and suspect screening, 
against a list of target or suspect explosives. To truly take advantage of the power of full-scan 
HRMS, it would be desirable to perform non-target analysis enabling the detection and 
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identification of unknown explosive substances. However, further work is required before this 
would be possible. Challenges remain regarding locating unknown peaks of interest amongst the 
large amount of data collected by full-scan HRMS. Since not all components of a sample are of 
interest in the forensic analysis of explosives, it is biased non-target screening [72], involving the 
discovery of new compounds related to known energetic materials that is of interest to forensic 
scientists. Two approaches have been used for discovery of relevant components in biased non-
target screening of new psychoactive substances (NPS), a top-down and a bottom-up approach 
[106]. The top-down approach, where abundant peaks are selected from the total ion 
chromatogram, may not be successful for discovery of trace explosives, since the explosive 
component often has a low abundance in comparison to matrix components. The bottom-up 
approach, where extracted ion chromatograms are generated for common fragment ions or 
neutral losses, may offer greater promise for biased non-target screening of energetic materials 
and warrants further investigation. In particular, use of the common fragment ions identified in 
Chapter 3 could be investigated. Once peaks of interest have been discovered the next challenge 
is to identify the relevant compound. Use of APCI makes identification of unknowns more 
challenging than with ESI. This is because ions may be produced with odd or even numbers of 
electrons, since both [M]-. and [M-H]-  ions can form by APCI. Determination of a molecular formula 
is further complicated by the presence of adduct and in-source fragment ions. Therefore, 
development of prediction models to predict the type of ions an analyte would form could also be 
of value here. 
 Optimisation of sample preparation for suspect screening and non-target analysis 
This thesis has predominantly focussed on the LC-HRMS method. However, having a ‘universal’ 
LC-HRMS method for suspect or non-target screening is only of value if the sample preparation 
method used is also ‘universal’. This is because only compounds that are recovered and extracted 
into solution can be detected by LC-HRMS. Sample preparation techniques, such as solid phase 
extraction (SPE), offer the potential for improved sensitivity due to a concentration factor. 
Additionally, suitable sample preparation techniques may be able to remove matrix, 
reducing/eliminating the effect of matrix on retention time and/or ion ratios and hence simplify 
identification. However, if sample preparation methods are too selective then some suspect or 
non-target compounds of interest may also be removed.  
220 
 
Research into sample preparation for suspect screening has already begun. With me as a co-
author, Rapp-Wright et al. assessed recoveries of the initial 18 target explosives used in this 
thesis, from wastewater, using 34 different SPE sorbents [130]. Suitability of the optimised SPE 
method, using Oasis HLB (divinylbenzene with n-vinylpyrrolidone) cartridges, for suspect 
screening was assessed by determining recoveries of an additional 17 explosives-related 
analytes which were not considered during optimisation. Recoveries for 15 of the 17 additional 
analytes were greater than 50 %, but the remaining two compounds, NQ and PA were not 
recovered [130]. This demonstrated the potential for suspect screening using SPE followed by 
LC-HRMS. However, a truly ‘universal’ sample preparation and LC-HRMS screening method is 
still yet to be achieved and assessment of recoveries from a wider range of forensically relevant 
matrices would be required.    
 LC-MS/HRMS 
For increased confidence of identification, LC-MS/HRMS could be investigated. In comparison to 
the in-source fragment ions used in this thesis, which could also result from coeluting compounds; 
LC-MS/HRMS increases the confidence of identification through linking high resolution fragment 
ions to a specific precursor m/z. Traditional, tandem mass spectrometry in multiple reaction 
monitoring (MRM) mode would not be suitable for suspect or non-target screening as only ions 
with preselected masses would be detected, but it could be useful for subsequent confirmatory 
analysis. For non-target screening there are two main approaches to the use of LC-MS/HRMS, 
data-independent and data-dependent acquisition [145]. With data-independent LC-MS/HRMS, 
typically all ions are fragmented, and so product and precursor ions can only be linked based on 
matching chromatographic retention times, as is the case with in-source fragmentation. To 
somewhat overcome this limitation, Sequential Windowed Acquisition of All Theoretical Fragment 
Ion Mass Spectra (SWATH) has been used in toxicology [146]. In this case the full m/z range is 
divided into fixed smaller m/z ranges which are each independently fragmented. Therefore, while 
product ions still cannot be directly linked to a specific precursor m/z, they can be linked to smaller 
m/z ranges. Data-dependent LC-MS/HRMS, where acquisition switches from HRMS to 
MS/HRMS only when ions are detected above a threshold abundance, has also been used in 
toxicology [147]. In this case, product ions can be directly linked to a specific precursor m/z, but 
only precursor ions detected above the threshold abundance will be fragmented. All in all, further 
work is required to investigate the additional value of LC-MS/HRMS compared to LC-HRMS and 
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the best modes of acquisition for targeted analysis, suspect screening and non-target analysis of 
energetic materials.     
 Comprehensive two-dimensional chromatography 
In this thesis, a good chromatographic separation, and the use of retention time windows as an 
identification criterion, was identified as one of the most effective ways to improve selectivity. 
However, despite extensive optimisation of the chromatographic separation in Chapter 2, full base 
line resolution was not achieved for all target compounds. Additionally, the ability to separate non-
target compounds will be dependent on the separation space available. There is a finite number 
of peaks that can be separated by a given method (peak capacity). One way to increase the 
separation space available, and reduce the probability of peaks overlapping, is the use of 
comprehensive two-dimensional (2D) chromatography. With comprehensive 2D chromatography 
the entire sample is separated in 2D, through two different stationary phases. If the two 
dimensions are orthogonal (i.e. there is no correlation in retention times) then the total 2D peak 
capacity is the product of the two individual peak capacities [148].  
The use of comprehensive 2D gas chromatography, or GC x GC, in Forensic Science was 
reviewed in 2016 by Sampat et al. [149] and again in 2018 by Gruber et al. due to a sharp increase 
in the number of forensic studies using GC x GC [150]. Both reviews concluded that GC x GC 
offered the benefits of enhanced peak capacity and sensitivity in several forensic areas. The 
forensic areas identified by Sampat et al. included qualitive and quantitative trace analysis in 
complex matrices, such as toxicology samples, untargeted screening and identification in 
environmental forensics and chemical profiling of illicit drugs, ignitable liquids, CRBN agents and 
explosives [149]. In the more recent review, Gruber et al. identified a general trend towards the 
use of GC x GC for chemical profiling, fingerprinting and classification of evidence types with 
complex chemical compositions and an increase in the use of chemometrics  [150]. Both reviews 
also recognised that further work was required before more widespread and routine forensic use 
of GC x GC. Sampat et al. recognised the need for easier data treatment and analysis, in addition 
to suitable databases to aid interpretation  [149]. Similarly, Gruber et al. identified the need for 
standardised analytical methods and data interpretation [150], which would also be required for 
the development of databases.  
Comprehensive 2D liquid chromatography, or LC x LC, has already shown promise for 
pharmaceutical analysis [151], but to the authors knowledge has not yet been used for the 
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analysis of explosives. Iguiniz and Heinisch acknowledged the attractiveness of the high peak 
capacity and concluded that since LC x LC has become more affordable the number of 
applications should increase. Therefore, future work could investigate the potential for LC x LC to 
improve peak capacity and increase confidence of identification in explosive screening. In addition 
to developing an analytical method, suitable methods for data analysis and interpretation would 
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1,2,2-Trinitro-1,3,5-triazinane  C1NCN(C(N1)([N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-]  
1,3,5-triazinane-2,4,6-trione c1(=O)[nH]c(=O)[nH]c(=O)[nH]1.c1(=O)[nH]c(=O)[nH]c(=O)[nH]1  








carbamimidamido)ethyl nitrate  
O=[N+]([O-])OCCN(N=O)C(=N)N[N+]([O-])=O 



























6-MAM CC(=O)O[C@H]1C=C[C@H]2[C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CCN3C)O  
Acebutolol CCCC(=O)Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O  
Acetazolamide CC(=O)Nc1nnc(s1)S(=O)(=O)N  
AICAR c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N 
Alprenolol CC(C)NCC(COc1ccccc1CC=C)O  
Altizide C=CCSC[C@@H]1Nc2cc(c(cc2S(=O)(=O)N1)S(=O)(=O)N)Cl  
Amiloride c1(c(nc(c(n1)Cl)N)N)/C(=N/C(=N)N)/O  
Aminoglutethimide CCC1(CCC(=O)NC1=O)c2ccc(cc2)N 
Anastrazole CC(C)(C#N)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2 
Table A. 1: List of analytes and SMILES used to generate mol cul r descriptors 
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Atenolol CC(C)NCC(COc1ccc(cc1)CC(=O)N)O  








Betaxolol CC(C)NCC(COc1ccc(cc1)CCOCC2CC2)O  




Bumetanide CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O  
Bunolol CC(C)(C)NC[C@@H](COc1cccc2c1CCCC2=O)O  
Bupropion CC(C(=O)c1cccc(c1)Cl)NC(C)(C)C  




Carteolol CC(C)(C)NCC(COc1cccc2c1CCC(=O)N2)O  
Carvedilol COc1ccccc1OCCNCC(COc2cccc3c2c4ccccc4[nH]3)O  
Celiprolol CCN(CC)C(=O)Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)(C)C)O  
Chlorexolone c1c2c(cc(c1Cl)S(=O)(=O)N)C(=O)N(C2)C3CCCCC3  
Chlorothiazide c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2  
Chlorthalidone c1ccc2c(c1)C(=O)NC2(c3ccc(c(c3)S(=O)(=O)N)Cl)O  
Clobenzorex CC(Cc1ccccc1)NCc2ccccc2Cl  
Clobetasol C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C
@]1(C(=O)CCl)O)C)O)F)C  
Clopamide CC1CCCC(N1NC(=O)c2ccc(c(c2)S(=O)(=O)N)Cl)C  
Cyclopenthiazide c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)CC3CCCC3 
DADP CC1(OOC(OO1)(C)C)C 








Diacetolol CC(C)NCC(COc1ccc(cc1C(=O)C)NC(=O)C)O  
Dichlorphenamide c1c(cc(c(c1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N  











Esmolol CC(C)NCC(COc1ccc(cc1)CCC(=O)OC)O  
Etacr. acid  CCC(=C)C(=O)c1ccc(c(c1Cl)Cl)OCC(=O)O  




Fencamfamin CCNC1C2CCC(C2)C1c3ccccc3  
Fenetylline CC(CC1=CC=CC=C1)NCCN2C=NC3=C2C(=O)N(C(=O)N3C)C 




















Hydrochloroth.  c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)NCN2  
Hydroflumeth. c1c(c(cc2c1NCNS2(=O)=O)S(=O)(=O)N)C(F)(F)F  
Isometheptene CC(CCC=C(C)C)NC  



































Mefenorex CC(Cc1ccccc1)NCCCCl  
Mefruside CC1(CCCO1)CN(C)S(=O)(=O)c2ccc(c(c2)S(=O)(=O)N)Cl  
MEKP CP dimer CCC1(OOC(OO1)(C)CC)C 
MEKP CP tetramer CCC1(C)OOC(C)(OOC(C)(OOC(C)(OO1)CC)CC)CC 
MEKP CP trimer CCC1(OOC(OOC(OO1)(C)CC)(C)CC)C 
MEKP DHP dimer CCC(C)(OO)OOC(C)(CC)OO 
MEKP DHP monomer CCC(C)(OO)OO 
MEKP DHP pentamer CCC(C)(OO)OOC(C)(CC)OOC(C)(CC)OOC(C)(CC)OOC(C)(CC)OO 
MEKP DHP tetetramer CCC(C)(OO)OOC(C)(CC)OOC(C)(CC)OOC(C)(CC)OO 
MEKP DHP trimer CCC(C)(OO)OOC(C)(CC)OOC(C)(CC)OO 
Methylprednisolone C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(
=O)C=C4)C)O)C)(C(=O)CO)O  















Nadoxolol  c1ccc2c(c1)cccc2OCC(C/C(=N/O)/N)O  
NB c1ccc(cc1)[N+](=O)[O-] 
NG C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-] 
Nikethamide CCN(CC)C(=O)c1cccnc1  
NM C[N+](=O)[O-] 
N-nitroso-DPA c1ccc(cc1)N(c2ccccc2)N=O 




Oxprenolol CC(C)NCC(COc1ccccc1OCC=C)O  
Oxycodone CN1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)OC  
Oxymorphone C[N@]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O  
PA c1c(cc(c(c1[N+](=O)[O-])O)[N+](=O)[O-])[N+](=O)[O-] 
Pemoline c1ccc(cc1)C2C(=O)N=C(O2)N  
Pentazocine C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(CCN2CC=C(C)C)C)O  
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Table A. 1 (Continued): List of analytes and SMILES used to generate molecular descriptors  
Analyte SMILES 
Pentetrazol C1CCc2nnnn2CC1  
Pethidine CCOC(=O)C1(CCN(CC1)C)c2ccccc2  
PETN C(C(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-])O[N+](=O)[O-] 
PGDN CC(CO[N+](=O)[O-])O[N+](=O)[O-] 
Phendimetrazine CC1C(OCCN1C)c2ccccc2  
Phenmetrazine CC1C(OCCN1)c2ccccc2  
Pindolol CC(C)NCC(COc1cccc2c1cc[nH]2)O 
Piretanide c1ccc(cc1)Oc2c(cc(cc2S(=O)(=O)N)C(=O)O)N3CCCC3  




Propranolol CC(C)NCC(COc1cccc2c1cccc2)O  












































































































Salmeterol c1ccc(cc1)CCCCOCCCCCCNCC(c2ccc(c(c2)CO)O)O  
SHN C([C@H]([C@H]([C@@H]([C@H](CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-
])O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-] 
Sotalol CC(C)NCC(c1ccc(cc1)NS(=O)(=O)C)O  
Strychnine c1ccc2c(c1)[C@]34CCN5[C@H]3C[C@@H]6[C@@H]7[C@@H]4N2C(=O)C[C@@H]7
OCC=C6C5  




Terbutaline CC(C)(C)NCC(c1cc(cc(c1)O)O)O  
Testolactone  C[C@]12CC[C@H]3[C@H]([C@@H]1CCC(=O)O2)CCC4=CC(=O)C=C[C@]34C  
Tetryl CN(c1c(cc(cc1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-] 
















Table A. 2 (Continued): Molecular descriptors and predicted retention times for ANN and MLR models using the Goryński et al. descriptors. 
   Molecular descriptors  Best ANN Original MLR Optimised MLR 
Dataset Analyte ANN subset ALOGP R2p BELe6 Average tRM (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) 
Explosives 1,2-DNG Training -0.418 0.392 0.000 4.42 3.95 -0.46 3.08 -1.33 3.99 -0.42 
Explosives 1,3-DNB Training 1.619 0.391 0.000 9.04 8.89 -0.16 6.53 -2.51 7.98 -1.06 
Explosives 1,3-DNG Training -0.418 0.366 0.000 4.02 4.06 0.04 2.83 -1.19 4.29 0.28 
Explosives 2,4-DA-6-NT Training 0.717 0.462 0.258 3.66 7.54 3.89 6.63 2.98 6.87 3.21 
Explosives 2,4-DNT Training 2.105 0.488 0.080 11.21 9.87 -1.34 8.59 -2.62 8.27 -2.94 
Explosives 2,6-DA-4-NT Training 0.717 0.461 0.220 3.16 7.38 4.22 6.48 3.33 6.66 3.50 
Explosives 2,6-DNT Training 2.105 0.471 0.098 11.04 10.15 -0.89 8.49 -2.55 8.57 -2.48 
Explosives 2-Am-4,6-DNT Training 1.358 0.460 0.275 10.67 9.25 -1.43 7.77 -2.91 8.24 -2.43 
Explosives 2-NT Training 2.211 0.513 0.000 10.29 9.49 -0.80 8.72 -1.57 7.73 -2.56 
Explosives 3,5-DNA Training 0.872 0.365 0.237 9.26 8.98 -0.28 5.88 -3.38 8.17 -1.09 
Explosives 3-NT Training 2.211 0.510 0.000 10.87 9.52 -1.35 8.69 -2.18 7.77 -3.11 
Explosives 4-Am-2,6-DNT Training 1.358 0.458 0.360 10.33 9.63 -0.71 8.06 -2.27 8.75 -1.59 
Explosives 4-NT Training 2.211 0.526 0.000 10.47 9.36 -1.11 8.85 -1.63 7.58 -2.89 
Explosives DEDPU Training 3.632 0.798 0.799 14.81 9.95 -4.86 16.82 2.02 11.76 -3.05 
Explosives DMNB Training 1.566 0.522 0.759 7.30 9.91 2.61 10.50 3.19 10.68 3.38 
Explosives DPA Training 3.380 0.835 0.652 13.97 8.64 -5.33 16.21 2.25 10.00 -3.96 
Explosives EGDN Training 0.093 0.357 0.000 5.44 5.29 -0.15 3.61 -1.83 5.39 -0.05 
Explosives ETN Training 0.062 0.353 0.728 11.60 10.48 -1.12 6.19 -5.41 9.52 -2.08 
Explosives HMTA Training 0.086 0.878 0.443 1.52 1.40 -0.12 10.26 8.75 1.88 0.37 
Explosives HND Training 2.747 0.678 1.157 15.57 12.03 -3.54 15.47 -0.10 13.45 -2.12 
Explosives MHN Training 0.031 0.390 1.025 14.55 11.90 -2.65 7.59 -6.97 10.72 -3.83 
Explosives NB Training 1.724 0.433 0.000 8.00 8.95 0.95 7.12 -0.88 7.70 -0.29 
Explosives NG Training 0.078 0.336 0.000 8.97 5.29 -3.68 3.38 -5.58 5.61 -3.36 
Explosives NM Training 0.291 0.335 0.000 1.85 5.79 3.95 3.73 1.89 6.03 4.19 
Explosives NQ Training -0.532 0.273 0.000 1.49 3.83 2.34 1.74 0.24 5.14 3.65 
Explosives PA Training 1.246 0.417 0.360 4.96 10.02 5.06 7.47 2.51 9.00 4.04 
Explosives PETN Training -0.184 0.357 0.559 12.39 8.83 -3.56 5.19 -7.20 8.03 -4.36 
Explosives PYX Training 4.013 0.813 1.188 16.90 13.92 -2.98 19.04 2.15 14.54 -2.36 




Table A. 2 (Continued): Molecular descriptors and predicted retention times for ANN and MLR models using the Goryński et al. descriptors. 
   Molecular descriptors  Best ANN Original MLR Optimised MLR 
Dataset Analyte ANN subset ALOGP R2p BELe6 Average tRM (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) 
Explosives R-Salt Training -0.325 0.477 0.228 3.54 4.66 1.12 4.90 1.36 4.49 0.95 
Explosives TATP Training 2.867 0.624 0.761 11.99 10.47 -1.52 13.70 1.71 12.06 0.07 
Explosives TEGDN Training -0.169 0.499 0.371 7.61 5.26 -2.36 5.90 -1.71 5.35 -2.26 
Explosives Tetryl Training 1.762 0.457 0.625 11.83 11.45 -0.38 9.71 -2.12 11.05 -0.77 
Explosives TMETN Training 0.412 0.408 0.559 11.78 9.24 -2.55 6.70 -5.09 8.61 -3.18 
Explosives TNB Training 1.513 0.362 0.360 9.81 11.33 1.52 7.39 -2.42 10.16 0.35 
Explosives TNT Training 1.999 0.456 0.360 12.25 11.23 -1.02 9.13 -3.12 10.02 -2.23 
Drugs 6-MAM Training 1.766 0.949 1.046 4.45 9.23 4.78 16.02 11.57 7.77 3.32 
Drugs Acebutolol Training 1.615 0.707 1.057 6.38 8.63 2.25 13.46 7.08 10.25 3.87 
Drugs Acetazolamide Training -1.206 0.680 0.084 2.15 -0.19 -2.34 4.83 2.68 10.09 7.94 
Drugs AICAR Training -2.913 0.608 0.631 1.42 0.86 -0.56 3.24 1.82 11.39 9.97 
Drugs Alprenolol Training 2.640 0.717 0.832 11.41 8.61 -2.81 14.47 3.06 7.49 -3.92 
Drugs Altizide Training 1.486 0.973 0.731 6.87 5.74 -1.13 14.62 7.75 9.30 2.43 
Drugs Andarine Training 2.315 0.695 0.978 12.40 9.20 -3.20 14.25 1.85 10.33 -2.06 
Drugs Atenolol Training 0.669 0.701 0.799 2.73 4.69 1.96 10.85 8.12 10.66 7.93 
Drugs Beclomethasone Training 1.905 0.903 1.162 11.52 10.65 -0.87 16.24 4.72 9.23 -2.28 
Drugs Benzoylecgonine Training 1.868 0.909 0.880 4.05 6.96 2.92 15.20 11.15 7.49 3.44 
Drugs Benzthiazide Training 2.498 0.956 1.008 9.39 9.82 0.42 17.19 7.80 22.36 12.97 
Drugs Beta\dexameth. Training 1.642 0.876 1.161 10.89 10.08 -0.81 15.52 4.63 9.03 -1.87 
Drugs Betaxolol Training 2.577 0.793 1.019 11.60 9.34 -2.26 15.79 4.19 3.88 -7.72 
Drugs Bisoprolol Training 2.031 0.791 1.017 9.59 8.34 -1.25 14.83 5.24 5.51 -4.09 
Drugs Budesonide Training 2.132 0.925 1.255 15.29 12.69 -2.60 17.18 1.89 9.95 -5.33 
Drugs Bumetanid Training 2.960 0.850 0.942 6.25 9.27 3.01 16.71 10.46 10.61 4.36 
Drugs Butizide Training 1.577 0.877 0.761 6.73 5.27 -1.46 13.95 7.23 7.57 0.85 
Drugs Canrenone Training 3.379 0.967 1.243 14.71 14.43 -0.28 19.66 4.95 9.86 -4.85 
Drugs Carphedon Training 0.254 0.801 0.664 5.16 2.37 -2.79 10.61 5.45 4.36 -0.81 
Drugs Celiprolol Training 1.597 0.720 1.195 7.66 10.39 2.73 14.06 6.40 3.30 -4.36 
Drugs Chlorexolone Training 2.348 0.925 0.895 9.74 8.04 -1.70 16.22 6.48 7.14 -2.60 
Drugs Chlorothiazide Training 0.450 0.767 0.443 2.08 2.17 0.09 9.81 7.73 7.55 5.48 
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Table A. 2 (Continued): Molecular descriptors and predicted retention times for ANN and MLR models using the Goryński et al. descriptors. 
   Molecular descriptors  Best ANN Original MLR Optimised MLR 
Dataset Analyte ANN subset ALOGP R2p BELe6 Average tRM (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) 
Drugs Chlorthalidone Training 1.507 0.932 0.702 4.91 5.13 0.22 14.15 9.24 14.42 9.51 
Drugs Clobenzorex Training 4.314 0.963 0.799 12.70 11.21 -1.49 19.58 6.88 11.19 -1.51 
Drugs Clobetasol Training 2.845 0.928 1.146 12.94 11.90 -1.04 18.02 5.07 10.69 -2.25 
Drugs Clopamide Training 2.318 0.885 0.995 6.01 8.77 2.76 16.15 10.14 12.67 6.67 
Drugs Cyclopenthiazide Training 2.118 1.034 1.047 9.61 10.89 1.28 17.44 7.83 4.78 -4.83 
Drugs Deflazacort Training 1.603 0.856 1.290 13.62 12.14 -1.48 15.74 2.12 9.91 -3.70 
Drugs Desonide Training 0.962 0.896 1.237 12.50 10.92 -1.58 14.84 2.34 7.90 -4.60 
Drugs Diacetolol Training 0.492 0.650 0.873 3.62 5.76 2.14 10.33 6.71 -0.40 -4.01 
Drugs Dichlorphenamide Training 0.815 0.768 0.105 4.19 3.15 -1.04 9.20 5.01 9.44 5.25 
Drugs Efaproxiral Training 3.858 0.831 0.979 7.28 11.43 4.15 18.19 10.90 11.39 4.11 
Drugs Etamivan Training 1.658 0.637 0.701 5.75 7.25 1.49 11.55 5.80 9.20 3.45 
Drugs Famprofazone Training 4.847 0.901 1.149 17.86 15.02 -2.84 21.17 3.31 14.93 -2.92 
Drugs Fenbutrazate Training 4.455 0.959 1.152 17.61 14.66 -2.95 21.07 3.46 13.51 -4.10 
Drugs Fencamfamin Training 3.086 1.014 0.799 10.22 9.31 -0.92 17.98 7.76 8.20 -2.02 
Drugs Fenetylline Training 1.785 0.889 0.996 9.46 7.98 -1.48 15.29 5.83 8.22 -1.24 
Drugs Fenfluramine Training 3.358 0.721 0.521 9.29 9.69 0.39 14.59 5.30 10.53 1.24 
Drugs Fludrocortisone Training 1.346 0.885 1.154 9.59 9.70 0.11 15.08 5.49 8.30 -1.29 
Drugs Flumethasone Training 1.480 0.861 1.159 11.13 9.74 -1.39 15.10 3.96 8.87 -2.26 
Drugs Fluticasone prop. Training 3.947 0.887 1.241 16.21 14.65 -1.56 19.84 3.63 13.86 -2.35 
Drugs FPCAM Training 2.999 0.877 1.231 10.79 13.02 2.23 18.10 7.31 12.06 1.27 
Drugs Fulvestrant Training 8.412 1.022 1.476 18.08 22.97 4.89 29.60 11.52 10.93 -7.15 
Drugs Furosemide Training 1.714 0.715 0.753 3.36 6.23 2.86 12.59 9.23 15.12 11.75 
Drugs Gestrinone Training 4.132 0.981 1.160 14.00 14.43 0.43 20.77 6.77 0.21 -13.79 
Drugs Hydrochloroth. Training 0.038 0.764 0.478 2.13 1.49 -0.64 9.21 7.08 8.00 5.88 
Drugs Hydroflumeth. Training 0.316 0.678 0.555 2.63 3.22 0.59 9.13 6.50 7.75 5.12 
Drugs Isometheptene Training 2.405 0.600 0.490 6.99 9.53 2.54 11.69 4.70 9.89 2.90 
Drugs Mefenorex Training 2.793 0.857 0.772 8.50 7.70 -0.80 15.87 7.37 9.28 0.78 
Drugs Methylprednisolone Training 1.446 0.874 1.161 11.44 9.84 -1.61 15.17 3.73 8.67 -2.77 
Drugs Ostarine Training 2.315 0.695 0.978 13.34 9.20 -4.14 14.25 0.91 7.75 -5.59 
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Table A. 2 (Continued): Molecular descriptors and predicted retention times for ANN and MLR models using the Goryński et al. descriptors. 
   Molecular descriptors  Best ANN Original MLR Optimised MLR 
Dataset Analyte ANN subset ALOGP R2p BELe6 Average tRM (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) 
Drugs Oxycodone Training 1.029 0.892 0.982 4.60 6.81 2.21 13.98 9.38 6.63 2.02 
Drugs Oxymorphone Training 0.778 0.952 0.972 2.94 7.14 4.20 14.10 11.16 5.39 2.45 
Drugs Pentazocine Training 4.348 0.851 0.992 8.59 12.51 3.92 19.26 10.67 13.64 5.05 
Drugs Pentetrazol Training 0.918 0.826 0.000 2.86 3.40 0.54 9.55 6.69 1.59 -1.27 
Drugs Phendimetrazine Training 1.998 0.744 0.799 6.32 6.72 0.39 13.52 7.20 9.19 2.87 
Drugs Phenmetrazine Training 1.462 0.773 0.472 5.19 4.30 -0.89 11.69 6.50 5.95 0.75 
Drugs Prenylamine Training 5.711 1.025 0.952 15.88 14.97 -0.91 23.11 7.23 14.07 -1.81 
Drugs Probenecid Training 2.821 0.791 0.799 5.30 8.13 2.83 15.38 10.08 9.86 4.56 
Drugs Propylhexedrine Training 2.739 0.753 0.545 8.76 7.66 -1.11 13.94 5.17 9.09 0.33 
Drugs Salmeterol Training 4.226 0.833 1.257 15.58 15.18 -0.40 19.85 4.27 11.00 -4.58 
Drugs Sotalol Training 0.967 0.728 0.761 2.91 4.63 1.72 11.48 8.57 5.16 2.25 
Drugs Tapentadol Training 3.441 0.705 0.809 7.33 10.53 3.20 15.64 8.30 12.52 5.18 
Drugs Terbutaline Training 1.254 0.702 0.761 2.83 5.50 2.67 11.71 8.88 9.95 7.12 
Drugs Testolactone Training 3.123 0.928 0.985 9.17 10.31 1.14 17.90 8.73 12.61 3.44 
Drugs Timolol Training 1.128 0.800 0.924 7.95 5.83 -2.12 13.04 5.10 6.61 -1.33 
Drugs Tramadol Training 2.701 0.785 1.009 7.12 9.50 2.37 15.89 8.76 11.28 4.16 
Drugs Triamcinolone Training 0.356 0.858 1.146 7.24 8.41 1.18 13.11 5.87 6.64 -0.60 
Drugs Triamterene Training 1.017 0.711 0.785 6.56 5.07 -1.49 11.49 4.93 9.74 3.19 
Drugs Xipamide Training 2.812 0.841 0.939 5.01 8.94 3.93 16.36 11.35 10.32 5.31 
Explosives 1,2-DNB Select 1.619 0.478 0.000 7.96 8.35 0.38 7.37 -0.59 6.98 -0.98 
Explosives 3,4-DNT Select 2.105 0.491 0.074 10.13 9.81 -0.33 8.60 -1.54 8.20 -1.93 
Explosives HMDD Select 1.738 0.699 0.149 4.43 6.03 1.60 10.26 5.83 5.51 1.08 
Explosives PGDN Select 0.471 0.400 0.000 7.50 6.04 -1.46 4.67 -2.83 5.64 -1.87 
Explosives RDX Select 0.623 0.474 0.563 5.95 8.33 2.38 7.71 1.76 8.28 2.32 
Explosives TATB Select -0.727 0.420 0.699 9.40 7.62 -1.79 5.39 -4.01 7.04 -2.37 
Drugs Amiloride Select -0.077 0.490 0.220 3.63 5.00 1.36 5.41 1.78 9.20 5.57 
Drugs Aminoglutethimide Select 1.285 0.748 0.799 4.99 5.26 0.27 12.35 7.36 9.15 4.16 
Drugs Bendroflumethiazide Select 2.179 0.923 0.802 8.50 6.92 -1.59 15.57 7.07 8.30 -0.21 
Drugs Bumetanide Select 2.960 0.850 0.942 6.28 9.27 2.98 16.71 10.43 9.29 3.01 
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Table A. 2 (Continued): Molecular descriptors and predicted retention times for ANN and MLR models using the Goryński et al. descriptors. 
   Molecular descriptors  Best ANN Original MLR Optimised MLR 
Dataset Analyte ANN subset ALOGP R2p BELe6 Average tRM (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) 
Drugs Bunolol Select 2.358 0.806 0.795 7.59 7.02 -0.58 14.72 7.13 2.66 -4.94 
Drugs Danazol Select 4.875 0.937 1.123 16.65 14.89 -1.76 21.47 4.82 12.84 -3.81 
Drugs Desacetyl deflazacort Select 1.224 0.887 1.217 10.85 10.69 -0.16 15.12 4.27 8.40 -2.45 
Drugs Esmolol Select 1.978 0.701 0.837 8.36 7.41 -0.95 13.21 4.85 5.28 -3.08 
Drugs Etacr. acid  Select 4.152 0.815 0.763 7.31 10.91 3.60 17.74 10.43 9.71 2.41 
Drugs Labetalol Select 2.330 0.840 1.038 9.84 9.11 -0.73 15.89 6.05 10.45 0.61 
Drugs Metoprolol Select 1.757 0.702 0.799 7.27 6.72 -0.55 12.71 5.44 8.91 1.64 
Drugs Norfenfluramine Select 2.577 0.665 0.348 8.60 8.67 0.07 12.09 3.49 8.67 0.07 
Drugs Pethidine Select 2.446 0.780 0.799 8.41 7.37 -1.04 14.63 6.22 9.65 1.24 
Drugs Propranolol Select 2.540 0.761 0.765 11.61 7.58 -4.03 14.48 2.88 3.35 -8.26 
Drugs Strychnine Select 1.146 1.073 1.050 8.14 10.73 2.59 16.18 8.03 5.15 -2.99 
Drugs Trichlormethiazide Select 1.364 1.003 0.515 4.92 4.77 -0.15 13.91 8.99 8.33 3.41 
Explosives 1-MNG Test -0.913 0.387 0.000 1.85 2.84 0.99 2.19 0.34 3.08 1.23 
Explosives DADP Test 1.911 0.583 0.000 8.43 7.94 -0.50 8.89 0.45 6.34 -2.09 
Explosives DMDPU Test 2.935 0.712 0.799 12.44 9.20 -3.23 14.81 2.37 11.39 -1.05 
Explosives HMTD Test 2.558 0.671 0.619 2.80 8.54 5.75 13.11 10.31 10.10 7.31 
Explosives HMX Test 0.831 0.563 0.627 4.64 6.89 2.25 9.16 4.52 8.02 3.39 
Explosives SHN Test 0.031 0.391 1.025 14.55 11.88 -2.67 7.60 -6.96 10.71 -3.85 
Drugs Anastrazole Test 2.966 0.841 0.761 8.02 8.05 0.03 15.97 7.95 7.16 -0.86 
Drugs Bambuterol Test 1.727 0.716 0.880 8.41 7.00 -1.41 13.09 4.68 10.94 2.53 
Drugs Bupropion Test 3.227 0.816 0.761 9.54 8.74 -0.81 16.17 6.63 10.54 1.00 
Drugs Carteolol Test 1.283 0.781 0.763 4.17 4.79 0.62 12.53 8.36 12.37 8.20 
Drugs Carvedilol Test 4.015 0.933 1.091 13.30 13.07 -0.23 19.85 6.55 8.71 -4.59 
Drugs Epitizide Test 1.876 0.926 0.658 6.68 5.47 -1.20 14.56 7.88 10.66 3.98 
Drugs Formoterol Test 1.929 0.811 1.051 7.71 8.58 0.87 14.98 7.27 7.09 -0.62 
Drugs Mefruside Test 1.528 0.926 0.925 9.61 7.09 -2.52 14.95 5.34 6.88 -2.73 
Drugs Nadoxolol Test 1.369 0.631 0.629 9.26 6.53 -2.73 10.74 1.48 7.48 -1.78 
Drugs Nikethamide Test 0.791 0.697 0.486 3.61 3.75 0.14 9.87 6.25 5.59 1.98 
Drugs Oxprenolol Test 2.232 0.674 0.827 9.46 8.32 -1.14 13.35 3.89 6.05 -3.41 
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Table A. 2 (Continued): Molecular descriptors and predicted retention times for ANN and MLR models using the Goryński et al. descriptors. 
   Molecular descriptors  Best ANN Original MLR Optimised MLR 
Dataset Analyte ANN subset ALOGP R2p BELe6 Average tRM (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) tRP (min) ΔtR (min) 
Drugs Pemoline Test 1.336 0.714 0.212 3.15 4.77 1.63 9.95 6.81 4.91 1.76 
Drugs Pindolol Test 1.926 0.738 0.830 4.86 6.81 1.95 13.46 8.59 8.90 4.04 
Drugs Piretanide Test 2.446 0.871 0.938 5.12 8.31 3.19 16.02 10.91 9.39 4.27 
Drugs Polythiazide Test 2.412 0.881 0.884 8.84 7.78 -1.06 15.86 7.03 11.84 3.00 





















Explosives 1,2-DNB Training 4 6 4 0 0 0 1 0 0 0 1 3.459 -0.484 1.886 1.619 1.60 7.96 8.35 0.39 
Explosives 1,2-DNG Training 4 3 7 0 0 0 0 0 0 0 0 2.322 0.321 -0.164 -0.418 0.86 4.42 5.29 0.88 
Explosives 1,3-DNB Training 4 6 4 0 0 0 1 0 0 0 1 3.459 -0.484 1.886 1.619 1.55 9.04 8.30 -0.75 
Explosives 1,3-DNG Training 4 3 7 0 0 0 0 0 0 0 0 2.322 0.321 -0.164 -0.418 0.97 4.02 5.43 1.42 
Explosives 1-MNG Training 2 3 5 0 0 0 0 0 0 0 0 1.585 1.161 -0.827 -0.913 -0.43 1.85 2.42 0.57 
Explosives 2,4-DNT Training 4 7 4 0 0 0 1 0 0 0 1 3.459 -0.523 2.239 2.105 2.10 11.21 9.48 -1.73 
Explosives 2,6-DA-4-NT Training 2 7 2 0 0 0 1 0 0 0 1 3.170 2.617 1.181 0.717 0.92 3.16 5.88 2.72 
Explosives 2,6-DNT Training 4 7 4 0 0 0 1 0 0 0 1 3.459 -0.523 2.239 2.105 2.10 11.04 9.48 -1.56 
Explosives 2-NT Training 2 7 2 0 0 0 1 0 0 0 1 3.170 -0.672 2.241 2.211 2.45 10.29 9.25 -1.04 
Explosives 3,4-DNT Training 4 7 4 0 0 0 1 0 0 0 1 3.459 -0.523 2.239 2.105 2.15 10.13 9.53 -0.60 
Explosives 3,5-DNA Training 4 6 4 0 0 0 1 0 0 0 1 3.459 0.829 1.395 0.872 1.63 9.26 7.57 -1.69 
Explosives 4-Am-2,6-DNT Training 4 7 4 0 0 0 1 0 0 0 1 3.459 0.756 1.748 1.358 1.88 10.33 8.44 -1.90 
Explosives 4-NT Training 2 7 2 0 0 0 1 0 0 0 1 3.170 -0.672 2.241 2.211 2.45 10.47 9.25 -1.22 
Explosives DADP Training 0 6 4 0 0 0 1 0 0 0 0 0.000 -0.576 1.107 1.911 1.23 8.43 7.04 -1.40 
Explosives DMDPU Training 1 15 1 0 0 0 2 0 0 0 2 3.807 -0.818 3.202 2.935 2.55 12.44 12.31 -0.13 
Explosives DPA Training 0 12 0 0 0 0 2 0 0 0 2 3.700 -0.352 3.395 3.380 3.12 13.97 11.98 -1.99 
Explosives EGDN Training 4 2 6 0 0 0 0 0 0 0 0 2.322 -0.192 0.056 0.093 1.51 5.44 6.13 0.69 
Explosives ETN Training 8 4 12 0 0 0 0 0 0 0 0 3.170 -0.197 1.125 0.062 3.21 11.60 11.41 -0.19 
Explosives HMDD Training 0 6 4 0 0 0 0 0 2 0 0 0.000 -0.484 0.359 1.738 0.00 4.43 2.75 -1.69 
Explosives HMTA Training 0 6 0 0 0 0 4 0 3 0 0 0.000 -0.576 1.107 0.086 0.98 1.52 1.70 0.19 
Explosives HMTD Training 0 6 6 0 0 0 0 0 0 0 0 0.000 -0.418 0.476 2.558 0.13 2.80 5.44 2.64 
Explosives HMX Training 8 4 8 0 0 0 0 0 1 0 0 3.170 -0.197 2.357 0.831 -1.71 4.64 5.20 0.57 
Explosives HND Training 12 12 12 0 0 0 2 0 0 0 2 4.644 0.023 3.141 2.747 4.44 15.57 14.64 -0.93 
Explosives NG Training 6 3 9 0 0 0 0 0 0 0 0 2.807 -0.195 0.575 0.078 2.41 8.97 8.86 -0.11 
Explosives NM Training 2 1 2 0 0 0 0 0 0 0 0 1.585 -0.215 -0.433 0.291 0.10 1.85 3.19 1.34 
Explosives NQ Training 3 1 2 0 0 0 0 0 0 0 0 2.000 3.831 -0.915 -0.532 -2.56 1.49 0.88 -0.61 
Explosives PA Training 6 6 7 0 0 0 1 0 0 0 1 3.700 0.138 1.543 1.246 -1.40 4.96 4.83 -0.13 



















Explosives PETN Training 8 5 12 0 0 0 0 0 0 0 0 3.170 -0.235 1.535 -0.184 3.64 12.39 12.64 0.25 
Explosives PGDN Training 4 3 6 0 0 0 0 0 0 0 0 2.322 -0.263 0.575 0.471 1.87 7.50 7.45 -0.05 
Explosives PYX Training 16 17 16 0 0 0 3 0 0 0 2 5.129 0.488 4.266 4.013 7.04 16.90 18.11 1.21 
Explosives R-Salt Training 3 3 3 0 0 0 1 0 0 0 0 2.000 -0.242 -0.635 -0.325 -1.18 3.54 1.30 -2.24 
Explosives SHN Training 12 6 18 0 0 0 0 0 0 0 0 3.700 -0.198 2.301 0.031 5.16 14.55 15.98 1.43 
Explosives TATB Training 6 6 6 0 0 0 1 0 0 0 1 3.700 4.331 0.102 -0.727 2.93 9.40 8.33 -1.08 
Explosives TEGDN Training 4 6 8 0 0 0 0 0 0 0 0 2.322 -0.367 0.346 -0.169 1.46 7.61 7.31 -0.30 
Drugs Acebutolol Training 2 18 4 0 0 0 1 0 0 0 1 3.170 0.998 1.589 1.615 -0.73 6.38 6.93 0.55 
Drugs Acetazolamide Training 3 4 3 0 0 1 0 0 0 0 0 3.170 1.837 -1.583 -1.206 -0.58 2.15 3.06 0.91 
Drugs Alprenolol Training 1 15 2 0 0 0 1 0 0 0 1 3.000 0.320 2.370 2.640 0.34 11.41 8.38 -3.03 
Drugs Altizide Training 5 11 4 0 0 0 2 0 0 0 1 3.585 2.094 0.568 1.486 1.08 6.87 5.70 -1.17 
Drugs Amiloride Training 2 6 1 0 0 0 1 0 0 0 0 3.170 6.789 0.157 -0.077 -0.92 3.63 3.35 -0.29 
Drugs Aminoglutethimide Training 2 13 2 0 0 0 2 0 0 0 1 3.170 1.193 1.377 1.285 1.27 4.99 6.76 1.77 
Drugs Anastrazole Training 0 17 0 0 0 1 1 0 0 0 1 3.807 -0.762 2.795 2.966 2.68 8.02 11.29 3.27 
Drugs Atenolol Training 1 14 3 0 0 0 1 0 0 0 1 3.000 1.986 0.925 0.669 -2.19 2.73 3.32 0.59 
Drugs Beclomethasone Training 4 22 5 0 0 1 3 0 0 1 0 2.322 0.882 1.962 1.905 2.25 11.52 11.30 -0.22 
Drugs Benzoylecgonine Training 2 16 4 0 0 1 2 1 0 0 1 3.170 -0.291 2.170 1.868 -0.21 4.05 3.46 -0.59 
Drugs Benzthiazide Training 5 15 4 0 0 0 3 0 0 0 2 4.170 1.126 1.793 2.498 0.99 9.39 8.11 -1.28 
Drugs Beta\dexameth. Training 4 22 5 0 0 1 3 0 0 1 0 2.322 0.882 1.855 1.642 1.92 10.89 10.88 -0.01 
Drugs Betaxolol Training 0 18 3 1 0 0 1 0 0 0 1 2.807 0.259 1.991 2.577 0.43 11.60 11.24 -0.36 
Drugs Bisoprolol Training 0 18 4 0 0 0 1 0 0 0 1 2.807 0.278 1.595 2.031 -0.22 9.59 7.60 -1.99 
Drugs Budesonide Training 4 25 6 0 0 2 3 0 1 1 0 2.322 0.161 2.014 2.132 3.02 15.29 13.36 -1.93 
Drugs Bupropion Training 1 13 1 0 0 0 1 0 0 0 1 3.000 -0.291 3.218 3.227 2.69 9.54 11.13 1.59 
Drugs Canrenone Training 4 22 3 0 0 2 3 0 0 1 0 2.322 -0.869 4.154 3.379 2.50 14.71 15.58 0.87 
Drugs Celiprolol Training 2 20 4 0 0 0 1 0 0 0 1 3.170 0.945 1.696 1.597 -0.41 7.66 7.81 0.15 
Drugs Chlorexolone Training 3 14 3 0 0 1 2 0 0 1 1 3.322 0.425 1.968 2.348 1.49 9.74 9.22 -0.52 
Drugs Chlorothiazide Training 5 7 4 0 0 0 2 0 0 0 1 3.585 1.539 0.187 0.450 -0.10 2.08 3.47 1.39 
Drugs Clobenzorex Training 0 16 0 0 0 0 2 0 0 0 2 3.700 -0.389 4.411 4.314 2.89 12.70 13.56 0.86 
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Drugs Clobetasol Training 4 22 4 0 0 1 3 0 0 1 0 2.322 0.212 2.855 2.845 2.74 12.94 12.67 -0.27 
Drugs Clopamide Training 3 14 3 0 0 0 2 0 0 0 1 3.322 1.159 2.008 2.318 1.75 6.01 8.37 2.37 
Drugs Cyclopenthiazide Training 4 13 4 0 0 1 2 0 0 0 1 3.459 1.993 1.181 2.118 1.51 9.61 7.71 -1.90 
Drugs Deflazacort Training 6 25 6 0 0 2 3 0 1 1 0 2.807 -0.372 2.305 1.603 2.43 13.62 13.79 0.17 
Drugs Desacetyl deflazacort Training 5 23 5 0 0 2 3 0 1 1 0 2.585 0.194 1.916 1.224 1.84 10.85 12.30 1.45 
Drugs Desonide Training 4 24 6 0 0 2 3 0 1 1 0 2.322 0.177 1.807 0.962 2.79 12.50 12.82 0.32 
Drugs Diacetolol Training 2 16 4 0 0 0 1 0 0 0 1 3.170 1.069 1.108 0.492 -1.40 3.62 5.19 1.58 
Drugs Dichlorphenamide Training 4 6 4 0 0 0 1 0 0 0 1 3.459 2.504 0.198 0.815 0.89 4.19 5.03 0.84 
Drugs Efaproxiral Training 2 20 4 0 0 0 2 0 0 0 2 3.907 0.233 3.125 3.858 0.38 7.28 11.10 3.82 
Drugs Epitizide Training 4 10 4 0 0 0 2 0 0 0 1 3.459 2.107 0.783 1.876 1.01 6.68 5.51 -1.17 
Drugs Esmolol Training 1 16 4 0 0 0 1 0 0 0 1 3.000 0.331 1.836 1.978 -0.42 8.36 7.34 -1.02 
Drugs Etamivan Training 1 12 3 0 0 0 1 0 0 0 1 3.000 -0.229 1.713 1.658 1.44 5.75 8.34 2.59 
Drugs Famprofazone Training 2 24 1 0 0 1 2 0 0 0 2 3.907 -0.848 4.389 4.847 1.18 17.86 13.38 -4.48 
Drugs Fencamfamin Training 0 15 0 0 0 2 2 0 0 0 1 2.807 -0.413 3.517 3.086 0.39 10.22 9.46 -0.76 
Drugs Fludrocortisone Training 3 21 5 0 0 1 3 0 0 1 0 2.000 0.908 1.728 1.346 1.54 9.59 9.98 0.39 
Drugs Flumethasone Training 4 22 5 0 0 1 3 0 0 1 0 2.322 0.891 1.962 1.480 1.74 11.13 10.84 -0.29 
Drugs Fulvestrant Training 1 32 3 0 0 1 3 0 0 1 1 3.000 0.113 6.073 8.412 7.56 18.08 18.21 0.13 
Drugs Gestrinone Training 4 21 2 0 0 1 3 0 0 1 0 2.585 -0.455 3.873 4.132 3.26 14.00 13.65 -0.35 
Drugs Hydrochloroth. Training 4 7 4 0 0 0 2 0 0 0 1 3.459 2.409 -0.547 0.038 0.00 2.13 2.31 0.19 
Drugs Hydroflumeth. Training 4 8 4 0 0 0 2 0 0 0 1 3.459 2.272 -0.077 0.316 0.23 2.63 3.35 0.72 
Drugs Labetalol Training 1 19 3 0 0 0 2 0 0 0 2 3.807 2.578 2.674 2.330 0.53 9.84 9.01 -0.83 
Drugs Methylprednisolone Training 4 22 5 0 0 1 3 0 0 1 0 2.322 0.872 1.747 1.446 1.97 11.44 10.81 -0.63 
Drugs Metoprolol Training 0 15 3 0 0 0 1 0 0 0 1 2.807 0.341 1.653 1.757 -0.59 7.27 6.62 -0.65 
Drugs Nadoxolol Training 1 14 3 0 0 0 2 0 0 0 2 3.700 1.986 1.974 1.369 1.63 9.26 8.61 -0.65 
Drugs Nikethamide Training 1 10 1 0 0 0 1 0 0 0 0 3.000 -0.748 1.020 0.791 0.54 3.61 5.26 1.65 
Drugs Ostarine Training 4 19 6 0 0 0 2 0 0 0 2 4.087 1.004 2.447 2.315 3.26 13.34 12.21 -1.13 
Drugs Oxprenolol Training 1 15 3 0 0 0 1 0 0 0 1 3.000 0.341 1.831 2.232 -0.15 9.46 7.30 -2.16 
Drugs Oxycodone Training 1 18 4 0 0 1 4 0 1 3 1 3.000 -0.326 1.381 1.029 0.15 4.60 3.79 -0.81 
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Drugs Pemoline Training 2 9 2 0 0 1 1 0 0 0 1 3.170 0.605 1.179 1.336 0.50 3.15 6.02 2.88 
Drugs Pentazocine Training 1 19 1 0 0 0 3 0 1 0 1 3.000 -0.432 3.777 4.348 1.89 8.59 8.81 0.21 
Drugs Pentetrazol Training 0 6 0 0 0 1 0 1 0 0 0 2.585 -0.576 1.666 0.918 0.22 2.86 2.57 -0.29 
Drugs Pethidine Training 1 15 2 0 0 0 2 0 0 0 1 3.000 -0.818 2.522 2.446 1.56 8.41 9.55 1.14 
Drugs Pindolol Training 0 14 2 0 0 1 1 0 0 1 1 3.459 1.142 1.306 1.926 -0.65 4.86 5.47 0.61 
Drugs Piretanide Training 3 17 5 0 0 1 2 0 0 0 2 4.000 1.045 1.371 2.446 0.07 5.12 6.00 0.89 
Drugs Polythiazide Training 4 11 4 0 0 0 2 0 0 0 1 3.459 1.282 1.051 2.412 1.59 8.84 6.66 -2.18 
Drugs Prenylamine Training 0 24 0 0 0 0 3 0 0 0 3 4.248 -0.514 5.475 5.711 2.60 15.88 17.69 1.81 
Drugs Probenecid Training 3 13 4 0 0 0 1 0 0 0 1 3.322 -0.198 1.979 2.821 0.13 5.30 7.78 2.48 
Drugs Prolintane Training 0 15 0 0 0 1 1 0 0 0 1 2.807 -0.917 3.517 4.043 1.36 9.25 11.15 1.90 
Drugs Propranolol Training 0 16 2 0 0 0 2 0 0 0 2 3.585 0.290 2.534 2.540 0.81 11.61 9.93 -1.67 
Drugs Propylhexedrine Training 0 10 0 0 0 0 1 0 0 0 0 0.000 -0.294 2.502 2.739 -0.30 8.76 8.10 -0.67 
Drugs Salmeterol Training 0 25 4 0 0 0 2 0 0 0 2 3.700 1.531 2.872 4.226 1.62 15.58 12.05 -3.53 
Drugs Sotalol Training 2 12 3 0 0 0 1 0 0 0 1 3.170 1.251 0.709 0.967 -1.97 2.91 3.09 0.18 
Drugs Strychnine Training 2 21 2 0 0 2 4 1 1 6 1 3.170 -0.830 2.904 1.146 0.21 8.14 8.88 0.74 
Drugs Tapentadol Training 0 14 1 0 0 0 1 0 0 0 1 2.807 -0.352 3.040 3.441 0.28 7.33 9.12 1.79 
Drugs Terbutaline Training 0 12 3 0 0 0 1 0 0 0 1 2.807 2.137 1.129 1.254 -1.94 2.83 3.34 0.51 
Drugs Testolactone Training 4 19 3 0 0 0 4 0 0 0 0 2.322 -0.851 3.485 3.123 3.07 9.17 10.34 1.17 
Drugs Timolol Training 0 13 3 0 0 1 1 0 0 0 0 2.585 0.472 1.223 1.128 -0.71 7.95 5.31 -2.64 
Drugs Triamcinolone Training 4 21 6 0 0 1 3 0 0 1 0 2.322 1.662 0.866 0.356 0.92 7.24 8.41 1.18 
Drugs Triamterene Training 0 12 0 0 0 0 3 0 0 0 1 4.170 3.956 2.703 1.017 1.10 6.56 5.31 -1.25 
Drugs Xipamide Training 3 15 4 0 0 0 2 0 0 0 2 4.000 1.908 2.384 2.812 1.15 5.01 8.98 3.97 
Explosives 2-Am-4,6-DNT Select 4 7 4 0 0 0 1 0 0 0 1 3.459 0.756 1.748 1.358 1.88 10.67 8.44 -2.23 
Explosives DEDPU Select 1 17 1 0 0 0 2 0 0 0 2 3.807 -0.836 3.695 3.632 3.26 14.81 13.62 -1.19 
Explosives NB Select 2 6 2 0 0 0 1 0 0 0 1 3.170 -0.636 1.887 1.724 1.81 8.00 8.02 0.03 
Explosives RDX Select 6 3 6 0 0 0 1 0 0 0 0 2.807 -0.195 1.401 0.623 -1.20 5.95 4.84 -1.11 
Explosives TATP Select 0 9 6 0 0 0 0 0 0 1 0 0.000 -0.586 1.769 2.867 2.16 11.99 10.32 -1.67 
Explosives Tetryl Select 8 7 8 0 0 0 1 0 0 0 1 3.907 -0.344 2.654 1.762 1.25 11.83 10.42 -1.41 
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Explosives TNB Select 6 6 6 0 0 0 1 0 0 0 1 3.700 -0.391 2.005 1.513 1.36 9.81 8.87 -0.95 
Drugs Bambuterol Select 2 18 5 0 0 0 1 0 0 0 1 3.170 0.327 1.032 1.727 -0.93 8.41 6.17 -2.24 
Drugs Bendroflumethiazide Select 4 15 4 0 0 0 3 0 0 0 2 4.087 1.881 1.582 2.179 1.48 8.50 7.92 -0.58 
Drugs Bumetanide Select 3 17 5 0 0 0 2 0 0 0 2 4.000 1.815 1.763 2.960 0.21 6.25 7.79 1.54 
Drugs Bunolol Select 1 17 3 0 0 0 2 0 0 0 1 3.000 0.284 2.323 2.358 0.15 7.59 8.08 0.48 
Drugs Carphedon Select 2 12 2 0 0 1 1 0 0 0 1 3.170 0.451 0.837 0.254 0.31 5.16 6.09 0.93 
Drugs Carvedilol Select 0 24 4 0 0 1 3 0 0 2 3 4.459 0.834 2.195 4.015 2.67 13.30 11.83 -1.47 
Drugs Danazol Select 1 22 2 0 0 2 3 0 0 2 0 3.000 -0.435 4.154 4.875 4.33 16.65 16.14 -0.51 
Drugs Furosemide Select 3 12 5 0 0 1 1 0 0 0 1 3.907 2.062 0.434 1.714 -0.74 3.36 3.66 0.30 
Drugs Isometheptene Select 1 9 0 0 0 0 0 0 0 0 0 1.000 -0.257 2.446 2.405 -0.03 6.99 8.19 1.20 
Drugs Mefruside Select 4 13 5 0 0 1 1 0 0 0 1 3.459 0.493 0.507 1.528 1.67 9.61 7.70 -1.91 
Drugs Norfenfluramine Select 0 10 0 0 0 0 1 0 0 0 1 2.807 0.547 3.246 2.577 0.18 8.60 8.20 -0.40 
Drugs Oxymorphone Select 1 17 4 0 0 1 4 0 1 3 1 3.000 0.304 1.143 0.778 0.34 2.94 3.50 0.56 
Drugs Phendimetrazine Select 0 12 1 0 0 0 2 0 0 0 1 2.807 -0.835 1.845 1.998 1.28 6.32 7.84 1.51 
Drugs Phenmetrazine Select 0 11 1 0 0 0 2 0 0 0 1 2.807 -0.277 1.564 1.462 0.09 5.19 5.95 0.75 
Drugs Trichlormethiazide Select 4 8 4 0 0 0 2 0 0 0 1 3.459 2.272 0.365 1.364 0.55 4.92 4.21 -0.71 
Explosives 2,4-DA-6-NT Test 2 7 2 0 0 0 1 0 0 0 1 3.170 2.617 1.181 0.717 0.92 3.66 5.88 2.22 
Explosives 3-NT Test 2 7 2 0 0 0 1 0 0 0 1 3.170 -0.672 2.241 2.211 2.45 10.87 9.25 -1.62 
Explosives DMNB Test 4 6 4 0 0 0 0 0 0 0 0 2.322 -0.484 1.699 1.566 1.82 7.30 9.24 1.94 
Explosives MHN Test 12 6 18 0 0 0 0 0 0 0 0 3.700 -0.198 2.301 0.031 5.16 14.55 15.98 1.43 
Explosives TMETN Test 6 5 9 0 0 0 0 0 0 0 0 2.807 -0.288 1.438 0.412 3.08 11.78 11.15 -0.63 
Explosives TNT Test 6 7 6 0 0 0 1 0 0 0 1 3.700 -0.428 2.359 1.999 1.79 12.25 9.96 -2.29 
Drugs 6-MAM Test 2 19 4 0 0 1 4 0 1 3 1 3.170 -0.342 2.339 1.766 0.50 4.45 6.28 1.83 
Drugs AICAR Test 1 9 5 0 0 2 0 0 0 0 0 2.807 5.194 -1.404 -2.913 -2.49 1.42 2.76 1.34 
Drugs Andarine Test 4 19 6 0 0 0 2 0 0 0 2 4.087 1.004 2.447 2.315 3.26 12.40 12.21 -0.19 
Drugs Bumetanide Test 3 17 5 0 0 0 2 0 0 0 2 4.000 1.815 1.763 2.960 0.21 6.28 7.79 1.51 
Drugs Butizide Test 4 11 4 0 0 0 2 0 0 0 1 3.459 2.109 0.646 1.577 0.78 6.73 5.24 -1.48 
Drugs Carteolol Test 1 16 3 0 0 0 2 0 0 0 1 3.000 1.062 1.306 1.283 -0.58 4.17 5.51 1.34 
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Drugs Chlorthalidone Test 3 14 4 0 0 1 2 0 0 1 2 4.000 1.959 1.638 1.507 0.41 4.91 6.51 1.60 
Drugs Etacr. acid Test 3 13 4 0 0 0 1 0 0 0 1 3.322 -0.198 3.010 4.152 -0.24 7.31 8.82 1.52 
Drugs Fenbutrazate Test 1 23 3 0 0 0 3 0 0 0 2 3.807 -0.843 3.313 4.455 4.45 17.61 14.92 -2.69 
Drugs Fenetylline Test 2 18 2 0 0 1 2 0 0 1 1 3.807 -0.277 2.444 1.785 -0.07 9.46 8.30 -1.15 
Drugs Fenfluramine Test 0 12 0 0 0 0 1 0 0 0 1 2.807 -0.229 3.790 3.358 0.48 9.29 9.76 0.46 
Drugs Fluticasone prop. Test 5 25 5 0 0 1 3 0 0 1 0 2.585 -0.334 3.412 3.947 3.71 16.21 14.45 -1.76 
Drugs Formoterol Test 1 19 4 0 0 0 2 0 0 0 2 3.807 1.736 1.659 1.929 -0.41 7.71 7.47 -0.24 
Drugs FPCAM Test 5 24 6 0 0 1 3 0 0 1 0 2.585 0.208 3.146 2.999 -1.11 10.79 9.88 -0.91 
Drugs Mefenorex Test 0 12 0 0 0 0 1 0 0 0 1 2.807 -0.305 3.390 2.793 0.98 8.50 9.72 1.22 
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Explosive 1,2-DNB Training 1.619 1.60 -3.12 0.000 1.750 2.515 0.038 7.96 7.30 -0.66 6.85 -1.11 7.15 -0.81 
Explosive 1,2-DNG Training -0.418 0.86 -1.07 0.000 1.423 2.602 0.447 4.42 4.46 0.04 5.47 1.06 6.22 1.81 
Explosive 1,3-DNB Training 1.619 1.55 -3.12 0.000 1.750 2.482 0.331 9.04 8.42 -0.62 7.00 -2.04 7.80 -1.24 
Explosive 1,3-DNG Training -0.418 0.97 -1.07 0.000 1.423 2.466 0.243 4.02 4.15 0.14 5.17 1.16 5.54 1.53 
Explosive 1-MNG Training -0.913 -0.43 -0.40 0.000 1.226 2.183 0.200 1.85 1.87 0.02 3.39 1.54 4.00 2.15 
Explosive 2,4-DA-6-NT Training 0.717 0.92 -2.41 0.000 1.215 2.657 0.068 3.66 4.98 1.32 5.78 2.13 6.46 2.81 
Explosive 2,6-DA-4-NT Training 0.717 0.92 -2.41 0.000 1.215 2.694 0.071 3.16 5.00 1.84 5.84 2.68 6.53 3.37 
Explosive 2,6-DNT Training 2.105 2.10 -3.47 0.000 1.382 2.843 0.232 11.04 9.36 -1.68 7.80 -3.24 8.04 -3.00 
Explosive 2-Am-4,6-DNT Training 1.358 1.88 -2.98 -1.000 1.215 2.695 0.508 10.67 8.72 -1.95 7.84 -2.84 7.62 -3.06 
Explosive 3,5-DNA Training 0.872 1.63 -2.62 0.000 1.459 2.642 0.327 9.26 7.29 -1.98 6.68 -2.58 7.58 -1.68 
Explosive 4-Am-2,6-DNT Training 1.358 1.88 -2.98 -1.000 1.215 2.907 0.261 10.33 7.93 -2.40 7.97 -2.36 7.33 -3.01 
Explosive 4-NT Training 2.211 2.45 -3.47 0.000 1.339 2.617 0.062 10.47 9.48 -0.99 7.55 -2.92 7.23 -3.24 
Explosive DADP Training 1.911 1.23 -2.34 0.000 2.774 2.331 0.032 8.43 7.67 -0.76 7.17 -1.26 6.22 -2.21 
Explosive DEDPU Training 3.632 3.26 -4.92 0.000 2.691 3.140 0.094 14.81 13.62 -1.19 10.71 -4.10 10.49 -4.31 
Explosive DMDPU Training 2.935 2.55 -4.43 -0.281 2.587 2.942 0.067 12.44 11.53 -0.91 9.69 -2.75 9.57 -2.86 
Explosive EGDN Training 0.093 1.51 -1.29 0.000 1.571 2.061 0.303 5.44 5.50 0.06 5.30 -0.15 5.25 -0.19 
Explosive ETN Training 0.062 3.21 -2.36 0.000 2.289 3.515 0.685 11.60 11.32 -0.28 9.54 -2.06 10.81 -0.79 
Explosive HMDD Training 1.738 0.00 -1.59 0.000 2.626 2.898 0.010 4.43 5.75 1.32 7.01 2.58 5.67 1.24 
Explosive HMTA Training 0.086 0.98 -2.34 0.000 3.024 2.878 0.003 1.52 5.53 4.01 7.19 5.67 8.49 6.97 
Explosive HMTD Training 2.558 0.13 -1.71 -1.122 2.925 3.053 0.025 2.80 6.42 3.63 8.75 5.95 5.21 2.41 
Explosive HND Training 2.747 4.44 -4.37 0.707 2.737 3.524 0.918 15.57 15.39 -0.18 11.77 -3.80 13.40 -2.17 
Explosive MHN Training 0.031 5.16 -3.53 0.410 2.843 3.532 0.803 14.55 14.55 0.00 11.09 -3.46 13.89 -0.66 
Explosive NM Training 0.291 0.10 -0.80 0.000 0.965 0.083 0.000 1.85 0.93 -0.92 0.70 -1.15 0.03 -1.82 
Explosive PA Training 1.246 -1.40 -2.77 -0.882 1.527 3.019 0.937 4.96 4.25 -0.70 6.71 1.76 8.77 3.81 
Explosive PETN Training -0.184 3.64 -2.76 0.000 2.483 3.549 0.610 12.39 12.04 -0.35 9.87 -2.52 11.70 -0.69 
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Explosive PGDN Training 0.471 1.87 -1.81 0.000 1.618 2.408 0.315 7.50 6.92 -0.59 6.32 -1.18 6.40 -1.10 
Explosive PYX Training 4.013 7.04 -5.50 2.209 2.950 3.553 0.583 16.90 16.60 -0.30 12.97 -3.93 14.73 -2.17 
Explosive RDX Training 0.623 -1.20 -2.63 -0.878 2.156 2.943 1.177 5.95 6.08 0.13 7.08 1.13 10.03 4.08 
Explosive R-Salt Training -0.325 -1.18 -0.60 0.000 1.918 2.552 0.598 3.54 2.80 -0.74 4.62 1.08 5.85 2.31 
Explosive TATB Training -0.727 2.93 -1.33 -0.517 2.335 3.076 1.972 9.40 10.67 1.27 9.64 0.24 12.01 2.60 
Explosive TATP Training 2.867 2.16 -3.00 -0.931 3.359 2.335 0.079 11.99 10.31 -1.68 9.40 -2.59 6.79 -5.20 
Explosive Tetryl Training 1.762 1.25 -3.88 0.000 1.820 3.488 1.203 11.83 10.47 -1.36 9.25 -2.58 12.48 0.66 
Explosive TMETN Training 0.412 3.08 -2.67 -0.721 2.242 3.313 0.436 11.78 9.99 -1.80 9.60 -2.18 9.71 -2.07 
Explosive TNT Training 1.999 1.79 -3.59 -0.882 1.608 3.045 0.694 12.25 10.04 -2.21 9.04 -3.21 9.42 -2.82 
Drug 6-MAM Training 1.766 0.50 -3.57 0.490 1.822 3.249 0.126 4.45 7.44 2.99 7.19 2.74 9.19 4.74 
Drug Acebutolol Training 1.615 -0.73 -2.82 0.133 2.238 3.255 0.039 6.38 5.37 -1.01 6.79 0.41 7.68 1.30 
Drug Acetazolamide Training -1.206 -0.58 0.35 0.000 0.711 2.481 0.155 2.15 2.56 0.41 3.13 0.98 9.16 7.01 
Drug AICAR Training -2.913 -2.49 0.17 -0.519 1.243 2.963 0.119 1.42 1.59 0.17 2.64 1.22 9.46 8.04 
Drug Alprenolol Training 2.640 0.34 -3.60 -0.298 2.023 3.240 0.060 11.41 7.37 -4.05 8.14 -3.28 8.96 -2.45 
Drug Altizide Training 1.486 1.08 -1.80 0.000 1.256 3.753 0.478 6.87 6.04 -0.83 8.24 1.37 8.36 1.49 
Drug Amiloride Training -0.077 -0.92 -1.39 -0.970 1.055 2.941 0.231 3.63 2.59 -1.04 5.30 1.67 7.82 4.19 
Drug Aminoglutethimide Training 1.285 1.27 -2.61 -0.457 1.675 2.879 0.117 4.99 6.34 1.35 7.33 2.34 8.56 3.57 
Drug Anastrazole Training 2.966 2.68 -4.03 0.000 2.157 3.312 0.137 8.02 11.97 3.95 9.85 1.83 7.62 -0.40 
Drug Andarine Training 2.315 3.26 -3.68 0.891 1.690 3.377 0.070 12.40 12.39 -0.01 8.95 -3.44 7.93 -4.47 
Drug Beclomethasone Training 1.905 2.25 -3.19 0.965 2.396 3.281 0.149 11.52 11.86 0.34 8.49 -3.03 9.54 -1.98 
Drug Bendroflumethiazide Training 2.179 1.48 -2.81 0.240 1.727 3.645 0.442 8.50 8.97 0.46 8.90 0.39 8.24 -0.27 
Drug Benzoylecgonine Training 1.868 -0.21 -3.40 0.000 2.002 3.187 0.086 4.05 6.07 2.03 7.13 3.09 8.47 4.42 
Drug Betaxolol Training 2.577 0.43 -3.22 0.000 2.525 3.288 0.051 11.60 8.42 -3.18 8.37 -3.23 7.85 -3.75 
Drug Bisoprolol Training 2.031 -0.22 -2.83 0.000 2.757 3.274 0.046 9.59 7.22 -2.37 7.83 -1.76 8.35 -1.25 
Drug Budesonide Training 2.132 3.02 -3.24 1.115 2.750 3.337 0.084 15.29 13.81 -1.48 9.28 -6.01 9.84 -5.45 
Drug Bumetanide (-) Training 2.960 0.21 -2.99 0.230 1.746 3.390 0.248 6.25 7.42 1.17 7.95 1.70 6.61 0.36 
Drug Bunolol Training 2.358 0.15 -3.55 0.000 2.233 3.264 0.035 7.59 7.38 -0.21 7.85 0.26 7.61 0.02 
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Drug Carphedon Training 0.254 0.31 -2.07 -0.683 1.629 2.808 0.114 5.16 3.67 -1.50 6.22 1.06 6.53 1.36 
Drug Carvedilol Training 4.015 2.67 -3.43 1.369 2.476 3.479 0.050 13.30 14.89 1.59 9.76 -3.54 5.95 -7.35 
Drug Chlorexolone Training 2.348 1.49 -3.20 0.000 1.782 3.450 0.126 9.74 8.58 -1.17 8.67 -1.07 6.25 -3.49 
Drug Chlorothiazide Training 0.450 -0.10 -1.42 -0.543 0.935 3.202 1.129 2.08 3.19 1.12 6.79 4.71 8.29 6.22 
Drug Chlorthalidone Training 1.507 0.41 -2.87 0.109 1.456 3.363 0.289 4.91 5.99 1.08 7.25 2.34 10.64 5.73 
Drug Clobenzorex Training 4.314 2.89 -5.64 -0.266 2.307 3.234 0.090 12.70 13.68 0.98 10.89 -1.81 10.74 -1.96 
Drug Clopamide Training 2.318 1.75 -3.24 0.000 1.865 3.406 0.093 6.01 9.02 3.01 8.79 2.79 10.30 4.29 
Drug Cyclopenthiazide Training 2.118 1.51 -2.41 0.000 1.918 3.663 0.430 9.61 8.77 -0.84 9.18 -0.43 5.41 -4.20 
Drug Danazol Training 4.875 4.33 -5.38 0.738 2.431 3.201 0.079 16.65 15.50 -1.15 11.36 -5.29 9.02 -7.64 
Drug Desonide Training 0.962 2.79 -3.04 1.106 2.623 3.306 0.095 12.50 12.14 -0.36 8.44 -4.06 10.24 -2.26 
Drug Diacetolol Training 0.492 -1.40 -2.34 0.084 2.012 3.253 0.052 3.62 3.29 -0.32 5.68 2.07 2.94 -0.68 
Drug Dichlorphenamide Training 0.815 0.89 -1.43 -0.940 1.364 3.312 0.956 4.19 5.50 1.31 8.21 4.02 7.45 3.26 
Drug Esmolol Training 1.978 -0.42 -3.07 -0.004 2.233 3.251 0.069 8.36 6.14 -2.22 7.29 -1.07 6.76 -1.60 
Drug Etacr. acid  Training 4.152 -0.24 -4.24 -0.470 1.150 3.305 0.559 7.31 7.90 0.59 8.49 1.18 7.83 0.52 
Drug Etamivan Training 1.658 1.44 -2.94 -0.788 1.928 2.899 0.097 5.75 7.10 1.35 8.08 2.33 7.27 1.51 
Drug Famprofazone Training 4.847 1.18 -5.62 0.883 2.804 3.426 0.063 17.86 15.37 -2.49 9.92 -7.94 11.29 -6.57 
Drug Fencamfamin Training 3.086 0.39 -4.75 -0.570 2.394 2.854 0.078 10.22 9.12 -1.10 8.36 -1.86 9.27 -0.95 
Drug Fenetylline Training 1.785 -0.07 -3.67 0.643 2.065 3.356 0.053 9.46 7.28 -2.18 7.04 -2.42 9.51 0.06 
Drug Fludrocortisone Training 1.346 1.54 -2.96 0.780 2.593 3.193 0.099 9.59 10.00 0.41 7.87 -1.72 9.32 -0.27 
Drug Flumethasone Training 1.480 1.74 -3.19 1.056 2.327 3.243 0.125 11.13 10.69 -0.44 7.78 -3.36 9.66 -1.47 
Drug FPCAM Training 2.999 -1.11 -4.38 1.256 2.437 3.337 0.131 10.79 10.27 -0.52 6.90 -3.89 10.36 -0.43 
Drug Fulvestrant Training 8.412 7.56 -7.30 2.108 3.542 3.598 0.074 18.08 17.49 -0.59 15.68 -2.40 8.68 -9.40 
Drug Furosemide Training 1.714 -0.74 -1.66 0.000 0.886 3.434 0.378 3.36 3.16 -0.21 6.35 2.98 9.68 6.32 
Drug Gestrinone Training 4.132 3.26 -5.10 0.549 2.234 3.172 0.072 14.00 14.08 0.08 10.26 -3.74 5.04 -8.96 
Drug Hydroflumeth. Training 0.316 0.23 -1.15 -0.300 1.098 3.186 0.696 2.63 3.70 1.07 6.50 3.87 6.99 4.36 
Drug Labetalol Training 2.330 0.53 -3.90 0.189 1.975 3.273 0.069 9.84 7.95 -1.89 7.82 -2.02 8.30 -1.54 
Drug Mefruside Training 1.528 1.67 -1.74 0.000 1.876 3.668 0.400 9.61 7.96 -1.65 8.90 -0.71 7.74 -1.87 
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Drug Methylprednisolone Training 1.446 1.97 -2.98 0.901 2.558 3.267 0.086 11.44 10.88 -0.56 8.18 -3.26 9.44 -2.00 
Drug Metoprolol Training 1.757 -0.59 -2.88 -0.122 2.289 3.205 0.057 7.27 5.52 -1.75 7.11 -0.16 8.85 1.58 
Drug Nadoxolol Training 1.369 1.63 -3.20 -0.295 1.626 3.163 0.070 9.26 7.28 -1.98 7.90 -1.36 8.42 -0.84 
Drug Nikethamide Training 0.791 0.54 -2.25 0.000 1.823 2.899 0.082 3.61 4.99 1.38 6.41 2.80 7.00 3.38 
Drug Norfenfluramine Training 2.577 0.18 -4.48 -1.000 1.549 2.685 0.118 8.60 7.01 -1.59 7.40 -1.20 8.14 -0.46 
Drug Ostarine Training 2.315 3.26 -3.68 0.891 1.690 3.377 0.070 13.34 12.39 -0.95 8.95 -4.39 7.75 -5.59 
Drug Oxprenolol Training 2.232 -0.15 -3.06 -0.247 2.070 3.248 0.059 9.46 6.11 -3.35 7.61 -1.85 7.84 -1.62 
Drug Oxymorphone Training 0.778 0.34 -2.37 0.094 1.771 3.126 0.181 2.94 5.23 2.29 6.62 3.68 7.75 4.81 
Drug Pemoline Training 1.336 0.50 -2.41 -1.033 1.201 2.617 0.148 3.15 5.10 1.95 6.52 3.38 5.55 2.40 
Drug Pentazocine Training 4.348 1.89 -5.01 0.000 2.435 3.098 0.076 8.59 13.02 4.43 9.92 1.32 9.60 1.01 
Drug Pentetrazol Training 0.918 0.22 -2.90 0.000 1.899 2.376 0.008 2.86 4.23 1.37 5.52 2.66 6.99 4.13 
Drug Phendimetrazine Training 1.998 1.28 -3.07 -1.000 2.137 2.891 0.073 6.32 7.28 0.96 8.43 2.10 7.19 0.87 
Drug Phenmetrazine Training 1.462 0.09 -2.79 -1.107 1.848 2.779 0.070 5.19 4.69 -0.50 7.09 1.90 6.53 1.34 
Drug Pindolol Training 1.926 -0.65 -2.54 -0.260 1.753 3.193 0.050 4.86 4.51 -0.35 6.78 1.92 7.69 2.83 
Drug Piretanide Training 2.446 0.07 -2.60 0.335 1.705 3.514 0.349 5.12 6.72 1.60 7.76 2.64 7.87 2.75 
Drug Prenylamine Training 5.711 2.60 -6.71 0.561 3.077 3.429 0.075 15.88 16.68 0.80 11.75 -4.13 12.62 -3.26 
Drug Propylhexedrine Training 2.739 -0.30 -3.73 0.000 3.186 2.747 0.049 8.76 9.15 0.39 7.70 -1.07 8.56 -0.20 
Drug Salmeterol Training 4.226 1.62 -4.10 1.290 2.912 3.408 0.053 15.58 15.40 -0.18 9.54 -6.05 8.23 -7.35 
Drug Sotalol Training 0.967 -1.97 -1.94 -0.208 1.845 3.130 0.060 2.91 2.86 -0.05 5.41 2.50 7.59 4.68 
Drug Tapentadol Training 3.441 0.28 -4.27 -0.790 2.437 2.902 0.096 7.33 9.26 1.92 8.69 1.36 8.28 0.94 
Drug Testolactone Training 3.123 3.07 -4.71 0.276 2.560 3.172 0.085 9.17 13.11 3.94 10.08 0.91 8.71 -0.46 
Drug Timolol Training 1.128 -0.71 -2.45 -0.006 2.542 3.328 0.158 7.95 5.64 -2.31 7.08 -0.86 7.61 -0.33 
Drug Tramadol Training 2.701 0.17 -3.55 -0.100 2.555 3.035 0.086 7.12 8.49 1.37 8.02 0.90 8.31 1.19 
Drug Triamcinolone Training 0.356 0.92 -2.10 0.956 2.217 3.204 0.124 7.24 7.42 0.18 6.57 -0.66 8.50 1.26 
Drug Trichlormethiazide Training 1.364 0.55 -1.59 -0.149 1.000 3.753 0.721 4.92 4.56 -0.36 7.94 3.02 8.32 3.40 
Drug Xipamide Training 2.812 1.15 -3.61 0.000 1.302 3.424 0.195 5.01 8.12 3.11 8.36 3.35 10.58 5.57 
Explosive 2,4-DNT Select 2.105 2.10 -3.47 0.000 1.382 2.693 0.518 11.21 10.10 -1.11 7.80 -3.41 8.52 -2.69 
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Explosive 3,4-DNT Select 2.105 2.15 -3.47 0.000 1.382 2.673 0.148 10.13 9.18 -0.96 7.50 -2.63 7.60 -2.54 
Explosive DMNB Select 1.566 1.82 -2.93 0.000 2.626 2.714 0.000 7.30 8.22 0.92 7.89 0.59 7.84 0.53 
Explosive HMX Select 0.831 -1.71 -3.59 -0.055 2.571 3.468 0.863 4.64 7.82 3.18 7.25 2.62 12.08 7.44 
Explosive NB Select 1.724 1.81 -3.12 0.000 1.801 2.397 0.010 8.00 7.56 -0.43 6.86 -1.13 6.90 -1.10 
Explosive TNB Select 1.513 1.36 -3.24 -0.882 1.918 2.984 0.844 9.81 9.48 -0.33 8.77 -1.04 9.71 -0.10 
Drug Atenolol Select 0.669 -2.19 -2.15 -0.085 1.855 3.225 0.057 2.73 2.70 -0.03 5.21 2.48 7.66 4.93 
Drug Benzthiazide Select 2.498 0.99 -3.02 0.298 1.651 3.755 0.330 9.39 8.22 -1.18 8.74 -0.65 13.59 4.20 
Drug Bumetanide (+) Select 2.960 0.21 -2.99 0.230 1.746 3.390 0.248 6.28 7.42 1.14 7.95 1.67 7.63 1.34 
Drug Bupropion Select 3.227 2.69 -4.45 -0.769 2.121 3.115 0.133 9.54 11.85 2.31 10.22 0.68 9.19 -0.35 
Drug Butizide Select 1.577 0.78 -1.88 0.000 1.601 3.485 0.525 6.73 6.37 -0.36 7.99 1.26 9.70 2.97 
Drug Carteolol Select 1.283 -0.58 -2.54 0.000 2.074 3.284 0.046 4.17 4.71 0.54 6.73 2.56 8.45 4.28 
Drug Desacetyl deflazacort Select 1.224 1.84 -3.15 1.104 2.350 3.254 0.097 10.85 10.60 -0.25 7.69 -3.16 9.80 -1.05 
Drug Efaproxiral Select 3.858 0.38 -4.36 0.418 2.153 3.321 0.057 7.28 10.31 3.03 8.52 1.23 9.46 2.18 
Drug Epitizide Select 1.876 1.01 -2.01 0.000 1.210 3.753 0.586 6.68 6.23 -0.45 8.45 1.77 7.66 0.99 
Drug Fenbutrazate Select 4.455 4.45 -4.54 0.905 2.771 3.424 0.073 17.61 16.48 -1.13 11.65 -5.96 10.33 -7.28 
Drug Fenfluramine Select 3.358 0.48 -5.02 -0.788 1.963 2.984 0.086 9.29 9.11 -0.19 8.60 -0.69 9.24 -0.05 
Drug Hydrochloroth. Select 0.038 0.00 -0.68 -0.543 1.040 3.212 0.894 2.13 2.86 0.73 6.50 4.38 6.09 3.97 
Drug Mefenorex Select 2.793 0.98 -4.62 -1.000 2.070 2.944 0.118 8.50 8.94 0.44 8.81 0.31 9.11 0.61 
Drug Polythiazide Select 2.412 1.59 -2.28 0.000 1.356 3.754 0.434 8.84 7.86 -0.98 9.08 0.24 11.80 2.97 
Drug Probenecid Select 2.821 0.13 -3.21 -0.011 2.034 3.155 0.170 5.30 7.65 2.35 7.82 2.52 8.08 2.78 
Drug Strychnine Select 1.146 0.21 -4.13 0.938 1.981 3.374 0.149 8.14 8.05 -0.09 6.79 -1.35 11.09 2.94 
Explosive 2-NT Test 2.211 2.45 -3.47 0.000 1.339 2.467 0.017 10.29 9.27 -1.02 7.28 -3.01 6.90 -3.39 
Explosive 3-NT Test 2.211 2.45 -3.47 0.000 1.339 2.427 0.077 10.87 9.48 -1.39 7.27 -3.60 6.99 -3.88 
Explosive DPA Test 3.380 3.12 -4.62 -1.000 2.852 2.617 0.092 13.97 12.03 -1.94 10.48 -3.48 9.05 -4.92 
Explosive NG Test 0.078 2.41 -1.81 -0.982 1.931 3.111 0.581 8.97 8.09 -0.87 8.70 -0.26 8.20 -0.77 
Explosive NQ Test -0.532 -2.56 -0.31 0.000 0.614 1.711 0.000 1.49 1.01 -0.49 0.87 -0.62 1.62 0.13 
Explosive SHN Test 0.031 5.16 -3.53 0.410 2.843 3.532 0.779 14.55 14.54 -0.01 11.08 -3.48 13.83 -0.72 
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Explosive TEGDN Test -0.169 1.46 -1.58 -0.934 2.590 3.132 0.111 7.61 4.92 -2.69 8.10 0.49 7.36 -0.25 
Drug Bambuterol Test 1.727 -0.93 -2.26 0.000 2.587 3.434 0.048 8.41 5.63 -2.79 7.32 -1.10 8.16 -0.26 
Drug Beta\dexameth. Test 1.642 1.92 -3.08 0.972 2.396 3.213 0.108 10.89 10.91 0.02 8.01 -2.89 9.32 -1.57 
Drug Canrenone Test 3.379 2.50 -5.38 0.762 2.762 3.224 0.067 14.71 13.91 -0.80 9.78 -4.92 8.70 -6.01 
Drug Celiprolol Test 1.597 -0.41 -2.93 0.377 2.638 3.318 0.031 7.66 6.89 -0.77 7.22 -0.44 6.55 -1.12 
Drug Clobetasol Test 2.845 2.74 -4.09 0.866 2.340 3.380 0.129 12.94 13.35 0.41 9.47 -3.47 10.30 -2.64 
Drug Deflazacort Test 1.603 2.43 -3.53 1.291 2.498 3.413 0.083 13.62 12.70 -0.92 8.49 -5.13 10.60 -3.02 
Drug Fluticasone prop. Test 3.947 3.71 -4.64 1.363 2.495 3.441 0.144 16.21 16.09 -0.12 10.51 -5.69 10.97 -5.24 
Drug Formoterol Test 1.929 -0.41 -2.89 0.464 1.932 3.242 0.074 7.71 5.97 -1.73 6.69 -1.02 6.98 -0.73 
Drug Isometheptene Test 2.405 -0.03 -3.68 0.000 2.465 2.609 0.046 6.99 7.41 0.42 6.94 -0.05 7.96 0.97 
Drug Oxycodone Test 1.029 0.15 -2.61 0.456 2.024 3.128 0.131 4.60 6.02 1.41 6.54 1.94 8.18 3.58 
Drug Pethidine Test 2.446 1.56 -3.75 -0.245 2.339 3.023 0.103 8.41 9.54 1.13 8.72 0.31 8.77 0.36 
Drug Prolintane Test 4.043 1.36 -4.75 -0.691 2.776 2.970 0.079 9.25 12.07 2.82 9.97 0.72 9.11 -0.14 
Drug Propranolol Test 2.540 0.81 -3.76 -0.087 2.158 3.225 0.045 11.61 8.36 -3.24 8.32 -3.29 7.59 -4.02 
Drug Terbutaline Test 1.254 -1.94 -2.36 -0.724 1.887 2.856 0.071 2.83 2.85 0.02 5.57 2.74 8.11 5.28 





























Explosives 1,2-DNB Training 1.6 3.557 0.000 0.144 0.000 12 0.000 0 0.000 40 0.000 7.96 8.54 0.58 8.16 0.20 
Explosives 1,3-DNB Training 1.55 3.557 0.000 0.096 0.000 8 0.000 0 0.000 30 0.000 9.04 9.42 0.38 8.87 -0.17 
Explosives 1,3-DNG Training 0.97 0.027 0.000 0.130 0.602 8 0.000 1 0.000 14 0.000 4.02 5.57 1.55 6.60 2.58 
Explosives 2,4-DA-6-NT Training 0.92 1.395 0.000 0.086 0.000 8 0.000 4 0.000 54 0.000 3.66 6.78 3.12 6.53 2.87 
Explosives 2-Am-4,6-DNT Training 1.88 3.055 0.000 0.086 0.000 40 0.000 2 0.000 92 0.837 10.67 8.96 -1.71 8.63 -2.04 
Explosives 3,4-DNT Training 2.15 5.014 0.000 0.113 0.000 24 0.000 0 0.000 66 2.328 10.13 9.21 -0.93 9.38 -0.75 
Explosives 3-NT Training 2.45 5.02 0.000 0.129 0.000 0 0.000 0 0.000 13 0.000 10.87 10.99 0.12 9.86 -1.01 
Explosives 4-Am-2,6-DNT Training 1.88 3.055 0.000 0.083 0.000 40 0.000 2 0.000 108 0.000 10.33 9.61 -0.72 8.82 -1.51 
Explosives 4-NT Training 2.45 5.02 0.000 0.160 0.000 0 0.000 0 0.000 10 2.768 10.47 8.74 -1.74 9.00 -1.47 
Explosives DADP Training 1.23 1.225 0.000 0.209 0.000 0 0.000 0 0.000 4 0.000 8.43 5.46 -2.98 5.98 -2.45 
Explosives DEDPU Training 3.26 13.651 2.157 0.103 2.398 636 0.780 0 0.000 270 0.794 14.81 14.58 -0.23 13.79 -1.02 
Explosives DMDPU Training 2.55 10.254 2.495 0.096 2.197 472 0.682 0 0.000 188 1.039 12.44 12.41 -0.03 12.31 -0.13 
Explosives DMNB Training 1.82 2.887 0.000 0.210 0.000 0 0.000 0 0.000 16 0.000 7.30 7.29 -0.01 7.17 -0.13 
Explosives DPA Training 3.12 11.526 1.095 0.210 0.693 136 0.000 1 0.000 44 0.000 13.97 13.00 -0.97 11.22 -2.75 
Explosives EGDN Training 1.51 0.003 0.000 0.137 0.000 0 0.000 0 0.000 6 0.700 5.44 5.97 0.53 7.02 1.58 
Explosives HMDD Training 0 0.129 0.000 0.250 0.000 60 0.000 0 0.000 28 0.000 4.43 2.45 -1.98 3.57 -0.86 
Explosives HMTA Training 0.98 1.225 0.000 0.335 0.000 0 0.000 0 0.000 72 0.000 1.52 3.41 1.89 3.76 2.24 
Explosives HMTD Training 0.13 0.226 0.000 0.223 0.000 138 0.000 0 0.000 42 0.000 2.80 3.07 0.27 4.16 1.36 
Explosives HMX Training -1.71 5.556 0.000 0.177 0.976 384 0.443 0 0.000 248 0.260 4.64 3.26 -1.38 4.22 -0.42 
Explosives HND Training 4.44 9.868 5.059 0.114 2.812 2992 0.623 1 0.004 1300 0.739 15.57 15.24 -0.33 14.47 -1.10 
Explosives MHN Training 5.16 5.296 7.066 0.044 2.528 788 0.835 0 0.006 702 0.983 14.55 15.56 1.01 14.73 0.18 
Explosives NB Training 1.81 3.562 0.000 0.129 0.000 0 0.000 0 0.000 4 0.000 8.00 9.18 1.18 8.66 0.66 
Explosives NG Training 2.41 0.331 0.000 0.089 0.602 20 0.000 0 0.000 50 0.447 8.97 8.51 -0.47 9.35 0.38 
Explosives NM Training 0.1 0.187 0.000 0.334 0.000 0 0.000 0 0.000 0 0.000 1.85 1.74 -0.11 2.50 0.65 
Table A. 5: Molecular descriptors and predicted retention times for best network and ensemble following genetic algorithm feature selection. 
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Explosives NQ Training -2.56 0.837 0.000 0.148 0.000 0 0.000 4 0.000 0 0.000 1.49 0.32 -1.17 1.33 -0.16 
Explosives PA Training -1.4 2.38 0.000 0.101 0.000 96 0.000 1 0.000 160 0.000 4.96 3.68 -1.28 4.52 -0.44 
Explosives PETN Training 3.64 2.355 0.000 0.072 1.785 144 0.559 0 0.000 168 0.000 12.39 10.85 -1.54 11.63 -0.76 
Explosives PGDN Training 1.87 0.331 0.000 0.130 0.000 0 0.000 0 0.000 18 0.608 7.50 6.88 -0.62 7.69 0.19 
Explosives RDX Training -1.2 1.963 0.000 0.183 0.000 72 0.000 0 0.000 96 0.000 5.95 2.63 -3.32 3.68 -2.27 
Explosives R-Salt Training -1.18 0.403 0.000 0.235 0.000 18 0.000 0 0.000 36 0.000 3.54 1.10 -2.44 2.51 -1.03 
Explosives SHN Training 5.16 5.296 4.133 0.045 2.528 788 0.835 0 0.006 702 0.983 14.55 14.89 0.34 14.38 -0.17 
Explosives TEGDN Training 1.46 0.12 9.367 0.108 1.383 52 0.080 0 0.008 18 0.982 7.61 9.21 1.60 8.99 1.38 
Explosives Tetryl Training 1.25 7.045 0.000 0.113 0.602 360 0.220 0 0.000 362 0.269 11.83 9.87 -1.97 9.28 -2.55 
Explosives TMETN Training 3.08 2.067 0.000 0.092 1.247 60 0.000 0 0.000 84 0.000 11.78 10.59 -1.19 10.97 -0.81 
Explosives TNB Training 1.36 4.022 0.000 0.069 0.000 72 0.000 0 0.000 96 0.000 9.81 9.96 0.15 9.21 -0.60 
Explosives TNT Training 1.79 5.563 0.000 0.083 0.000 96 0.000 0 0.000 160 0.331 12.25 10.94 -1.31 9.90 -2.36 
Drugs Acebutolol Training -0.73 2.526 15.143 0.080 2.822 590 0.761 3 0.006 347 1.375 6.38 7.20 0.82 7.62 1.24 
Drugs Acetazolamide Training -0.58 2.505 2.238 0.278 0.000 6 0.000 3 0.000 69 1.415 2.15 3.16 1.01 2.73 0.58 
Drugs AICAR Training -2.49 1.97 3.657 0.120 1.107 449 0.109 7 0.000 346 1.123 1.42 2.00 0.58 2.31 0.89 
Drugs Alprenolol Training 0.34 5.619 8.333 0.110 2.371 222 0.676 2 0.012 103 1.638 11.41 8.65 -2.76 8.06 -3.36 
Drugs Altizide Training 1.08 0.323 6.583 0.203 2.517 747 0.501 4 0.010 681 0.973 6.87 6.46 -0.41 6.10 -0.77 
Drugs Amiloride Training -0.92 0.025 1.275 0.133 0.577 76 0.000 8 0.000 130 0.821 3.63 2.61 -1.02 2.66 -0.97 
Drugs Anastrazole Training 2.68 7.813 2.616 0.146 2.578 732 0.754 0 0.000 420 1.490 8.02 10.21 2.19 11.26 3.24 
Drugs Beclomethasone Training 2.25 3.848 10.683 0.135 2.751 5110 0.967 3 0.009 2574 1.319 11.52 10.30 -1.22 10.56 -0.96 
Drugs Benzoylecgonine Training -0.21 4.71 6.634 0.170 2.570 1164 0.608 1 0.012 537 0.622 4.05 7.00 2.95 6.73 2.68 
Drugs Benzthiazide Training 0.99 3.216 12.931 0.169 3.084 1835 0.648 3 0.008 1001 0.930 9.39 7.94 -1.45 8.59 -0.80 
Drugs Beta\dexameth. Training 1.92 3.439 9.534 0.119 2.724 5110 0.966 3 0.009 2574 1.035 10.89 10.02 -0.87 10.20 -0.69 
Drugs Betaxolol Training 0.43 3.964 10.256 0.099 2.772 504 0.799 2 0.008 147 1.334 11.60 8.54 -3.06 8.54 -3.06 
Drugs Bisoprolol Training -0.22 2.545 11.248 0.101 2.859 458 0.764 2 0.010 148 1.061 9.59 7.60 -1.99 7.52 -2.07 
Drugs Budesonide Training 3.02 4.058 25.012 0.103 3.174 7476 1.007 2 0.009 3292 0.989 15.29 14.96 -0.33 14.05 -1.24 
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Drugs Bumetanide Training 0.21 3.108 14.148 0.115 2.967 1105 0.761 4 0.009 598 0.932 6.28 7.83 1.55 7.99 1.71 
Drugs Bunolol Training 0.15 5.397 17.900 0.130 2.638 650 0.761 2 0.014 312 1.654 7.59 8.74 1.15 8.58 0.99 
Drugs Butizide Training 0.78 0.417 5.844 0.182 2.159 624 0.511 4 0.000 673 0.745 6.73 4.26 -2.47 6.02 -0.71 
Drugs Canrenone Training 2.5 17.257 9.204 0.141 2.690 4256 0.932 0 0.008 1734 1.010 14.71 14.94 0.23 13.92 -0.79 
Drugs Carteolol Training -0.58 1.706 15.700 0.127 2.606 642 0.761 3 0.009 305 1.572 4.17 6.99 2.82 6.75 2.58 
Drugs Carvedilol Training 2.67 4.819 18.370 0.105 3.018 3136 0.972 3 0.004 970 0.989 13.30 13.82 0.52 12.66 -0.64 
Drugs Celiprolol Training -0.41 2.876 19.924 0.085 3.106 935 0.802 3 0.008 485 1.415 7.66 8.33 0.67 8.66 1.00 
Drugs Chlorexolone Training 1.49 3.875 6.391 0.187 2.472 1121 0.539 2 0.012 625 0.722 9.74 7.95 -1.79 7.96 -1.78 
Drugs Chlorthalidone Training 0.41 2.681 0.333 0.194 2.347 1439 0.492 4 0.000 858 1.285 4.91 4.46 -0.45 5.61 0.70 
Drugs Clobenzorex Training 2.89 19.458 2.784 0.185 2.601 442 0.518 1 0.006 138 1.208 12.70 12.65 -0.05 12.99 0.29 
Drugs Clopamide Training 1.75 4.034 12.067 0.165 2.952 962 0.586 3 0.012 502 0.623 6.01 8.71 2.70 9.14 3.13 
Drugs Deflazacort Training 2.43 5.312 23.340 0.089 3.264 7576 1.086 1 0.010 3464 0.986 13.62 14.71 1.09 13.88 0.26 
Drugs Desacetyl deflazacort Training 1.84 3.67 13.903 0.107 2.962 6704 0.993 2 0.010 2995 1.067 10.85 11.82 0.97 11.43 0.58 
Drugs Diacetolol Training -1.4 1.229 8.363 0.082 2.557 431 0.730 3 0.006 288 1.525 3.62 5.08 1.46 5.48 1.86 
Drugs Dichlorphenamide Training 0.89 0.039 0.870 0.292 0.000 78 0.000 4 0.000 191 0.611 4.19 3.09 -1.10 3.06 -1.13 
Drugs Efaproxiral Training 0.38 9.766 9.435 0.111 2.915 1148 0.761 2 0.011 592 1.291 7.28 9.24 1.96 9.51 2.23 
Drugs Epitizide Training 1.01 0.613 7.292 0.191 2.507 923 0.331 4 0.009 839 0.981 6.68 6.50 -0.19 6.54 -0.14 
Drugs Esmolol Training -0.42 3.372 13.074 0.097 2.525 386 0.761 2 0.012 125 1.522 8.36 7.96 -0.40 7.46 -0.90 
Drugs Etacr. acid  Training -0.24 9.061 3.865 0.252 1.761 280 0.221 1 0.007 230 1.589 7.31 7.91 0.60 6.41 -0.90 
Drugs Famprofazone Training 1.18 19.259 24.626 0.105 3.280 2378 0.879 0 0.006 1075 0.994 17.86 16.67 -1.19 14.93 -2.93 
Drugs Fenbutrazate Training 4.45 10.976 14.590 0.112 3.058 1933 0.877 0 0.006 606 0.955 17.61 16.88 -0.73 15.47 -2.14 
Drugs Fenetylline Training -0.07 5.972 16.905 0.128 2.807 1762 0.882 1 0.008 779 0.468 9.46 9.69 0.23 9.36 -0.10 
Drugs Fenfluramine Training 0.48 14.367 0.881 0.134 1.375 98 0.288 1 0.000 122 0.896 9.29 10.93 1.64 9.90 0.61 
Drugs Flumethasone Training 1.74 3.848 13.027 0.115 2.754 5828 0.963 3 0.009 2905 1.200 11.13 10.87 -0.26 10.73 -0.40 
Drugs Formoterol Training -0.41 2.753 21.550 0.111 2.889 1227 0.799 4 0.008 391 0.929 7.71 8.39 0.68 8.16 0.45 
Drugs FPCAM Training -1.11 9.9 15.058 0.098 3.090 7218 0.964 2 0.008 3594 1.082 10.79 10.91 0.12 10.19 -0.60 
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Drugs Fulvestrant Training 7.56 36.885 41.129 0.105 3.539 6581 1.232 2 0.006 2507 0.733 18.08 18.65 0.57 20.47 2.39 
Drugs Furosemide Training -0.74 0.189 5.187 0.139 2.418 586 0.302 4 0.010 426 0.843 3.36 5.38 2.02 4.76 1.40 
Drugs Hydrochloroth. Training 0 0.299 0.000 0.225 0.000 270 0.000 4 0.000 341 0.821 2.13 2.56 0.43 2.99 0.86 
Drugs Hydroflumeth. Training 0.23 0.006 0.000 0.153 0.000 603 0.061 4 0.000 566 0.710 2.63 3.32 0.69 4.21 1.58 
Drugs Isometheptene Training -0.03 5.983 0.603 0.129 0.000 0 0.000 1 0.000 5 2.000 6.99 6.97 -0.02 6.68 -0.31 
Drugs Mefenorex Training 0.98 11.489 0.044 0.165 1.868 74 0.142 1 0.012 42 1.570 8.50 9.10 0.60 8.80 0.30 
Drugs Mefruside Training 1.67 0.257 7.805 0.179 2.658 971 0.623 2 0.010 685 0.705 9.61 7.42 -2.19 7.75 -1.86 
Drugs Methylprednisolone Training 1.97 3.051 14.854 0.117 2.677 4367 0.956 3 0.011 2176 1.003 11.44 10.70 -0.74 10.54 -0.90 
Drugs Metoprolol Training -0.59 2.732 6.922 0.103 2.397 272 0.761 2 0.011 95 1.497 7.27 7.07 -0.20 6.30 -0.97 
Drugs Nikethamide Training 0.54 1.041 0.001 0.156 0.000 48 0.164 0 0.000 38 0.421 3.61 4.52 0.91 5.66 2.05 
Drugs Norfenfluramine Training 0.18 10.54 0.004 0.165 0.000 24 0.000 2 0.000 83 1.271 8.60 8.87 0.27 7.30 -1.30 
Drugs Oxprenolol Training -0.15 3.351 3.473 0.094 2.412 263 0.678 2 0.010 113 1.248 9.46 7.35 -2.11 6.78 -2.68 
Drugs Oxymorphone Training 0.34 1.308 0.553 0.171 0.375 3325 0.640 2 0.000 1627 1.498 2.94 3.46 0.52 5.03 2.09 
Drugs Pentazocine Training 1.89 14.263 5.471 0.122 2.347 1168 0.761 1 0.019 655 1.421 8.59 9.41 0.82 10.75 2.16 
Drugs Pentetrazol Training 0.22 2.776 0.000 0.293 0.000 12 0.000 0 0.000 20 0.000 2.86 3.82 0.96 3.95 1.09 
Drugs Pethidine Training 1.56 6.362 3.045 0.124 1.386 352 0.640 0 0.000 243 1.249 8.41 8.87 0.46 9.44 1.03 
Drugs Piretanide Training 0.07 1.88 4.319 0.114 2.592 1527 0.743 3 0.012 748 1.088 5.12 6.45 1.33 6.35 1.23 
Drugs Polythiazide Training 1.59 1.104 10.946 0.170 2.507 1159 0.494 3 0.009 948 1.020 8.84 7.78 -1.06 8.22 -0.62 
Drugs Prenylamine Training 2.6 29.979 7.451 0.125 3.135 1368 0.799 1 0.001 394 2.155 15.88 16.77 0.89 16.07 0.19 
Drugs Probenecid Training 0.13 3.915 5.937 0.134 1.920 288 0.602 1 0.000 226 0.789 5.30 6.08 0.78 7.38 2.08 
Drugs Prolintane Training 1.36 12.371 5.665 0.142 1.386 231 0.414 0 0.000 105 0.500 9.25 12.52 3.27 11.16 1.91 
Drugs Propranolol Training 0.81 6.42 6.232 0.123 2.427 458 0.626 2 0.009 192 1.718 11.61 8.99 -2.62 8.63 -2.98 
Drugs Salmeterol Training 1.62 8.248 21.373 0.104 2.991 1412 1.034 4 0.004 352 1.053 15.58 13.29 -2.29 12.03 -3.55 
Drugs Tapentadol Training 0.28 9.244 0.586 0.114 1.363 111 0.624 1 0.000 138 1.690 7.33 8.03 0.70 8.18 0.85 
Drugs Testolactone Training 3.07 12.144 0.622 0.152 2.045 2200 0.744 0 0.021 1015 1.351 9.17 9.11 -0.06 10.82 1.65 
Drugs Timolol Training -0.71 1.496 20.367 0.121 2.594 572 0.761 2 0.010 258 1.337 7.95 7.58 -0.37 7.41 -0.54 
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Drugs Tramadol Training 0.17 5.374 4.331 0.117 1.711 492 0.717 1 0.000 315 1.110 7.12 6.59 -0.53 7.65 0.53 
Drugs Triamterene Training 1.1 7.309 3.611 0.142 1.812 861 0.298 6 0.012 406 1.018 6.56 7.94 1.38 7.31 0.75 
Drugs Trichlormethiazide Training 0.55 0.133 0.285 0.253 1.889 622 0.089 4 0.000 580 1.147 4.92 3.67 -1.25 4.32 -0.60 
Explosives 1-MNG Select -0.43 0.684 0.000 0.172 0.000 0 0.000 2 0.000 1 0.000 1.85 3.10 1.25 3.85 2.00 
Explosives 2,4-DNT Select 2.1 5.014 0.000 0.113 0.000 14 0.000 0 0.000 58 0.776 11.21 10.15 -1.06 9.55 -1.66 
Explosives 2,6-DA-4-NT Select 0.92 1.395 0.000 0.086 0.000 8 0.000 4 0.000 44 3.178 3.16 5.83 2.67 6.33 3.17 
Explosives 2-NT Select 2.45 5.02 0.000 0.138 0.000 0 0.000 0 0.000 16 0.000 10.29 10.80 0.51 9.72 -0.57 
Explosives 3,5-DNA Select 1.63 1.945 0.000 0.069 0.000 24 0.000 2 0.000 62 0.000 9.26 8.85 -0.41 8.41 -0.85 
Explosives ETN Select 3.21 1.266 1.525 0.068 1.332 114 0.000 0 0.000 166 0.794 11.60 10.52 -1.08 11.36 -0.24 
Drugs Andarine Select 3.26 5.987 10.773 0.088 3.005 2276 0.799 3 0.009 1008 0.936 12.40 12.42 0.02 12.41 0.01 
Drugs Bambuterol Select -0.93 1.064 33.943 0.099 3.047 796 0.761 2 0.010 491 0.694 8.41 9.65 1.24 9.38 0.97 
Drugs Carphedon Select 0.31 0.701 3.094 0.172 1.425 244 0.047 2 0.000 165 1.355 5.16 4.84 -0.32 5.86 0.70 
Drugs Desonide Select 2.79 3.264 18.304 0.108 3.044 7390 0.993 2 0.010 3439 1.079 12.50 13.56 1.06 12.93 0.43 
Drugs Etamivan Select 1.44 2.934 1.173 0.114 1.363 130 0.193 1 0.000 111 0.880 5.75 7.62 1.87 8.52 2.77 
Drugs Fencamfamin Select 0.39 12.371 0.000 0.177 0.693 425 0.353 1 0.000 259 0.727 10.22 9.61 -0.61 8.23 -1.99 
Drugs Fludrocortisone Select 1.54 2.987 12.545 0.123 2.583 4441 0.945 3 0.011 2227 0.877 9.59 9.70 0.11 9.68 0.09 
Drugs Fluticasone prop. Select 3.71 11.64 23.138 0.088 3.379 8144 1.007 1 0.007 3998 1.135 16.21 16.34 0.13 16.11 -0.10 
Drugs Nadoxolol Select 1.63 3.898 4.570 0.111 2.314 468 0.389 4 0.009 217 0.790 9.26 8.79 -0.48 8.57 -0.69 
Drugs Ostarine Select 3.26 5.987 10.773 0.088 3.005 2276 0.799 3 0.009 1008 0.936 13.34 12.42 -0.92 12.41 -0.93 
Drugs Pemoline Select 0.5 1.391 0.000 0.198 0.000 106 0.000 2 0.000 95 1.163 3.15 4.33 1.18 4.75 1.60 
Drugs Phendimetrazine Select 1.28 3.404 0.887 0.153 0.000 170 0.275 0 0.000 92 0.214 6.32 7.31 0.99 7.36 1.04 
Drugs Propylhexedrine Select -0.3 6.262 0.000 0.158 0.000 16 0.039 1 0.000 17 1.375 8.76 6.37 -2.39 5.94 -2.83 
Drugs Strychnine Select 0.21 8.431 1.484 0.168 1.609 7129 0.817 0 0.000 2406 1.691 8.14 9.69 1.55 8.80 0.66 
Drugs Terbutaline Select -1.94 1.275 9.263 0.147 1.906 116 0.299 4 0.000 141 0.205 2.83 2.70 -0.13 3.92 1.09 
Drugs Triamcinolone Select 0.92 0.75 11.668 0.121 2.649 5110 0.925 4 0.009 2574 0.884 7.24 7.96 0.72 8.38 1.14 
Explosives 1,2-DNG Test 0.86 0.027 0.000 0.124 0.000 4 0.000 1 0.000 20 0.421 4.42 5.26 0.84 6.19 1.77 
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Explosives 2,6-DNT Test 2.1 5.014 0.000 0.105 0.000 12 0.000 0 0.000 68 0.000 11.04 10.92 -0.12 9.82 -1.22 
Explosives PYX Test 7.04 18.199 8.482 0.104 3.682 8868 1.152 2 0.007 3148 0.659 16.90 17.68 0.78 17.90 1.00 
Explosives TATB Test 2.93 0.01 0.000 0.068 0.000 150 0.000 6 0.000 384 0.235 9.40 8.94 -0.46 8.39 -1.01 
Explosives TATP Test 2.16 3.13 0.000 0.111 0.000 120 0.246 0 0.000 96 0.000 11.99 9.38 -2.61 9.00 -3.00 
Drugs 6-MAM Test 0.5 5.473 5.070 0.155 2.127 3581 0.741 1 0.000 1650 1.406 4.45 7.49 3.04 8.42 3.97 
Drugs Aminoglutethimide Test 1.27 1.896 0.134 0.152 0.732 345 0.212 3 0.000 229 1.692 4.99 5.75 0.76 6.42 1.43 
Drugs Atenolol Test -2.19 0.855 6.837 0.115 2.412 258 0.669 4 0.009 130 1.633 2.73 4.63 1.90 3.52 0.79 
Drugs Bendroflumethiazide Test 1.48 2.503 11.010 0.153 2.775 2293 0.762 4 0.010 1289 0.841 8.50 7.98 -0.52 8.45 -0.05 
Drugs Bumetanide Test 0.21 3.108 14.148 0.115 2.967 1105 0.761 4 0.009 598 0.932 6.25 7.83 1.58 7.99 1.74 
Drugs Bupropion Test 2.69 10.356 1.577 0.182 2.043 113 0.452 1 0.000 158 1.229 9.54 10.80 1.26 10.98 1.44 
Drugs Chlorothiazide Test -0.1 0.035 0.000 0.229 0.000 270 0.000 3 0.000 341 0.821 2.08 2.24 0.16 3.00 0.92 
Drugs Clobetasol Test 2.74 8.152 10.348 0.126 2.836 5110 0.966 2 0.009 2574 0.847 12.94 12.85 -0.09 12.46 -0.48 
Drugs Cyclopenthiazide Test 1.51 1.396 7.940 0.192 2.538 1267 0.512 4 0.010 868 0.946 9.61 7.14 -2.47 7.22 -2.39 
Drugs Danazol Test 4.33 17.257 8.778 0.137 2.713 4248 0.977 1 0.009 1647 0.983 16.65 16.39 -0.26 15.31 -1.34 
Drugs Gestrinone Test 3.26 15.002 7.048 0.154 2.470 2558 0.847 1 0.007 1079 1.095 14.00 14.26 0.26 13.45 -0.55 
Drugs Labetalol Test 0.53 7.151 12.048 0.116 2.800 1029 0.741 5 0.004 352 0.761 9.84 9.40 -0.45 9.04 -0.80 
Drugs Oxycodone Test 0.15 1.907 2.814 0.145 0.732 3691 0.746 1 0.000 1757 1.292 4.60 4.68 0.08 6.11 1.51 
Drugs Phenmetrazine Test 0.09 2.446 0.887 0.162 0.000 122 0.000 1 0.000 62 0.280 5.19 5.27 0.08 5.52 0.33 
Drugs Pindolol Test -0.65 1.707 5.411 0.123 2.266 357 0.583 3 0.011 178 1.745 4.86 6.54 1.68 5.38 0.52 
Drugs Sotalol Test -1.97 0.503 6.636 0.128 2.006 168 0.468 3 0.020 170 0.756 2.91 4.92 2.01 3.13 0.22 
Drugs Xipamide Test 1.15 5.683 5.957 0.150 2.975 1108 0.559 4 0.012 639 0.583 5.01 7.72 2.71 8.12 3.11 
OGSR 2,4-DNDPA External 3.76 10.784 2.880 0.166 1.788 506 0.361 1 0.012 232 0.712 16.58 11.72 -4.86 13.87 -2.71 
OGSR 2-NDPA External 3.58 10.475 0.445 0.182 1.068 276 0.000 1 0.000 127 1.244 16.43 12.44 -3.99 14.37 -2.06 
OGSR 4,4'-DNDPA External 3.78 10.784 3.634 0.187 2.096 536 0.296 1 0.016 180 0.305 14.87 10.39 -4.48 13.97 -0.90 
OGSR 4-NDPA External 3.36 10.475 2.173 0.198 1.623 288 0.000 1 0.012 100 0.263 14.19 10.66 -3.53 14.22 0.03 
OGSR Dimethyl phthalate External 1.88 4.018 0.000 0.086 0.000 56 0.000 0 0.000 70 1.517 7.38 9.29 1.91 7.50 0.12 
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OGSR N-nitroso-DPA External 3.03 10.385 1.719 0.191 0.693 220 0.000 0 0.000 92 1.134 13.45 12.31 -1.14 14.04 0.59 
MEKPs MEKP CP dimer External 2.08 3.216 0.000 0.154 0.000 0 0.000 0 0.000 20 0.000 - 8.89 - 8.49 - 
MEKPs MEKP CP tetramer External 4.50 11.535 8.758 0.074 2.565 876 0.997 0 0.000 328 1.125 - 17.10 - 15.49 - 
MEKPs MEKP CP trimer External 3.44 6.996 1.915 0.094 0.000 267 0.445 0 0.000 138 0.708 - 13.64 - 11.77 - 
MEKPs MEKP DHP dimer External 3.19 2.067 0.438 0.096 0.000 0 0.182 2 0.000 16 0.948 - 9.83 - 9.61 - 
MEKPs MEKP DHP monomer External 1.33 0.093 0.000 0.127 0.000 0 0.000 2 0.000 0 0.000 - 6.13 - 6.54 - 
MEKPs MEKP DHP pentamer External 8.28 14.812 34.125 0.055 3.325 1398 1.026 2 0.012 496 0.973 - 21.78 - 19.44 - 
MEKPs MEKP DHP tetetramer External 6.65 9.800 17.611 0.066 2.937 672 1.002 2 0.011 264 0.962 - 18.50 - 16.75 - 
MEKPs MEKP DHP trimer External 4.91 5.483 3.751 0.077 2.296 206 0.439 2 0.000 104 0.950 - 13.78 - 13.76 - 
MNs M-1,2,3,4,5-PN External 3.74 1.968 1.462 0.048 2.149 551 0.676 1 0.000 560 0.929 - 10.50 - 11.83 - 
MNs M-1,2,3,4,6-PN External 3.79 1.968 6.025 0.046 2.279 537 0.624 1 0.008 513 0.947 - 12.18 - 12.21 - 
MNs M-1,2,3,5,6-PN External 3.74 1.968 4.411 0.057 2.277 554 0.670 1 0.006 501 1.000 - 11.60 - 11.89 - 
MNs M-1,2,3,4-TN External 2.28 0.284 3.338 0.052 1.759 336 0.351 2 0.000 391 0.874 - 8.28 - 9.80 - 
MNs M-1,2,3,5-TN External 2.35 0.284 3.612 0.055 1.889 353 0.303 2 0.000 383 0.935 - 8.46 - 9.98 - 
MNs M-1,2,4,5-TN External 2.60 0.284 2.307 0.065 1.935 371 0.335 2 0.000 383 0.960 - 8.30 - 9.93 - 
MNs M-1,3,4,5-TN External 2.57 0.284 1.311 0.052 1.824 356 0.316 2 0.000 392 0.895 - 8.35 - 9.93 - 
MNs M-2,3,4,5-TN External 2.32 0.284 0.231 0.054 1.529 356 0.321 2 0.000 430 0.874 - 7.72 - 9.33 - 
MNs M-1,2,3,6-TN External 2.32 0.284 3.331 0.057 1.943 349 0.304 2 0.008 343 0.960 - 9.31 - 9.59 - 
MNs M-1,2,4,6-TN  External 2.60 0.284 2.792 0.068 2.055 357 0.325 2 0.008 345 0.967 - 9.34 - 9.71 - 
MNs M-1,3,4,6-TN External 2.73 0.284 5.823 0.049 2.096 352 0.314 2 0.017 354 0.921 - 9.22 - 9.86 - 
MNs M-1,2,5,6-TN External 2.28 0.284 4.013 0.053 1.940 370 0.353 2 0.006 334 1.032 - 9.30 - 9.73 - 
MNs M-1,2,3-TriN External 0.72 0.091 1.872 0.065 1.347 179 0.155 3 0.000 245 0.863 - 5.75 - 7.19 - 
MNs M-1,2,4-TriN External 0.92 0.091 0.010 0.077 1.606 206 0.039 3 0.000 247 0.899 - 5.86 - 7.29 - 
MNs M-1,3,4-TriN External 0.87 0.091 2.363 0.057 1.519 203 0.155 3 0.000 253 0.847 - 6.21 - 7.65 - 
MNs M-2,3,4-TriN External 0.80 0.091 0.001 0.060 0.806 194 0.075 3 0.000 282 0.818 - 5.73 - 6.94 - 
MNs M-1,2,6-TriN External 0.69 0.091 5.293 0.067 1.613 213 0.141 3 0.008 209 0.992 - 7.66 - 7.45 - 
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MNs M-1,3,6-TriN  External 0.91 0.091 4.309 0.066 1.820 214 0.166 3 0.017 217 0.947 - 7.29 - 7.12 - 
SNs S-2,3,4,5,6-PN External 3.74 1.968 3.688 0.050 2.149 551 0.676 1 0.000 560 0.929 - 10.99 - 12.10 - 
SNs S-1,3,4,5,6-PN External 3.79 1.968 6.332 0.048 2.279 537 0.624 1 0.008 513 0.947 - 12.21 - 12.22 - 
SNs S-1,2,4,5,6-PN External 3.74 1.968 4.190 0.064 2.277 554 0.670 1 0.006 501 1.000 - 11.43 - 11.77 - 
SNs S-1,2,3,5,6-PN External 3.74 1.968 6.749 0.055 2.277 554 0.670 1 0.006 501 1.000 - 12.12 - 12.21 - 
SNs S-1,2,3,4,6-PN External 3.79 1.968 6.661 0.051 2.279 537 0.624 1 0.008 513 0.947 - 12.22 - 12.22 - 
SNs S-1,2,3,4,5-PN External 3.74 1.968 2.746 0.052 2.149 551 0.676 1 0.000 560 0.929 - 10.72 - 11.95 - 
SNs S-3,4,5,6-TN External 2.28 0.284 3.555 0.059 1.759 336 0.351 2 0.000 391 0.874 - 8.20 - 9.73 - 
SNs S-2,4,5,6-TN External 2.35 0.284 4.190 0.065 1.889 353 0.303 2 0.000 383 0.935 - 8.40 - 9.91 - 
SNs S-2,3,5,6-TN External 2.60 0.284 2.719 0.073 1.935 371 0.335 2 0.000 383 0.960 - 8.25 - 9.87 - 
SNs S-2,3,4,6-TN External 2.57 0.284 3.741 0.058 1.824 356 0.316 2 0.000 392 0.895 - 8.76 - 10.17 - 
SNs S-2,3,4,5-TN External 2.32 0.284 0.000 0.058 1.529 356 0.321 2 0.000 430 0.874 - 7.60 - 9.24 - 
SNs S-1,4,5,6-TN External 2.32 0.284 4.625 0.060 1.943 349 0.304 2 0.008 343 0.960 - 9.46 - 9.70 - 
SNs S-1,3,5,6-TN External 2.60 0.284 1.998 0.071 2.055 357 0.325 2 0.008 345 0.967 - 9.19 - 9.57 - 
SNs S-1,3,4,6-TN External 2.73 0.284 6.238 0.057 2.096 352 0.314 2 0.017 354 0.921 - 9.18 - 9.80 - 
SNs S-1,3,4,5-TN External 2.57 0.284 3.655 0.058 1.824 356 0.316 2 0.000 392 0.895 - 8.74 - 10.16 - 
SNs S-1,2,5,6-TN External 2.28 0.284 2.842 0.063 1.940 370 0.353 2 0.006 334 1.032 - 8.97 - 9.44 - 
SNs S-1,2,4,6-TN External 2.60 0.284 6.084 0.060 2.055 357 0.325 2 0.008 345 0.967 - 9.95 - 10.22 - 
SNs S-1,2,4,5-TN External 2.60 0.284 3.570 0.063 1.935 371 0.335 2 0.000 383 0.960 - 8.60 - 10.13 - 
SNs S-1,2,3,6-TN External 2.32 0.284 4.941 0.056 1.943 349 0.304 2 0.008 343 0.960 - 9.56 - 9.80 - 
SNs S-1,2,3,5-TN External 2.35 0.284 4.661 0.057 1.889 353 0.303 2 0.000 383 0.935 - 8.64 - 10.09 - 
SNs S-1,2,3,4-TN External 2.28 0.284 2.871 0.055 1.759 336 0.351 2 0.000 391 0.874 - 8.13 - 9.69 - 
SNs S-1,2,3-TrN External 0.72 0.091 1.424 0.064 1.347 179 0.155 3 0.000 245 0.863 - 5.69 - 7.14 - 
SNs S-1,2,4-TrN External 0.92 0.091 2.785 0.069 1.606 206 0.039 3 0.000 247 0.899 - 6.43 - 7.77 - 
SNs S-1,2,5-TrN External 0.87 0.091 4.614 0.068 1.601 220 0.020 3 0.000 240 0.992 - 6.72 - 7.98 - 
SNs S-1,2,6-TrN External 0.69 0.091 5.407 0.074 1.613 213 0.141 3 0.008 209 0.992 - 7.60 - 7.37 - 
265 
 





















SNs S-1,3,4-TrN External 0.87 0.091 2.848 0.066 1.519 203 0.155 3 0.000 253 0.847 - 6.16 - 7.58 - 
SNs S-1,3,5-TrN External 1.03 0.091 3.204 0.066 1.622 212 0.068 3 0.000 248 0.909 - 6.63 - 7.98 - 
SNs S-1,3,6-TrN External 0.69 0.091 5.318 0.073 1.613 213 0.141 3 0.008 209 0.992 - 7.60 - 7.37 - 
SNs S-2,3,4-TrN External 0.80 0.091 0.000 0.066 0.806 194 0.075 3 0.000 282 0.818 - 5.63 - 6.85 - 
SNs S-2,3,5-TrN External 1.05 0.091 0.173 0.071 1.332 212 0.026 3 0.000 277 0.899 - 6.11 - 7.43 - 
SNs S-2,3,6-TrN External 0.83 0.091 3.805 0.068 1.514 219 0.146 3 0.000 246 0.932 - 6.26 - 7.63 - 
SNs S-2,4,5-TrN External 1.05 0.091 0.000 0.071 1.332 212 0.026 3 0.000 277 0.899 - 6.08 - 7.41 - 
SNs S-2,4,6-TrN External 1.03 0.091 3.168 0.071 1.622 212 0.068 3 0.000 248 0.909 - 6.56 - 7.90 - 
SNs S-2,5,6-TrN External 0.87 0.091 5.148 0.072 1.601 220 0.020 3 0.000 240 0.992 - 6.75 - 7.99 - 
SNs S-3,4,5-TrN External 0.80 0.091 0.010 0.067 0.806 194 0.075 3 0.000 282 0.818 - 5.62 - 6.83 - 
SNs S-3,4,6-TrN External 0.87 0.091 3.357 0.066 1.519 203 0.155 3 0.000 253 0.847 - 6.25 - 7.65 - 
SNs S-3,5,6-TrN External 0.92 0.091 0.061 0.080 1.606 206 0.039 3 0.000 247 0.899 - 5.83 - 7.25 - 
SNs S-4,5,6-TrN External 0.72 0.091 2.129 0.068 1.347 179 0.155 3 0.000 245 0.863 - 5.76 - 7.18 - 
SNs S-1,2-DN External -0.70 1.198 1.774 0.084 1.105 90 0.000 4 0.000 135 0.900 - 4.46 - 5.25 - 
SNs S-1,3-DN External -0.46 1.198 2.100 0.078 1.233 96 0.001 4 0.000 140 0.844 - 4.93 - 5.74 - 
SNs S-1,4-DN External -0.46 1.198 2.771 0.090 1.320 112 0.004 4 0.000 140 0.893 - 4.91 - 5.70 - 
SNs S-1,5-DN External -0.52 1.198 4.629 0.080 1.227 116 0.016 4 0.000 136 0.985 - 5.18 - 5.94 - 
SNs S-1,6-DN External -0.69 1.198 3.861 0.102 1.438 114 0.109 4 0.017 114 0.985 - 6.05 - 4.62 - 
SNs S-2,3-DN External -0.54 1.198 0.341 0.078 0.346 88 0.000 4 0.000 160 0.830 - 4.32 - 4.95 - 
SNs S-2,4-DN External -0.25 1.198 0.000 0.081 0.806 100 0.000 4 0.000 162 0.844 - 4.74 - 5.46 - 
SNs S-2,5-DN External -0.21 1.198 0.161 0.083 1.086 112 0.005 4 0.000 158 0.985 - 4.85 - 5.64 - 
SNs S-2,6-DN External -0.52 1.198 3.891 0.085 1.227 116 0.016 4 0.000 136 0.985 - 5.01 - 5.77 - 
SNs S-3,4-DN External -0.60 1.198 0.032 0.077 0.000 90 0.000 4 0.000 164 0.766 - 4.13 - 4.68 - 
SNs S-3,5-DN External -0.25 1.198 0.016 0.077 0.806 100 0.000 4 0.000 162 0.844 - 4.80 - 5.52 - 
SNs S-3,6-DN External -0.46 1.198 2.117 0.079 1.320 112 0.004 4 0.000 140 0.893 - 4.94 - 5.77 - 
SNs S-4,5-DN External -0.54 1.198 0.016 0.090 0.346 88 0.000 4 0.000 160 0.830 - 4.11 - 4.73 - 
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SNs S-4,6-DN External -0.46 1.198 3.275 0.091 1.233 96 0.001 4 0.000 140 0.844 - 4.95 - 5.70 - 
SNs S-5,6-DN External -0.70 1.198 2.118 0.083 1.105 90 0.000 4 0.000 135 0.900 - 4.52 - 5.31 - 
SNs S-1-MN External -2.18 3.361 1.772 0.119 0.958 40 0.000 5 0.000 61 0.918 - 3.32 - 3.28 - 
SNs S-2-MN External -1.79 3.361 0.367 0.098 0.346 32 0.000 5 0.000 74 0.918 - 3.59 - 3.54 - 
SNs S-3-MN External -1.98 3.361 0.000 0.091 0.000 30 0.000 5 0.000 75 0.788 - 3.24 - 3.21 - 
SNs S-4-MN External -1.98 3.361 0.078 0.105 0.000 30 0.000 5 0.000 75 0.788 - 3.08 - 3.03 - 
SNs S-5-MN External -1.79 3.361 0.168 0.093 0.346 32 0.000 5 0.000 74 0.918 - 3.62 - 3.58 - 
SNs S-6-MN External -2.18 3.361 2.089 0.119 0.958 40 0.000 5 0.000 61 0.918 - 3.35 - 3.32 - 
C3H6O6N6 2,4,6-Trinitro-1,3,5-triazinane  External -3.18 1.963 0.000 0.183 0.000 72 0.000 3 0.000 96 0.000 - -0.30 - 0.78 - 
C3H6O6N6 N,N',N''-Trinitro-1,2,3-  
cyclopropanetriamine  
External -4.56 0.034 0.000 0.132 0.000 30 0.000 3 0.000 108 0.830 - -2.67 - -0.47 - 
C3H6O6N6 1,3,5-Trinitro-1,2,3-triazinane  External -1.27 0.990 0.000 0.170 0.000 72 0.000 1 0.000 96 0.000 - 2.05 - 3.24 - 
C3H6O6N6 2-(N'-Nitro-N-nitroso-  
carbamimidamido)ethyl nitrate  
External -2.14 0.065 0.000 0.130 0.759 25 0.000 2 0.000 56 1.389 - 1.25 - 2.65 - 
C3H6O6N6 1,2,2-Trinitro-1,3,5-triazinane  External 0.63 3.265 0.000 0.184 0.000 36 0.000 2 0.000 157 0.000 - 5.91 - 5.69 - 
C17H7O16N11 3,6-Dinitro-N,N'-bis(2,4,6- trinitrophenyl)- 
2,5-pyridinediamine  
External 5.78 18.199 19.868 0.103 3.572 8860 1.179 2 0.009 3148 0.841 - 17.28 - 17.66 - 
C17H7O16N11 2,6-Dinitro-N,N'-bis(2,4,6- trinitrophenyl)- 
3,5-pyridinediamine  
External 6.09 18.199 19.716 0.095 3.687 8868 1.152 2 0.007 3148 0.801 - 17.59 - 18.01 - 





External -4.96 3.884 1.248 0.055 0.000 234 0.000 6 0.000 264 0.352 - -0.38 - 0.61 - 
C6H6O6N6 N,N',N''-Trihydroxy-2,4,6-trinitroso-  
1,3,5-benzenetriamine 
External -2.56 2.492 0.000 0.097 0.000 234 0.000 6 0.000 264 0.352 - 1.64 - 2.03 - 
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External -4.96 3.884 1.248 0.055 0.000 234 0.000 6 0.000 264 0.352 - -0.38 - 0.61 - 
C6H6O6N6 1-[(2Z)-2-Methyl-3-nitro-2-propen-1-yl]- 
3,5-dinitro-1H-1,2,4-triazole 
External 0.28 5.866 0.000 0.144 1.086 157 0.043 0 0.000 234 1.380 - 7.15 - 7.59 - 
C6H6O6N6 1-(2-Methyl-3-nitro-2-propen-1-yl)-  
3,5-dinitro-1H-1,2,4-triazole  





External -4.96 3.884 1.248 0.055 0.000 234 0.000 6 0.000 264 0.352 - -0.38 - 0.61 - 
C6H6O6N6 N-{1-[Amino(oxo)acetyl]-3,5-dioxo-  
1,2,4-triazolidin-4-yl}ethanediamide  






Table A. 6 (Continued): Molecular descriptors and predicted retention times for best ANN and ensemble following forward selection - Part A 

























3N IDE nR08 
Explosives 1,2-DNB Training 1.60 0.000 16 -3.11 0 0.284 73.9 9.055 0.027 0.497 2.120 4 3.949 0.00 42.3 24 0 2.28 0 
Explosives 1,2-DNG Training 0.86 0.936 13 -1.16 0 1.037 150.2 4.326 1.330 0.625 2.206 0 3.680 0.09 66.0 12 0 2.73 0 
Explosives 1,3-DNB Training 1.55 0.602 16 -3.11 0 0.284 76.3 9.005 0.748 0.497 0.197 0 3.934 0.00 44.2 18 0 2.47 0 
Explosives 1-MNG Training -0.43 0.346 9 -0.53 0 0.992 85.5 6.549 0.870 0.679 0.051 0 3.619 0.00 36.0 1 0 2.46 0 
Explosives 2,4-DA-6-NT Training 0.92 0.000 17 -2.44 0 0.331 66.2 10.639 0.138 0.676 1.371 4 3.930 0.00 41.8 12 0 2.26 0 
Explosives 2,4-DNT Training 2.10 1.006 18 -3.45 0 0.268 84.0 9.796 0.822 0.610 1.655 4 3.955 0.00 52.5 27 0 2.50 0 
Explosives 2-Am-4,6-DNT Training 1.88 1.006 20 -2.98 0 0.313 93.5 14.405 0.827 0.661 1.235 8 3.972 0.00 61.0 30 0 2.50 0 
Explosives 2-NT Training 2.45 0.000 13 -3.45 0 0.207 47.3 5.808 0.014 0.616 2.171 0 3.892 0.00 27.7 8 0 2.15 0 
Explosives 3,4-DNT Training 2.15 0.647 18 -3.45 0 0.268 82.5 10.825 0.362 0.610 3.352 6 3.965 0.00 51.3 29 0 2.41 0 
Explosives 3,5-DNA Training 1.63 0.602 18 -2.65 0 0.333 86.1 14.740 0.764 0.584 0.127 0 3.950 0.00 52.3 20 0 2.48 0 
Explosives 4-NT Training 2.45 0.647 13 -3.45 0 0.207 49.3 4.602 0.389 0.616 1.214 0 3.883 0.00 29.3 6 0 2.34 0 
Explosives DADP Training 1.23 0.000 16 -2.37 0 0.750 95.5 4.870 0.037 0.378 0.233 0 3.652 0.49 28.7 0 0 2.13 0 
Explosives DEDPU Training 3.26 3.098 27 -4.83 1 0.871 183.5 23.795 5.455 0.471 15.504 352 3.866 0.66 136.1 94 16 3.05 0 
Explosives DMNB Training 1.82 0.000 18 -2.93 0 0.310 80.0 5.865 0.007 0.412 1.297 0 3.874 0.00 66.0 8 0 2.16 0 
Explosives EGDN Training 1.51 0.759 10 -1.37 0 1.092 123.7 3.589 1.342 0.547 2.108 0 3.643 0.00 45.0 6 0 2.73 0 
Explosives HMDD Training 0.00 0.000 16 -1.66 0 0.964 111.9 2.572 0.002 0.422 0.235 27 3.649 0.05 21.3 34 6 2.19 2 
Explosives HMTA Training 0.98 0.000 18 -2.37 0 1.875 56.8 0.700 0.000 0.313 0.000 6 3.820 0.00 13.4 96 12 1.81 3 
Explosives HMTD Training 0.13 0.000 18 -1.77 0 1.084 171.6 6.473 0.003 0.373 3.860 69 3.612 0.25 29.4 48 6 2.29 0 
Explosives HMX Training -1.71 1.996 28 -3.56 1 0.679 261.1 14.552 1.641 0.432 18.086 114 3.855 0.04 122.6 272 20 2.85 1 
Explosives HNDPA Training 4.44 3.407 47 -4.30 1 0.390 370.0 43.669 7.469 0.421 11.694 1297 4.065 0.36 303.6 470 4 3.33 0 
Explosives MHN Training 5.16 3.115 38 -3.51 1 1.092 571.0 38.176 7.246 0.428 17.963 357 3.818 0.86 435.0 214 0 3.24 0 
Explosives NB Training 1.81 0.000 11 -3.11 0 0.214 41.0 3.511 0.015 0.472 0.146 0 3.862 0.00 22.4 4 0 2.15 0 
Explosives NG Training 2.41 1.502 17 -1.87 0 1.092 225.5 15.971 4.354 0.515 1.020 0 3.708 0.08 105.0 28 0 2.93 0 
Explosives NM Training 0.10 0.000 3 -0.91 0 0.545 14.3 0.000 0.000 0.614 0.000 0 3.558 0.00 6.0 0 0 1.00 0 
Explosives PA Training -1.40 1.359 23 -2.79 0 0.471 125.5 19.405 1.308 0.566 0.614 24 4.005 0.00 82.2 64 0 2.56 0 
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Explosives PGDN Training 1.87 0.759 12 -1.87 0 0.854 133.7 4.582 1.394 0.571 1.974 0 3.671 0.00 55.0 10 0 2.71 0 
Explosives R-Salt Training -1.18 0.482 15 -0.72 0 0.689 116.4 2.074 0.088 0.513 7.332 0 3.679 0.00 42.9 63 9 2.46 0 
Explosives SHN Training 5.16 3.115 38 -3.51 1 1.092 571.0 46.694 7.524 0.428 30.904 357 3.818 0.83 435.0 214 0 3.24 0 
Explosives TATP Training 2.16 0.000 24 -3.00 0 0.778 194.8 22.141 0.194 0.334 29.694 12 3.659 0.84 55.9 0 0 2.30 0 
Explosives TEGDN Training 1.46 1.869 16 -1.65 0 1.090 305.4 10.127 7.377 0.448 6.666 26 3.621 0.00 120.0 18 0 3.57 0 
Explosives Tetryl Training 1.25 2.031 29 -3.84 0 0.413 191.3 22.313 2.852 0.546 4.283 92 4.030 0.00 134.9 156 4 2.77 0 
Explosives TMETN Training 3.08 1.537 21 -2.69 0 0.803 254.4 26.192 4.252 0.496 0.586 0 3.737 0.00 136.0 24 0 2.96 0 
Explosives TNB Training 1.36 1.247 21 -3.23 0 0.349 113.8 18.009 1.293 0.474 0.153 0 3.988 0.00 72.5 42 0 2.56 0 
Explosives TNT Training 1.79 1.479 23 -3.56 0 0.326 121.0 20.966 1.323 0.567 1.221 24 4.009 0.00 82.2 64 0 2.56 0 
Drugs Acebutolol Training -0.73 3.017 31 -2.83 1 0.832 329.0 33.468 12.370 0.594 10.019 277 3.888 0.82 225.5 40 6 3.63 0 
Drugs Acetazolamide Training -0.58 1.595 19 0.18 0 1.626 88.3 1.217 3.690 0.766 2.388 6 4.684 0.01 58.9 30 8 2.68 0 
Drugs AICAR Training -2.49 2.220 28 0.01 0 1.059 176.2 8.344 5.186 0.724 13.398 291 3.953 0.37 96.3 91 10 2.92 0 
Drugs Alprenolol Training 0.34 2.528 22 -3.57 1 0.869 200.3 24.095 7.653 0.607 9.034 95 3.840 0.80 117.0 10 2 3.28 0 
Drugs Altizide Training 1.08 3.006 35 -1.86 1 1.328 195.5 15.906 6.336 0.713 11.774 390 4.684 0.18 129.9 60 10 3.26 0 
Drugs Aminoglutethimide Training 1.27 2.232 26 -2.63 1 0.621 112.5 20.408 3.935 0.637 9.256 155 3.904 0.08 82.5 16 4 2.81 0 
Drugs Anastrazole Training 2.68 3.244 34 -3.98 1 0.827 178.1 33.579 5.059 0.563 14.840 308 3.954 0.54 158.1 112 6 3.05 0 
Drugs Bambuterol Training -0.93 3.311 37 -2.30 1 1.050 370.7 29.952 8.520 0.541 22.770 254 3.886 0.74 257.9 53 3 3.40 0 
Drugs Bendroflumethiazide Training 1.48 3.273 46 -2.82 1 1.539 279.6 24.340 6.824 0.634 18.878 1133 4.681 0.23 189.6 86 10 3.36 0 
Drugs Benzoylecgonine Training -0.21 2.898 33 -3.38 1 0.761 217.9 21.512 6.282 0.598 7.717 640 3.878 0.39 114.9 71 4 3.10 0 
Drugs Benzthiazide Training 0.99 3.197 42 -3.02 1 1.227 258.4 18.861 10.626 0.641 15.321 964 4.687 0.24 182.5 82 10 3.57 0 
Drugs Beta\dexameth. Training 1.92 3.337 53 -3.08 1 0.546 264.3 47.182 8.449 0.573 36.423 2577 4.013 1.18 128.5 0 0 3.15 0 
Drugs Budesonide Training 3.02 3.644 57 -3.23 1 0.709 352.9 61.752 9.164 0.529 38.028 4022 4.018 1.21 144.9 0 0 3.37 1 
Drugs Bumetanide  Training 0.21 3.495 36 -2.99 1 1.473 268.3 34.113 6.788 0.648 15.618 460 4.623 0.55 199.9 36 2 3.20 0 
Drugs Bumetanide  Training 0.21 3.495 36 -2.99 1 1.473 268.3 34.113 6.788 0.648 15.618 460 4.623 0.55 199.9 36 2 3.20 0 
Drugs Bunolol Training 0.15 2.598 31 -3.53 1 0.767 246.8 34.912 9.722 0.580 4.684 277 3.920 0.84 129.4 13 3 3.35 0 
Drugs Bupropion Training 2.69 2.537 23 -4.38 1 0.522 118.6 17.561 4.982 0.565 9.698 75 3.946 0.14 93.8 6 6 2.89 0 
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Drugs Butizide Training 0.78 2.886 35 -1.93 1 1.282 172.4 15.322 5.350 0.657 18.268 370 4.684 0.29 113.4 54 10 3.06 0 
Drugs Canrenone Training 2.50 3.208 48 -5.27 1 0.627 227.9 42.667 8.839 0.500 25.027 2238 3.996 0.73 92.4 0 0 3.19 0 
Drugs Carteolol Training -0.58 2.585 31 -2.56 1 0.830 254.8 32.295 9.823 0.606 6.083 265 3.907 0.87 131.2 40 7 3.39 0 
Drugs Celiprolol Training -0.41 3.183 37 -2.93 1 0.896 412.1 41.331 12.456 0.543 13.864 424 3.891 1.12 294.8 73 12 3.73 0 
Drugs Chlorexolone Training 1.49 2.896 35 -3.19 1 0.944 177.8 15.463 7.637 0.627 9.350 599 4.629 0.19 106.7 83 8 3.10 0 
Drugs Clobenzorex Training 2.89 2.779 24 -5.51 1 0.482 153.9 14.334 3.872 0.528 16.351 220 3.945 0.36 102.6 16 2 3.26 0 
Drugs Clobetasol Training 2.74 3.391 53 -4.03 1 0.493 258.4 50.311 8.669 0.580 35.998 2577 4.017 0.96 128.5 0 0 3.15 0 
Drugs Clopamide Training 1.75 2.950 34 -3.23 1 0.991 225.3 22.949 7.914 0.628 10.908 495 4.628 0.33 150.0 100 12 3.20 0 
Drugs Cyclopenthiazide Training 1.51 3.145 39 -2.44 1 1.208 209.1 26.096 4.745 0.609 20.653 778 4.684 0.33 131.1 68 10 3.24 0 
Drugs Danazol Training 4.33 3.284 48 -5.27 0 0.517 212.7 45.547 7.194 0.550 30.828 2217 4.017 0.72 82.9 44 1 3.15 0 
Drugs Diacetolol Training -1.40 2.799 29 -2.37 1 0.852 280.9 28.332 11.077 0.619 7.242 200 3.886 0.96 184.4 28 6 3.48 0 
Drugs Dichlorphenamide Training 0.89 1.659 26 -1.51 0 1.335 90.7 6.297 1.841 0.637 6.244 15 4.675 0.32 83.5 0 0 2.54 0 
Drugs Efaproxiral Training 0.38 3.031 37 -4.29 1 0.738 322.8 25.554 10.333 0.588 15.319 571 3.885 0.45 228.4 25 4 3.68 0 
Drugs Epitizide Training 1.01 3.003 40 -2.06 1 1.404 262.9 14.261 7.629 0.722 13.472 480 4.684 0.18 164.9 69 10 3.39 0 
Drugs Etacr. acid  Training -0.24 2.745 26 -4.18 1 0.585 180.1 15.224 6.653 0.730 9.370 108 4.071 0.31 131.7 0 0 3.18 0 
Drugs Etamivan Training 1.44 2.249 21 -2.95 1 0.897 134.0 22.145 2.998 0.598 5.697 64 3.873 0.49 89.9 14 5 2.85 0 
Drugs Famprofazone Training 1.18 3.614 42 -5.49 0 0.811 342.5 40.987 10.676 0.504 45.302 1262 3.930 1.34 255.0 329 18 3.52 0 
Drugs Fenbutrazate Training 4.45 3.193 38 -4.47 1 0.922 379.4 45.291 6.840 0.504 44.644 1038 3.863 0.59 238.2 82 5 3.68 0 
Drugs Fencamfamin Training 0.39 2.453 25 -4.66 1 0.889 105.6 19.482 0.424 0.522 13.497 243 3.927 0.44 59.2 19 2 2.72 0 
Drugs Fludrocortisone Training 1.54 3.233 51 -2.96 1 0.548 254.5 49.928 8.014 0.540 37.399 2192 3.999 1.03 118.8 0 0 3.15 0 
Drugs Flumethasone Training 1.74 3.386 55 -3.18 1 0.564 283.5 50.836 8.086 0.584 40.334 2923 4.018 1.27 138.6 0 0 3.15 0 
Drugs Formoterol Training -0.41 2.974 34 -2.90 1 0.792 321.0 28.148 7.711 0.631 23.274 570 3.880 0.45 226.5 54 4 3.73 0 
Drugs FPCAM Training -1.11 3.653 59 -4.31 1 0.625 365.0 68.119 7.498 0.574 40.832 3725 4.021 1.33 187.7 0 0 3.28 0 
Drugs Fulvestrant Training 7.56 3.846 65 -7.09 0 1.041 786.6 81.092 19.933 0.444 41.891 2788 4.233 1.50 496.2 0 0 4.29 0 
Drugs Furosemide Training -0.74 2.870 32 -1.73 1 1.031 190.0 18.808 7.548 0.765 6.606 373 4.628 0.12 143.5 34 2 3.17 0 
Drugs Hydroflumeth. Training 0.23 2.305 35 -1.25 1 1.756 158.0 14.916 2.737 0.717 5.034 265 4.679 0.22 95.9 42 5 2.73 0 
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Drugs Labetalol Training 0.53 2.954 33 -3.86 1 0.609 280.0 29.140 11.853 0.622 19.616 482 3.887 0.62 206.7 26 2 3.65 0 
Drugs Mefruside Training 1.67 3.058 38 -1.80 1 1.273 222.3 30.871 4.565 0.623 23.666 552 4.681 0.23 183.9 73 3 3.20 0 
Drugs Metoprolol Training -0.59 2.483 23 -2.89 1 1.000 247.8 23.058 11.766 0.571 11.051 106 3.832 0.80 143.6 11 2 3.56 0 
Drugs Nadoxolol Training 1.63 2.551 26 -3.20 1 0.635 199.9 20.815 7.662 0.648 2.478 223 4.008 0.18 103.2 6 0 3.24 0 
Drugs Nikethamide Training 0.54 1.833 16 -2.29 0 0.872 85.6 10.809 0.952 0.592 6.774 24 3.814 0.43 58.5 17 6 2.62 0 
Drugs Ostarine Training 3.26 3.156 47 -3.64 1 0.699 505.3 30.983 14.125 0.664 7.121 1039 3.947 0.76 367.6 152 8 3.89 0 
Drugs Oxprenolol Training -0.15 2.652 23 -3.06 1 1.000 244.6 26.333 8.746 0.601 6.655 106 3.829 0.72 130.9 11 2 3.36 0 
Drugs Oxycodone Training 0.15 2.857 45 -2.63 1 0.816 190.1 41.042 3.104 0.603 21.776 1700 4.078 0.17 62.2 88 2 2.72 1 
Drugs Oxymorphone Training 0.34 2.596 44 -2.41 1 0.698 165.4 36.690 1.752 0.639 22.202 1499 4.076 0.19 53.8 83 2 2.60 1 
Drugs Pemoline Training 0.50 1.465 19 -2.44 0 0.889 84.4 6.574 0.723 0.671 4.496 69 3.862 0.09 42.5 8 4 2.56 0 
Drugs Pentazocine Training 1.89 2.944 35 -4.91 1 0.667 175.3 41.273 6.322 0.547 24.946 481 3.980 0.85 88.1 69 5 3.10 1 
Drugs Pentetrazol Training 0.22 0.000 14 -2.90 0 0.511 50.2 0.543 0.006 0.532 0.133 9 3.871 0.00 14.8 37 10 2.05 0 
Drugs Phendimetrazine Training 1.28 2.031 20 -3.07 0 1.094 92.4 12.686 1.359 0.549 10.294 75 3.843 0.26 48.2 20 2 2.61 0 
Drugs Polythiazide Training 1.59 3.169 42 -2.32 1 1.382 274.4 16.860 7.592 0.705 15.396 557 4.689 0.25 177.2 115 10 3.37 0 
Drugs Prenylamine Training 2.60 3.337 34 -6.52 0 0.926 266.0 37.383 7.175 0.439 29.111 709 3.897 0.40 210.9 19 2 3.55 0 
Drugs Probenecid Training 0.13 2.710 26 -3.20 1 1.545 164.9 24.936 5.754 0.589 22.351 156 4.639 0.23 141.5 42 7 3.12 0 
Drugs Prolintane Training 1.36 2.811 21 -4.66 1 1.412 120.3 23.367 3.473 0.462 15.176 147 3.823 0.66 81.2 37 5 2.87 0 
Drugs Propranolol Training 0.81 2.528 26 -3.73 1 0.820 204.6 23.743 8.863 0.571 6.466 197 4.008 0.88 103.5 12 2 3.28 0 
Drugs Propylhexedrine Training -0.30 1.531 13 -3.70 0 1.000 68.7 17.945 0.610 0.363 6.675 1 3.680 0.24 38.7 2 0 2.58 0 
Drugs Sotalol Training -1.97 2.492 25 -1.99 1 1.557 173.7 16.544 8.628 0.627 11.586 87 4.598 0.61 125.3 19 8 3.29 0 
Drugs Strychnine Training 0.21 3.185 51 -4.08 1 0.815 198.6 33.442 3.126 0.610 28.239 3598 4.084 0.27 53.8 331 17 2.72 1 
Drugs Tapentadol Training 0.28 2.535 21 -4.21 1 0.740 119.2 30.463 1.649 0.528 19.380 75 3.853 0.30 93.4 18 0 2.85 0 
Drugs Testolactone Training 3.07 2.900 40 -4.63 1 0.648 177.2 42.652 6.837 0.517 20.813 1072 3.956 0.57 65.7 0 0 3.04 0 
Drugs Timolol Training -0.71 2.627 30 -2.48 1 0.886 282.7 28.327 8.492 0.527 9.471 277 4.176 0.74 149.8 147 12 3.42 0 
Drugs Tramadol Training 0.17 2.837 28 -3.52 1 0.879 161.3 38.240 3.511 0.520 20.811 231 3.898 0.41 101.1 24 0 2.93 0 
Drugs Triamterene Training 1.10 2.624 30 -3.89 1 1.066 133.1 13.338 5.783 0.585 9.246 440 4.035 0.08 75.7 119 16 2.99 0 
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Drugs Trichlormethiazide Training 0.55 2.712 34 -1.67 1 1.136 150.9 10.314 4.550 0.736 5.647 290 4.685 0.06 98.7 63 10 2.92 0 
Drugs Xipamide Training 1.15 3.077 36 -3.58 1 0.991 203.8 25.099 6.960 0.706 12.075 600 4.628 0.13 164.0 45 4 3.19 0 
Explosives 2,6-DA-4-NT Select 0.92 0.647 17 -2.44 0 0.331 67.2 10.904 0.428 0.676 1.350 0 3.925 0.00 42.8 8 0 2.38 0 
Explosives 2,6-DNT Select 2.10 0.602 18 -3.45 0 0.268 82.6 11.432 0.702 0.610 1.428 12 3.961 0.00 50.9 32 0 2.44 0 
Explosives DPA Select 3.12 2.197 17 -4.55 0 0.929 75.7 11.478 1.689 0.350 2.835 64 3.850 0.09 43.4 12 4 2.77 0 
Explosives ETN Select 3.21 2.222 24 -2.39 0 1.092 334.1 28.217 6.072 0.478 8.091 36 3.757 0.24 190.0 70 0 3.04 0 
Explosives NQ Select -2.56 0.000 7 -0.45 0 0.877 44.7 0.009 0.003 0.769 1.048 0 3.643 0.00 21.0 0 4 1.96 0 
Explosives PETN Select 3.64 2.116 26 -2.78 1 0.953 349.9 34.980 4.727 0.459 1.168 0 3.769 0.00 210.0 48 0 2.98 0 
Drugs 6-MAM Select 0.50 3.117 45 -3.54 1 0.814 230.1 34.582 3.711 0.638 27.230 1675 4.071 0.37 77.0 75 2 2.90 1 
Drugs Andarine Select 3.26 3.156 47 -3.64 1 0.699 505.3 30.983 14.125 0.664 7.121 1039 3.947 0.76 367.6 152 8 3.89 0 
Drugs Atenolol Select -2.19 2.361 24 -2.20 1 0.847 232.9 24.089 10.802 0.638 6.117 114 3.837 0.78 143.4 11 2 3.51 0 
Drugs Carvedilol Select 2.67 3.192 44 -3.41 1 0.959 523.6 40.610 13.141 0.544 12.231 1612 4.164 0.60 246.7 112 5 3.92 0 
Drugs Chlorothiazide Select -0.10 2.062 29 -1.50 0 1.357 101.8 9.836 2.301 0.718 3.468 142 4.687 0.12 64.9 31 5 2.63 0 
Drugs Chlorthalidone Select 0.41 3.074 38 -2.88 1 0.955 163.2 21.909 4.108 0.657 7.151 784 4.628 0.23 118.6 42 6 3.01 0 
Drugs Desacetyl deflazacort Select 1.84 3.438 55 -3.14 1 0.656 281.3 51.335 8.635 0.578 37.159 3662 4.027 1.33 118.6 92 6 3.23 1 
Drugs Fenfluramine Select 0.48 2.220 22 -4.92 1 0.616 140.2 18.865 3.396 0.592 15.726 50 3.859 0.12 89.3 4 2 2.99 0 
Drugs Fluticasone prop. Select 3.71 3.872 61 -4.56 1 0.899 403.2 74.954 9.797 0.570 45.384 4150 4.051 1.96 226.2 0 0 3.34 0 
Drugs Hydrochloroth. Select 0.00 2.062 29 -0.80 0 1.357 104.1 10.589 2.363 0.714 4.498 142 4.683 0.16 64.9 31 5 2.63 0 
Drugs Isometheptene Select -0.03 1.658 10 -3.64 0 1.111 61.5 8.371 1.994 0.493 5.600 0 3.602 0.14 45.0 1 0 2.68 0 
Drugs Mefenorex Select 0.98 2.313 16 -4.54 1 0.510 109.8 17.102 3.531 0.571 10.762 35 3.805 0.18 71.3 6 2 3.08 0 
Drugs Methylprednisolone Select 1.97 3.374 50 -2.98 1 0.532 248.4 53.888 8.148 0.546 33.301 2242 3.999 1.20 119.9 0 0 3.16 0 
Drugs Pethidine Select 1.56 2.687 26 -3.72 1 0.882 148.7 27.102 2.692 0.540 14.312 141 3.890 0.37 101.2 21 1 2.81 0 
Drugs Terbutaline Select -1.94 2.322 23 -2.39 1 0.661 134.9 18.749 4.478 0.618 10.540 52 3.856 0.31 91.2 7 3 2.93 0 
Drugs Triamcinolone Select 0.92 3.282 53 -2.14 1 0.570 269.4 48.288 8.029 0.599 37.658 2577 4.011 1.15 128.5 0 0 3.15 0 
Explosives 1,3-DNG Test 0.97 0.796 13 -1.16 0 1.037 155.4 13.009 4.560 0.625 0.001 0 3.657 0.00 66.0 8 0 2.88 0 
Explosives 3-NT Test 2.45 0.000 13 -3.45 0 0.207 48.3 6.235 0.105 0.616 2.418 0 3.885 0.00 28.4 5 0 2.23 0 
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Explosives 4-Am-2,6-DNT Test 1.88 0.602 20 -2.98 0 0.313 92.6 17.731 0.731 0.661 1.289 16 3.976 0.00 60.0 36 0 2.46 0 
Explosives DMDPU Test 2.55 2.719 25 -4.36 1 0.877 156.1 22.560 5.490 0.464 9.020 232 3.856 0.30 104.7 84 8 3.06 0 
Explosives PYX Test 7.04 3.890 68 -5.37 0 0.425 688.3 91.684 7.772 0.433 46.089 4107 4.075 0.52 617.0 1198 12 3.76 0 
Explosives RDX Test -1.20 1.247 21 -2.65 0 0.667 166.0 5.283 0.481 0.470 15.254 0 3.850 0.00 72.5 114 15 2.56 0 
Explosives TATB Test 2.93 1.645 27 -1.42 0 0.472 141.3 15.055 0.985 0.446 6.782 147 4.042 0.00 103.7 120 0 2.53 0 
Drugs Amiloride Test -0.92 1.906 21 -1.47 0 0.590 109.3 6.614 3.401 0.722 6.940 40 3.962 0.06 75.4 37 12 2.78 0 
Drugs Beclomethasone Test 2.25 3.428 53 -3.18 1 0.488 257.1 45.846 8.449 0.573 38.015 2577 4.073 1.18 128.5 0 0 3.15 0 
Drugs Betaxolol Test 0.43 2.771 29 -3.21 1 0.932 337.7 25.957 14.313 0.544 12.070 213 3.836 0.89 194.4 15 2 3.79 0 
Drugs Bisoprolol Test -0.22 2.784 28 -2.84 1 1.065 401.2 28.937 13.703 0.514 12.677 192 3.831 0.78 221.1 15 2 3.88 0 
Drugs Carphedon Test 0.31 2.153 23 -2.12 1 0.684 123.9 16.424 4.182 0.634 8.109 136 3.863 0.10 75.3 44 5 2.95 0 
Drugs Deflazacort Test 2.43 3.699 59 -3.51 1 0.742 371.5 54.005 11.321 0.562 37.245 4063 4.028 1.39 164.3 104 6 3.42 1 
Drugs Desonide Test 2.79 3.503 58 -3.04 1 0.711 319.3 64.118 8.391 0.543 45.365 3993 4.021 1.51 130.0 0 0 3.26 1 
Drugs Esmolol Test -0.42 2.663 26 -3.06 1 0.942 291.1 28.075 13.131 0.583 9.705 137 3.836 0.86 179.9 13 2 3.68 0 
Drugs Fenetylline Test -0.07 2.912 38 -3.64 1 0.958 311.5 24.820 7.170 0.602 27.491 931 3.981 0.40 176.7 344 17 3.58 0 
Drugs Gestrinone Test 3.26 3.036 41 -5.00 1 0.463 171.3 35.074 5.841 0.572 27.661 1325 3.999 0.47 81.0 0 0 3.09 0 
Drugs Norfenfluramine Test 0.18 1.650 20 -4.40 0 0.619 104.0 12.083 2.294 0.649 7.545 14 3.857 0.20 64.5 0 0 2.71 0 
Drugs Phenmetrazine Test 0.09 1.727 18 -2.81 0 0.995 80.5 11.828 0.773 0.592 6.657 56 3.836 0.16 40.3 9 2 2.56 0 
Drugs Pindolol Test -0.65 2.411 25 -2.56 1 0.895 193.3 24.184 8.413 0.640 7.334 179 4.042 0.91 97.4 34 4 3.22 0 
Drugs Piretanide Test 0.07 3.627 39 -2.62 1 1.423 252.4 28.471 4.744 0.647 23.698 737 4.623 0.61 181.3 93 5 3.07 0 
Drugs Salmeterol Test 1.62 3.045 37 -4.05 0 0.720 585.7 61.428 19.868 0.508 13.376 683 3.872 1.14 364.2 36 1 4.30 0 
OGSR 2,4-DNDPA External 3.76 2.645 27 -4.44 1 0.285 165.4 16.843 5.027 0.464 7.190 226 3.974 0.07 108.9 89 4 3.09 0 
OGSR 2-NDPA External 3.58 2.491 22 -4.39 0 0.285 117.4 10.775 1.444 0.438 7.006 139 3.923 0.10 69.3 49 4 2.86 0 
OGSR 4,4'-DNDPA External 3.78 2.432 27 -4.44 1 0.285 183.7 15.473 7.890 0.464 4.540 236 3.935 0.11 118.5 76 4 3.37 0 
OGSR 4-NDPA External 3.36 2.322 22 -4.39 0 0.285 125.5 13.135 5.219 0.438 3.251 132 3.910 0.10 76.5 38 4 3.11 0 
OGSR Dimethyl phthalate External 1.88 1.572 18 -3.22 0 0.975 104.7 14.274 0.634 0.588 2.328 11 3.870 0.28 61.4 0 0 2.57 0 
OGSR N-nitroso-DPA External 3.03 2.293 20 -4.38 0 0.266 104.2 9.676 1.560 0.378 4.490 112 3.874 0.05 63.6 48 8 2.74 0 
274 
 
Table A. 6 (Continued): Molecular descriptors and predicted retention times for best ANN and ensemble following forward selection - Part A 

























3N IDE nR08 
MEKPs MEKP CP di. External 2.08 1.609 18 -3.02 0 0.688 125.4 9.711 0.135 0.376 3.850 2 3.686 0.34 46.0 0 0 2.48 0 
MEKPs MEKP CP tet. External 4.50 3.425 36 -4.55 0 0.719 440.1 48.528 2.879 0.311 57.758 238 3.703 0.78 153.0 0 0 3.03 0 
MEKPs MEKP CP tri. External 3.44 2.755 27 -3.83 0 0.708 248.9 31.984 1.803 0.335 32.247 57 3.695 1.02 88.4 0 0 2.64 0 
MEKPs MEKP DHP di. External 3.19 2.097 18 -2.69 0 0.583 203.9 16.991 0.754 0.454 12.279 5 3.621 0.57 91.0 0 0 2.71 0 
MEKPs MEKP DHP mon. External 1.33 0.000 9 -1.61 0 0.500 71.6 2.311 0.001 0.585 0.735 0 3.541 0.00 28.0 0 0 1.90 0 
MEKPs MEKP DHP pent. External 8.28 3.483 45 -4.98 0 0.667 994.0 96.347 9.896 0.334 61.314 386 3.693 1.58 496.0 0 0 3.82 0 
MEKPs MEKP DHP tet. External 6.65 3.195 36 -4.29 0 0.650 665.8 73.588 6.402 0.358 47.792 178 3.678 1.35 325.0 0 0 3.54 0 
MEKPs MEKP DHP tri. External 4.91 2.790 27 -3.54 1 0.625 402.3 40.946 3.151 0.394 20.500 51 3.656 0.94 190.0 0 0 3.19 0 
MNs M-1,2,3,4,5-PN External 3.74 2.932 34 -2.65 1 1.064 479.5 31.980 4.753 0.484 20.233 264 3.809 0.76 351.0 165 0 3.13 0 
MNs M-1,2,3,4,6-PN External 3.79 2.870 34 -2.65 1 1.064 489.6 34.541 7.361 0.484 13.388 228 3.800 0.70 351.0 147 0 3.24 0 
MNs M-1,2,3,5,6-PN External 3.74 2.860 34 -2.65 1 1.064 494.2 30.090 7.537 0.484 22.142 255 3.792 0.74 351.0 148 0 3.28 0 
MNs M-1,2,3,4-TN External 2.28 2.709 30 -1.83 0 1.037 395.1 27.039 4.425 0.521 13.185 135 3.793 0.71 276.0 107 0 3.03 0 
MNs M-1,2,3,5-TN External 2.35 2.645 30 -1.83 0 1.037 402.5 29.224 5.985 0.521 10.147 174 3.783 0.47 276.0 108 0 3.15 0 
MNs M-1,2,4,5-TN External 2.60 2.617 30 -1.83 0 1.037 404.3 30.898 4.707 0.521 18.353 187 3.781 0.72 276.0 108 0 3.17 0 
MNs M-1,3,4,5-TN External 2.57 2.630 30 -1.83 0 1.037 400.7 29.809 4.856 0.521 14.722 162 3.789 0.54 276.0 107 0 3.14 0 
MNs M-2,3,4,5-TN External 2.32 2.709 30 -1.83 0 1.037 391.0 28.691 2.606 0.521 24.638 187 3.800 0.64 276.0 122 0 3.00 0 
MNs M-1,2,3,6-TN External 2.32 2.617 30 -1.83 0 1.037 412.2 39.288 9.222 0.521 9.457 138 3.774 0.62 276.0 93 0 3.27 0 
MNs M-1,2,4,6-TN  External 2.60 2.561 30 -1.83 0 1.037 413.9 34.167 7.463 0.521 11.542 159 3.769 0.49 276.0 93 0 3.28 0 
MNs M-1,3,4,6-TN External 2.73 2.545 30 -1.83 0 1.037 410.3 28.793 7.458 0.521 9.916 141 3.777 0.59 276.0 92 0 3.24 0 
MNs M-1,2,5,6-TN External 2.28 2.604 30 -1.83 0 1.037 417.5 32.864 9.261 0.521 12.370 169 3.763 0.46 276.0 94 0 3.31 0 
MNs M-1,2,3-TriN External 0.72 2.439 26 -1.03 0 1.012 317.2 31.283 6.126 0.549 9.562 57 3.767 0.51 210.0 62 0 2.99 0 
MNs M-1,2,4-TriN External 0.92 2.335 26 -1.03 0 1.012 321.3 25.383 4.486 0.549 10.353 91 3.760 0.40 210.0 62 0 3.07 0 
MNs M-1,3,4-TriN External 0.87 2.314 26 -1.03 0 1.012 319.1 21.706 4.500 0.549 10.148 75 3.768 0.55 210.0 61 0 3.04 0 
MNs M-2,3,4-TriN External 0.80 2.421 26 -1.03 0 1.012 310.0 22.729 2.137 0.549 14.953 85 3.781 0.51 210.0 73 0 2.88 0 
MNs M-1,2,6-TriN External 0.69 2.318 26 -1.03 0 1.012 336.9 30.889 9.400 0.549 9.029 85 3.738 0.39 210.0 51 0 3.29 0 
MNs M-1,3,6-TriN  External 0.91 2.219 26 -1.03 0 1.012 334.7 37.032 9.394 0.549 8.043 84 3.743 0.53 210.0 50 0 3.26 0 
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SNs S-2,3,4,5,6-PN External 3.74 2.932 34 -2.65 1 1.064 479.5 39.612 5.046 0.484 14.254 264 3.809 0.77 351.0 165 0 3.13 0 
SNs S-1,3,4,5,6-PN External 3.79 2.870 34 -2.65 1 1.064 489.6 38.529 7.847 0.484 11.517 228 3.800 0.68 351.0 147 0 3.24 0 
SNs S-1,2,4,5,6-PN External 3.74 2.860 34 -2.65 1 1.064 494.2 42.495 7.572 0.484 20.996 255 3.792 0.78 351.0 148 0 3.28 0 
SNs S-1,2,3,5,6-PN External 3.74 2.860 34 -2.65 1 1.064 494.2 39.796 9.173 0.484 18.856 255 3.792 0.78 351.0 148 0 3.28 0 
SNs S-1,2,3,4,6-PN External 3.79 2.870 34 -2.65 1 1.064 489.6 37.501 7.874 0.484 18.945 228 3.800 0.81 351.0 147 0 3.24 0 
SNs S-1,2,3,4,5-PN External 3.74 2.932 34 -2.65 1 1.064 479.5 33.674 4.175 0.484 28.340 264 3.809 0.62 351.0 165 0 3.13 0 
SNs S-3,4,5,6-TN External 2.28 2.709 30 -1.83 0 1.037 395.1 30.752 5.105 0.521 19.690 135 3.793 0.83 276.0 107 0 3.03 0 
SNs S-2,4,5,6-TN External 2.35 2.645 30 -1.83 0 1.037 402.5 29.893 6.037 0.521 17.048 174 3.783 0.66 276.0 108 0 3.15 0 
SNs S-2,3,5,6-TN External 2.60 2.617 30 -1.83 0 1.037 404.3 33.053 4.075 0.521 28.133 187 3.781 0.58 276.0 108 0 3.17 0 
SNs S-2,3,4,6-TN External 2.57 2.630 30 -1.83 0 1.037 400.7 27.779 5.373 0.521 12.010 162 3.789 0.58 276.0 107 0 3.14 0 
SNs S-2,3,4,5-TN External 2.32 2.709 30 -1.83 0 1.037 391.0 30.330 2.890 0.521 14.899 187 3.800 0.71 276.0 122 0 3.00 0 
SNs S-1,4,5,6-TN External 2.32 2.617 30 -1.83 0 1.037 412.2 33.047 9.256 0.521 16.095 138 3.774 0.52 276.0 93 0 3.27 0 
SNs S-1,3,5,6-TN External 2.60 2.561 30 -1.83 0 1.037 413.9 36.822 7.397 0.521 10.496 159 3.769 0.45 276.0 93 0 3.28 0 
SNs S-1,3,4,6-TN External 2.73 2.545 30 -1.83 0 1.037 410.3 30.493 7.945 0.521 8.414 141 3.777 0.69 276.0 92 0 3.24 0 
SNs S-1,3,4,5-TN External 2.57 2.630 30 -1.83 0 1.037 400.7 30.102 5.151 0.521 11.153 162 3.789 0.75 276.0 107 0 3.14 0 
SNs S-1,2,5,6-TN External 2.28 2.604 30 -1.83 0 1.037 417.5 30.710 7.658 0.521 8.357 169 3.763 0.54 276.0 94 0 3.31 0 
SNs S-1,2,4,6-TN External 2.60 2.561 30 -1.83 0 1.037 413.9 35.512 7.884 0.521 6.783 159 3.769 0.35 276.0 93 0 3.28 0 
SNs S-1,2,4,5-TN External 2.60 2.617 30 -1.83 0 1.037 404.3 36.570 5.104 0.521 10.545 187 3.781 0.44 276.0 108 0 3.17 0 
SNs S-1,2,3,6-TN External 2.32 2.617 30 -1.83 0 1.037 412.2 37.457 9.267 0.521 12.741 138 3.774 0.57 276.0 93 0 3.27 0 
SNs S-1,2,3,5-TN External 2.35 2.645 30 -1.83 0 1.037 402.5 33.190 6.159 0.521 11.297 174 3.783 0.58 276.0 108 0 3.15 0 
SNs S-1,2,3,4-TN External 2.28 2.709 30 -1.83 0 1.037 395.1 31.416 5.226 0.521 11.537 135 3.793 0.65 276.0 107 0 3.03 0 
SNs S-1,2,3-TrN External 0.72 2.439 26 -1.03 0 1.012 317.2 29.677 6.153 0.549 12.741 57 3.767 0.47 210.0 62 0 2.99 0 
SNs S-1,2,4-TrN External 0.92 2.335 26 -1.03 0 1.012 321.3 28.345 5.324 0.549 6.914 91 3.760 0.36 210.0 62 0 3.07 0 
SNs S-1,2,5-TrN External 0.87 2.318 26 -1.03 0 1.012 327.8 27.922 6.269 0.549 5.852 113 3.750 0.45 210.0 63 0 3.18 0 
SNs S-1,2,6-TrN External 0.69 2.318 26 -1.03 0 1.012 336.9 34.262 9.400 0.549 4.423 85 3.738 0.46 210.0 51 0 3.29 0 
SNs S-1,3,4-TrN External 0.87 2.314 26 -1.03 0 1.012 319.1 24.828 5.335 0.549 8.614 75 3.768 0.65 210.0 61 0 3.04 0 
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SNs S-1,3,5-TrN External 1.03 2.260 26 -1.03 0 1.012 325.6 28.008 4.401 0.549 6.152 105 3.756 0.33 210.0 62 0 3.15 0 
SNs S-1,3,6-TrN External 0.69 2.318 26 -1.03 0 1.012 336.9 31.193 9.402 0.549 6.903 85 3.738 0.35 210.0 51 0 3.29 0 
SNs S-2,3,4-TrN External 0.80 2.421 26 -1.03 0 1.012 310.0 20.722 2.257 0.549 12.020 85 3.781 0.53 210.0 73 0 2.88 0 
SNs S-2,3,5-TrN External 1.05 2.335 26 -1.03 0 1.012 316.6 18.922 4.166 0.549 10.952 122 3.770 0.54 210.0 74 0 3.02 0 
SNs S-2,3,6-TrN External 0.83 2.297 26 -1.03 0 1.012 325.7 23.187 6.033 0.549 12.855 97 3.759 0.63 210.0 62 0 3.16 0 
SNs S-2,4,5-TrN External 1.05 2.335 26 -1.03 0 1.012 316.6 26.651 2.310 0.549 9.694 122 3.770 0.32 210.0 74 0 3.02 0 
SNs S-2,4,6-TrN External 1.03 2.260 26 -1.03 0 1.012 325.6 23.784 4.973 0.549 6.192 105 3.756 0.21 210.0 62 0 3.15 0 
SNs S-2,5,6-TrN External 0.87 2.318 26 -1.03 0 1.012 327.8 23.464 6.139 0.549 9.725 113 3.750 0.46 210.0 63 0 3.18 0 
SNs S-3,4,5-TrN External 0.80 2.421 26 -1.03 0 1.012 310.0 22.233 2.863 0.549 12.049 85 3.781 0.73 210.0 73 0 2.88 0 
SNs S-3,4,6-TrN External 0.87 2.314 26 -1.03 0 1.012 319.1 23.019 5.276 0.549 9.718 75 3.768 0.66 210.0 61 0 3.04 0 
SNs S-3,5,6-TrN External 0.92 2.335 26 -1.03 0 1.012 321.3 28.640 4.486 0.549 9.418 91 3.760 0.37 210.0 62 0 3.07 0 
SNs S-4,5,6-TrN External 0.72 2.439 26 -1.03 0 1.012 317.2 27.690 6.141 0.549 15.173 57 3.767 0.46 210.0 62 0 2.99 0 
SNs S-1,2-DN External -0.70 2.069 22 -0.28 0 0.992 244.3 26.451 6.297 0.563 4.395 29 3.728 0.37 153.0 29 0 3.00 0 
SNs S-1,3-DN External -0.46 1.941 22 -0.28 0 0.992 244.0 31.356 6.294 0.563 7.979 30 3.731 0.30 153.0 28 0 3.00 0 
SNs S-1,4-DN External -0.46 1.883 22 -0.28 0 0.992 246.4 22.422 5.461 0.563 4.536 43 3.728 0.36 153.0 28 0 3.05 0 
SNs S-1,5-DN External -0.52 1.915 22 -0.28 0 0.992 251.6 24.358 6.308 0.563 4.047 56 3.717 0.31 153.0 29 0 3.15 0 
SNs S-1,6-DN External -0.69 1.915 22 -0.28 0 0.992 259.8 30.341 9.533 0.563 2.779 43 3.697 0.35 153.0 20 0 3.26 0 
SNs S-2,3-DN External -0.54 2.042 22 -0.28 0 0.992 235.8 15.384 2.645 0.563 12.855 32 3.750 0.50 153.0 37 0 2.83 0 
SNs S-2,4-DN External -0.25 1.941 22 -0.28 0 0.992 238.2 16.626 1.912 0.563 6.396 53 3.744 0.18 153.0 37 0 2.89 0 
SNs S-2,5-DN External -0.21 1.915 22 -0.28 0 0.992 243.4 15.288 4.263 0.563 6.261 73 3.733 0.31 153.0 38 0 3.02 0 
SNs S-2,6-DN External -0.52 1.915 22 -0.28 0 0.992 251.6 21.624 6.142 0.563 4.844 56 3.717 0.39 153.0 29 0 3.15 0 
SNs S-3,4-DN External -0.60 2.015 22 -0.28 0 0.992 232.9 15.936 1.960 0.563 9.721 25 3.757 0.59 153.0 36 0 2.73 0 
SNs S-3,5-DN External -0.25 1.941 22 -0.28 0 0.992 238.2 20.282 2.501 0.563 7.062 53 3.744 0.34 153.0 37 0 2.89 0 
SNs S-3,6-DN External -0.46 1.883 22 -0.28 0 0.992 246.4 27.235 6.329 0.563 6.988 43 3.728 0.27 153.0 28 0 3.05 0 
SNs S-4,5-DN External -0.54 2.042 22 -0.28 0 0.992 235.8 23.533 2.321 0.563 8.015 32 3.750 0.43 153.0 37 0 2.83 0 
SNs S-4,6-DN External -0.46 1.941 22 -0.28 0 0.992 244.0 22.512 4.762 0.563 5.666 30 3.731 0.35 153.0 28 0 3.00 0 
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SNs S-5,6-DN External -0.70 2.069 22 -0.28 0 0.992 244.3 23.954 6.298 0.563 6.901 29 3.728 0.27 153.0 29 0 3.00 0 
SNs S-1-MN External -2.18 1.516 18 0.42 0 0.983 173.4 22.530 6.463 0.554 2.751 14 3.675 0.24 105.0 7 0 2.97 0 
SNs S-2-MN External -1.79 1.516 18 0.42 0 0.983 166.4 13.813 2.632 0.554 4.816 16 3.702 0.29 105.0 13 0 2.81 0 
SNs S-3-MN External -1.98 1.468 18 0.42 0 0.983 163.0 21.458 2.701 0.554 6.375 5 3.713 0.20 105.0 12 0 2.67 0 
SNs S-4-MN External -1.98 1.468 18 0.42 0 0.983 163.0 15.226 1.735 0.554 5.795 5 3.713 0.33 105.0 12 0 2.67 0 
SNs S-5-MN External -1.79 1.516 18 0.42 0 0.983 166.4 17.138 2.796 0.554 4.045 16 3.702 0.23 105.0 13 0 2.81 0 
SNs S-6-MN External -2.18 1.516 18 0.42 0 0.983 173.4 23.123 6.458 0.554 2.777 14 3.675 0.22 105.0 7 0 2.97 0 
C3H6O6N6 2,4,6-Trinitro-1,3,5-
triazinane  
External -3.18 1.247 21 -2.65 0 0.835 146.8 4.443 0.449 0.530 5.133 0 3.858 0.00 72.5 102 12 2.56 0 
C3H6O6N6 N,N',N''-Trinitro-1,2,3- 
cyclopropanetriamine  
External -4.56 1.484 21 -1.49 0 0.500 176.7 3.581 1.322 0.530 3.682 0 3.901 0.00 89.9 78 12 2.79 0 
C3H6O6N6 1,3,5-Trinitro-1,2,3-
triazinane  
External -1.27 1.247 21 -2.27 0 0.500 161.0 4.688 0.720 0.592 13.767 0 3.854 0.00 72.5 110 14 2.56 0 
C3H6O6N6 2-(N'-Nitro-N-nitroso- 
carbamimidamido) 
ethyl nitrate  
External -2.14 1.639 17 -1.56 0 0.833 200.6 7.127 3.062 0.772 7.427 20 3.704 0.09 105.0 50 9 3.03 0 
C3H6O6N6 1,2,2-Trinitro-1,3,5-
triazinane  










External 6.09 3.883 68 -5.37 0 0.425 673.6 68.083 12.839 0.433 15.335 4107 4.075 0.70 617.0 1238 12 3.76 0 
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C6H6O6N6 4,5,6-Trinitro-1,2,3-
benzenetriamine 



























External 0.28 2.162 25 -3.62 0 0.551 181.8 10.901 4.229 0.643 6.465 98 3.997 0.23 118.8 204 13 3.03 0 
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Molecular descriptors (20-32 out of 32) 
Av. tRM 
(min) 






























Explosives 1,2-DNB Training -1.436 27.8 0 0.028 1.60 1.433 1 0.000 45.8 0.00 0 106 0 7.96 8.69 0.73 8.68 0.72 
Explosives 1,2-DNG Training -1.457 32.7 0 0.025 0.86 0.724 2 0.000 44.8 0.02 0 92 0 4.42 4.29 -0.13 4.13 -0.29 
Explosives 1,3-DNB Training -1.546 27.2 0 0.020 1.55 1.356 3 0.000 39.5 0.01 0 102 0 9.04 9.43 0.39 9.14 0.10 
Explosives 1-MNG Training 0.000 18.9 0 0.018 -0.43 0.387 1 0.000 21.0 0.01 0 9 0 1.85 2.15 0.30 2.04 0.19 
Explosives 2,4-DA-6-NT Training -1.514 24.4 0 0.020 0.92 1.366 3 0.000 73.1 0.00 0 50 0 3.66 5.06 1.40 5.21 1.55 
Explosives 2,4-DNT Training -1.362 32.9 0 0.022 2.10 1.415 5 0.000 50.7 0.01 0 138 0 11.21 10.08 -1.13 9.45 -1.76 
Explosives 2-Am-4,6-DNT Training -1.024 41.1 0 0.020 1.88 1.352 7 0.000 74.7 0.01 0 178 0 10.67 8.43 -2.24 8.22 -2.45 
Explosives 2-NT Training 0.000 14.1 0 0.027 2.45 1.393 0 0.000 45.8 0.00 0 25 0 10.29 9.17 -1.12 9.18 -1.11 
Explosives 3,4-DNT Training -1.436 33.0 0 0.021 2.15 1.482 4 0.000 50.9 0.06 0 140 0 10.13 9.86 -0.27 9.39 -0.74 
Explosives 3,5-DNA Training -1.469 34.2 0 0.014 1.63 1.314 5 0.000 68.5 0.01 0 136 0 9.26 8.01 -1.25 7.97 -1.29 
Explosives 4-NT Training 0.000 13.4 0 0.021 2.45 1.403 2 0.000 28.8 0.00 0 23 0 10.47 10.04 -0.43 9.76 -0.71 
Explosives DADP Training 0.000 13.5 0 0.018 1.23 0.815 16 0.000 46.8 0.04 0 0 0 8.43 7.80 -0.63 7.61 -0.82 
Explosives DEDPU Training 0.108 30.7 0 0.025 3.26 3.172 3 0.094 167.5 0.18 1 512 0 14.81 13.50 -1.31 12.84 -1.97 
Explosives DMNB Training -1.649 65.4 0 0.029 1.82 0.551 4 0.000 77.9 0.00 0 48 0 7.30 9.24 1.94 9.15 1.85 
Explosives EGDN Training 0.000 16.3 0 0.020 1.51 0.549 1 0.000 19.3 0.00 0 38 0 5.44 5.34 -0.10 5.57 0.13 
Explosives HMDD Training -1.108 10.0 2 0.029 0.00 1.390 1 0.000 71.2 0.01 0 120 8 4.43 2.72 -1.71 2.65 -1.78 
Explosives HMTA Training -1.600 5.7 4 0.018 0.99 1.607 0 0.000 65.3 0.00 0 156 12 1.52 2.65 1.13 2.57 1.05 
Explosives HMTD Training -1.108 13.4 2 0.025 0.13 1.842 1 0.000 87.7 0.03 0 210 12 2.80 3.57 0.77 3.49 0.69 
Explosives HMX Training 1.000 100.2 4 0.019 -1.71 1.602 20 0.250 105.8 0.19 0 2068 8 4.64 3.07 -1.57 3.86 -0.78 
Explosives HNDPA Training 1.610 187.6 0 0.018 4.44 2.479 70 1.035 182.7 0.18 0 6229 0 15.57 16.28 0.71 16.11 0.54 
Explosives MHN Training 2.035 277.9 0 0.012 5.16 1.794 36 0.969 244.4 0.27 0 4958 0 14.55 16.09 1.54 15.53 0.98 
Explosives NB Training 0.000 10.7 0 0.025 1.81 1.340 0 0.000 25.8 0.00 0 15 0 8.00 9.30 1.30 9.38 1.38 
Explosives NG Training 0.771 50.2 0 0.015 2.41 0.562 5 0.125 55.6 0.02 0 326 0 8.97 8.92 -0.05 8.82 -0.16 
Table A. 7: Molec lar descriptors and predicted retention tim s for best ANN and ensemble following forward selection - Part B 
281 
 




Molecular descriptors (20-32 out of 32) 
Av. tRM 
(min) 






























Explosives NM Training 0.000 2.0 0 0.035 0.10 0.178 0 0.000 5.9 0.00 0 0 0 1.85 1.69 -0.16 2.45 0.60 
Explosives PA Training -0.408 63.8 0 0.018 1.75 1.279 11 0.000 81.9 0.01 0 424 0 4.96 5.32 0.36 6.20 1.24 
Explosives PGDN Training 0.000 24.8 0 0.030 1.87 0.661 2 0.000 34.4 0.02 0 60 0 7.50 6.34 -1.16 6.52 -0.99 
Explosives R-Salt Training -1.427 22.2 0 0.027 -1.18 1.060 0 0.000 61.3 0.00 0 189 6 3.54 2.57 -0.97 2.76 -0.79 
Explosives SHN Training 2.035 277.9 0 0.012 5.16 1.536 36 0.969 236.2 0.28 0 4958 0 14.55 16.15 1.60 15.83 1.28 
Explosives TATP Training -1.000 33.2 0 0.012 2.16 0.968 48 0.000 183.3 0.10 0 0 0 11.99 12.44 0.45 11.19 -0.80 
Explosives TEGDN Training 0.484 47.2 0 0.020 1.46 0.823 1 0.094 111.1 0.00 0 284 0 7.61 9.19 1.58 8.76 1.15 
Explosives Tetryl Training 1.000 102.6 0 0.029 1.25 2.130 21 0.125 102.6 0.12 0 1358 0 11.83 10.66 -1.17 10.81 -1.02 
Explosives TMETN Training 0.771 78.0 0 0.016 3.08 0.491 15 0.375 115.1 0.07 0 483 0 11.78 10.90 -0.88 11.15 -0.63 
Explosives TNB Training -0.408 53.0 0 0.014 1.36 1.315 9 0.000 81.0 0.01 0 342 0 9.81 10.06 0.25 9.98 0.16 
Explosives TNT Training -0.408 62.2 0 0.019 1.79 1.359 11 0.000 84.0 0.02 0 424 0 12.25 10.46 -1.79 10.18 -2.07 
Drugs Acebutolol Training 0.580 91.8 0 0.016 1.68 1.905 16 0.365 272.0 0.20 1 279 0 6.38 6.82 0.44 7.27 0.89 
Drugs Acetazolamide Training -1.173 28.5 0 0.039 -0.31 0.320 9 0.000 26.8 0.03 0 49 0 2.15 2.53 0.38 2.25 0.10 
Drugs AICAR Training -0.218 47.8 0 0.018 -2.49 1.970 14 0.247 99.5 0.08 0 252 1 1.42 2.60 1.18 1.86 0.44 
Drugs Alprenolol Training -0.667 39.2 0 0.018 2.78 2.267 5 0.165 144.2 0.15 0 63 0 11.41 7.61 -3.80 7.81 -3.60 
Drugs Altizide Training 0.265 74.8 0 0.036 1.10 0.384 44 0.358 218.3 0.06 1 212 1 6.87 4.98 -1.89 5.55 -1.32 
Drugs Amino-
glutethimide 
Training -0.505 38.1 0 0.021 1.27 2.060 12 0.062 107.1 0.06 0 51 0 4.99 5.44 0.44 6.15 1.16 
Drugs Anastrazole Training 0.077 49.6 0 0.024 2.68 2.749 42 0.339 292.8 0.08 1 653 0 8.02 11.77 3.75 10.57 2.55 
Drugs Bambuterol Training 0.727 101.5 0 0.012 1.50 2.998 52 0.786 555.1 0.22 1 1325 0 8.41 7.26 -1.15 6.61 -1.80 
Drugs Bendro-
flumethiazide 
Training 0.764 97.7 0 0.024 1.49 2.272 105 0.491 210.8 0.17 0 418 1 8.50 7.23 -1.27 7.37 -1.13 
Drugs Benzoylecgonine Training 0.531 46.9 1 0.024 2.29 2.431 15 0.278 126.5 0.10 1 362 0 4.05 5.90 1.85 6.18 2.13 
Drugs Benzthiazide Training 1.000 73.1 0 0.030 1.98 1.582 57 0.408 213.9 0.08 0 383 0 9.39 8.16 -1.23 8.73 -0.66 
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Drugs Beta\dexameth. Training 1.361 110.4 0 0.017 1.92 2.909 143 0.596 231.7 0.38 0 0 0 10.89 11.37 0.48 11.03 0.14 
Drugs Budesonide Training 1.425 91.6 0 0.017 3.02 3.427 123 0.729 387.3 0.37 0 0 1 15.29 13.09 -2.20 12.76 -2.53 
Drugs Bumetanide  Training 0.706 76.5 0 0.026 3.00 3.168 25 0.530 343.8 0.16 1 183 0 6.25 6.96 0.71 7.19 0.94 
Drugs Bumetanide  Training 0.706 76.5 0 0.026 3.00 3.168 25 0.530 343.8 0.16 1 183 0 6.28 6.96 0.68 7.19 0.91 
Drugs Bunolol Training -0.087 50.0 0 0.017 2.57 2.038 25 0.293 139.2 0.15 1 99 0 7.59 7.39 -0.20 7.76 0.17 
Drugs Bupropion Training -1.000 37.8 0 0.031 3.08 1.594 15 0.207 96.6 0.08 0 25 0 9.54 10.96 1.42 10.76 1.22 
Drugs Butizide Training -0.151 71.8 0 0.035 0.79 1.147 56 0.299 144.5 0.11 1 181 1 6.73 5.32 -1.41 5.60 -1.13 
Drugs Canrenone Training 0.988 49.9 0 0.018 2.50 3.212 91 0.411 182.9 0.25 1 0 0 14.71 13.69 -1.02 12.72 -1.99 
Drugs Carteolol Training -0.005 47.2 0 0.018 1.84 2.247 26 0.255 135.6 0.16 1 199 0 4.17 5.27 1.10 5.96 1.79 
Drugs Celiprolol Training 0.744 113.8 0 0.015 2.06 2.549 43 0.564 318.1 0.26 0 932 0 7.66 8.10 0.44 9.38 1.72 
Drugs Chlorexolone Training 0.142 49.9 0 0.033 1.49 1.774 31 0.293 107.7 0.09 1 327 0 9.74 8.81 -0.93 8.37 -1.37 
Drugs Clobenzorex Training -0.502 23.1 0 0.027 4.54 2.966 4 0.177 171.4 0.10 0 75 0 12.70 13.95 1.25 13.50 0.80 
Drugs Clobetasol Training 1.361 108.7 0 0.017 2.74 2.751 143 0.596 226.5 0.41 0 0 0 12.94 12.98 0.04 12.61 -0.33 
Drugs Clopamide Training -0.031 64.0 1 0.033 1.75 1.351 35 0.330 139.0 0.12 1 441 0 6.01 8.85 2.84 8.46 2.45 
Drugs Cyclopenthiazide Training 0.265 66.7 0 0.033 1.52 1.440 56 0.373 217.4 0.09 1 272 1 9.61 7.33 -2.29 7.77 -1.85 
Drugs Danazol Training 0.796 46.7 0 0.021 4.33 3.285 90 0.402 210.7 0.21 0 259 1 16.65 15.83 -0.82 15.54 -1.11 
Drugs Diacetolol Training 0.355 75.5 0 0.014 1.00 1.711 16 0.259 154.1 0.22 1 214 0 3.62 4.98 1.36 5.50 1.88 
Drugs Dichlorphenamide Training -1.000 60.9 0 0.070 0.90 0.099 38 0.000 76.4 0.03 0 0 0 4.19 5.05 0.86 4.85 0.66 
Drugs Efaproxiral Training 0.528 64.1 0 0.017 3.83 3.249 37 0.306 200.3 0.17 0 163 0 7.28 9.98 2.70 10.58 3.30 
Drugs Epitizide Training 0.510 101.8 0 0.035 1.03 0.288 96 0.583 206.3 0.05 0 270 1 6.68 5.15 -1.53 5.60 -1.08 
Drugs Etacr. acid  Training 0.228 63.8 0 0.071 3.38 1.777 12 0.177 91.9 0.19 0 0 0 7.31 5.61 -1.71 6.98 -0.33 
Drugs Etamivan Training -0.778 36.4 0 0.021 1.46 1.674 5 0.181 125.5 0.10 0 109 0 5.75 6.10 0.35 6.49 0.74 
Drugs Famprofazone Training 1.000 51.5 2 0.022 3.76 4.649 26 0.440 354.6 0.37 0 2245 0 17.86 15.83 -2.03 15.63 -2.23 
Drugs Fenbutrazate Training 1.000 52.3 1 0.019 4.48 4.153 13 0.215 373.3 0.22 0 699 0 17.61 15.07 -2.54 15.13 -2.48 
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Drugs Fencamfamin Training -0.954 18.0 0 0.022 3.44 2.868 1 0.043 178.8 0.10 0 62 0 10.22 7.98 -2.24 8.43 -1.79 
Drugs Fludrocortisone Training 1.208 105.4 0 0.017 1.54 2.642 130 0.505 229.8 0.32 0 0 0 9.59 10.32 0.73 10.53 0.94 
Drugs Flumethasone Training 1.418 128.1 0 0.017 1.74 2.983 161 0.658 264.7 0.36 0 0 0 11.13 11.46 0.33 10.78 -0.35 
Drugs Formoterol Training 0.807 61.3 0 0.022 1.61 3.061 17 0.321 353.5 0.15 1 368 0 7.71 6.81 -0.90 7.26 -0.45 
Drugs FPCAM Training 1.427 145.8 0 0.016 2.58 3.084 182 0.842 370.0 0.35 0 0 0 10.79 9.49 -1.30 9.72 -1.07 
Drugs Fulvestrant Training 1.859 149.3 0 0.017 7.56 2.737 153 0.652 535.4 0.51 0 0 0 18.08 16.76 -1.32 17.80 -0.28 
Drugs Furosemide Training 0.414 59.0 0 0.031 2.35 1.677 26 0.265 113.5 0.07 1 114 1 3.36 3.99 0.63 4.56 1.20 
Drugs Hydroflumeth. Training 0.214 76.1 0 0.026 0.24 0.630 77 0.167 102.3 0.11 0 175 2 2.63 2.87 0.24 2.97 0.34 
Drugs Labetalol Training 0.484 63.9 0 0.026 2.74 3.199 16 0.224 166.9 0.16 1 165 0 9.84 10.05 0.21 9.83 -0.02 
Drugs Mefruside Training 0.121 83.6 1 0.030 1.67 1.154 81 0.163 205.6 0.09 1 402 0 9.61 7.20 -2.41 6.72 -2.89 
Drugs Metoprolol Training -0.437 42.0 0 0.019 1.85 2.201 6 0.224 105.8 0.17 1 75 0 7.27 6.72 -0.55 6.55 -0.72 
Drugs Nadoxolol Training -0.111 34.2 0 0.019 1.65 2.440 6 0.200 109.0 0.06 1 99 0 9.26 8.06 -1.20 7.42 -1.84 
Drugs Nikethamide Training -1.344 19.8 0 0.028 0.54 1.797 0 0.056 75.9 0.07 0 75 0 3.61 6.02 2.41 5.92 2.31 
Drugs Ostarine Training 1.286 140.8 0 0.015 3.26 3.182 91 0.776 197.7 0.23 0 1567 0 13.34 14.21 0.87 12.97 -0.37 
Drugs Oxprenolol Training -0.522 42.6 0 0.015 2.29 1.749 5 0.193 174.4 0.14 1 75 0 9.46 6.68 -2.78 6.46 -3.00 
Drugs Oxycodone Training 0.829 47.1 1 0.024 0.91 2.054 50 0.171 228.0 0.07 1 589 0 4.60 4.29 -0.31 4.70 0.10 
Drugs Oxymorphone Training 0.712 48.2 1 0.018 1.01 2.140 50 0.087 210.8 0.05 1 529 0 2.94 4.18 1.24 4.47 1.53 
Drugs Pemoline Training -1.000 15.7 0 0.031 0.50 2.174 1 0.028 49.0 0.01 0 19 0 3.15 4.53 1.38 4.52 1.37 
Drugs Pentazocine Training 0.082 33.3 1 0.023 3.80 1.494 28 0.311 199.7 0.16 0 353 0 8.59 10.54 1.95 11.34 2.75 
Drugs Pentetrazol Training -1.915 7.8 0 0.028 0.22 1.355 0 0.000 50.4 0.00 0 58 0 2.86 4.91 2.05 5.17 2.31 
Drugs Phendimetrazine Training -1.085 15.4 1 0.030 1.91 2.125 1 0.028 91.5 0.07 0 102 0 6.32 7.46 1.14 7.10 0.78 
Drugs Polythiazide Training 0.816 110.2 1 0.035 1.59 0.414 107 0.583 276.5 0.08 0 628 1 8.84 6.34 -2.50 6.32 -2.52 
Drugs Prenylamine Training 1.000 33.8 0 0.020 5.40 4.189 6 0.241 329.9 0.13 0 204 0 15.88 15.75 -0.13 15.83 -0.05 
Drugs Probenecid Training -0.287 69.2 1 0.018 3.05 1.424 12 0.212 189.5 0.05 1 183 0 5.30 6.26 0.96 6.69 1.39 
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Drugs Prolintane Training -1.000 18.6 1 0.023 4.35 2.100 1 0.087 137.2 0.14 0 144 0 9.25 9.20 -0.05 9.24 -0.01 
Drugs Propranolol Training -0.618 30.8 0 0.020 3.26 2.480 7 0.168 107.9 0.17 1 86 0 11.61 9.53 -2.08 9.07 -2.54 
Drugs Propylhexedrine Training -2.000 13.6 0 0.031 2.72 0.938 0 0.028 82.8 0.06 0 13 0 8.76 7.62 -1.14 8.28 -0.48 
Drugs Sotalol Training -0.768 54.0 0 0.016 0.29 2.106 18 0.247 91.0 0.17 1 102 0 2.91 3.53 0.62 3.77 0.86 
Drugs Strychnine Training 1.116 35.1 1 0.019 1.62 4.210 51 0.102 247.0 0.12 1 1535 0 8.14 8.25 0.11 7.64 -0.50 
Drugs Tapentadol Training -0.864 30.7 1 0.021 2.64 1.799 5 0.128 191.3 0.10 0 163 0 7.33 7.18 -0.15 7.82 0.49 
Drugs Testolactone Training 0.655 43.3 0 0.020 3.07 2.442 53 0.255 167.0 0.16 1 0 0 9.17 12.34 3.17 12.00 2.83 
Drugs Timolol Training -0.275 39.7 0 0.019 1.53 1.721 19 0.240 145.4 0.12 1 650 0 7.95 7.13 -0.82 7.53 -0.42 
Drugs Tramadol Training -0.362 38.1 1 0.024 2.54 2.022 11 0.172 179.7 0.11 1 308 0 7.12 6.47 -0.65 7.07 -0.05 
Drugs Triamterene Training -0.345 22.7 0 0.034 1.20 2.535 11 0.137 95.0 0.03 0 348 0 6.56 6.34 -0.22 7.09 0.53 
Drugs Trichlor-
methiazide 
Training 0.075 67.8 0 0.036 0.76 -0.150 56 0.233 98.6 0.06 0 156 2 4.92 3.84 -1.08 4.67 -0.25 
Drugs Xipamide Training 0.106 74.0 0 0.030 2.88 1.788 43 0.352 172.1 0.03 1 130 0 5.01 8.36 3.35 8.06 3.05 
Explosives 2,6-DA-4-NT Select -1.545 24.0 0 0.020 0.92 1.330 4 0.000 64.6 0.01 0 48 0 3.16 5.64 2.48 5.67 2.51 
Explosives 2,6-DNT Select -1.312 33.7 0 0.021 2.10 1.400 3 0.000 59.6 0.00 0 140 0 11.04 9.63 -1.41 9.20 -1.84 
Explosives DPA Select -1.175 9.7 0 0.036 3.12 2.087 0 0.049 52.5 0.02 0 22 0 13.97 13.27 -0.70 12.91 -1.06 
Explosives ETN Select 1.000 103.9 0 0.013 3.21 0.836 12 0.312 101.0 0.12 0 1092 0 11.60 12.84 1.24 12.27 0.67 
Explosives NQ Select 0.000 8.5 0 0.029 -0.98 0.420 0 0.000 13.2 0.00 0 0 0 1.49 0.90 -0.59 0.24 -1.25 
Explosives PETN Select 1.000 119.4 0 0.016 3.64 0.518 22 0.750 196.0 0.08 0 1248 0 12.39 10.48 -1.91 10.75 -1.64 
Drugs 6-MAM Select 0.836 42.2 1 0.017 1.44 2.667 46 0.390 198.9 0.11 1 653 0 4.45 6.23 1.78 6.25 1.80 
Drugs Andarine Select 1.286 140.8 0 0.015 3.26 3.182 91 0.776 197.7 0.23 0 1567 0 12.40 14.21 1.81 12.97 0.57 
Drugs Atenolol Select -0.332 50.0 0 0.019 0.24 2.134 9 0.227 89.5 0.18 1 74 0 2.73 3.70 0.97 3.84 1.11 
Drugs Carvedilol Select 1.271 47.0 0 0.028 4.06 3.971 18 0.333 328.3 0.23 0 688 0 13.30 13.77 0.47 13.73 0.43 
Drugs Chlorothiazide Select -0.867 46.8 0 0.039 -0.02 0.527 36 0.083 71.2 0.08 0 106 0 2.08 3.85 1.77 3.89 1.81 
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Drugs Chlorthalidone Select 0.514 59.4 0 0.032 0.41 2.765 52 0.575 165.5 0.05 1 114 0 4.91 5.33 0.42 5.49 0.58 
Drugs Desacetyl 
deflazacort 
Select 1.425 81.1 0 0.016 1.84 3.630 123 0.623 273.1 0.38 0 288 0 10.85 11.31 0.46 11.05 0.20 
Drugs Fenfluramine Select -0.492 42.0 0 0.026 3.34 1.898 9 0.137 124.4 0.03 0 39 0 9.29 8.09 -1.20 8.64 -0.65 
Drugs Fluticasone prop. Select 1.790 164.2 0 0.016 3.71 2.407 182 0.979 360.3 0.52 0 0 2 16.21 15.33 -0.88 14.55 -1.66 
Drugs Hydrochloroth. Select -0.869 47.9 0 0.039 0.01 0.322 36 0.083 75.5 0.07 0 106 2 2.13 3.55 1.42 3.72 1.59 
Drugs Isometheptene Select 0.000 15.8 0 0.033 2.99 0.641 1 0.000 64.8 0.05 0 5 0 6.99 6.74 -0.25 7.29 0.30 
Drugs Mefenorex Select -1.000 19.3 0 0.030 3.51 1.787 0 0.043 134.7 0.05 0 27 0 8.50 9.04 0.54 9.27 0.77 
Drugs Methyl-
prednisolone 
Select 1.119 89.2 0 0.018 1.97 2.563 111 0.536 250.1 0.35 0 0 0 11.44 11.02 -0.42 11.42 -0.02 
Drugs Pethidine Select -0.569 33.5 1 0.021 2.45 1.969 6 0.149 217.3 0.08 0 242 0 8.41 8.01 -0.40 8.09 -0.32 
Drugs Terbutaline Select -1.000 44.7 0 0.020 0.52 1.649 18 0.300 106.3 0.07 0 32 0 2.83 3.40 0.57 3.73 0.90 
Drugs Triamcinolone Select 1.398 113.2 0 0.017 0.92 2.849 143 0.596 241.6 0.33 0 0 0 7.24 8.37 1.13 8.58 1.34 
Explosives 1,3-DNG Test -1.476 32.1 0 0.013 0.97 0.431 3 0.125 24.4 0.03 0 90 0 4.02 4.40 0.38 4.47 0.45 
Explosives 3-NT Test 0.000 13.6 0 0.026 2.45 1.345 1 0.000 39.4 0.00 0 23 0 10.90 9.11 -1.79 9.21 -1.69 
Explosives 4-Am-2,6-DNT Test -1.104 41.5 0 0.019 1.88 1.352 6 0.000 82.5 0.01 0 180 0 10.30 7.94 -2.36 7.96 -2.34 
Explosives DMDPU Test -0.610 24.4 0 0.022 2.55 2.301 3 0.063 109.2 0.14 0 412 0 12.40 11.51 -0.89 11.29 -1.11 
Explosives PYX Test 2.591 291.0 0 0.013 7.04 4.372 160 1.608 468.9 0.29 0 21069 0 16.90 16.78 -0.12 18.08 1.18 
Explosives RDX Test -0.222 51.9 3 0.021 -1.20 1.120 9 0.000 88.4 0.06 0 597 6 5.95 4.00 -1.95 4.04 -1.91 
Explosives TATB Test 0.619 80.1 0 0.014 2.93 2.017 15 0.000 122.8 0.17 0 615 0 9.40 11.72 2.32 11.92 2.52 
Drugs Amiloride Test -0.991 29.4 0 0.036 1.58 1.231 8 0.118 50.2 0.06 0 78 0 3.63 3.63 0.00 4.53 0.90 
Drugs Beclomethasone Test 1.369 101.1 0 0.018 2.25 2.431 143 0.596 233.1 0.42 0 0 0 11.50 12.45 0.95 12.03 0.53 
Drugs Betaxolol Test 0.265 43.1 0 0.016 2.87 2.161 10 0.259 144.3 0.22 1 131 0 11.60 10.21 -1.39 9.67 -1.93 
Drugs Bisoprolol Test 0.512 61.9 0 0.016 2.21 2.620 10 0.302 210.2 0.23 1 132 0 9.59 8.68 -0.91 8.43 -1.16 
286 
 




Molecular descriptors (20-32 out of 32) 
Av. tRM 
(min) 






























Drugs Carphedon Test -0.505 29.7 0 0.029 0.31 2.145 5 0.134 81.7 0.04 0 140 0 5.16 4.10 -1.06 4.65 -0.51 
Drugs Deflazacort Test 1.857 93.8 0 0.015 2.43 3.762 144 0.896 315.5 0.44 0 365 0 13.60 13.50 -0.10 12.71 -0.89 
Drugs Desonide Test 1.425 88.5 0 0.016 2.79 3.097 175 0.707 305.1 0.41 0 0 0 12.50 12.94 0.44 12.19 -0.31 
Drugs Esmolol Test 0.252 58.0 0 0.016 2.02 2.016 10 0.299 108.1 0.21 1 101 0 8.36 7.31 -1.05 7.40 -0.96 
Drugs Fenetylline Test 1.013 49.2 0 0.025 2.20 3.974 20 0.293 275.9 0.12 1 2120 0 9.46 9.68 0.22 9.53 0.06 
Drugs Gestrinone Test 0.673 48.0 0 0.019 3.26 2.784 46 0.365 193.9 0.20 0 0 1 14.00 13.14 -0.86 13.15 -0.85 
Drugs Norfenfluramine Test -1.000 35.6 0 0.027 2.78 1.803 9 0.000 72.4 0.05 0 0 0 8.60 8.17 -0.43 8.01 -0.59 
Drugs Phenmetrazine Test -1.177 13.4 0 0.029 1.67 1.959 0 0.000 75.9 0.04 0 26 0 5.19 5.43 0.24 5.68 0.49 
Drugs Pindolol Test -0.656 28.1 0 0.024 1.86 2.188 7 0.184 95.1 0.17 0 148 1 4.86 5.13 0.27 5.92 1.06 
Drugs Piretanide Test 0.744 62.0 0 0.022 2.80 3.527 33 0.513 316.4 0.15 1 567 0 5.12 7.46 2.34 7.40 2.28 
Drugs Salmeterol Test 1.000 86.0 0 0.017 3.90 3.131 7 0.149 173.1 0.36 0 320 0 15.60 15.43 -0.17 15.61 0.01 
OGSR 2,4-DNDPA External 0.424 43.3 0 0.030 3.76 2.976 9 0.240 86.9 0.04 0 650 0 16.58 13.94 -2.64 13.87 -2.71 
OGSR 2-NDPA External -0.766 23.2 0 0.032 3.58 2.937 2 0.115 80.0 0.02 0 225 0 16.43 14.76 -1.67 14.37 -2.06 
OGSR 4,4'-DNDPA External 0.401 38.9 0 0.028 3.78 2.516 12 0.299 73.1 0.04 0 647 0 14.87 14.05 -0.82 13.97 -0.90 
OGSR 4-NDPA External -0.950 21.8 0 0.035 3.36 2.281 4 0.174 60.6 0.03 0 222 0 14.19 14.53 0.34 14.22 0.03 
OGSR Dimethyl 
phthalate 
External -0.869 27.4 0 0.037 1.88 1.506 1 0.000 118.1 0.03 0 0 0 7.38 7.91 0.53 7.50 0.12 
OGSR N-nitroso-DPA External -1.000 16.2 0 0.035 3.03 2.292 0 0.049 69.7 0.01 0 156 0 13.45 14.27 0.82 14.04 0.59 
MEKPs MEKP CP di. External -1.486 20.9 0 0.030 2.08 0.989 16 0.000 82.1 0.03 0 0 0 - 11.16 - 10.29 - 
MEKPs MEKP CP tet. External 0.437 94.2 0 0.022 4.50 2.479 96 0.535 412.0 0.12 0 0 0 - 16.37 - 16.14 - 
MEKPs MEKP CP tri. External -0.673 50.7 0 0.027 3.44 0.998 48 0.000 246.8 0.12 0 0 0 - 15.54 - 14.72 - 
MEKPs MEKP DHP di. External -1.345 58.5 0 0.026 3.19 0.568 16 0.000 121.4 0.05 0 0 0 - 13.28 - 12.11 - 
MEKPs MEKP DHP mon. External 0.000 16.9 0 0.037 1.33 0.416 0 0.000 51.1 0.01 0 0 0 - 4.15 - 4.79 - 
MEKPs MEKP DHP pent. External 0.740 337.8 0 0.017 8.28 0.831 160 0.781 528.2 0.28 0 0 0 - 16.76 - 17.64 - 
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MEKPs MEKP DHP tet. External 0.425 218.6 0 0.017 6.65 0.696 96 0.531 375.7 0.24 0 0 0 - 16.63 - 17.19 - 
MEKPs MEKP DHP tri. External -0.432 125.6 0 0.021 4.91 1.107 48 0.281 308.1 0.14 0 0 0 - 15.20 - 14.62 - 
MNs M-1,2,3,4,5-PN External 1.720 227.41 0 0.017 3.74 1.598 27 0.719 226.7 0.22 0 3143 0 - 14.25 - 13.06 - 
MNs M-1,2,3,4,6-PN External 1.894 223.7 0 0.012 3.79 1.467 28 0.750 210.7 0.22 0 3141 0 - 14.06 - 13.03 - 
MNs M-1,2,3,5,6-PN External 1.894 222.5 0 0.013 3.74 1.712 28 0.656 184.6 0.21 0 3141 0 - 14.53 - 13.33 - 
MNs M-1,2,3,4-TN External 1.366 180.5 0 0.013 2.28 1.391 20 0.500 191.2 0.20 0 1830 0 - 12.40 - 11.39 - 
MNs M-1,2,3,5-TN External 1.502 179.5 0 0.017 2.35 1.256 20 0.531 157.6 0.17 0 1830 0 - 11.87 - 11.26 - 
MNs M-1,2,4,5-TN External 1.390 179.3 0 0.017 2.60 1.239 20 0.469 178.0 0.18 0 1830 0 - 12.76 - 12.01 - 
MNs M-1,3,4,5-TN External 1.442 180.1 0 0.018 2.57 1.108 20 0.469 191.4 0.17 0 1830 0 - 12.35 - 11.67 - 
MNs M-2,3,4,5-TN External 1.472 183.0 0 0.018 2.32 1.264 19 0.437 218.9 0.17 0 1832 0 - 12.67 - 11.72 - 
MNs M-1,2,3,6-TN External 1.464 176.5 0 0.012 2.32 1.137 21 0.438 123.8 0.22 0 1828 0 - 11.97 - 11.66 - 
MNs M-1,2,4,6-TN  External 1.361 176.4 0 0.015 2.60 1.377 21 0.563 157.2 0.16 0 1828 0 - 12.14 - 11.69 - 
MNs M-1,3,4,6-TN External 1.390 177.2 0 0.013 2.73 0.994 21 0.594 177.0 0.17 0 1828 0 - 12.69 - 11.91 - 
MNs M-1,2,5,6-TN External 1.353 175.5 0 0.013 2.28 1.348 21 0.344 126.8 0.17 0 1828 0 - 12.24 - 11.53 - 
MNs M-1,2,3-TriN External 1.000 139.9 0 0.013 0.72 1.008 14 0.312 120.3 0.18 0 940 0 - 7.33 - 7.63 - 
MNs M-1,2,4-TriN External 1.000 139.7 0 0.015 0.92 1.235 14 0.375 149.1 0.13 0 940 0 - 7.33 - 7.52 - 
MNs M-1,3,4-TriN External 1.000 140.1 0 0.013 0.87 0.930 14 0.312 156.0 0.15 0 940 0 - 7.80 - 7.65 - 
MNs M-2,3,4-TriN External 1.000 142.4 0 0.018 0.80 1.052 13 0.187 183.7 0.14 0 942 0 - 7.72 - 7.53 - 
MNs M-1,2,6-TriN External 1.000 136.7 0 0.014 0.69 1.188 15 0.250 90.1 0.15 0 938 0 - 7.27 - 7.63 - 
MNs M-1,3,6-TriN  External 1.000 137.2 0 0.013 0.91 1.245 15 0.406 87.1 0.18 0 938 0 - 7.21 - 7.96 - 
SNs S-2,3,4,5,6-PN External 1.720 227.4 0 0.016 3.74 1.330 27 0.719 224.9 0.24 0 3143 0 - 13.81 - 12.90 - 
SNs S-1,3,4,5,6-PN External 1.894 223.7 0 0.014 3.79 1.290 28 0.750 204.7 0.24 0 3141 0 - 13.84 - 13.00 - 
SNs S-1,2,4,5,6-PN External 1.894 222.5 0 0.014 3.74 1.405 28 0.656 180.5 0.24 0 3141 0 - 14.1 - 13.36 - 
SNs S-1,2,3,5,6-PN External 1.894 222.5 0 0.012 3.74 1.755 28 0.656 158.5 0.28 0 3141 0 - 14.27 - 13.42 - 
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SNs S-1,2,3,4,6-PN External 1.894 223.7 0 0.012 3.79 1.442 28 0.750 202.1 0.28 0 3141 0 - 14.29 - 13.40 - 
SNs S-1,2,3,4,5-PN External 1.720 227.4 0 0.017 3.74 1.764 27 0.719 225.7 0.20 0 3143 0 - 14.29 - 13.21 - 
SNs S-3,4,5,6-TN External 1.366 180.5 0 0.013 2.28 1.357 20 0.500 184.3 0.26 0 1830 0 - 12.77 - 11.89 - 
SNs S-2,4,5,6-TN External 1.502 179.5 0 0.015 2.35 1.622 20 0.531 156.6 0.24 0 1830 0 - 12.46 - 11.77 - 
SNs S-2,3,5,6-TN External 1.390 179.3 0 0.016 2.60 1.404 20 0.469 172.0 0.16 0 1830 0 - 12.87 - 12.23 - 
SNs S-2,3,4,6-TN External 1.442 180.1 0 0.020 2.57 1.258 20 0.469 181.7 0.21 0 1830 0 - 12.34 - 11.61 - 
SNs S-2,3,4,5-TN External 1.472 183.0 0 0.019 2.32 1.333 19 0.437 219.9 0.22 0 1832 0 - 12.13 - 11.40 - 
SNs S-1,4,5,6-TN External 1.464 176.5 0 0.012 2.32 1.354 21 0.438 126.5 0.22 0 1828 0 - 12.48 - 11.84 - 
SNs S-1,3,5,6-TN External 1.361 176.4 0 0.015 2.60 1.472 21 0.563 156.0 0.15 0 1828 0 - 11.86 - 11.59 - 
SNs S-1,3,4,6-TN External 1.390 177.2 0 0.013 2.73 1.172 21 0.594 166.6 0.22 0 1828 0 - 12.66 - 11.98 - 
SNs S-1,3,4,5-TN External 1.442 180.1 0 0.016 2.57 1.182 20 0.469 193.5 0.22 0 1830 0 - 12.49 - 11.76 - 
SNs S-1,2,5,6-TN External 1.353 175.5 0 0.017 2.28 1.300 21 0.344 154.8 0.20 0 1828 0 - 11.87 - 11.23 - 
SNs S-1,2,4,6-TN External 1.361 176.4 0 0.016 2.60 0.975 21 0.563 154.6 0.16 0 1828 0 - 11.66 - 11.42 - 
SNs S-1,2,4,5-TN External 1.390 179.3 0 0.016 2.60 1.012 20 0.469 172.5 0.16 0 1830 0 - 11.78 - 11.50 - 
SNs S-1,2,3,6-TN External 1.464 176.5 0 0.013 2.32 1.377 21 0.438 124.3 0.25 0 1828 0 - 12.09 - 11.75 - 
SNs S-1,2,3,5-TN External 1.502 179.5 0 0.016 2.35 1.347 20 0.531 150.9 0.21 0 1830 0 - 11.91 - 11.45 - 
SNs S-1,2,3,4-TN External 1.366 180.5 0 0.014 2.28 1.241 20 0.500 181.6 0.22 0 1830 0 - 12.1 - 11.36 - 
SNs S-1,2,3-TrN External 1.000 139.9 0 0.012 0.72 1.245 14 0.312 119.8 0.21 0 940 0 - 7.51 - 7.76 - 
SNs S-1,2,4-TrN External 1.000 139.7 0 0.016 0.92 0.920 14 0.375 134.4 0.14 0 940 0 - 7.03 - 7.42 - 
SNs S-1,2,5-TrN External 1.000 138.9 0 0.017 0.87 0.886 14 0.281 116.1 0.17 0 940 0 - 7.14 - 7.52 - 
SNs S-1,2,6-TrN External 1.000 136.7 0 0.015 0.69 0.909 15 0.250 84.1 0.18 0 938 0 - 6.87 - 7.51 - 
SNs S-1,3,4-TrN External 1.000 140.1 0 0.013 0.87 1.088 14 0.312 146.9 0.20 0 940 0 - 7.76 - 7.77 - 
SNs S-1,3,5-TrN External 1.000 139.5 0 0.017 1.03 0.891 14 0.406 156.0 0.12 0 940 0 - 6.82 - 7.35 - 
SNs S-1,3,6-TrN External 1.000 136.7 0 0.015 0.69 1.218 15 0.250 89.0 0.15 0 938 0 - 7.02 - 7.48 - 
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SNs S-2,3,4-TrN External 1.000 142.4 0 0.021 0.80 1.220 13 0.187 176.8 0.19 0 942 0 - 7.54 - 7.39 - 
SNs S-2,3,5-TrN External 1.000 141.7 0 0.018 1.05 1.244 13 0.312 146.0 0.18 0 942 0 - 8.15 - 7.89 - 
SNs S-2,3,6-TrN External 1.000 139.4 0 0.017 0.83 1.291 14 0.219 125.9 0.22 0 940 0 - 7.94 - 7.93 - 
SNs S-2,4,5-TrN External 1.000 141.7 0 0.021 1.05 1.000 13 0.312 175.5 0.12 0 942 0 - 6.97 - 7.36 - 
SNs S-2,4,6-TrN External 1.000 139.5 0 0.022 1.03 0.933 14 0.406 141.8 0.12 0 940 0 - 6.82 - 7.21 - 
SNs S-2,5,6-TrN External 1.000 138.9 0 0.017 0.87 1.188 14 0.281 121.7 0.16 0 940 0 - 7.60 - 7.67 - 
SNs S-3,4,5-TrN External 1.000 142.4 0 0.016 0.80 1.119 13 0.187 186.2 0.21 0 942 0 - 8.06 - 7.74 - 
SNs S-3,4,6-TrN External 1.000 140.1 0 0.013 0.87 1.092 14 0.312 145.4 0.21 0 940 0 - 7.93 - 7.83 - 
SNs S-3,5,6-TrN External 1.000 139.7 0 0.015 0.92 1.302 14 0.375 144.6 0.13 0 940 0 - 7.03 - 7.43 - 
SNs S-4,5,6-TrN External 1.000 139.9 0 0.013 0.72 1.187 14 0.312 122.2 0.18 0 940 0 - 7.78 - 7.84 - 
SNs S-1,2-DN External 0.898 105.7 0 0.015 -0.70 0.759 9 0.187 81.0 0.15 0 392 0 - 3.90 - 4.37 - 
SNs S-1,3-DN External 0.825 106.0 0 0.013 -0.46 1.082 9 0.250 82.6 0.14 0 392 0 - 3.93 - 4.61 - 
SNs S-1,4-DN External 0.750 105.9 0 0.015 -0.46 0.797 9 0.187 105.4 0.14 0 392 0 - 4.04 - 4.44 - 
SNs S-1,5-DN External 0.707 105.4 0 0.019 -0.52 0.748 9 0.156 86.3 0.11 0 392 0 - 3.90 - 4.34 - 
SNs S-1,6-DN External 0.605 103.7 0 0.014 -0.69 0.792 10 0.219 53.0 0.13 0 390 0 - 3.85 - 4.39 - 
SNs S-2,3-DN External 0.915 107.7 0 0.018 -0.54 1.133 8 0.062 120.1 0.19 0 394 0 - 4.50 - 4.69 - 
SNs S-2,4-DN External 0.828 107.6 0 0.022 -0.25 0.888 8 0.187 132.9 0.10 0 394 0 - 3.99 - 4.27 - 
SNs S-2,5-DN External 0.750 107.1 0 0.018 -0.21 0.765 8 0.187 110.5 0.12 0 394 0 - 4.43 - 4.65 - 
SNs S-2,6-DN External 0.707 105.4 0 0.020 -0.52 0.806 9 0.156 85.7 0.14 0 392 0 - 4.03 - 4.41 - 
SNs S-3,4-DN External 0.926 108.0 0 0.012 -0.60 1.010 8 0.000 138.9 0.18 0 394 0 - 4.51 - 4.61 - 
SNs S-3,5-DN External 0.828 107.6 0 0.018 -0.25 0.830 8 0.187 141.5 0.11 0 394 0 - 4.17 - 4.52 - 
SNs S-3,6-DN External 0.750 105.9 0 0.015 -0.46 1.076 9 0.187 82.8 0.16 0 392 0 - 3.95 - 4.53 - 
SNs S-4,5-DN External 0.915 107.7 0 0.017 -0.54 0.822 8 0.062 143.0 0.12 0 394 0 - 4.04 - 4.41 - 
SNs S-4,6-DN External 0.825 106.0 0 0.014 -0.46 0.776 9 0.250 110.7 0.13 0 392 0 - 4.04 - 4.45 - 
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SNs S-5,6-DN External 0.898 105.7 0 0.015 -0.70 1.071 9 0.187 86.1 0.12 0 392 0 - 3.97 - 4.32 - 
SNs S-1-MN External -0.817 77.5 0 0.015 -2.18 0.629 5 0.125 50.3 0.10 0 105 0 - 2.53 - 1.91 - 
SNs S-2-MN External -0.861 78.7 0 0.021 -1.79 0.633 4 0.062 81.0 0.10 0 107 0 - 2.66 - 2.08 - 
SNs S-3-MN External -0.823 79.0 0 0.015 -1.98 0.881 4 0.000 79.9 0.12 0 107 0 - 2.56 - 2.01 - 
SNs S-4-MN External -0.823 79.0 0 0.013 -1.98 0.705 4 0.000 100.3 0.11 0 107 0 - 2.66 - 2.04 - 
SNs S-5-MN External -0.861 78.7 0 0.021 -1.79 0.570 4 0.062 81.5 0.08 0 107 0 - 2.59 - 2.02 - 

















) ethyl nitrate  




External -0.445 50.7 1 0.024 0.63 1.159 3 0.000 70.8 0.00 0 461 4 - 5.01 - 5.23 - 
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External 0.530 74.2 0 0.014 -0.63 1.483 3 0.000 134.2 0.08 0 450 0 - 3.32 - 3.39 - 
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External 0.206 73.7 0 0.019 -4.24 1.688 16 0.187 46.4 0.07 0 402 0 - 1.88 - 0.13 - 
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